Yaya tsawon lokacin da wadannan alamun suka kasance?
Kuma musamman ma a shekarunku, duk wani ciwon kirji ana bi da shi ta wannan hanyar.
Kuma yana da rashin lafiya.
Kuma za su duba yawan cholesterol da kuma hawan jini.
Shin kuna da zazzabi yanzu?
Shin har yanzu kuna da ciwon kirji?
Kuma banda haka, kuna da wahalar numfashi?
Kuma ku gaya musu abin da sauran alamun cutar suke nunawa.
Kuma yaya zafin jikinka ya tashi?
Ni / Ni ma na yi mummunan rauni.
Kuma na ɗan sami sanyi da tari.
Kuma a yau, ina da mummunan ciwon kirji.
Kuma wannan ba shine lokacin da kuke da ciwon hayfeba ba?
Kuma hakan ya sa na ji ciwon kirji.
Kuma ina ganin ina da zazzabi.
Kuma ina so ku gaya mini inda bugun zuciya yake.
Kuma wasu daga cikinsu suna da zazzaɓi.
Kuma kana da tarihin ciwon sukari.
Kuma kuma, kun san, idan na yi rauni, sai na ji kamar ba a so ni.
Kuma mutane suna ta yi min ba'a a duk lokacin.
Kuma kana da bugun zuciya.
Kuma ya ce kana da matsin lamba a cikin kirjinka.
Shin wani a cikin iyalinku yana da matsalar zuciya, cututtukan zuciya, ciwon zuciya, hawan cholesterol, hawan jini?
Shin kun lura da wasu alamun ko matsaloli kamar yadda ciwon tsoka yake?
Shin akwai wani a gida da ke fama da irin wannan ciwo kamar ku?
Kuna da wasu alamun cutar?
Shin kana da matsalar numfashi?
Har yanzu kuna da ciwon kirji?
Domin, wannan shine lokacin mura.
Amma bai kamata mu manta da bugun zuciya ba.
Amma yanzu, matsala mafi muhimmanci ita ce ciwon kirji.
Amma na samu matsala na numfashi.
Amma na san mutane da yawa sun yi tsalle a kaina.
Amma duk wani ciwon kirji da muke da shi, yana bukatar kulawa da kyau.
Amma kana numfashi yadda ya kamata, ko ba haka ba?
Na manta da wannan bugun kirji.
Kana jin kamar wani yana matse ka a ƙirjinka?
Har yanzu ina jin kamar na gaji da numfashi.
Shin suna fama da irin wannan cututtuka?
Shin kana da hawan jini ko kuma wata cuta mai tsanani?
Shin akwai wasu cututtuka na kullum da ke damun lafiyarka kamar ciwon sukari?
Shin akwai wani numfashi da ke tare da bugun zuciya?
Shin kana da hawan jini?
Shin kuna da wahalar numfashi?
Waɗanne alamun cututtuka ne kuka sani yana da su?
Kuna ganin hoton?
Sha ruwa mai yawa a yau.
Amma na yi gwajin ciwon sukari.
Amma yana da halaye iri ɗaya da na samu.
Yaya zafin jikinka yake?
Mene ne hawan jini?
Idan za ku ci gaba da ciwon zazzabi,
Idan muna da maki 102 ko sama da haka,
Kuna tsammanin alamunku da matsalolinku suna buƙatar ƙarin bincike?
Ina da zazzabi jiya.
Ina da ɗan zazzaɓi.
Na yi rashin lafiya jiya.
Ina jin ciwon kirji mai tsanani a nan.
Ina da wahalar numfashi.
Zan aiko muku da hoto.
Ina da ciwon kirji a yau.
Ina da ɗan ciwon kai a yau, kuma ina da ɗan zafin jiki.
Ina tsammanin mura ce.
Ina tsammanin wannan ƙananan mura ne.
Shin kamar wani mutum mai nauyi yana zaune a kan kirjinka ne?
Ya fara da ciwon kai, kuma ya fara da zazzabi kusan lokaci guda.
Ina tsaye a tsakiyar kirji.
Yana kama da matsi a cikin kirji.
Yana cikin ƙirjina.
Wannan shi ne abin da na sanya a tsakiyar kirjina.
Shin a tsakiyar kirjin ne?
Na ji ciwon kirji.
Ina matukar damuwa da wannan bugun kirji.
Ina so in kwatanta wannan bugun kirji kuma in gaya muku.
Kamar hawan jini ko ciwon sukari.
A gabansa, a tsakiyarsa, a wani wuri.
Yanzu za ku iya cin takpirina don zazzabi.
Mary, tsawon kwanaki nawa ne kake fama da wadannan alamun?
Yanzu kun ce kuna da ciwon kirji.
Wani lokaci ina jin ciwon kirji.
To, ban da ciwo, waɗanne alamu kuke da su?
Ko kuwa wani ya hau kirjinka?
Ba su da kyau, suna rashin lafiya, suna tari, suna ciwon kai, kuma suna ciwon tsoka.
Ni, a tsakiyar kirji.
A wannan hoton, ku nuna mini, ina ne yake ciwo?
Idan kana da zazzabi,
To, kuna ganin wasu daga cikin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da wasu daga cikin irin wannan alamun?
Faɗa mini labarin abin da ya sa ka yi baƙin ciki.
Da dare sai na fara samun zazzabi.
Na yi zazzabi na kwana biyu.
Ina da zazzabi tun da daddare.
Ya ce, "Abin da ya fi kyau shi ne, dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan magani na dakunan shan shan magani na dakuna na dakuna.
To, za ku iya gaya mana game da bugun kirjinku?
Ee, na yi bugun jini a gaban jikina, a nan a cikin kirji.
Ee, Ina da ciwon kirji mai tsanani.
Ee, ina da ciwon kirji.
Yaya ciwon kirji yake?
Yaushe ne ciwon kirji ya fara?
Ina kirjinka yake bugawa?
A ina ne kuke jin ciwon kirji?
Kuna jin kamar yana jingina a kirjinku?
Ka sani, ina da ciwon sukari, da ciwon sukari.
Kun ce kuna fama da wannan ciwon kirji.
A tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020, cutar coronavirus (COVID-19) ta karu sosai a cikin ƙasashen Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya.
Shafin na Cigaban Cutar Coronavirus (COVID-19) ya nuna cewa akwai irin wannan yanayin a cikin Tarayyar Turai / Kasashen da ke da iyaka da ke da iyaka da Burtaniya, kuma ya tabbatar da cewa cutar ta COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe, a cikin matakai daban-daban dangane da ƙasa.
Dangane da kwarewar da aka samu a Italiya, ƙasashe, asibitoci da cibiyoyin kulawa mai mahimmanci ya kamata su haɓaka shirye-shiryen su don karuwar masu cutar COVID-19 waɗanda ke buƙatar kulawa ta musamman.
A ranar 31 ga Disamba, 2019, an ba da rahoton bayyanar cutar huhu da ba a san dalilin cutar ba a Wuhan, lardin Hubei, China.
A ranar 9 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Kula da Cututtuka ta China ta ba da rahoton gano wani abu da ke haifar da cutar Novel Coronavirus, wanda yanzu ake kira da mummunar cutar numfashi ta coronavirus 2 (SARS-CoV-2).
Tun daga wannan lokacin, cutar da cutar SARS-CoV-2 ta haifar ana kiranta cutar coronavirus (COVID-19).
A yau, akwai tabbacin cewa kusan kashi 80 cikin 100 na waɗanda ke da cutar COVID-19 sun kamu da cutar huhu, amma ba cutar huhu ba, amma sun kamu da cututtukan numfashi masu sauƙi, kuma mafi yawansu sun warke.
A cikin kusan kashi 14 cikin dari na cutar, COVID-19 ta canza zuwa wani yanayi mai tsanani wanda ke buƙatar asibiti, kuma a cikin sauran kashi 6 cikin dari, an sami mummunan rashin lafiya wanda ke buƙatar kulawa mai mahimmanci.
Yawan mutuwar marasa lafiya da ke asibiti saboda COVID-19 ya kai kashi 4 cikin dari.
A cikin wannan binciken, za mu bincika yanayin yiwuwar yaduwar COVID-19 a cikin ƙasashen EU / EEA da Burtaniya ta ƙasa kuma mu kwatanta su da China da Hubei.
Mun kuma kwatanta adadin masu kamuwa da cutar COVID-19 a yanzu a cikin Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya da kuma adadin masu kamuwa da cutar a Italiya a tsakanin 31 ga Janairu da 15 ga Maris, 2020.
An samu karin kamuwa da cutar COVID-19 a EU/EEA da Birtaniya
Bayan barkewar cutar a China, COVID-19 ya ci gaba da yaduwa zuwa wasu yankuna, kuma cutar ta COVID-19 ta yi tashin gwauron zabi a sauran ƙasashe a duniya.
A ranar 11 ga Maris, 2020, Darakta Janar na Hukumar Lafiya ta Duniya (WHO) ya ayyana COVID-19 a matsayin annoba.
A cewar ma'anar barkewar cutar ta WHO, an tabbatar da farkon cutar COVID-19 a cikin mutanen Turai, kamar yadda aka bayyana a cikin mujallar likitanci ta Eurosurveillance 2020, Spiteri et al., a ranar 5 ga Maris.
An gano mutane uku na farko da suka kamu da cutar a cikin EU/EEA a Faransa a ranar 24 ga Janairu, 2020, wadanda suka dawo daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano cututtukan COVID-19 a cikin kasashe 30 na Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya (UK), tare da samun karuwar masu kamuwa da cutar 39,768 da mutuwar 1,727 tsakanin 31 ga Disamba, 2019, da kuma a cikin Italiya, wanda ya kai mutane 17,750 da suka kamu da cutar tare da mutuwar 1,441.
Samun adadin yaduwar COVID-19 da kuma yawan yaduwar cutar
Cibiyar Kula da Cututtuka ta Turai (ECDC) tana sabunta bayanan COVID-19 kowace rana da karfe 8:00 na safe, daga ma'aikatun kiwon lafiya na ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki, da kuma daga tushen hukuma kamar WHO.
An yi amfani da wannan bayanin don kimanta yiwuwar yanayin COVID-19 a EU/EEA da Burtaniya da kuma kwatanta yanayin ƙasashen da yanayin Italiya.
A matsayin samfurin sake fasalin yanayin COVID-19 na yanzu, mun ƙididdige adadin sake fasalin yanayin COVID-19 a cikin EU / EEA da Burtaniya a cikin kwanaki 14 da sama da haka daga 1 ga Janairu zuwa 15 ga Maris, 2020, kuma muna ɗaukar shi azaman ma'aunin COVID-19.
Mun kuma bayyana adadin masu kamuwa da cutar a kowace kasa a ranar 15 ga Maris, 2020 da karfe 8:00 na safe, idan aka kwatanta da adadin masu kamuwa da cutar a Italiya a tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Yanayin COVID-19 a cikin EU/EEA da UK
A cikin kwanaki 14 da suka gabata, yawan masu kamuwa da cutar COVID-19 a cikin ƙasashen Tarayyar Turai (EU) / EEA da Burtaniya sun yi daidai da yawan masu kamuwa da cutar a lardin Hubei na kasar Sin (Hoto 1).
Idan aka duba duk EU/EEA da Burtaniya, ƙididdigar sake dawowar COVID-19 ta fara tashi a kusan 21 ga Fabrairu, sannan ta yi ƙaruwa sosai a kusan 28 ga Fabrairu, 2020 (a cikin ƙarin bayani).
Wannan ya samo asali ne daga karuwar adadin wadanda suka kamu da cutar a Italiya, wanda ya nuna irin wannan karuwar a cikin cutar COVID-19 a duk ƙasashen Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya (bayanai na gaba).
Hoto na 2 ya kwatanta karuwar adadin cututtukan COVID-19 a cikin EU/EEA da Burtaniya da Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Bayan makonni uku da ƙasa, sauran ƙasashe 15 na Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya sun ba da rahoton adadin adadin waɗanda suka kamu da cutar a Italiya a ranar 15 ga Maris da karfe 8:00 na safe.
Sakamakonmu ya nuna cewa adadin masu kamuwa da COVID-19 yana ƙaruwa cikin sauri a cikin EU / EEA da Burtaniya.
Bayanan da aka lura da su na COVID-19 sun nuna cewa cutar tana karuwa a cikin daidaito a duk ƙasashe.
A cikin ƙasashe, ayyukan lafiyar jama'a na ƙasa suna kan matakai daban-daban, a cikin yanayi daban-daban, kuma duk da bambance-bambance a cikin ƙasashe daban-daban a cikin ƙayyadaddun ƙididdigar cutar da kuma hanyoyin da ake buƙata don zaɓar marasa lafiya don tabbatar da COVID-19, gami da haɗakar gwaji, har yanzu suna ci gaba.
A farkon watan Maris na 2020, likitoci a yankunan da cutar ta bulla a Italiya sun bayyana cewa kusan kashi 10 cikin 100 na marasa lafiya da ke dauke da cutar COVID-19 na bukatar kulawa mai tsanani, kuma kafofin watsa labarai sun bayyana cewa asibitoci da cibiyoyin kulawa mai tsanani a yankunan sun kai matakin karbar marasa lafiya.
A matakin Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA), kashi 6% da 1% na yawan marasa lafiya na COVID-19 da ke asibiti da/ko cibiyoyin kulawa mai tsanani ne kawai ke da damar (ba a bayyana bayanan ba).
Amma, ya kamata a yi bincike a kan su a cikin tsari don ƙarfafa bayanan da ake da su na yanzu, wanda ke mai da hankali kan adadin masu cutar da kuma mutuwar.
Wani bincike da aka gudanar a shekarar 2010-11 ya gano cewa adadin gadaje na kulawar gaggawa da kulawar lokaci-lokaci a Turai ya bambanta sosai daga ƙasa zuwa ƙasa, inda Jamus ke da gadaje 29.2 a kowace mutane 100,000, yayin da Portugal ke da gadaje 4.2 kawai.
Wannan yana nufin cewa suna da albarkatu da yawa kuma ba su da yawa fiye da Italiya (wanda ke da gado 12.5 na kulawa mai mahimmanci da kulawa mai matsakaici a cikin mutane 100,000 a cikin 2010-11).
An haɗa yanayin tunanin da aka tsara wanda ke da alaƙa da wadatar kulawar lafiya a cikin ƙasashen EU / EEA da Burtaniya tare da ƙididdigar sake kamuwa da cutar a cikin marasa lafiya da ke cikin asibiti na COVID-19 waɗanda ke da haɗarin ƙetare &gt; 90% na ƙwayoyin cuta masu saurin kulawa da ke da alaƙa da ƙimar kulawa mai mahimmanci a cikin ƙasashe na EU / EEA da Burtaniya a cikin sabuntawa ta shida na ECDC na Saurin Binciken Hadarin COVID-19.
Saboda cutar tana da yawa a cikin wasu yankuna na EU/EEA da Burtaniya, kuma asibitoci da cibiyoyin kula da gaggawa suna iya kula da ƙididdigar yawan jama'a, ya kamata a samar da bayanai game da barkewar cutar da kuma yawan kulawar gaggawa ga cibiyoyin kula da gaggawa na yankin don ƙididdigar ƙididdiga na matakin 2 (NUTS-2).
Kwarewar Italiya da kuma damar da ake da ita a yanzu a wasu ƙasashe suna nuna cewa annobar COVID-19 tana ci gaba da sauri a cikin EU / EEA da Burtaniya.
Saboda haka, ya kamata kasashe, asibitoci da cibiyoyin kulawa na musamman suyi shiri don sarrafa yaduwar cutar SARS-CoV-2 a yankin da kuma karuwar adadin marasa lafiya na COVID-19 da ke buƙatar kulawa ta musamman, kamar yadda ya faru a yankunan da ke fama da cutar a Italiya.
A cikin rahoton da ECDC ta yi kwanan nan, an nuna cewa, don jinkirta yaduwar SARS-COV-2, ana buƙatar saurin, shiri da kuma ingantaccen tsarin kula da cutar, tare da sauyawa daga hanawa zuwa sauƙaƙa. Idan yawan masu haƙuri ya ƙaru kamar yadda aka zata, rashin shiri na gaba na iya haifar da rashin isasshen lokaci ga masu yanke shawara da asibitoci don fahimtar yanayin cutar da amsawa yadda ya kamata.
A cikin wannan rahoton, an bayyana matakan kiwon lafiya na jama'a don rage lalacewar cutar.
Akwai damar da za a iya ba da ta gajerun lokuta don ƙasashe su ƙara haɓaka ƙoƙarin sarrafa su don rage yaduwar SARS-CoV-2 da rage matsin lamba a kan kiwon lafiya.
Idan ba mu yi nasara ba, tsarin kiwon lafiya na sauran kasashen EU / EEA na iya fuskantar karuwar marasa lafiya da ke buƙatar kulawa mai mahimmanci a cikin kwanaki ko makonni masu zuwa.
Cutar Coronavirus ta 2019 (COVID-19), wacce ke haifar da cutar ta numfashi mai tsanani (SARS-CoV-2), ta kashe mutane sama da 3,000 a China da sauran sassan duniya, kuma ta haifar da bala'i ga bil'adama.
SARS-CoV-2 wanda ya yi kama da kwayar cutar SARS, wanda ya haifar da cutar SARS a cikin dubban mutane a 2003, na iya zama mai cutar daga ɓeraye, yana haifar da halaye iri ɗaya ta hanyar irin wannan ɓangaren.
Koyaya, COVID-19 yana da ƙarancin ƙarfi da ƙarancin mutuwa fiye da SARS, amma yana da saurin yaduwa, yana cutar da tsofaffi fiye da matasa, kuma yana cutar da maza fiye da mata.
A cikin martani ga saurin rubuce-rubuce game da cutar da ke tasowa, an yi ƙoƙari a cikin wannan labarin don samar da cikakken bayani game da abubuwan bincike masu saurin canzawa.
Za mu yi aiki don hada abubuwa kamar nazarin annoba, binciken dalilin cutar, nazarin kwayar cutar, ganewar asali, magani, kimantawa da rigakafin cutar.
Duk da yake akwai tambayoyi da yawa da har yanzu ake bukatar amsa, muna fatan wannan bita zai taimaka wajen fahimtar cutar da kuma kawar da ita.
Bikin bazara da aka yi a ranar 25 ga Janairu, 2020 ya zama abin tunawa ga duk Sinawa waɗanda aka bukaci su zauna a gida tsawon makonni a lokacin hutu da kuma bayan hutu saboda barkewar cutar coronavirus.
A ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya (WHO) ta sanya masa suna SARS-CoV-2, kuma ta sanya sunan cutar da ke da alaƙa da cutar COVID-19 (COVID-19), saboda kwayar cutar ta yi kama da kwayar cutar coronavirus (CoV) da ta haifar da barkewar cutar numfashi mai tsanani (SARS) a 2003.
Cutar ta fara ne a birnin Wuhan na kasar Sin kuma ta yadu cikin sauri a duk fadin kasar Sin da kuma kasashe kusan 50 a duniya.
Ya zuwa ranar 2 ga Maris, 2020, cutar ta haifar da sama da mutane 80,000 da suka kamu da cutar COVID-19, sama da 40,000 aka sallame su daga asibiti, kuma sama da 3,000 sun mutu.
Hukumar Lafiya ta Duniya ta yi gargadin cewa COVID-19 shine babban makiyin jama'a kuma yana iya zama mai ƙarfi fiye da ta'addanci.
Rahoton farko na binciken kwayar cutar bayan warewar marasa lafiya da yawa, kamar yadda aka bayyana a PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), an gabatar da shi ne a ranar 7 ga Janairu, 2020, kuma a cikin watanni biyu, an buga sama da takardu 200 da suka shafi binciken cutar, nazarin annoba, bincike kan dalilin cutar, ganewar asali da magani na COVID-19.
Wannan bita ya yi ƙoƙari ya taƙaita bincike na ci gaba a kan sabon yanki mai saurin canzawa.
A duk lokacin da zai yiwu, za mu gwada COVID-19 da SARS da sauran cututtukan da ke haifar da CoV, da kuma cutar numfashi ta Gabas ta Tsakiya (MERS, annoba da ta barke a shekarar 2012).
Za mu tattauna duk abin da muka sani game da rigakafin cutar da kuma yadda za a iya yin hasashen cutar, da kuma wasu batutuwan da suka rage.
CoVs sune kwayoyin cuta waɗanda ba su da haɗari ga mutane, galibi suna haifar da kimanin kashi 15% na yanayin sanyi na matakin 4.
Amma a wannan karni, mun gano sau biyu cewa mutane suna da cutar coronavirus: SARS-CoV da MERS-CoV, wanda ya fara a China a 2003 da Saudi Arabia a 2012, kuma nan da nan ya bazu zuwa wasu ƙasashe tare da mummunan ƙimar kamuwa da cuta da mutuwar.
Saboda haka, annobar COVID-19 ta yanzu ita ce ta uku ta CoV a tarihin ɗan adam.
An fara ba da rahoton wani mummunan fashewar cutar huhu ta sanyi da ba a san asalinsa ba a Wuhan ga Hukumar Lafiya ta Kasa ta China a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an sanar da sakamakon cutar.
An ba da rahoton mutuwar farko a Wuhan a ranar 15 ga Janairu, 2020.
A halin yanzu, annobar ta bazu cikin sauri zuwa garuruwa, jihohi da ƙasashe masu iyaka.
A ranar 20 ga watan Janairu, an sanar da cewa ma'aikatan kiwon lafiya sun kamu da cutar, kuma an yi la'akari da cewa ana iya yada cutar daga mutum zuwa mutum.
A ranar 23 ga watan Janairu, an dakatar da duk hanyoyin sufuri na jama'a a Wuhan kuma an kulle birnin.
A ranar 24 ga watan Janairu, binciken farko na cutar ya gano cewa daga cikin mutane 41 da aka tabbatar da cutar, 21 ne suka yi tafiya zuwa kasuwar abincin teku ta Wuhan, inda ake ganin cutar ta samo asali ne daga dabba da ba a bayyana sunanta ba.
A ranar 30 ga watan Janairu, WHO ta ayyana barkewar cutar a matsayin gaggawa ta duniya.
A lokacin da aka fitar da wannan rahoto, cutar ta riga ta bazu a duk fadin kasar Sin da kuma kusan wasu kasashe 50 a duniya (Hoto na 2).
Yanayin yana ci gaba da canzawa, kuma har yanzu ana bukatar tantance ƙarshen yaduwar cutar da kuma tsananin cutar.
A cewar wani bincike na cibiyoyi da dama da aka gudanar a kan marasa lafiya 8,866 da suka hada da 4,021 da suka tabbatar da cutar COVID-19 a ranar 11 ga Fabrairu, 2020, ana samun cikakken bayani game da cutar a wannan hanyar.
SARS-CoV-2 na iya kamuwa da cutar a kowane zamani, amma yawanci ana kamuwa da ita ne tsakanin shekaru 30 zuwa 65.
Kusan rabin wadanda suka kamu da cutar (47.7%) sun haura shekaru 50 kuma yawan cutar bai kai shekaru 20 ba, tare da kamuwa da mutane 14 a cikin wadanda shekarunsu ba su kai 10 ba.
Cutar SARS-CoV-2 ta fi yawa a cikin maza (0.27/100,000) fiye da mata (0.31/100,000).
COVID-19 ya yadu a cikin manyan wurare, musamman a lardin Hubei da kewayenta.
Daga farkon cutar zuwa gano cutar, COVID-19 yana ɗaukar matsakaicin kwanaki 5 (2-9).
Matsakaicin lokacin haihuwa ya kasance kwanaki 4.8 (3.0-7.2).
Matsakaicin lokacin daga bayyanar cututtuka zuwa mutuwa shine kwanaki 9.5 (kwanaki 4.8 zuwa 13).
Matsakaicin yawan haifuwa (R0) shine 3.77 (95% CI, 3.51-4.05) kuma daidaitaccen R0 shine 2.23-4.82.
A ranar 23 ga Janairu, shekarar 2020, adadin masu kamuwa da cutar ya ninka sau da yawa, daidai da lokacin da motocin sufuri da yawa ke tafiya kafin bikin bazara na kasar Sin.
Mutuwar masu haƙuri da aka tabbatar da su 1.44% (95% CI: 1.10-1.86%) da kuma daidaitaccen mutuwar da aka yi daidai da dukkan marasa lafiya 3.06% (95% CI: 2.02-4.59%).
Manyan kungiyoyi uku da ke da hadarin kamuwa da cutar COVID-19 sune maza, mutanen da shekarunsu suka haura 60 da kuma wadanda ke da mummunar cutar huhu.
CoVs wani yanki ne na manyan ƙwayoyin cuta masu ɗauke da RNA guda ɗaya, DNA-sealing.
Ana iya rarraba su zuwa nau'i huɗu, wato alpha, beta, gamma da delta, daga cikinsu alpha- da beta-CoVs na iya yaduwa ga mutane.
A cikin SARS-CoV da MERS-CoV, furotin Envelope Spike ((S) glicocin yana haɗuwa da masu karɓar kwayar halitta, enzymes na angiotensin converting 2 (ACE2) da peptidine peptides 4 ((DPP4), kowannensu.
An fitar da kwayar RNA ta kwayar cutar zuwa cikin cytoplasm: Bayan an maye gurbin kwayar cutar, kwayar RNA ta kwayar halitta wacce ta kunshi glycoprotein da nucleotides sun zama mai saurin kamuwa da cuta wanda ya kunshi plasma, wanda ya hada da membrane na plasma kuma ya fitar da kwayar cutar.
A ranar 10 ga Janairu, 2020, an gano jerin kwayoyin halittar SARS-CoV-2.
A cikin samfurori 10 na kwayoyin halitta da aka tattara daga kasuwar abincin teku ta Hunan, Wuhan, Huanan, inda cutar ta fara, an gano SARS-CoV-2 a matsayin sabon nau'in beta-CoV tare da daidaiton kwayoyin halitta sama da kashi 99.98%.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV ta hanyar kwayoyin halitta.
A cikin binciken da aka yi ta hanyar microscope na lantarki, an gano ƙananan ƙwayoyin SARS-CoV-2 a cikin ƙananan sassan jikin jikin mutum.
An gano ACE2 na mutum a matsayin mai karɓar bakuncin SARS-CoV-2 da SARS-CoVs.
Koyaya, furotin S na SARS-CoV-2 wanda ke manne da ACE2 na ɗan adam ya fi SARS-CoV rauni, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da kamuwa da cuta mai ƙarfi fiye da SARS-CoV.
Kwayar cutar SARS-CoV-2 na iya zama wani nau'in furotin da aka samar da orf3b da kuma nau'in furotin da aka samar da orf8.
Ko da yake orf3b na cutar SARS-CoV-2 na iya zama alama ce ta kamuwa da cutar, kuma yana iya hana IFNβ faruwa, orf8 ba shi da wani yanki mai tasiri ko tsari.
A ranar 18 ga Fabrairu, 2020, Zhou da sauransu sun gabatar da tsarin cryo-EM na cikakken mutum ACE2 wanda ya haɗu da mai ɗaukar amino acid B0AT1 tare da ƙuduri 2.9 Å.
An gano cewa wani rukunin da ke da tsarin bude da rufe ya zama dimer, wanda ACE2-B0AT1 ke iya haɗa sunadarai biyu na S, wanda zai iya ganowa da kuma gane cutar ta CoV.
B0AT1 na iya zama wata manufa ta maganin cutar a gwajin maganin cutar don rage kamuwa da cutar SARS-CoV-2.
Mai karɓa na asali da mai karɓa na matsakaici
An gano cewa SARS-CoV da MERS-CoV sun samo asali ne daga barbashi kuma sun yadu ga mutane ta hanyar cats da raƙuma.
Idan aka kwatanta yanayin SARS-CoV-2 da sauran CoVs, sabon kwayar cutar ta yi kama da CoVs masu kama da SARS da aka samu a cikin bat-SL-CoVZX45 da bat-SL-CoVZX21, wanda ya nuna cewa bat-SL-CoVZX21 ne asalin SARS-CoV-2.
Koyaya, ba a san mai watsa shiri na matsakaici wanda ya taimaka wa cutar ta tsallaka shingen nau'in zuwa ga mutane ba kuma hanyar watsawa har yanzu tana da mahimmanci.
Ji da wasu sun ba da shawarar cewa maciji na iya zama matsakaici a hanyar da cutar ke yaduwa daga bat zuwa mutane, saboda duk wasu abubuwan da suka canza a cikin furotin S suna da nau'in iri ɗaya.
Masu bincike a Guangzhou, China sun ce wani bincike na asali wanda ya gano daidaiton kashi 99 cikin dari na kwayar cutar coronavirus (CoV) da SARS-CoV-2 wanda aka saba amfani da shi a maganin gargajiya na kasar Sin, wanda ke da dogon lebe, wanda yake amfani da kwayar dabbobi masu shayarwa, na iya zama mai karɓar bakuncin cutar SARS-CoV-2.
Duk da haka, bambancin kashi ɗaya cikin ɗari na rarraba tsakanin kwayoyin halittar biyu har yanzu bambanci ne mai mahimmanci, don haka muna jiran sakamakon ƙarshe don tabbatar da hujjoji (Figure, Figure 33).
Ba a san yawancin kaddarorin kimiyyar jiki na SARS-CoV-2 ba.
SARS-CoV da MERS-CoV na iya rayuwa a cikin bututun gwaji na tsawon awanni 48 a cikin bushewar yanayi da kuma tsawon kwanaki 5 a yanayin zafi da ke ƙasa da 20 °C da kuma danshi 40% zuwa 50%.
SARS-CoV-2 na iya samun irin wannan alamun.
SARS-CoV-2 ba shi da juriya ga hasken ultraviolet da kuma dumama na minti 30 a 56 °C, kuma ether, 75% ethanol, maganin kashe ƙwayoyin cuta mai dauke da chlorine, acid acetic, chlorophenic da sauran mai mai mai na iya kashe kwayar cutar. Koyaya, chlorophenic acid ba zai iya kashe kwayar cutar ba.
A takaice, dukkan mutane ba su da rigakafin cutar SARS-CoV-2 kuma saboda haka ba su da kariya ga sabon kwayar cutar.
A halin yanzu, ba a bayyana cikakken binciken da aka yi game da yadda garkuwar jikin mutum ke amsa SARS-CoV-2 ba.
Saboda haka, zamu iya komawa ga binciken da aka yi a baya game da wasu CoVs, musamman SARS-CoV da MERS-CoV (Fig. (Fig. 4) 4.4).
Gabaɗaya, bayan kamuwa da cuta ta mamaye mai karɓa, tsarin rigakafin mai karɓa na farko yana gane shi ta hanyar masu karɓar tsarin ganewa (PRRs), gami da masu karɓar mai kama da C-type lectin (TLR), mai karɓar mai kama da Toll (NLR), mai karɓar NOD (NLR), da mai karɓar RIG-I (RLR).
Ta hanyoyi daban-daban, kwayar cutar tana haifar da kumburi da kuma haɓaka ƙwayoyin dendritic (tsarin garkuwar jiki) ban da hana yaduwar kwayar cutar, kuma ƙwayoyin phagocyte suna haifar da nau'in I interferon (IFNs) wanda ke hanzarta cinyewar ƙwayoyin cutar.
Koyaya, furotin N na SARS-CoV na iya taimakawa kwayar cutar ta tsere daga amsawar rigakafi.
Ba da daɗewa ba, amsawar rigakafin da ta dace ta shiga cikin yaƙi da cutar.
Kwayoyin jini na T, ciki har da CD4 + da CD8 + T, suna taka muhimmiyar rawa wajen hana cutar.
CD4 + T cells suna motsa B cells don samar da kwayoyin cutar anti-virus, yayin da CD8 + T cells ke kashe kwayoyin cutar kai tsaye.
Kwayoyin T masu taimako suna samar da sitokin mai kumburi don taimakawa ƙwayoyin da ke kare su.
Koyaya, CoV na iya hana T-cell aiki ta hanyar haifar da mutuwar T-cell.
Hakanan, rigakafin jiki na rigakafin jini, gami da abubuwan ƙarfafawa kamar C3a, C5a da ƙwayoyin cuta, yana da mahimmanci don yaƙar kamuwa da kwayar cutar.
Misali, kwayoyin cutar da aka samo daga marasa lafiya da suka warke sun lalata MERS-CoV.
A gefe guda, yawan maganin rigakafi yana haifar da fitowar kayan aikin freudial wanda ke haifar da mummunan lalacewa ga huhu da sassan jiki, wanda a cikin mawuyacin yanayi zai iya haifar da lalacewar gabobin jiki da kuma mutuwa.
A cikin tsarin cutar ta SARS-CoV-2, cutar tana iya kamuwa da mata masu juna biyu da tsofaffi da ke da cututtukan da ke tattare da cutar.
A al'ada, mutanen da suka kamu da cutar da yawa ko kuma wadanda suke da tsarin rigakafi mai rauni suna da damar kamuwa da cutar fiye da sauran mutane.
Wani bincike da aka gudanar a Wuhan kan mutane 425 da suka kamu da cutar ya kiyasta cewa matsakaicin lokacin cutar SARS-CoV-2 na farawa tsakanin kwana 1 zuwa 14, mafi yawan kwanaki 3 zuwa 7.
Amma, wani binciken da aka yi kan marasa lafiya 1,099 ya nuna cewa matsakaicin lokacin fara cutar kwanaki uku ne, kuma lokacin da za a iya fara cutar daga kwanaki 0 zuwa 24.
Kamar yadda aka ambata a sama, wani binciken da aka yi kwanan nan bisa ga kamuwa da cutar a cikin mutane 8,866 ya nuna cewa tsawon lokacin kamuwa da cutar ya kai kwanaki 4.8 (3.0-7.2).
Yana da mahimmanci ga hukumomin kiwon lafiya su daidaita tsawon lokacin keɓewa wanda ya dace da lokacin ɓarkewar cutar, don hana yaduwar cutar daga waɗanda ba su da alamun cutar ga wasu.
A matsayin al'ada, duk wanda ya sadu da wanda ke dauke da cutar ko wanda ya kamu da cutar ya kamata a killace shi na tsawon kwanaki 14.
Ya kamata a kara wa'adin hana zirga-zirga da keɓewa zuwa kwanaki 24?
Mafi yawan lokutan bayyanar cutar COVID-19 shine rashin lafiya, amma kuma ana iya samun wasu alamun cutar tare da wasu alamun cutar, kamar tari, numfashi, ciwon tsoka, ciwon kai, ciwon kai, ciwon wuya, hanci, ciwon kirji, amai, kumburi da amai.
Wasu marasa lafiya sun sami matsalar numfashi da / ko rashin isasshen iskar oxygen a cikin jini da huhu a cikin mako guda bayan fara cutar.
A cikin mawuyacin hali, marasa lafiya suna iya samun saurin ci gaba da bayyanar cututtukan numfashi, cutar jini, acidic hyperglycemia da zub da jini.
Ya kamata a fara gano cutar a farkon lokacin da aka gano marasa lafiya da zazzabi da / ko alamun cututtukan numfashi, da kuma marasa lafiya masu ciwo mai tsanani, koda kuwa ba a gano rashin daidaito na huhu ba.
Wani binciken binciken da aka gudanar a yankin da aka gudanar a ƙarshen Disamba na 2019, ya nuna cewa kashi 98 cikin 100 na alamun cutar rashin lafiya, tari 76% na rashin numfashi, kashi 55% na numfashi da kashi 3% na amai, kuma kashi 8% na marasa lafiya sun bukaci taimakon numfashi.
An gano irin wannan yanayin a cikin wasu binciken biyu da aka yi kwanan nan a kan dangi da kuma wani rukuni na mutane da suka kamu da cutar daga wani wanda ba shi da alamun cutar.
Idan aka kwatanta, wani binciken al'umma da aka gudanar a shekarar 2012 ya nuna cewa rashin lafiya (98%), tari (47%) da kuma wahalar numfashi (55%) sune manyan alamun cutar a cikin marasa lafiyar MERS-CoV.
Koyaya, kashi 80% daga cikinsu suna buƙatar taimakon numfashi, wanda ya fi yawan waɗanda ke fama da COVID-19, wanda kusan ya yi daidai da MERS, wanda ke da haɗarin rayuwa fiye da COVID-19.
An kuma lura da amai (26%) da ciwon makogwaro (21%) a cikin marasa lafiyar MERS.
A cikin marasa lafiya da cutar SARS, rashin lafiya (99% zuwa 100%), tari (29% zuwa 75%), numfashi mai wuya (40% zuwa 42%), amai (20 zuwa 25%) da ciwon makogwaro (13 zuwa 25%) sune manyan alamun cutar, kuma kusan 14% zuwa 20% na marasa lafiya suna buƙatar taimakon numfashi.
A ranar 14 ga Fabrairu, an tabbatar da kamuwa da cutar 66,576 a duniya, kuma yawan mutuwar COVID-19 ya kai kashi 2%.
Idan aka kwatanta, a watan Nuwamba na 2002, mutuwar SARS ta kai kashi 10 cikin dari na 8,096 da aka tabbatar da cutar.
A cikin binciken da aka gudanar a watan Yunin 2012, an tabbatar da cewa akwai cutar MERS, inda kashi 37% na mutane 2,494 suka mutu.
A cewar wani binciken farko, R0 (matsakaicin kamuwa da cutar) na SARS-CoV-2 ya kai 6.47 a cikin kashi 95% na tabbataccen kashi (CI) na 5.71-7.23, yayin da R0 (matsakaicin kamuwa da cutar) na SARS-CoV kawai ya kai 2 zuwa 4.
An kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV dangane da alamun cutar, mutuwar, da R0 (matsakaicin yawan kamuwa da cutar) a cikin tebur na 1.1.
Bisa ga kididdigar da ke sama, SARS-CoV-2 ya fi MERS-CoV da SARS-CoV yaduwa, amma yawan mutuwar ya fi na biyun ƙasa.
Saboda haka, cutar SARS-CoV-2 ta fi MERS-CoV da SARS-CoV wuya a sarrafa.
Cutar ta hanyar jama'a tana faruwa ne a cikin iyali ɗaya ko kuma daga taron jama'a ɗaya ko daga motoci kamar jiragen ruwa na alatu.
Masu cutar sune mutanen da suka yi tafiya ko mazauna Wuhan ko wasu wuraren da cutar ta bulla a cikin makonni biyu kafin bayyanar cututtuka ko kuma sun kasance tare da wanda ya kamu da cutar ko kuma wanda ya kamu da cutar.
Amma, mutane na iya ɗaukar kwayar cutar sama da makonni biyu ba tare da nuna alamun cutar ba, kuma ana iya sake ɗaukar kwayar cutar a cikin marasa lafiya da suka warke kuma an ba da gargadin cewa za a ƙara tsawaita lokacin keɓewa.
A farkon matakin, yawan ƙwayoyin jini na marasa lafiya (musamman ƙwayoyin jini na jini) na iya zama daidai ko raguwa.
Misali, a cikin marasa lafiya 1,099 na COVID-19, an gano ƙarancin ƙarancin ƙarancin ƙwayoyin lymphocytes, ciki har da ƙarancin ƙwayoyin lymphocytes da ke ƙasa da 1 × 109/L, da ƙarancin ƙwayoyin lymphocytes da ke ƙasa da 4 × 109/L, da kuma ƙaruwa a cikin sinadarin amino-transferase enzyme da kuma kasancewar kwayar cutar a cikin jini.
Wasu marasa lafiya sun sami karuwar kwayar jini (myoglobin) da kuma hanta da kuma sinadarin tsoka a cikin jini, kuma mafi yawan marasa lafiya sun sami karuwar furotin mai amsawa C da kuma yawan kwayar jini.
A cikin marasa lafiya masu kamuwa da cutar, yawan D-dimer, wani nau'in fibrin a cikin jini, yana ƙaruwa kuma yawan ƙwayoyin jini na ƙwayoyin jini yana raguwa.
Yawancin marasa lafiya da ke fama da COVID-19 suna da alamun cututtukan kirji da ba su dace ba, wanda ke nuna cewa akwai tabo a cikin huhu, kamar inuwa ko gilashi.
Marasa lafiya sukan sha wahala daga cututtukan huhu da ba su da kyau, raunin huhu mai tsanani da kuma mummunar cutar numfashi (ARDS).
Lokacin da ARDS ta faru, ana iya samun kumburi da ƙarancin ruwa da kuma haɓakar ƙwayoyin cuta, wanda ke haifar da lalacewar tsarin musayar gas.
Rashin aikin nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in nau'in
Saboda haka, mafi munin sakamakon CT scan na kirji ya yi daidai da mafi munin cutar.
A ranar 18 ga Fabrairu, 2020, binciken farko na cutar COVID-19 wanda ya mutu sakamakon kamuwa da cutar ya gano ƙwayoyin cuta a cikin huhu, ɓarkewar ƙwayoyin halide, ƙwayoyin jini tsakanin ƙwayoyin jijiyoyin jini, da ƙwayoyin cuta a cikin huhu. Ya dace da cututtukan cututtukan ƙwayoyin cuta, ARDS, kuma yayi kama da SARS da MERS.
Babban ka'ida don gano COVID-19 shine amfani da hanyar gano SARS-CoV-2 RNA ta hanyar aikin haɗin DNA mai haɓaka enzyme da kuma aikin haɗin haɗin enzymatic polymerase (RT-PCR).
Amma yawan kuskuren gwajin cutar ya kara saurin barkewar cutar, kuma an fara amfani da fasahohin kiwon lafiya a kasar Sin a ranar 13 ga Fabrairu, 2020 don yin bincike (ba wai kawai ta hanyar RT-PCR ba).
Irin wannan yanayin ya faru ne a gwajin SARS.
Saboda haka, haɗuwa da bincike, wanda ya ƙunshi tarihin cutar, binciken asibiti, gwajin gwaji da binciken X-ray, yana da mahimmanci kuma yana da mahimmanci don gudanar da ingantaccen bincike.
A ranar 14 ga Fabrairu, 2020, ƙungiyar Feng Zhang ta bayyana hanyar gano SARS-CoV-2 ta amfani da hanyar CRISPR mai tushen SHERLOCK, wanda ke ba da damar gano ɓangarorin SARS-CoV-2 RNA na halitta daga 20 × 10-18 mol/L zuwa 200 × 10-18 mol/L (kwafi 10-100 a kowace microliter da aka saka) ta amfani da sandar ma'auni a cikin ruwa a cikin ƙasa da awa ɗaya, ba tare da buƙatar amfani da kayan auna ba.
Ana fatan cewa idan aka tabbatar da shi a gwajin asibiti, sabon tsarin zai inganta amsawa da dacewa sosai.
Saboda babu wani sabon abu na cutar coronavirus, likitoci da yawa na iya ba da kulawa ta musamman ga marasa lafiya na COVID-19 a lokaci guda yayin da ake gwada magunguna daban-daban da aka riga aka yi amfani da su ko aka ba da shawarar su don magance wasu cututtukan coronavirus, kamar su SARS-CoV, MERS-CoV da wasu cututtukan kwayar cuta (tebur (tebur 2).
Magungunan sun hada da magungunan cutar da ake da su da kuma masu yuwuwa, maganin hana kamuwa da cuta, steroids, jini daga marasa lafiya da suka warke, maganin gargajiya na kasar Sin da kuma tallafi na tunani.
An kuma ba da shawarar yin amfani da jini daga marasa lafiya da suka warke.
Kamfanonin harhada magunguna na gasa don samar da kwayoyin cuta da kuma alluran rigakafi da ke yaki da cutar.
Kwayar SARS-CoV-2 tana fara kai hari ga huhu, amma kuma tana iya kai hari ga wasu gabobin jiki da ke nuna enzyme ACE2, kamar tsarin gastrointestinal da koda.
Duk da haka, rashin lafiya da kuma lalacewar numfashi shine babban barazana ga marasa lafiya kuma babban dalilin mutuwa.
Saboda haka, taimakon numfashi yana da mahimmanci wajen sauƙaƙa alamun cutar da ceton rayuka, kuma ya ƙunshi maganin oxygen na yau da kullun, yawan iskar oxygen, na'urar numfashi / fitarwa da na'urar numfashi ta atomatik, dangane da tsananin cutar.
Ana iya ba da taimakon oxygenation na membrane na ƙwayar cuta (ECMO) ga marasa lafiya da ke fama da cututtukan numfashi mai tsanani. Wannan fasaha ce da ke hana aikin zuciya da huhu da aka gyara, wanda ake amfani da shi wajen magance cututtukan zuciya da cututtukan numfashi.
Bugu da kari, kiyaye daidaiton lantarki da kare ayyukan gabobin jiki masu mahimmanci na da mahimmanci ga marasa lafiya da SARS-CoV-2 don hanawa da kuma magance kamuwa da cuta na biyu da kuma guba na jini.
An san cewa Cytokine Storm sakamakon yawan amsawar garkuwar jiki ne a cikin marasa lafiya da SARS da MERS.
Cytoplasmic hyperdismation na kwayar halitta wani nau'i ne na tsarin kumburi wanda ya haifar da tsarin tsinkaye na kwayar halitta, gami da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Wannan rikicewar kwayar halitta a cikin kwayoyin tana ƙarfafa ƙwayoyin cuta don samar da adadi mai yawa na kayan aikin freudical, wanda shine babban dalilin haifar da ARDS da sauran lalacewar gabobin jiki.
Ana bukatar maganin cututtukan cytokine a cikin marasa lafiya masu tsanani, musamman ma a cikin marasa lafiya masu tsanani.
An yi amfani da maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut
Sauran magungunan hana hana kamuwa da cuta don guguwar cytokine (haɓaka yawan kwayar cytokine) sun haɗa da daidaita martani na rigakafin kai tsaye na kwayar cuta, hana IFN- γ, IL-1 da TNF, hana kwayar JAK, siginar kwayar cytokine mataki na 4 da kuma hana HDAC.
Ana amfani da steroids a matsayin maganin rigakafi a cikin maganin SARS don rage tsananin kumburi.
Koyaya, ba a sami sakamako mai kyau na ƙarin steroids don mummunan lalacewar huhu a cikin marasa lafiya na SARS da COVID-19.
Maimakon haka, suna iya haifar da mummunan sakamako na gefe, musamman mutuwar ƙashin ƙashi, wanda ke da tasiri sosai a kan kimantawa da tsinkaya.
Koyaya, ana ba da shawarar yin amfani da maganin cortisone a cikin ƙananan allurai tare da daidaito na lokaci don marasa lafiya masu cutar COVID-19.
Har zuwa yanzu, babu maganin rigakafi mai inganci da aka amince da shi.
Koyaya, allurar remdesivir, mai kama da nucleotide, ya kasance mai tasiri a cikin wani mara lafiyar Amurka wanda ke da COVID-19.
Remdesivir wani magani ne mai hana kwayar cutar Ebola wanda Gilead ta fara kirkirarsa don magance cututtukan da kwayar cutar Ebola da Marlburg ke haifarwa.
Daga baya, an nuna cewa remdesivir yana iya hana wasu ƙwayoyin cuta masu amfani da RNA guda ɗaya, ciki har da ƙwayoyin cuta na MERS da SARS.
Dangane da wannan, Gilead ta ba da sinadarin zuwa China don yin gwajin haɗin gwiwa a cikin mutanen da ke kamuwa da cutar SARS-CoV-2, kuma tana fatan sakamako.
Bugu da ƙari, baricitinb, interferon-alpha, leptinvar/ritonavar da ribarvirin ana la'akari da su azaman magunguna masu yuwuwa ga marasa lafiya da ke nuna alamun cututtukan numfashi na yau da kullun.
Hauka, kumburi, tashin zuciya, raunin hanta da sauran halayen da ba su dace ba na iya faruwa bayan maganin hade da maganin Lopinavir / ritonavir.
Ya kamata a kula da hulɗar da ke tsakanin waɗannan hanyoyin magani da sauran magungunan da ake amfani da su a cikin marasa lafiya.
An samar da jini da kuma kwayoyin rigakafi daga marasa lafiya da suka warke
An yi amfani da jini daga marasa lafiya da suka warke daga kamuwa da cutar don magance wasu marasa lafiya da ke fama da cutar ko kuma hana kamuwa da wani wanda ba shi da cutar.
A cikin marasa lafiya da suka warke da gaske, yawanci suna da ƙarfin ƙwayoyin cuta masu guba a cikin jinin su.
Kwayoyin rigakafin cuta sun hada da sunadarai na rigakafi da kwayoyin B suka samar, wasu nau'ikan kwayoyin jini, don yaki da masu cutar da sauran masu kutsawa daga waje, kuma suna gane kwayoyin daban-daban daga cikin masu cutar kuma suna lalata su kai tsaye.
Dangane da wannan, an tattara jini daga marasa lafiya da suka warke daga COVID-19 kuma an yi wa marasa lafiya 10 masu ciwo mai tsanani allurar.
A cikin awanni 24, alamun cutar sun ragu tare da raguwar kumburi, raguwar kwayar cutar da kuma ingantaccen iskar oxygen a cikin jini.
Amma, kafin a samu takamaiman maganin, ana bukatar a yi bincike da kuma bayani a kan wannan maganin.
Bugu da ƙari, ana iya yin la'akari da wasu abubuwan da ke tattare da jini, kamar yadda aka bayyana a sakamakon maganin.
Misali, kwayoyin cutar suna kara tayar da martani na rigakafi, saboda haka suna haifar da cutar cytokine release syndrome, wanda ke iya zama mai guba wanda zai iya hallaka rai.
Yawancin lokaci, ana bukatar karin jini don magance cututtukan hanta.
Akwai matsala wajen samar da takamaiman kwayoyin cutar da sauri don magance cutar ta duniya.
Saboda haka, yana da mahimmanci kuma yana da amfani a ware ƙwayoyin cuta daga marasa lafiya da ke murmurewa da kuma gano kwayoyin cuta masu tasiri don yaƙar sunadarai masu mahimmanci na kwayar cutar ko gano lambobin kwayoyin halitta waɗanda ke haifar da kwayoyin cuta masu tasiri.
Ta wannan hanyar, za mu iya ƙara samar da ƙwayoyin cuta.
An yi amfani da TCM a cikin maganin cututtuka daban-daban a cikin Sin na dubban shekaru.
Duk da haka, tasirinsa ya dogara ne akan haɗuwa da abubuwa daban-daban waɗanda zasu kasance cikin maganin da zai bambanta dangane da yadda ake gano cutar bisa ka'idodin TCM.
Yawancin abubuwan da suka fi tasiri ba a san su ba, ko kuma ba su da cikakkun bayanai don ganowa da tabbatar da irin waɗannan abubuwan ko haɗuwa mafi kyau.
A halin yanzu, babu ingantaccen magani don COVID-19, kuma TCM ya zama ɗayan manyan hanyoyin maye gurbin marasa lafiya waɗanda ke da ƙananan alamun cutar ko waɗanda ke murmurewa daga mawuyacin yanayi.
Misali, an gano cewa Shu Feng Jie Du capsules da Lian Hua Qing Wen capsules suna da tasiri wajen maganin COVID-19.
An gano mafi girman adadin masu warkewa daga COVID-19 a larduna da dama na kasar Sin, ciki har da Gangzhou (63.7%), Ningxia (50%) da Hunan (50%), inda kashi 87% na marasa lafiyar su suka yi amfani da TCM, yayin da lardin Hubei, inda kusan kashi 30% na marasa lafiya suka yi amfani da TCM, ya sami mafi ƙarancin adadin masu warkewa (13%) a cikin marasa lafiyar COVID-19.
Amma wannan kwatancen ne kawai, saboda ana bukatar la'akari da wasu abubuwa da yawa da zasu iya tasiri a cikin kimantawa, kamar yawan marasa lafiya da kuma tsananin cutar.
A ranar 18 ga Fabrairu, 2020, Boli Zhang da abokan aikinsa sun buga wani bincike don kwatanta maganin musamman na maganin yamma (WM) da kuma maganin hadewar WM da TCM.
An gano cewa lokacin da ake buƙata don dawo da zafin jiki, warkar da alamun bayyanar cututtuka da kuma asibiti ya yi ƙasa sosai a cikin ƙungiyar da ke amfani da WM + TCM fiye da ƙungiyar da ke amfani da WM ɗaya.
Mafi ban sha'awa, yanayin cutar (daga mai sauƙi zuwa mai tsanani) ya ragu sosai a cikin rukunin WM + TCM fiye da rukunin WM guda ɗaya (7.4% da 46.2%), kuma yawan mutuwa ya yi ƙasa a cikin rukunin WM + TCM fiye da rukunin WM guda ɗaya (8.8% da 39%).
Koyaya, inganci da amincin TCM har yanzu suna jiran ƙarin gwaji na gwaji mai tsari a cikin manyan cibiyoyi da yawa.
Zai kuma kasance mai ban sha'awa don gano fasalin bayyanar aikin aiki da kuma bayyana abubuwan da ke cikin maganin TCM ko kuma yiwuwar amfani da shi.
Mutanen da ke da shakku ko kuma waɗanda suka tabbatar da cutar COVID-19 galibi suna cikin matsanancin damuwa game da cutar mai saurin yaduwa da kuma kashe rai, kuma waɗanda ke da takunkumin tafiye-tafiye suna fuskantar baƙin ciki, kadaici da fushi.
Bugu da ƙari, cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan
An bayar da rahoton cewa a farkon cutar SARS, ana samun cututtukan cututtukan kwakwalwa da yawa, gami da yawan damuwa, damuwa, tashin hankali, nuna alamun rashin tausayi, rashin hankali da kuma ƙoƙarin kashe kansa.
Ana iya zargi mutum da kansa saboda bin diddigin hulɗa da ƙuntatawa tafiye-tafiye da keɓewa, wanda ya zama dole a matsayin wani ɓangare na martani na lafiyar jama'a ga yaduwar COVID-19, wanda ke ƙara damuwa ga al'umma, kuma yana cutar da danginsu da abokan su, waɗanda ke keɓewa da kuma wulakanci.
Ya kamata a samar da kulawar lafiyar hankali ga marasa lafiya na COVID-19, waɗanda ake zargi da cutar, waɗanda suka kasance tare da su, da kuma jama'a waɗanda ke buƙatar taimako.
Tallafin tunani ya kamata ya hada da kafa kungiyoyin kiwon lafiya na tunani masu sassa daban-daban, sadarwa a bayyane kuma a kai a kai game da ingantaccen bayani game da barkewar cutar SARS-CoV-2 da shirye-shiryen magani, da kuma amfani da na'urorin lantarki da aikace-aikacen zamani don kauce wa hulɗa da juna.
Ingantattun alluran rigakafi suna da mahimmanci wajen yanke hanyar kamuwa da cuta daga dabbobi da mutane masu kamuwa da cuta zuwa masu karɓar cutar, inda ƙwayoyin cuta ke haɓaka, kuma suna da mahimmanci kamar yadda maganin hana kamuwa da cuta yake a cikin sarrafa cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Ana kokarin samar da maganin rigakafi na tushen furotin S don samar da maganin rigakafi mai tasiri na dogon lokaci da / ko rigakafi da ke kare SARS-CoV.
An gwada allurar rigakafin da aka yi amfani da ita don maganin SARS a kan dabbobi.
Amma, kafin a fara binciken asibiti, ba za a iya tantance ingancin alluran rigakafin da aka ba da shawarar a cikin tsofaffi da kuma dabbobi masu haɗari ba, da kuma ko za su iya hana kamuwa da kwayar cutar daga dabbobi zuwa mutane.
Wannan kuma na iya faruwa ne saboda ba a samu wani sabon kamuwa da cutar SARS ba tun bayan shekara 17.
Akasin haka, an ci gaba da samun cututtukan MERS a wasu lokuta da kuma a cikin yankin Gabas ta Tsakiya, kuma ci gaba da kamuwa da cutar daga dabbobi zuwa mutane a yankunan da cutar ta faru ya sa cutar ta bazu zuwa wasu yankuna.
An aiwatar da dabarun rigakafin MERS ta hanyar yin amfani da allurar rigakafin da ta ƙunshi ƙwayoyin cuta da aka kashe, plasma na DNA, masu ɗaukar hoto na kwayar cuta, nanoparticles, ƙwayoyin cuta masu kama da kwayar cuta da kuma subunits na furotin (ƙwayoyin cuta da aka tsara ta amfani da takamaiman ƙwayoyin cuta) da kuma wasu alluran rigakafin da aka gwada a dabbobi.
Samar da maganin rigakafin SARS-CoV-2 mai inganci da aminci ga marasa garkuwar cuta na daga cikin gaggawa da muhimman ayyuka wajen shawo kan annobar.
Duk da haka, akwai ƙalubale don shawo kan matsalar saboda tsawon lokacin da ake buƙata don samar da allurar rigakafi da kuma bambance-bambancen bambance-bambancen CoVs (tazarar watanni 18).
A matsayinta na sabuwar cuta, COVID-19 ta fara nuna cikakken hanyar cutar bayan ta kamu da dubban marasa lafiya.
A mafi yawan cututtukan, marasa lafiya suna samun sauƙi a hankali ba tare da ci gaba ba.
Amma kamar SARS da MERS, COVID-19 yana da haɗari da mutuwa a cikin marasa lafiya masu kamuwa da cutar.
Saboda haka, hukumomin kiwon lafiya suna buƙatar ƙirƙirar tsarin tsinkaya na cutar don ba da fifiko ga kulawa, musamman a yankunan da ke da iyakantaccen albarkatu.
Binciken asibiti ya zuwa yanzu ya nuna cewa waɗannan abubuwan suna da tasiri ko alaƙa da yiwuwar cutar a cikin marasa lafiya na COVID-19 (tebur (tebur 33):
Shekaru: Shekaru shine mafi mahimmancin abin da ke haifar da cutar SARS, kuma ya zama gaskiya ga COVID-19.
Kamar yadda aka ambata a sama, wani bincike da aka gudanar kan marasa lafiya 8,866 ya nuna cewa COVID-19 ya fi kamuwa da mutanen da ke tsakanin shekaru 30-65, tare da 47.7% na waɗanda ke da shekaru 50 da haihuwa.
Marasa lafiya da ke buƙatar kulawa mai mahimmanci galibi marasa lafiya ne kuma cututtukan na gaba suna faruwa sosai a cikin tsofaffi (yawan shekaru 51 da matsakaicin shekaru 66). Ana ba da shawarar yin la'akari da shekaru a matsayin ma'ana yayin tsinkaya sakamakon marasa lafiya na COVID-19.
Jima'i: SARS-CoV-2 ya fi kamuwa da maza fiye da mata kamar yadda aka bayyana a sama (0.31/100,000 da 0.27/100,000).
Yanayin fashewar cutar da kuma yanayin da ya biyo baya: Marasa lafiya na COVID-19 waɗanda ke buƙatar kulawa mai mahimmanci suna iya fuskantar mummunan bugun zuciya da bugun zuciya.
Cutar zuciya ita ce babbar hanyar mutuwar marasa lafiya na SARS.
SARS-CoV-2 na iya haɗuwa da ACE2-lactose cholangiocytes kuma yana iya haifar da rashin ciwon hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa shekaru da rigakafi ba su da alaƙa da juna, kuma suna iya yin tasiri da juna.
Binciken da ba na al'ada ba - C-reactive protein (CRP) a cikin jini yana nuna ƙarancin kumburi ko raunin nama kuma an ba da shawarar a matsayin mai yiwuwa mai faɗi game da yanayin cutar, amsawa ga magani da kuma dawowa daga ƙarshe.
An kuma ba da shawarar cewa akwai alaƙa tsakanin tsananin COVID-19, kimanta yanayin cutar, da matakin CRP.
Bugu da kari, ƙaruwar lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Ana samun waɗannan enzymes a wurare da yawa na jiki, musamman a zuciya da hanta, kuma ana samar da su yayin lalacewar nama.
Saboda haka, suna nuna alamun rashin aiki na hanta ko koda.
Babban bayyanar cututtuka: A cikin kimantawa na COVID-19 da ƙarin ƙarin cututtuka, ya kamata a yi la'akari da ɗaukar hoto na kirji da ci gaban bayyanar cututtuka a cikin lokaci, tare da wasu batutuwa.
Amfani da steroids: Kamar yadda aka ambata a sama, steroids sune magungunan hana rigakafi waɗanda galibi ana amfani dasu azaman maganin haɗin gwiwa don rage tsananin ciwo mai kumburi don cututtukan cututtuka.
An yi amfani da maganin corticosteroid mai yawa a cikin marasa lafiya masu saurin SARS, saboda haka yawancin waɗanda suka tsira sun sha wahala daga osteonecrosis na avascular, wanda ya haifar da nakasa na tsawon rai da kuma lalacewar lafiya.
Saboda haka, idan ya cancanta, ya kamata a ba da steroid a cikin ƙananan allurai na ɗan gajeren lokaci ga marasa lafiyar COVID-19.
Damuwa ta hankali: Kamar yadda aka ambata a sama, yawancin marasa lafiya suna fuskantar damuwa fiye da yadda aka saba saboda tsawan lokacin hana tafiya, gami da ganin mutuwar dangi, abokan marasa lafiya da rashin tabbas game da rayuwa.
Tallafi na hankali da tallafi na dogon lokaci yana da mahimmanci don taimakawa marasa lafiya su warke daga damuwa da dawowa cikin rayuwar yau da kullun.
Ya zuwa yanzu, binciken yawan jama'a a cikin yankuna da yankuna ya nuna cewa COVID-19 yana da alamun cututtukan cututtuka daban da SARS.
Baya ga shiga cikin ƙananan hanyoyin numfashi, SARS-CoV-2 na iya shiga cikin ƙananan hanyoyin numfashi, yana iya yaduwa kamar sauran CoVs waɗanda ke haifar da mura, yana haifar da rashin ƙarfi ko rashin bayyanar cututtuka a farkon lokacin.
Wannan ya sa sarrafa cutar ya zama da wahala, saboda marasa lafiya masu kamuwa da cutar na iya yada kwayar cutar a cikin matakan farko ko kuma lokacin da ake kamuwa da cutar, a lokutan tafiye-tafiye na yau da kullun.
Koyaya, ana tsammanin kamuwa da SARS-CoV yana faruwa ne yayin da marasa lafiya ke da mummunan ciwo, kuma babu farkon kamuwa da cutar.
Saboda haka, barkewar cutar COVID-19 ta yanzu ta fi ta SARS tsanani kuma yana da wahalar sarrafawa.
A halin yanzu, ana aiwatar da kyawawan ayyuka a cikin kasar Sin, gami da kulle Wuhan da garuruwan da ke kewaye da shi da kuma ci gaba da takunkumin tafiye-tafiye da ya shafi kusan dukkan al'umma, don shawo kan yaduwar cutar SARS-CoV-2.
Ko da yake wadannan matakan sun yi tasiri sosai ga tattalin arzikin kasar da sauran bangarori, amma yawan sabbin masu kamuwa da cutar na raguwa, wanda ke nuna cewa annobar ta ragu.
Mafi kyawun hasashen shine cewa za a iya kawo ƙarshen barkewar cutar a watan Maris, kuma matakin dawowa zai ɗauki watanni 3-4.
Amma wasu masana ba su da irin wannan ra'ayin.
Paul Hunter da wasu sun yi hasashen cewa cutar COVID-19, wacce ta fi SARS kamuwa da cuta, ba za ta kare ba a shekarar 2020.
Ira Longini, et al., sun gina wani tsari da zai iya hango sakamakon annobar, kuma sun kammala cewa SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan mutanen duniya.
Kungiyar Kanada ta bayar da rahoton cewa an gano SARS-CoV-2 a cikin tsakiyar hanyar numfashi da kuma cikin hancin marasa lafiya waɗanda suka warke kuma aka kwantar da su a asibiti fiye da makonni biyu, wanda ke nuna cewa sabon kwayar cutar tana da yanayin sake dawowa na yanayi kamar yadda yake a cikin mura.
Amma, akwai alamun da ke nuna cewa akwai kyakkyawan ci gaba a cikin ƙarancin adadin sabbin cututtukan cutar a China, kuma matakan dabarun da ake aiwatarwa a yanzu suna nuna cewa suna da tasiri.
A baya, an yi hasashen cewa adadin mutanen da ke fama da cutar Ebola zai kai miliyan daya, kuma rabin mutane miliyan za su mutu.
Amma, ana iya samun sauƙin kamuwa da cutar ta hanyar tsauraran takunkumin tafiye-tafiye da keɓewa.
Akwai yiwuwar SARS-CoV-2 zai iya zama mai saurin kamuwa da cuta kamar SARS-CoV kuma daga ƙarshe ya ɓace ko kuma ya zama wani nau'in kwayar cuta da ba ta da daidaituwa a cikin mutane.
An kwatanta yaduwar cutar ta COVID-19 da SARS da MERS a ƙasa (Hoto: 55).
SARS-CoV-2 ya fi yaduwa ta hanyar tari ko hancin, kuma ana iya yada shi ta hanyar hulɗa kai tsaye da abubuwan da kwayar cutar ke mannewa.
An kuma gano kwayar cutar a cikin fitsari, wanda ke haifar da sabon yiwuwar yaduwar cutar ta bakin bakin ta hanyar fitsari da hannaye.
Wani binciken da aka yi kwanan nan kan mutane 138 da suka kamu da cutar, ciki har da wasu mutane 17 da suka kamu da cutar da kuma ma'aikatan kiwon lafiya 40, ya nuna cewa kashi 41% na kamuwa da cutar na iya faruwa ne a asibiti.
Saboda haka, ya kamata a yi amfani da rigakafin rigakafi mai kyau don kare mutane, musamman masu ba da kiwon lafiya, ma'aikatan jin kai, dangi, abokan aiki, da kuma marasa lafiya ko waɗanda suka yi hulɗa da waɗanda ke da cutar.
Matakan farko na kariya da za a iya amfani da su don rage haɗarin kamuwa da cuta sune abin rufe fuska. Amfani da abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 (jerin # 1860s) na iya taimakawa wajen sarrafa yaduwar kwayar cutar.
Masks na tiyata na iya hana yaduwar iska da mannewa da fuska da abubuwa, hanyoyin da za a iya yada ruwa daga mai cutar zuwa wani.
Koyaya, kawai abin rufe fuska na N95 (jerin # 1860s) na iya kare ƙananan ƙwayoyin cuta na kwayar cuta daga 10 nanometers zuwa 80 nanometers, kuma kawai kashi 5% na ƙwayar cuta na kwayar cuta na iya kamuwa. SARS-CoV-2 yayi kama da SARS-CoV a girma, tare da ƙwayoyin cuta guda biyu masu girman kusan 85 nanometers.
Kwayoyin sun iya karya ko da abin rufe fuska guda biyar da aka haɗa tare, don haka masu ba da kiwon lafiya da ke hulɗa kai tsaye da marasa lafiya za su yi amfani da abin rufe fuska na N95 (jerin # 1860s) maimakon abin rufe fuska na tiyata.
Masu ba da kiwon lafiya su sa abin rufe fuska da kuma tufafin kariya na dacewa don rage haɗuwa da cutar.
Hakanan za'a iya yada kwayar cutar daga mutum zuwa mutum ta hanyar ido.
A ranar 22 ga Janairu, 2020, likita ya kamu da cutar SARS-CoV-2 yayin da yake sanye da abin rufe fuska na N95. Mai yiwuwa kwayar cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu ba da kiwon lafiya ya kamata su sanya abin rufe fuska ko tabarau yayin hulɗa da marasa lafiya.
An ba da shawarar sosai ga jama'a a yankunan da ke da cutar ko kuma masu yuwuwar kamuwa da cutar su wanke hannayensu da sabulu sau da yawa, su zauna a gida, su yi ƙoƙarin keɓe kansu ta hanyar iyakance motsin su, da kuma iyakance hulɗa da mutanen da ke da cutar.
A cikin mutane, ana ganin nesa da mutum mai nisa da ƙafa uku daga mai haƙuri ya dace.
Wadannan matakan na da tasiri wajen rage hadarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo ga dan Adam a matsayin sabon nau'in kwayar cutar, rahoton na ranar 7 ga Janairu, 2020, ya nuna cewa yana da matukar dacewa da SARS-CoV, yana nuna cewa China tana cikin yanayin gaggawa, wanda ke tunatar da cutar SARS mai tsanani a 2003.
Amma har zuwa 19 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Wuhan ta ƙarfafa jama'a cewa ba za a sami matsala wajen hanawa da sarrafa cutar ba saboda sabon kwayar cutar ba ta da saurin yaduwa kuma akwai iyakancewar yaduwar cutar daga mutum zuwa mutum.
Wannan sakon ya rage yawan hankalin jama'a, musamman a lokacin da ake shirin bikin bazara a duk fadin kasar, wanda ya rasa wannan muhimmin lokaci don kiyaye cutar a Wuhan.
Cibiyoyin Kula da Cututtuka a China za su iya koyon wannan darasi mai wahala kuma suyi ci gaba mai mahimmanci a nan gaba.
Misali, wadannan hukumomi ya kamata su (1) yi taka tsantsan wajen yin sanarwar jama'a domin kowacce kalma tana da muhimmanci ga jama'a kuma tana iya canza tunaninsu da yanke shawara; (2) su kara yin taka tsantsan wajen amsa bayanai na musamman daga asibitoci maimakon jira na hukuma daga likitoci ko jami'ai; (3) su kara takaitawa wajen shawo kan wata cuta mai yuwuwa tun daga farkon matakin maimakon kokarin kwantar da hankalin jama'a; (4) su kara yada hanyoyin da suka dace da kuma ingantattun hanyoyin da za su kara wayar da kan jama'a game da cututtukan da suka addabi jama'a, kuma a rika duba yadda jama'a ke amsawa.
Cutar COVID-19, wacce ta haifar da sabon kwayar cutar SARS-CoV-2, ta fara ne a karshen watan Disamba na 2019.
A cikin kasa da watanni biyu na rubuta wannan sakon, ya riga ya yadu a duk fadin kasar Sin da kuma kusan kasashe 50 a duniya.
A yayin da cutar ke da kamanceceniya da SARS-CoV, kuma akwai kamanceceniya tsakanin COVID-19 da SARS, wanda ya sa barkewar COVID-19 ta zama kamar sake barkewar SARS.
Koyaya, akwai wasu mahimman bambance-bambance tsakanin COVID-19 da SARS, waɗanda suke da mahimmanci don sarrafa cutar da kula da marasa lafiya.
COVID-19 ya fi faruwa a cikin tsofaffi fiye da matasa, maza fiye da mata, kuma yawan rashin lafiya da mutuwa sun fi girma a cikin tsofaffi fiye da matasa.
SARS na da yawan mutuwar da ta fi ta COVID-19 (10.91% da 1.44%).
Marasa lafiya na COVID-19 na iya daukar kwayar cutar daga gare su ko da kuwa ba su nuna alamun cutar ba. A SARS, marasa lafiya galibi suna kamuwa da cutar lokacin da suka yi rashin lafiya sosai. Saboda haka, yaduwar cutar COVID-19 ta fi SARS wuya a sarrafa.
Wannan ya bayyana wani bangare dalilin da yasa SARS-CoV-2 ke yaduwa da sauri fiye da SARS-CoV.
Wasu marasa lafiya na COVID-19 ba su da cutar SARS-CoV-2 kuma gwajin RNA na yau da kullun na iya nuna rashin cutar.
A gefe guda kuma, marasa lafiya da suka warke na iya sake kamuwa da cutar.
Wadannan binciken sun kara hadarin yaduwar cutar sosai.
A yayin da ake ci gaba da bincike kan cutar COVID-19, akwai wasu muhimman batutuwa da za a ci gaba da magance su:
Daga ina SARS-CoV-2 ya fito?
Ko da yake an gano daidaiton kwayoyin halittar kashi 96 cikin dari tsakanin SARS-CoV-2 da SARS-CoVs na bakin teku, ba za mu iya yanke shawarar cewa SARS-CoV-2 na bakin teku ba.
Wani dan wasan kwallon kafa ya ce, "A cikin 'yan wasan da suka yi wasa a gasar cin kofin duniya, akwai wasu da suka yi wasa a gasar cin kofin duniya, kuma sun yi wasa a gasar cin kofin duniya".
Ba tare da sanin amsoshin 1 da 2 ba, ba za mu iya dakatar da yaduwar cutar yadda ya kamata ba, kuma barkewar cutar na iya sake faruwa a kowane lokaci.
Yawancin bincike na kwayoyin halitta da nazarin kwayoyin sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, amma ta yaya ainihin yadda kwayar cutar ta shiga cikin ƙwayoyin numfashi da kuma haifar da canje-canje na pathological?
Shin kwayar cutar ta hada kai da kwayoyin da ke nuna ACE2 a wasu sassan jikin mutum?
Idan ba tare da amsoshi masu ma'ana ga waɗannan tambayoyin ba, ba za mu iya samun saurin ganewar asali da kuma ingantaccen magani ba.
A cikin wannan labarin, mun tattauna yadda za a magance wannan annoba.
Ta yaya kwayar cutar ke canzawa daga mutum zuwa mutum?
Zai iya zama annoba, ya ɓace kamar SARS, ko kuma ya sake dawowa kamar mura?
Ko da yake yana da muhimmanci, zai iya ɗaukan lokaci kafin a sami amsoshin tambayoyin da aka ambata a sama da kuma wasu da yawa.
Amma duk da haka, ba mu da wani zaɓi don dakatar da cutar da wuri-wuri kuma mu koma rayuwarmu ta yau da kullun, ko da menene farashin.
An gano cewa cutar coronavirus ta mutum ta samo asali ne daga kwayar cutar coronavirus.
Juyin halittar halitta da daidaitawa sun tura juyin halitta tare da kwayar cutar corona (CoVs) da kuma masu daukar bakuncin su, wadanda suka hada da mutane, har tsawon shekaru.
Kafin 2003, an gano cewa nau'ikan CoVs guda biyu (HCoVs) a cikin mutane suna haifar da rashin lafiya wanda ba shi da tsanani kamar sanyi.
A cikin annobar cutar ta SARS da cutar ta MERS, an yi wani juyi a kan yadda cutar HCoV za ta iya zama mai hallaka da kuma kisa.
Bayyanar SARS-CoV-2 a cikin babban yankin China a ƙarshen 2019 ya sake ba da damar CoVs, wanda ya ba mu mamaki da yawan yaduwar cutar, amma ya fi ƙarancin cutarwa idan aka kwatanta da nau'in SARS-CoV.
Cutar HCoVs na iya yaduwa daga dabbobi zuwa ga mutane, kuma fahimtar asalin dabbobi na HCoVs zai taimaka mana muyi aiki da kyau.
Yawancin kwayar cutar HCoVs da ta fara kamuwa da su daga batsa sun samo asali ne daga batsa da ba su da cutar.
An kuma gano masu karɓar wasu HCoVs.
Gano dabbobi masu ba da gida yana da alaƙa kai tsaye da rigakafin cututtukan ɗan adam.
Binciken hulɗar mai karɓar kwayar cutar CoV a cikin dabbobi na iya kuma samar da muhimmiyar fahimta game da cutar ta CoV a cikin mutane.
A cikin wannan bita, mun gabatar da cikakken bayani game da nau'ikan HCoVs bakwai da suka wanzu, tare da mai da hankali kan rikodin binciken su da kuma rikicewar tsakanin asalin dabbobi da nau'in su.
Abu mai mahimmanci shine cewa zamu iya kwatanta HCoVs daban-daban daga yanayin juyin halitta na kwayar cuta da kuma sake fasalin kwayoyin halitta.
An tattauna game da cutar COVID-19 a wannan labarin.
Bugu da ƙari, an nuna abubuwan da ake buƙata don sauyawar mai watsa shiri da kuma tasirin juyin halitta na kwayar cutar akan tsananin cutar.
Kwayar cuta ta corona (CoVs) wani nau'in kwayar cuta ce ta coronavirus wanda ya ƙunshi rukuni na ƙwayoyin cuta masu amfani da RNA guda ɗaya.
Wadannan ƙwayoyin cuta suna da siffar kambi a ƙarƙashin microscope, saboda haka sun karɓi mafi girma daga cikin ƙwayoyin cuta na RNA, waɗanda aka sani da CoVs, daga 26 zuwa 32 kilobytes.
Tsarin CoVs yana da ƙwayoyin halitta marasa rarrabuwa waɗanda ke da tsari iri ɗaya.
An kiyasta cewa kashi biyu bisa uku na abun da ke cikin kwayoyin halitta ya ƙunshi manyan sigogi biyu (ORF1a da ORF1b) waɗanda suke a kan juna, wanda aka fassara su a matsayin polyprotein pp1a da pp1ab.
Polyproteins suna aiki don samar da sunadarai 16 marasa tsari, waɗanda aka ayyana a matsayin nsp1 ~ 16.
Sauran sassan tsarin ORFs, wanda ke dauke da kwayoyin halitta, sun hada da spike (S), envelope (E), membrane (M) da nucleoprotein (N).
Hakanan an tsara adadin sunadarai na musamman na CoVs daban-daban.
Bisa ga bambancin jerin sunayen sunadarai, an rarraba masu cutar CoVs zuwa nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan.
Shaidar nazarin kwayoyin halitta ta nuna cewa tsuntsaye sune manyan wuraren tattara gamma-CoVs da delta-CoVs, yayin da berayen da masu ciwon daji ke aiki a matsayin tushen asalin yawancin alpha-CoVs da beta-CoVs.
CoVs sun kasance masu iyakance nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan nau'ikan
A yau, an gano nau'ikan CoVs guda bakwai (HCoVs) da ke haifar da cutar a cikin ɗan adam.
Daga cikinsu, HCoV-229E da HCoV-NL63 sune kwayoyin cutar alpha-CoVs.
Sauran cututtukan kwayar cutar guda biyar sune HCoV-OC43, HCoV-HKU1, cutar coronavirus mai saurin kamuwa da cutar numfashi (SARS-CoV), cutar coronavirus mai kamuwa da cutar numfashi ta Gabas ta Tsakiya (MERS-CoV), da kuma SARS-CoV-2.
Cutar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 suna haifar da alamun rashin lafiya kamar sanyi da / ko zawo.
Idan aka kwatanta, SARS-CoV, MERS-CoV da sabon SARS-CoV-2 suna da babban haɗarin kamuwa da kwayar cutar ta kwayar cuta, suna haifar da kamuwa da cuta mai saurin numfashi tare da ƙaruwa na cututtukan numfashi mai tsanani (ARDS) da cututtukan huhu masu tsanani a cikin marasa lafiya da yawa.
An gano kwayar cutar HCoV-229E ta farko, B814, daga hanci daga wani mai sanyi a tsakiyar shekarun 1960.
Tun daga wannan lokacin, an sami ƙarin sani ta hanyar nazarin duka HCoV-229E da HCoV-OC43 waɗanda ke haifar da alamun iyakance.
A zahiri, har zuwa barkewar cutar SARS, an yarda da cewa kamuwa da kwayar cutar HCoVs ba ta da haɗari.
Cutar SARS da ta barke a 2003 na daya daga cikin mafi muni a tarihin zamani, inda ta cutar da mutane sama da 8,000, kuma ta yi sanadiyar mutuwar kusan kashi 10 cikin dari.
Shekaru goma bayan haka, barkewar cutar ta MERS a Gabas ta Tsakiya ta haifar da barkewar annobar a cikin yankin Larabawa, kuma ta haifar da yaduwar ta zuwa sauran duniya.
HCoV (2019-nCoV) wanda ya bayyana a cikin 2019, wanda daga baya aka sake masa suna SARS-CoV-2, shine babban dalilin cutar coronavirus mai yaduwa ta 2019 (COVID-19), wanda ya kashe mutane 3,120 kuma ya haifar da kamuwa da mutane sama da 91,000, a ranar 3 ga Maris, 2020.
Kamar yadda aka nuna, duniya tana shirin barkewar cutar SARS-CoV-2.
Dukkanin nau'ikan HCoVs guda bakwai da ke iya yaduwa daga dabbobi zuwa ga mutane sun fara kamuwa da su ne daga barbashi, beraye ko dabbobin gida.
Bayanai daban-daban sun goyi bayan asalin HCoVs daga shayarwa, inda ƙwayoyin cuta ke da kyakkyawar jituwa kuma ba su nuna bambancin kwayar halitta ba amma suna da kyau.
Cutar COVID-19 ta haifar da manyan kalubale na likita, kimiyya, zamantakewa da na tunani a China da kuma duniya baki daya.
Binciken asalin kwayar cutar HCoVs yana ba da tsari don fahimtar tarihin halitta, gami da abubuwan da ke haifar da ƙuntatawa na canjin jinsuna.
Hakanan yana iya zama jagora ko kuma tallafawa mahalarta, matsakaici da kuma masu kamuwa da cutar SARS-CoV-2, waɗanda ke da mahimmancin shiga cikin rigakafin kamuwa da cuta a nan gaba.
A cikin wannan bita, mun gabatar da ra'ayoyi game da asalin kamuwa da cutar daga dabbobi zuwa ga mutane, kamuwa da kwayar cutar, da kamuwa da kwayar cutar HCoVs.
Musamman, mun tattauna game da yanayin da ya fi dacewa da kwayar cutar HCoVs, wanda ke iya haifar da rashin lafiya a cikin mahaifansu na halitta amma yana haifar da cutar bayan yaduwar sabon mai masaukin zuwa cikin jinsuna.
Mun kuma sake nazarin tsarin juyin HCoV wanda ke haifar da karuwar yaduwar cutar yayin da cutar ke raguwa.
An kuma tattauna sakamakon barkewar cutar SARS-CoV-2 a halin yanzu.
An san kwayar cutar CoVs ta hanyar dabbobi tun daga ƙarshen 1930.
Kafin a fara ware kwayar HCoV-229E B814 daga abubuwan hanci na marasa lafiya masu yawan kamuwa da mura, an gano bambance-bambancen CoVs a cikin dabbobin da suka kamu da cutar, wadanda suka hada da kaji, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekarun da suka gabata, an gano nau'ikan HCoVs guda bakwai.
An ba da taƙaitaccen tarihin gano cutar HCoVs a cikin jerin shekaru (Table 1) don samar da cikakkun bayanai da fahimta.
An fara ware kwayar HCoV-229E daga marasa lafiya da ke dauke da cutar ta sama a shekarar 1966, kuma daga baya ta daidaita don rayuwa a cikin layukan ƙwayoyin huhu na WI-38.
Marasa lafiya da ke dauke da cutar HCoV-229E suna nuna alamun sanyi da suka hada da ciwon kai, hanci, rashin jin daɗi da ciwon makogwaro, zazzabi da tari wanda aka gano tsakanin kashi 10 zuwa 20% na kamuwa da cutar.
Bayan 1967, an ware HCoV-OC43 daga ci gaban kwayoyin halitta da kuma juyin halitta na gaba a cikin kwakwalwar ƙuda.
Alamomin gwajin kamuwa da HCoV-OC43 da HCoV-229E suna da kamanceceniya, kuma ba za a iya rarrabe alamun cutar daga wasu cututtukan cututtukan numfashi kamar su cutar mura ta A da rhinovirus ba.
Dukansu HCoV-229E da HCoV-OC43 suna da yaduwar duniya kuma suna yaduwa a lokacin hunturu a lokacin yanayin zafi.
A cikin al'ada, nau'ikan cutar biyu suna da lokacin haifuwa na ƙasa da mako guda, tare da makonni biyu na rashin lafiya.
Wani gwaji na ɗan adam mai son rai ya nuna cewa mai lafiya wanda ke kamuwa da HCoV-229E yana da alamun sanyi mai sauƙi.
An samu wasu marasa lafiya masu rauni da ke fama da cutar ta hanyar numfashi mai tsanani.
SARS, wanda kuma aka sani da cutar huhu ta musamman, ita ce annoba ta farko da aka fara rubutawa a tarihin ɗan adam, wanda ke haifar da cutar SARS-CoV, kuma an gano nau'in HCoV na uku.
An gano cewa farkon cutar SARS ta faru ne a ƙarshen 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta bazu zuwa kasashe da nahiyoyi daban-daban a duniya, inda ta yi sanadiyar mutuwar mutane 774 da kuma kamuwa da cutar a cikin mutane 8,096.
An kiyasta cewa za a iya samun kusan mutane biyu da suka kamu da cutar a cikin kwanaki 4 zuwa 7 na lokacin farawa, ban da waɗanda ke kamuwa da cutar a cikin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin.
A cikin marasa lafiya da ke dauke da cutar SARS-CoV, alamun cututtukan numfashi na ƙarshe sun bayyana bayan bayyanar ciwon tsoka, ciwon kai, zazzabi, rashin jin daɗi da tashin zuciya, da kuma rashin numfashi da tari.
Rashin ƙarancin ƙwayoyin lymphocytes, rikitarwa a gwajin aikin hanta, da kuma ƙaruwa a cikin metabolism na enzyme sune abubuwan da ke faruwa a cikin SARS.
An kuma lura da lalacewar ƙananan ƙwayoyin huhu, ƙaruwa a cikin ƙwayoyin epithelial na huhu, da ƙaruwa a cikin ƙwayoyin ƙwayoyin ƙwayoyin cuta (macrophages) a cikin marasa lafiya da ke dauke da cutar SARS.
Kimanin kashi 20-30% na marasa lafiya suna buƙatar kulawa ta ciki da taimakon na'urar numfashi.
Cutar ta iya kamuwa da ƙananan hanyoyin numfashi, da kuma wasu sassan jiki, ciki har da hanta da koda, kuma ana iya samun sa ta hanyar wani yanayi mai tsanani na kwayar halitta da ake kira cytochine storm, wanda zai iya zama mai mutuwa a cikin marasa lafiya masu fama da cutar, musamman marasa lafiyar da ke fama da rashin kariya.
An fara gano cutar ne ta hanyar gwajin ƙwayar huhu na wani mai cutar da ya yi tafiya daga Guangzhou zuwa Hong Kong.
Tun daga wannan lokacin, an yi gagarumin ƙoƙari wajen gano cutar HCoV.
An ware HCoV-NL63 daga jariri mai wata bakwai a Netherlands a ƙarshen 2004.
An gano cewa ana yaduwa a cikin yara ƙanana, tsofaffi, da marasa lafiya masu rauni tare da cututtukan numfashi.
A cikin cututtukan da ke haifar da HCoV-NL63, alamun sun hada da kumburi, ciwon ido, zazzabi da kuma ciwon huhu.
Wani bincike mai zaman kansa ya nuna cewa an gano irin wannan kwayar cutar a hancin wani jariri mai wata takwas da ke fama da cutar huhu a Netherlands.
An gano shi a Netherlands, amma a zahiri ya yadu a duk duniya.
An kiyasta cewa HCoV-NL63 yana haifar da kimanin kashi 4.7% na cututtukan numfashi, tare da mafi yawan lokuta a lokacin bazara, bazara da farkon hunturu.
HCoV-NL63 yana da alaƙa da ciwon makogwaro wanda aka fi sani da ciwon makogwaro.
A cikin shekarar, an ware HCoV-HKU1 daga wani mai shekaru 71 da ke asibiti da cutar huhu da kuma cutar huhu a Hong Kong.
Baya ga cutar huhu da cutar sankarar bargo da ke yaduwa a cikin al'umma, an ba da rahoton cewa HCoV-HKU1 yana da alaƙa da mummunan cutar sankarar bargo.
An gano HCoV-HKU1, wanda ke haifar da cutar numfashi mai laushi, wanda yake kama da HCoV-NL63, HCoV-229E da HCoV-OC43, a duk duniya.
Dukkanin nau'ikan HCoVs guda huɗu da aka samu daga al'umma suna da ƙarancin yiwuwar canzawa ta hanyar kwayar halitta wanda zai iya zama mai jituwa da ɗan adam kuma ya haifar da ƙarin cututtukan da ke haifar da kwayar cutar gaba ɗaya, amma a cikin wani yanayi mai wuya, an gano wani nau'in kwayar cutar HCoV-NL63 mai saurin yaduwa da cutar da ke iya cutar da ƙananan hanyoyin rayuwa a cikin China.
Gabaɗaya, waɗannan HCoVs suna da ƙarancin ƙarfi ko rashin cutarwa yayin da suke da tasirin watsawa da ci gaba da kasancewa tsakanin mutane.
An fara ware kwayar cutar MERS-CoV a cikin 2012 daga huhu na wani mutum mai shekaru 60 da ke fama da cutar huhu da kuma rashin aikin koda a Saudiyya.
A gaskiya, yawancin cututtukan da aka tabbatar da su a dakin gwaje-gwaje sun samo asali ne daga Gabas ta Tsakiya, kuma an ba da rahoton ɓarkewar cututtukan daga wasu wurare, wanda wani lokacin ya samo asali ta hanyar hulɗa ta kusa, a cikin ƙasashen Turai da Tunisia.
Wani sabon fashewar cutar a shekarar 2015 ya faru ne a Koriya ta Kudu inda aka tabbatar da kamuwa da cutar mutum 186.
A cikin bayanin da aka yi na SARS da MERS, wanda ke da kamanni, ana nuna alamun ci gaba a matsayin mummunar cutar huhu.
Ba kamar SARS ba, yawancin marasa lafiya da ke dauke da cutar MERS sun sami mummunan lalacewar koda, wanda ya sanya MERS ta zama ta musamman tsakanin cututtukan da HCoV ke haifarwa.
Fiye da kashi 30 cikin dari na waɗanda suka kamu da cutar suna nuna alamun ciwon ciki da na ciki kamar su amai da amai.
A ranar 14 ga watan Fabrairun 2020, an samu rahoton kamuwa da cutar fiye da 2,500 da aka tabbatar da gwajin gwaje-gwaje, tare da yawan mutuwar kashi 34.4%, wanda ya sanya MERS-CoV daya daga cikin cututtukan da suka fi kowa barazana da aka taba gani.
An gano wasu gungun masu fama da cutar huhu a Wuhan, lardin Hubei, China, a tsakiyar Disamba zuwa ƙarshen Disamba, 2019, bisa ga nazarin da aka yi game da cutar SARS-CoV-2.
Kungiyar Lafiya ta Duniya ta ayyana barkewar cutar SARS-CoV-2 a matsayin gaggawa ta lafiyar jama'a mai matukar damuwa a duniya, kuma ta sanya sunan cutar COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da kamuwa da cutar a duniya, wanda ya kai kashi 3.4% na masu mutuwa.
A cikin wannan labarin, an nuna cewa yawan mutanen da suka mutu a birnin Hubei na kasar Sin ya kai kashi 4.2 bisa dari, yayin da na kasashen waje ya kai kashi 1.2 bisa dari.
Cutar SARS-CoV-2 tana da mummunar kamuwa da cuta ta hanyar numfashi kamar SARS-CoV da MERS-CoV, wanda ke nuna alamun zazzabi, tari da wahalar numfashi.
Wasu marasa lafiya suna da zawo.
Cutar huhu na daya daga cikin cututtukan da suka fi tsanani, kuma yana iya kara zuwa wani mummunan cututtukan numfashi.
Koyaya, SARS-CoV da SARS-CoV-2 suna da kamanceceniya sosai saboda yawan kwayoyin halitta na kashi 82%, kuma an rarraba su zuwa ƙananan rukunin bishiyoyin halittu.
SARS-CoV-2 yana da ƙananan cututtuka amma yana da yaduwar yaduwa fiye da SARS-CoV da MERS-CoV.
An kuma gano wasu mutane da ke dauke da cutar SARS-CoV-2 ba tare da nuna alamun cutar ba, wanda hakan na iya zama wani abu da ya haifar da saurin yaduwar cutar a duniya.
A cikin wannan labarin, an bayyana cewa SARS-CoV-2 yana da cututtuka da yawa da kuma bambance-bambance tsakanin SARS-CoV-2 da sauran nau'ikan HCoVs shida.
An yi amfani da wannan hanyar don gano yanayin da ke tattare da cutar HCoVs.
A cewarsa, SARS-CoV-2 yana bin tsarin da sauran nau'ikan HCoVs shida ke bi.
Na biyu, yanayin cutar COVID-19 ya kasance tsakanin SARS-CoV da nau'ikan HCoVs guda huɗu (HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63) waɗanda suka fi yawa a cikin jama'a.
A gefe guda, kamuwa da cutar SARS-CoV-2 tana nuna alamun cututtukan da aka saba gani a cikin kamuwa da kwayar cutar HCoVs a cikin mutane, gami da bayyanar cututtukan da ba a nuna alamun cutar ba ko kuma marasa tsanani ko kuma marasa alamun cutar.
A wasu kalmomi, ƙananan ƙananan lokuta na COVID-19 masu tsanani suna faruwa a cikin SARS-CoV.
Na uku, yana nuna wasu halaye masu ban sha'awa na HCoVs da SARS-CoVs masu yaduwar zamantakewar al'umma a cikin cutar SARS-CoV-2.
A gefe guda, cutar SARS-CoV-2 tana da cutarwa, aƙalla kamar HCoVs a cikin mutane.
A wasu kalmomi, ko cutar SARS-CoV-2 ta ragu bayan kamuwa da cutar a cikin mutane, kamar yadda ya faru a SARS-CoV da MERS-CoV, har yanzu ana bukatar a bincika.
A ƙarshe, ana iya gano SARS-CoV-2 a cikin ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar ƙazamar
Ana bukatar nazarin gwaji na gaba don bayyana ko cutar SARS-CoV-2 ta hanyar hanci da jini tana taka muhimmiyar rawa a cikin cutar SARS-CoV.
Yana da ban sha'awa musamman idan za a iya gano SARS-CoV-2 wanda ke fitowa daga yanayi kamar yadda ake iya ganowa daga kamuwa da cuta ta hanyar HCoVs.
Koyaya, fasalulluka na SARS-CoV-2, gami da iyawar yaduwar cutar, cutar, da kuma iyawar yaduwar cutar bayan barkewar cutar a cikin mutane, na iya tasiri ga ƙarshen barkewar COVID-19.
Dukkanin nau'ikan HCoVs guda huɗu na al'umma suna haifar da alamun rashin ƙarfi kuma suna da kyau a cikin mutane.
A wani bangare kuma, yana iya zama gaskiya cewa mutane sun daidaita da waɗannan nau'ikan HCoVs huɗu.
A wasu kalmomi, duka biyun na iya zama ragowar cututtukan HCoVs na annoba na baya.
An cire mutane da suka kamu da HCoVs da ke haifar da kamuwa da cuta mai tsanani a cikin mutane da kuma wadanda suka kamu da cutar HCoVs.
Don yin hakan, HCoVs suna yin kwafi a cikin mutane don ba da isasshen lokaci don daidaitawa da haɗuwa da abubuwan da ke hana su.
A wannan yanayin, da zarar cutar SARS-CoV-2 ta yi tsawo, za ta iya cutar da mutane da yawa kuma za ta iya daidaitawa da mutane masu rai.
Idan ya daidaita, zai yi wuya a hana yaduwar cutar a cikin mutane masu rai ta hanyar keɓewa ko wasu matakan sarrafa cutar.
Shekaru da yawa, CoVs na cikin al'umma suna yaduwa tsakanin mutane, suna haifar da mura a cikin mutanen da ke da rigakafi na yau da kullun.
Wadannan ƙwayoyin cuta ba sa bukatar dabbobi masu karɓar bakuncin su.
Idan aka kwatanta, SARS-CoV da MERS-CoV masu yawan kamuwa da cuta ba su da jituwa sosai a cikin mutane, kuma ba za su iya hana yaduwar cutar a cikin mutane ba.
Suna buƙatar riƙewa da yaduwa a cikin dabbobi masu ɗaukar hoto kuma suna neman damar watsawa ga mutane masu rauni ta hanyar ɗaya ko fiye da matsakaici da masu watsawa.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma nau'ikan HCoVs huɗu da ke faruwa a cikin mutane.
Yana da saurin yaduwa kamar nau'ikan HCoVs huɗu da ke faruwa a cikin mutane a halin yanzu.
Koyaya, yana da saurin kamuwa fiye da HCoVs na zamantakewar al'umma kuma yana da saurin kamuwa da cutar fiye da SARS-CoV ko MERS-CoV.
Ya daidaita sosai ga mutane kuma har yanzu yana yaduwa daga mutum zuwa mutum ba tare da kamuwa da cutar ko kuma matsakaiciyar kamuwa da cutar daga dabbobi ba.
Kafin tattauna asalin dabbobi na HCoVs, an tattauna abubuwan da suka bambanta da kuma bambancin HCoVs dangane da juyin halitta, yanayin, ajiyar cuta, matsakaici da fadada.
Idan dabba ta sami wani dangi na kusa wanda ke da babban daidaito a matakin tsarin kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar kwayoyin halittar HCoVs.
Kwayar cutar ta farko tana da sauƙin daidaitawa kuma babu kamuwa da cuta a wannan wurin.
Mai karɓar cutar da ke ɗauke da irin wannan kwayar cutar yana ɗaukar HCoV a cikin lokaci mai tsawo.
A cikin duka shari'o'in, masu karɓar cutar sun kamu da cutar ta halitta kuma sun kasance tushen karɓar cutar ta HCoV ko kuma ƙwayoyin cutar asalin su.
A wani bangare kuma, idan HCoV ya fara ne a matsayin matsakaiciyar hanyar shiga kafin ya kai ga mutane, to yana iya kamuwa da cutar gaba daya ba tare da ya daidaita da sabon hanyar shiga ba.
Wannan mai karɓar ba wai kawai yana aiki ne a matsayin tushen tushen kamuwa da cuta tsakanin mutane ba, amma kuma yana aiki ne a matsayin mai karɓar baƙo mai yaduwar cuta wanda zai iya haɓaka yawan kamuwa da cuta tsakanin mutane ta hanyar haifar da kwayar cutar ta ɗan lokaci da kuma cutar ga mutane.
Idan HCoV bai iya sarrafa yaduwarsa a cikin mai karɓar baƙi ba, zai iya haifar da kamuwa da cuta mara kyau.
A gefe guda, HCoVs na iya zama masu cutarwa a cikin mai karɓar bakuncin, wanda ke haifar da ɓarkewar cutar.
A wannan yanayin, matsakaicin yarda ya zama nau'in yarda na halitta.
Bayanai na yaduwar cutar da rigakafin cutar sun nuna cewa an sami tarihin haɗuwa da dabbobi masu farauta a farkon cutar SARS.
Binciken da aka yi bayan barkewar cutar ta hanyar gwajin jini ya nuna cewa masu cinikin dabbobi suna da mafi girman yaduwar maganin SARS-CoV (SARS-CoV IgG) idan aka kwatanta da sauran jama'a.
An gano larvae na cat (Paguma larvata) da kuma albasa a cikin kasuwannin da ke sayar da dabbobi masu rai a matsayin masu dauke da kwayar cutar SARS-CoV, wanda ya yi kama da SARS-CoV.
A bayyane yake cewa, ba a sake samun labarin cutar SARS ba bayan an kashe dukkan kuliyoyin da ke kasuwa.
Koyaya, an nuna cewa cats na daji ko na gonaki ba su da damar kamuwa da SARS-CoV ba tare da hulɗa da dabbobi masu rai ba, kuma cats na iya zama masu karɓar SARS-CoV a matsayin masu karɓar cutar na matsakaici, maimakon masu karɓar cutar ta halitta.
An gano cewa dabbobi daban-daban, musamman a cikin kasuwannin Guangzhou, suna da kashi 80% na rigakafin SARS-CoV, kuma ba a manta da yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa suna iya zama masu karɓar SARS-CoV kai tsaye.
Duk waɗannan suna iya zama masu karɓar cutar SARS-CoV na ƙarshe.
Binciken da aka yi na biye da cutar SARS-CoV a cikin dabbobi ya nuna cewa akwai dangantaka ta kusa da SARS-Rhinolophus bat CoV HKU3 (SARSr-Rh-BatCoV HKU3) wanda ke da alaƙa da SARS, ban da bat CoV a cikin madarar dawakai na kasar Sin.
Wadannan shinkafa suna da kwayar cutar SARS-CoV kuma suna da tsarin kwayar halitta iri daya da SARSr-Rh-BatCoV HKU3.
Wannan da sauran CoVs na bat suna da kamanceceniya tsakanin SARS-CoV da tsarin kwayoyin halitta na 88-92%.
Wadannan binciken sun kafa sabon ka'idar cewa barayin gida ne da ke dauke da kwayoyin cuta da ke haifar da cututtuka ga mutane.
An gano nau'ikan SARS daban-daban, kamar su CoVs (SL-CoVs), daga batsa, amma ba a iya ware su a matsayin kwayar cutar mai rai ba sai dai don WIV1 da aka ayyana.
An gano enzyme mai sauya fasalin kwayar halittar mutum 2 (ACE2) a matsayin mai karɓar cutar SARS-CoV.
WIV1 ya samo asali ne daga samfurori na hanji na bat, wanda ya nuna cewa bat, cat da kuma ACE2 na mutum suna amfani da su a matsayin masu shiga cikin kwayar halitta.
Wani abu mai ban sha'awa shi ne cutar SARS, wadda ta nuna cewa jini na marasa lafiya da ke fama da cutar ta narcolepsy ya rage lalacewar cutar WIV1.
Ya zuwa yanzu, WIV1 ya nuna cewa yana da kusanci da SARS-CoV a cikin batsa, wanda ke da kashi 95% na daidaiton tsarin kwayoyin halitta.
Duk da irin kamanceceniya tsakanin kwayoyin halittar da ke tsakanin kwayar cutar biyu, ana yarda da cewa WIV1 ba kwayar cutar asali ce da ke da alaƙa kai tsaye da SARS-CoV ba, kuma ba a yarda da cewa batsa ba mai karɓar karɓar karɓar SARS-CoV kai tsaye ba.
Bayanan ilimin halittu na Phylogenetic sun nuna cewa MERS-CoVs suna da kwayar cutar bat CoV-HKU4 da kuma CoV-HKU5 na bat.
CoV-HKU4 da MERS-CoV suna yaduwa ta hanyar mai karɓar mai karɓar dipeptidyl peptidase 4 (DPP4) don shigar da kwayar cutar.
Sakamakon RNA polymerase enzymes na MERS-CoV yana da kusanci da na kwayoyin halittar beta-CoVs da aka gano a Turai da Afirka.
Har zuwa yanzu, ba a gano MERS-CoV a cikin namun daji ba.
MERS-CoV da kuma danginsa na kusa, bat CoV-HKU25, suna da kashi 87% na tsarin kwayoyin halitta na asali.
Saboda haka, ba zai yiwu ba cewa barayin su ne ke da damar kaiwa MERS-CoV kai tsaye.
A wani bangaren kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa raƙuman da ke da nau'in kwari suna iya kamuwa da cutar MERS-CoV, kamar raƙuman da ke da asalin Gabas ta Tsakiya a ƙasashe daban-daban na Afirka.
An cire kwayar cutar MERS-CoV mai kama da kwayar cutar da aka gano a cikin mutane daga hanci na raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
Ya kuma nuna cewa, idan aka gwada da MERS-CoV, raƙuma da ke kamuwa da cutar ba su da wata matsala mai tsanani, amma suna iya daukar kwayar cutar ta hanyar cutar.
Kamel din da ke dauke da cutar ba kawai yana fitar da kwayar cutar ta hanyar numfashi ba, amma kuma ta hanyar hanyar gurbatacciyar hanyar-gurguwar ciki, wacce ita ce babbar hanyar da ake fitar da kwayar cutar daga cikin barkon.
Koyaya, tambayoyin sun kasance game da yiwuwar kamuwa da mutum-da-mutum ko kuma ba a san yadda ake yada cutar ba, wanda ya ƙunshi nau'in dabbobi marasa suna waɗanda ke da cutar MERS-CoV, waɗanda ba su da tarihin hulɗa da raƙuma kafin mummunan harin.
SARS-CoV-2 yana da kashi 96.2% na kwayar halitta tare da CoV RaTG13 wanda aka gano daga Rhinolophus affinis.
Kamar yadda yake a cikin SARS-CoV da MERS-CoV, bambancin sakamakon tsakanin SARS-CoV-2 da RaTG13 ya kasance mai kyau don ƙayyade alaƙar asalin.
Idan ba a gano kusan iri ɗaya ba a nan gaba, ba za a iya cewa batsa ba za ta iya zama mai karɓar bakuncin SARS-CoV-2 ba.
Ana iya tunanin cewa matsakaicin kamuwa da cutar daga dabbobi na SARS-CoV-2 na iya kasancewa tsakanin kisan da aka yi wa nau'in namun daji a kasuwar sayar da abincin teku ta Hunan, wanda ke nuna cewa akwai wasu cututtukan farko da suka shafi COVID-19 da kuma yanayin watsawa daga dabbobi zuwa mutane.
Yawancin binciken da aka yi kwanan nan bisa sakamakon binciken kwayoyin halitta sun nuna cewa wani karamin rukuni na dabbobi masu shayarwa da aka sani da cutar ta Manis javanica na iya daukar nauyin beta-CoVs na asali da ke da alaƙa da SARS-CoV-2.
Wannan sabon kwayar cutar ta CoV tana da kashi 85 zuwa 92% na SARS-CoV-2 a cikin kwayar halitta.
Duk da haka, suna da kusanci da kusan kashi 90% na halaye tare da RaTG13 a matakin tsara kwayar halitta.
Sun haɗu zuwa ƙananan ƙwayoyin cuta guda biyu na SARS-CoV-2 da kuma irin wannan ƙwayoyin cuta a kan bishiyar juyin halitta, ɗayan wanda ya fi kama da mai karɓar karɓa (RBD) wanda ke dauke da SARS-CoV-2 tare da 97.4% na keɓaɓɓun tsarin amino acid.
Bambanci na musamman shine cewa RBDs na SARS-CoV-2 da RaTG13 suna da babban digiri na daidaito a cikin jerin kwayoyin halittarsu, duk da cewa sun fi bambanta.
Wani bincike na farko kan kwakwalwan da ke dauke da cutar ya nuna cewa cire kwayar cutar daga samfurorin huhu ya canza zuwa wani hali mai kama da SARS-CoV-2.
Wannan binciken ya hada maɓuɓɓugar bayanai daban-daban kuma ya tsaya ne a kan ƙoƙarin warkar da cututtukan mutane don haifar da wani bangare na sakamakon kwayar cutar na kashi 86.3 cikin dari na asalin kwayar cutar.
Ba a kuma cire yiwuwar cewa farantin zai iya zama mai karɓar bakuncin SARS-CoV-2 ba.
Koyaya, a halin yanzu, bambancin sakamakon binciken tsakanin SARS-CoV-2 da beta-CoVs na SARS-CoV-2 na platelet ba zai iya tabbatar da cewa SARS-CoV-2 ya samo asali kai tsaye daga kwayar cutar platelet ba.
Bugu da kari, tazarar tsakanin SARS-CoV-2 da RaTG13 ta fi tazarar tsakanin SARS-CoV-2 da SARS-CoV-2 da ke da alaƙa da beta-CoVs.
Ana buƙatar tabbatar da juyin halitta na kamuwa da cutar SARS-CoV-2 a cikin barbashi, tsutsa da sauran dabbobi masu shayarwa.
An gano mafi girman daidaiton kwayar halitta tsakanin SARS-CoV-2 da RBDs, yayin da beta-CoVs masu alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13, ke da mafi girman daidaiton kwayar halitta.
Akwai kuma hasashe da yawa da ke nuna cewa babban kamannin da ke tsakanin RBDs na SARS-CoV-2 da beta-CoVs da SARS-CoV-2 ya samo asali ne daga juyin halitta na zaɓi-solution.
Amincewar tana buƙatar haɗuwa tsakanin beta-CoV mai alaƙa da SARS-CoV-2 da RaTG13 na nau'in dabbobi na daji na uku.
Ana iya ganin cewa bambancin da ke haifar da sauyin yanayi ya zama babban abin motsawa a cikin juyin halitta, wanda ya zama sananne a tsakanin beta-CoVs.
Har yanzu ana ci gaba da yanke hukunci kan asalin dabbobi na SARS-CoV-2.
Baya ga HCoVs, wadanda ke da babban ci gaban cutar, ana kuma nazarin asalin kwayar cutar HCoV-229E, HCoV-OC43, HCoV-NL63, da HCoV-HKU1.
Shaidar kwayar halitta ta nuna cewa duk HCoV-NL63 da HCoV-229E sun samo asali ne daga CoVs na bat, yayin da aka gano asalin kwayar cutar HCoV-OC43 da HCoV-HKU1 a cikin dabbobi masu cutar.
An bayar da rahoton cewa an gano CoV, wanda aka sanya wa suna ARCoV.2 (Appalachian Ridge CoV), a cikin madara mai launin fata na Arewacin Amurka, wanda ya nuna kusancin HCoV-NL63.
A gefe guda kuma, HCoV-229E yana da alaƙa da kwayar halitta tare da wani nau'in bat CoV da aka gano a Ghana, wanda aka yi wa lakabi da Hipposideros/GhanaKwam/19/2008, kuma ana ganin manyan raƙuma ne ke ɗaukar bakuncinsa.
Don ƙarin haske, an taƙaita ilimin yanzu game da asalin dabbobi, wanda aka sani da HCoVs, a hoto na 1 da kuma tebur na 2.
Nazarin juyin halitta ya nuna cewa akwai shaidar cewa akwai kwayar cutar HCoVs tsakanin jinsuna daban-daban a tarihi.
An rubuta barkewar cutar numfashi a kusan 1890, lokacin da HCoV-OC43 ya shiga tsakanin jinsuna kuma ya kai ga mutane ta hanyar dabbobin gida.
Tarihin yaduwar kwayar cutar HCoV-229E tsakanin jinsuna ba shi da cikakkiyar bayani.
An gano alpha-CoVs na bat da ke da alaƙa da HCoV-229E.
Daga cikinsu akwai alpha-CoV wanda aka samo a cikin dabba mai gashi na nau'in raƙumi.
Akwai shaidu daban-daban na kai tsaye daga bat zuwa mutum.
A cikin wannan yanayin, mutane sun fara saduwa da batsa, ba alpacas ba.
Maimakon haka, mutane suna hulɗa da alpacas sosai.
Na biyu, alpha-CoVs na bat da ke da alaƙa da HCoV-229E sun bambanta a cikin bat, ba tare da haifar da cutar ba, kuma alpha-CoV na alpha-CoV yana haifar da cututtukan numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, alpha-CoV da aka samu a cikin dabbobi masu gashi na raƙumi ba a samu a cikin namun daji.
Saboda wannan, ba a cire yiwuwar kamuwa da kwayar cutar alpha-CoV daga mutane daga wani nau'in dabba mai gashi mai kama da HCoV-229E ba.
A gaskiya ma, batsa ce tushen kai tsaye na ƙwayoyin cuta masu cutarwa ga mutane, ciki har da kwayar cutar rabies, Ebola, Ne-parovirus da kuma cutar shan inna.
Saboda haka, ba abin mamaki bane cewa beraye na iya kaiwa mutane cutar HCoV-229E kai tsaye.
A wasu kalmomin, alpha-CoVs suna aiki ne a matsayin kwayar HCoV-229E, wanda dabba mai gashi mai launin gashi da raƙuma ke aiki a matsayin matsakaiciyar hanyar watsa kwayar cutar daga ƙwayoyin cuta zuwa mutane, kamar yadda yake a lokacin kamuwa da cutar MERS-CoV.
MERS-CoV yana daya daga cikin mafi kyawun misalai na watsawa tsakanin jinsuna, ba kawai daga barbashi zuwa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman.
An gano MERS-CoV wanda ya samo asali ne daga batsa a matsayin farkon ganowa kuma an inganta shi a cikin binciken da aka yi.
An gano cewa barayi suna yada nau'ikan kwayar cutar da ke da matukar tasiri ga musayar sassan kwayoyin halittar tsakanin jinsuna da kuma yaduwar tsakanin jinsuna.
Rayuwa mai tsawo, tarin tsibirai masu kusanci, kusanci da dangantaka da kuma iyawar tashi duk yanayi ne da ke ba da damar masu rarraba cutar.
A wasu kalmomi, MERS-CoV ya kasance a cikin kwandon kwalba na shekaru da yawa.
Wannan ya dace da yanayin da raƙuman suke ciki, inda suka canza daga wurin ajiyar cutar kai tsaye zuwa wurin ajiyar cuta mai dorewa da ke wanzuwa a dabi'a.
An kuma kiyaye MERS-CoV don rage saurin canzawa, wanda ke haifar da rashin ƙarfi a cikin waɗannan dabbobin.
Raramar kamuwa da cutar zuwa ga mutane ta faru ne ta hanyar hadari, wanda ke haifar da cewa mutane ba za su iya yada MERS-CoV zuwa wasu masu karɓa ba.
Idan akwai wani abu, za a iya kwatanta rawar raƙuma a cikin cutar MERS-CoV da rawar da diski ke takawa a cikin cutar SARS-CoV-2.
Musamman beta-CoVs na plaque suna haifar da ƙaruwar kamuwa da cuta a cikin plaques.
Suna iya zama masu karɓar ƙarshen hanya don SARS-CoV-2 da ke da alaƙa da cutar sankarar fata, da kuma beta-CoVs.
Ya kamata a yi la'akari da ko za a lissafa ko a cire yiwuwar daban-daban na cutar SARS-CoV-2 daga dabbobi zuwa mutane a cikin gwaje-gwajen gaba.
Da farko, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun
Mutane na iya raba mahalli tare da batsa ta hanyar kashe batsa ko hakar kwal.
Na biyu, diski na iya zama mai karɓar mai karɓar mai karɓar mai karɓar mai karɓar wanda ya haifar da cutar da ke da alaƙa da SARS-CoV-2.
Mutane sun kamu da cutar ta hanyar yanka da sayar da naman da aka yi musu da kuma cinye shi.
Yawancin dabbobi masu shayarwa, ciki har da dabbobin gida, na iya zama masu saurin kamuwa da SARS-CoV-2.
Binciken rigakafi tsakanin dabbobin gida da na daji ya tabbatar da wannan.
Na uku, ana iya samun cutar SARS-CoV-2 ta hanyar sake haɗuwa da daidaitawa a cikin nau'in na uku wanda ke hulɗa da duka ɓeraye da kuma ƙwayoyin cuta.
Ana ci gaba da bincike kan asalin dabbobi na SARS-CoV-2.
Baya ga masu karɓar dabbobi daban-daban, akwai manyan ayyuka guda uku na kwayar cutar a cikin sauƙaƙewa don ƙetare shingen tsakanin nau'ikan.
Na farko, suna da sauyi mai yawa a cikin kwafin RNA.
Idan aka kwatanta da ƙwayoyin cuta na RNA guda ɗaya, ƙimar canjin CoVs da aka kiyasta ya dogara da tsarin daidaituwa a cikin sabbin masu karɓar CoV, wanda aka ƙayyade azaman matsakaicin matsakaicin canji na matsakaici zuwa matsakaici, a cikin ƙimar sauyawa ~ 10-4 a kowace 2 a kowace shekara.
CoVs suna da enzyme mai karantawa da gyara exoribonuclaese, wanda hana shi yana haifar da sauye-sauye masu yawa, wanda zai iya haifar da lalacewa ko ma rashin rayuwa.
Wani abu mai ban sha'awa, Remdesivir, wanda ke da tasirin nukiliya, an gano cewa yana iya hana kwayar cutar CoV ta hanyar hana wannan kwayar cutar ta endocoronavirus da kuma RNA-dependent RNA polymerase enzymes.
Remdesivir wani magani ne da aka gwada wanda ke da babbar dama wajen yaki da cutar SARS-CoV-2.
Koyaya, ƙimar canzawar CoVs kusan sau miliyan fiye da waɗanda suke maraba da su.
Bugu da ƙari, yawan canji yakan kasance mai girma idan CoVs ba su daidaita da mai ɗaukar cutar ba.
Idan aka kwatanta da SARS-CoV mai saurin canzawa, an ba da shawarar cewa SARS-CoV-2 yana da ƙarancin canji kuma yana da daidaito mafi girma a cikin mutane.
Wannan ya nuna cewa cutar ta riga ta kamuwa da wasu dabbobin da ke kusa da mutane.
Baya ga SARS-CoV-2, yana da alaƙa da MERS-CoV, wanda ya dace da ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙ
A ka'ida, canjin kwayoyin ba zai iya haifar da rashin ingancin alluran rigakafin SARS-CoV-2 da magungunan cutar ba.
Na biyu, babban kwayar RNA a cikin CoVs yana ba da damar sauyawa a cikin gyaran kwayar halitta don sauyawa da sake haɗawa, don haka yana ƙara yiwuwar juyin halitta tsakanin jinsuna, wanda hakan zai ba da damar fitowar sabbin CoVs lokacin da yanayi ya dace.
Ana tallafawa ta da wasu nau'ikan buɗe-karatun tsarin karatu da kuma hanyoyin gina jiki waɗanda ke yin lambar zuwa ƙarshen 3 'na chromosome.
Na uku, CoVs suna canzawa cikin sauri da kuma sau da yawa yayin kwafin RNA ta hanyar wani nau'in kwafin-zaɓaɓɓen kwafi.
Ana samun canjin fiber yayin kwafin RNA na CoV a cikin mai karɓa wanda ke aiki azaman mai ɗaukar hoto.
Babban wadatar samfurori da kuma sake haɗuwa da kwayar RNA na kwayar halitta na iya haifar da sabbin kwayar cutar CoVs.
An gano shaidar juyin halitta na haɗuwa da kwayar halitta ba kawai a cikin HCoV-HKU1 da HCoV-OC43 ba, har ma a cikin CoVs na dabbobi kamar su bat SL-CoV da bat CoV-HKU9.
Amsar mai karɓar kwayar cutar da ke da alaƙa da yaduwar cutar
Baya ga abubuwan guda uku da suka shafi kwayar cutar da aka ambata a sama, wurin da mai watsawa yake da kuma hulɗar kwayar cutar wani babban abu ne wanda ke tasiri kan kamuwa da kwayar cutar tsakanin jinsuna.
A wannan mahallin, an gano sake haɗuwa da SARS-CoV a matsayin misali na al'ada wanda ke nuna hujja na zaɓi a cikin rikice-rikice tsakanin jinsuna.
Dangane da kwatancen SARS-CoVs na mutum da na cat, ana tunanin cewa SARS-CoV na iya haifar da saurin daidaitawa a cikin masu karɓa daban-daban, musamman tare da canje-canje a cikin RBD na furotin S.
A cikin furotin S na CoV, RBD yana da ma'amala mai ƙarfi ta hanyar zaɓaɓɓun mai karɓar mai karɓar ƙwayoyin cuta da kuma amsawar rigakafin rigakafi.
RBD a cikin SARS-CoV yana cikin 318 zuwa 510 amino acid a kan S1 na farko, wanda shine mai karɓar mai karɓar cutar a cikin shigar da kwayar cutar, ban da ACE2 na ɗan adam.
RBD na SARS-CoV yana iya ganewa a cikin nau'ikan masu karɓar ACE2 na dabbobi daban-daban, gami da bat, catfish, beraye da kuma tiger.
A zahiri, an bincika nau'ikan amino acid guda shida ne kawai daga kwayar cutar ta mutum da cat da ke keɓewa a cikin RBD, kuma huɗu daga cikinsu suna cikin masu karɓar ACE2 waɗanda ke da alaƙa da masu karɓar don hulɗa.
SARS-CoV na cat yana da sauye-sauye K479N da S487T a cikin RBD, wanda zai iya haɓaka iyawar mai karɓar ACE2 na ɗan adam da kuma haɗin haɗin haɗin (spike) na furotin.
A wasu kalmomi, maye gurbin waɗannan amino acid guda biyu na iya zama mahimmanci ga rashin lafiyar mutum.
Abin lura shi ne SARS-CoV-2 yana da mai karɓar mai karɓar ƙwayar cuta mai kama da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin sashin S1 na furotin S ya nuna cewa furotin S na iya samun canji a cikin daidaiton ACE2 na ɗan adam.
A zahiri, binciken cryo-EM ya nuna cewa akwai haɗuwa da sauri sau 10 zuwa 20 fiye da haɗin haɗin tsakanin ƙwayoyin ACE2 na ɗan adam da SARS-CoV S.
Yana da ban sha'awa kuma don tantance ko wani babban wurin zama yana da mahimmanci don yaduwar SARS-CoV-2.
Abin sha'awa, HCoV-NL63 yana da alaƙa da ACE2, amma tare da wani ɓangare na S.
Akwai wasu wuraren ajiyar cutar HCoVs da yawa, kamar su N amino peptides don HCoV-229E da 9-O-acetylated cysteine don HCoV-OC43.
Ana iya la'akari da su don yiwuwar nasarar daidaitawa na CoVs a cikin mutane bayan yaduwar kwayar cutar a cikin jinsuna daga masu ba da izinin dabbobi.
Baya ga masu karɓar kwayar halitta, wasu dalilai da ƙuntatawa waɗanda suka dogara da mai karɓar baƙi suna mamaye sakamakon kamuwa da kwayar HCoVs tsakanin jinsuna.
Bambancin dake tsakanin mutane da wuraren da HCoVs ke kamuwa da cutar, kamar su batsa, raƙuma da beraye, na iya zama wani shinge ga rikice-rikice na kamuwa da cuta.
HCoVs suna buƙatar mamaye wuraren da aka ƙuntata su don samun nasarar yaduwar cutar ta hanyar mamaye wuraren da aka ƙuntata su.
A wannan yanayin, har yanzu akwai buƙatar gano abubuwan da ke cikin kwayoyin a cikin mahimman hanyoyin hulɗar kwayar cutar da mai masaukin baki da kuma gano fasalin bayyanar.
Yin amfani da mafi girman matakin CRISPR na iya taimakawa wajen gano tushen mai karɓar cutar da kuma ƙuntatawa ga SARS-CoV-2 a cikin binciken kwayoyin halitta na bambancin bambancin.
An bayyana sabon kwayar cutar HCoVs: koma baya zuwa asalin
Bambancin bambancin CoVs na Bat yana ba da dama ga sabon bayyanar HCoVs.
A wannan yanayin, CoVs na bat suna aiki a matsayin magungunan HCoVs.
Bugu da ƙari, saurin canzawa da haɗuwa da kwayar halitta suna haifar da juyin HCoV kuma suna aiki a matsayin matakai biyu masu mahimmanci a cikin wannan tsari.
Misali, adanawa ko rasa kwayoyin halittar da ke yin kwafin sabon furotin na iya canza fasalin kwayar cutar sosai.
An yi tunanin cewa ORF8 yana da mahimmanci a cikin daidaitawa a cikin mutane saboda an gano cewa ƙwayoyin cuta masu alaƙa da SARS-CoV suna rarrabuwa amma suna ɓoye wasu sunadaran ORF8 daban.
An gano siffofin da ke hana kwayar halitta ta 29-genome na SARS-CoVs a cikin nau'ikan da aka ware a farkon kamuwa da mutane.
Wannan kawar za a iya la'akari da shi azaman canji mai dacewa ta hanyar ORF8 zuwa ORF8a da ORF8b da musayar mai karɓar ajiyar cuta.
Bugu da kari, SARS-CoV na iya samun tarihin sake haɗuwa ta hanyar jerin alpha- da gamma-CoVs waɗanda ke da ƙananan ƙananan yankuna masu sake haɗawa waɗanda aka rarrabe a cikin enzymes na RNA polymerase.
Ana iya rarrabe wuraren sake haɗuwa a cikin nsp9, nsp10 mafi yawa, kuma a cikin sassan nsp14.
Hakazalika, cutar MERS-CoV da ta barke a cikin tumatir da ke cikin Saudi Arabiya ta nuna cewa an sami sake haɗuwa tsakanin dangi daban-daban.
Baya ga SARS-CoV da MERS-CoV, an gano abubuwan da suka faru na sake haɗuwa a cikin sauran HCoVs, kuma binciken ya nuna cewa HCoVs suna sake haɗuwa da wasu CoVs na dabbobi a cikin kwayoyin halittarsu waɗanda ba su da alaƙa da tsarin su.
Ya kamata a lura cewa zaɓin da ba na halitta ba zai iya haifar da canje-canje da ba a so a cikin ƙwayoyin halittar kwayar cutar, wanda zai iya haifar da sauƙin zaɓin da ke shafar ƙwayoyin cuta, kamar tsarin rigakafin mai masaukin baki.
Misali na irin wannan tasirin shine asarar ORF4 gaba daya a cikin kwayar HCoV-229E wanda ke haifar da lalata kwayar nukiliya biyu.
Yayin da aka gano ORF4 wanda ba a lalata shi ba a cikin ƙwayoyin cuta na bat da camel da ke da alaƙa da HCoV-229E, alpha-CoV na alfa-farin ya nuna shigar da kwayar halitta guda ɗaya wanda ke haifar da ƙaura.
A ƙarshe, amma mafi mahimmanci, juyin halitta na sabon kwayar cutar HCoVs yana da tasiri ta hanyar zaɓin tilas a cikin wuraren karɓar su.
Lokacin da aka kamu da CoVs a cikin barayi, ba a nuna alamun cutar ko kuma a nuna alamun cutar mai laushi, wanda ke nuna alaƙar CoVs da barayin.
Ya nuna cewa barayin sun dace da CoVs da kuma bangarorin jiki.
Misali, rashin daidaito a cikin motsawar amsawar kumburi a cikin beraye yana rage tasirin kamuwa da kwayar cutar ta CoVs.
Bugu da ƙari, aikin kwayar cutar mai kisa a cikin beraye yana da rauni saboda ƙaruwa a cikin mai karɓar karɓar karɓar karɓar NKG2/CD94 da ƙananan ƙarancin ƙwayoyin ƙwayoyin ƙwayoyin cuta na rukuni na I.
Bugu da ƙari, nau'ikan oxygen masu karɓa (ROS) waɗanda aka samar ta hanyar aikin metabolism na batsa suna hana kwafin CoVs kuma suna shafar duka karatun da enzyme exoribonuclease ke yi, don haka yana ba da matsin lamba don samar da nau'ikan ƙwayoyin cuta masu saurin kamuwa da cuta lokacin da aka gabatar da su cikin sabon mai karɓar cutar.
Hakanan bambance-bambancen CoV masu cutarwa na iya canzawa ta hanyar sake haɗuwa, wanda ke haifar da adana sabbin sunadarai ko siffofin furotin don dacewa da mai masaukin.
Saboda haka, ba zato ba tsammani cewa sabon fitowar HCoVs a cikin shekaru ashirin da suka gabata ba haɗari ba ne.
CoVs ba su da alamun cutar ko kuma suna haifar da alamun cutar a cikin masu karɓar ajiya kamar su bat da raƙuma.
Suna yin kwafi sosai ba tare da su kwace amsawar rigakafin mai karɓa ba.
A nan ne asirin yadda masu dauke da cutar ke iya samun cututtuka masu tsanani a cikin mutane da ba su nuna alamun cutar ba.
Alamun cutar suna da tsanani saboda yawan amsawar rigakafi da kuma bayyanar cututtukan numfashi, wanda ya sa cutar huhu ta fi tsanani yayin da amsawar rigakafin ta fi karfi.
Akasin haka, akwai bambanci tsakanin amsawar rigakafi daga kwafin CoV yayin rashin alamun kamuwa da cuta.
Hanyar katsewar amsawar rigakafi, wata dabara iri ɗaya wacce ke shafar maganin rigakafin SARS-CoV-2, na iya zama mai fa'ida.
Amsar rigakafin cutar tana da ƙarfi musamman a cikin ɓeraye.
Saboda haka, ciyar da nau'in nau'in I na iya zama mai amfani, aƙalla a farkon matakin kamuwa da cutar SARS-CoV-2 a cikin mutane.
Bugu da ƙari, ƙwarewar NLRP3 a cikin ƙwararrun ba cikakke ba ne.
Saboda wannan dalili, ƙuntatawa na MCC950 da NLRP3 na iya zama da amfani a cikin maganin COVID-19.
An gano cewa bayyanar cutar SARS-CoV-2 ta kasance cikin tsari na yau da kullun kamar yadda bayyanar SARS-CoV da MERS-CoVs suka kasance.
A zahiri, an gano cewa beta-CoV na bat yana da kashi 95% na kwayar halitta tare da SARS-CoV, kuma beta-CoV na bat yana da kashi 96% na kwayar halitta tare da SARS-CoV-2.
A zahiri, an gano cewa cat da sauran dabbobi da ke kasuwa suna da kwayar cutar da ta yi daidai da SARS-CoV, kuma ba a gano masu karɓar karɓar karɓa kai tsaye ga SARS-CoV-2 ba.
An gano beta-CoVs na platelet suna da alaƙa da SARS-CoV-2, kuma an nuna cewa platelets na iya zama mai karɓar mai karɓar cutar ta matsakaici ko kuma beta-CoVs na platelet na iya ba da gudummawar wani ɓangare na kwayar halitta zuwa nau'in SARS-CoV-2 na ƙarshe.
Duk da cewa tambayoyi na ci gaba, babu wata hujja da ta nuna cewa SARS-CoV-2 ya kasance sanadiyar ko kuma ba da gangan ba.
An sake dawo da CoVs saboda barkewar cutar SARS-CoV-2.
Nazarin CoVs a cikin beraye da sauran dabbobi ya canza fahimtarmu game da mahimmancin dabbobi a cikin yaduwar kamuwa da cuta ta hanyar asalin dabbobi da kuma yadda ake daukar HCoVs.
Akwai shaidar da ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 sun samo asali ne daga bat kuma sun yadu ga mutane ta hanyar kamuwa da cutar ta matsakaici.
Idan aka yi la'akari da cewa cutar SARS-CoV ta samo asali ne daga hulɗa tsakanin mutane da ƙwayoyin cuta a cikin kasuwa, rufe kasuwanni da ke sayar da kifi mai rai da kashe ƙwayoyin cuta na iya kawo ƙarshen barkewar cutar SARS.
A irin wannan dalili, gano beta-CoVs a cikin kwayar cutar ta kwayar cuta, wacce ke da alaƙa da SARS-CoV-2, ya kamata a cire kwayar cuta daga kasuwannin sayar da kayayyaki don hana yaduwar cutar ta hanyar dabbobi.
Koyaya, ko SARS-CoV-2 ya yadu ga mutane ta hanyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfajiyar farfaji.
A wasu kalmomi, MERS-CoV ya kasance a cikin kwando na tsawon lokaci.
A cikin wannan labarin, an bayyana cewa, "Kamar yadda aka yi a baya, an yi amfani da wannan hanya ta hanyar yin amfani da shi a matsayin hanyar da za a iya amfani da ita a cikin gidajen cin abinci, da kuma a cikin gidajen cin abinci.
An rarraba su a duk Gabas ta Tsakiya da Afirka.
Ba zai yiwu a saki dukkan raƙuma ba don sarrafa MERS, kamar yadda aka yi a kasuwannin namun daji a cikin China don hana yaduwar SARS-CoV da SARS-CoV-2.
Ya kamata a yi amfani da cikakkiyar hanyar da za ta iya inganta ingantaccen maganin rigakafin MERS-CoV don raƙuman ruwa, tare da haɗa sauran matakan sarrafa kamuwa da cuta don dakatar da kamuwa da cutar MERS.
Ba za a iya kawar da wadannan ƙwayoyin cuta ba, kuma za a iya samar da sababbin kwayoyin da ke haifar da cutar.
CoVs daban-daban na dabbobi suna yawo a cikin daji.
Akwai bambance-bambancen bat CoVs, musamman wadanda ke da damar yaduwa daga dabbobi zuwa ga mutane.
Akwai damar da yawa cewa waɗannan CoVs na asali zasu iya canzawa kuma su haɗu da haifar da sabbin CoVs waɗanda zasu iya yaduwa da / ko kuma kashe mutane a nan gaba.
Ya kamata a rufe wasu wuraren da ke da al'adun cin namun daji a China don rage hulɗa mara amfani tsakanin mutane da dabbobi.
Tare da wahalar gwajin SARS, MERS da COVID-19, ya kamata a sami shirye-shirye mafi kyau da shirye-shiryen amsawa.
A gaskiya, yawancin ƙwayoyin cuta sun daɗe suna wanzuwa a duniya.
Suna rayuwa a cikin gidajensu har sai an bar su su fita daga jikin su.
Ko da yake akwai wasu halaye a cikin batutuwan da ke taimakawa wajen yaduwar kwayar cutar, mutane za su iya rage haɗuwa da su idan sun san cewa suna nesa da batutuwan da sauran dabbobin daji.
Ci gaba da lura da dabbobi masu rai yana da mahimmanci don ƙarin fahimtar alaƙar muhalli tsakanin CoVs da masu karɓar cutar ta halitta, wanda zai tabbatar da cewa yana da amfani wajen hana kamuwa da cutar daga dabba zuwa mutum da kuma yaduwar cutar nan gaba.
A ƙarshe, hanya mafi inganci don hana yaduwar kwayar cutar ta hanyar dabbobi ita ce nisantar da mutane daga wuraren da za su iya samun ajiyar cututtukan halitta na ƙwayoyin cuta da ke yaduwa ta hanyar dabbobi.
Har yanzu akwai wasu ɓangarori marasa ma'ana a cikin asirin asalin SARS-CoV-2 na dabbobi zuwa mutane.
Da farko, yana da ban sha'awa a ga ko a wane yanayi ne keɓaɓɓun halittu na bat da kuma na kwalta suke da su, idan dabbobin sun iya yada kwayar cutar SARS-CoV-2 zuwa ga kwalta.
Na biyu, idan da akwai wani tasiri na kai tsaye da ake samu a kan cutar daga bakin ɓarayi zuwa mutum, ya kamata a bincika yadda mutane ke kamuwa da cutar daga bakin ɓarayi.
Na uku, idan dabbobi masu shayarwa na uku da gaske ne matsakaici, yana da muhimmanci a bayyana yadda suke hulɗa da nau'ikan halittu daban-daban, ciki har da mutane, batsa da kuma tsinkaye.
A ƙarshe, dabbobi masu shayarwa da yawa, gami da dabbobin gida, suna da saukin kamuwa da SARS-CoV-2 kuma ya kamata a sanya su a cikin sa ido da gwaji don kamuwa da cutar.
Ana sa ran cewa a nan gaba za a iya gano SARS-CoV-2 ko kuma kwayar cutar asalinta, wanda kusan ya yi kama da shi, a cikin mahaifarsu ta halitta, idan sun kasance bat, scarab, ko wani dabba.
Binciken da aka yi a baya zai bayyana hanyar juyin halittar SARS-CoV-2 a cikin dabbobi tare da mahimman abubuwan da ke tattare da rigakafin COVID-19 da sarrafawa a cikin mutane.
Ana buƙatar haɓaka ƙididdigar bincike na waɗanda ake zargi da COVID-19 da waɗanda aka tabbatar da su.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta buga jagorar da ta dace don ganewar asali da maganin kamuwa da cutar coronavirus (2019-nCoV) na 2019, wanda ya ƙunshi ƙwarewarmu kuma ya ba da kyakkyawan tunani don magance wannan annoba ta duniya.
Koyaya, cutar coronavirus 2019 (COVID-19) sabuwar cuta ce kuma fahimtarmu da fahimtarmu suna ci gaba da haɓaka bisa ga binciken bincike na yanzu da ƙwarewar aikin magani, don haka ana ci gaba da sabunta hanyoyin bincike da magani.
A cikin wannan wasikar, mun amsa wani tsokaci game da jagorarmu, kuma mun bayyana sabon tsarin bincike na marasa lafiya da marasa lafiya da aka tabbatar da cutar COVID-19 bisa ga sabon jagorar bincike da magani na COVID-19 (na bakwai) da Kwamitin Lafiya na Jiha na Jamhuriyar Jama'ar Sin ya fitar.
A watan Disamba na 2019, an bullo da cutar coronavirus (2019-nCoV) na 2019, wanda yanzu aka sanya masa suna cutar coronavirus ta 2019 (COVID-19), kuma an sanya wa cutar sunan coronavirus mai saurin kamuwa da cutar numfashi ta 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, WHO ta ayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta rubuta jagorar shawarwari masu sauƙi kuma an buga ta kan layi a cikin Binciken Likita na Sojoji a ranar 06 ga Fabrairu, 2020.
Tun bayan da aka fitar da shi, ya sami kulawa sosai.
Ya kamata a lura cewa ko da yake COVID-19 sabuwar cuta ce, bisa ga binciken da ake gudanarwa da kuma kwarewar likitanci, iliminmu da iliminmu game da cutar yana ci gaba da ƙaruwa, kuma ta haka ne ci gaba da inganta hanyoyin ganewar asali da hanyoyin magani.
A tsakanin 16 ga Janairu, 2020 zuwa 3 ga Maris, 2020, Hukumar Lafiya ta Kasa ta Jamhuriyar Jama'ar Sin (http://www.nhc.gov.cn/) ta fitar da jagororin bincike da magani na COVID-19 wanda ya hada da gyare-gyare guda bakwai dangane da wasu abubuwan da ke canzawa.
Zhou et al., wanda ya gabatar da shawarar da aka yi a kan ƙwarewar asibiti, yanzu ya yi tsokaci kan jagorarmu.
Ƙoƙarinsu ya ba da sabon haske game da hanyarmu kuma zai zama muhimmin abin tunani a cikin magance wannan annoba ta duniya.
Muna godiya da su don aikin da suka yi da kuma amincewa da su.
Amma, bisa ga sabon tsarin bincike da kuma nazarin ka'idojin cutar COVID-19 (na bakwai na bita), aikin su na bukatar sabuntawa.
A karkashin gyare-gyare na bakwai (Maris 3, 2020), idan babu bayyanannen tarihin cutar da za a tabbatar da lamarin da ake zargi, ana buƙatar ɗayan ɗayan abubuwan da ke tattare da cutar da ke tattare da alamun asibiti guda biyu don yin cikakken bincike, ko kuma ya dace da alamun asibiti guda uku:
Bayanan cutar: (1) tafiya ko zama a Wuhan da kewayenta ko wasu wuraren da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) haɗuwa da cutar SARS-CoV-2 (tare da gwajin nucleic acid na roba); (3) haɗuwa da wasu marasa lafiya da ke Wuhan da kewayenta ko wasu wuraren da aka ba da rahoton cutar COVID-19 a cikin kwanaki 14 da suka gabata; (4) haɗuwa da marasa lafiya da ke da alamun cutar ko kuma alamun cutar da ke faruwa a cikin hanyar tafiya; da kuma (2) haɗuwa da wasu marasa lafiya da ke da alamun cutar da ke faruwa a cikin hanyar da aka ba da rahoton cutar (kamar su yara, yara, yara da yara); da kuma 2 / 2 baƙi da ke cikin gida da wuraren shakatawa.
Alamun: (1) rashin lafiya da / ko alamun cututtukan numfashi, (2) alamun a cikin hoton hoto na kamuwa da COVID-19, (3) jimlar adadin ƙwayoyin jini waɗanda ke nuna cewa ƙididdigar ƙwayoyin jini (Lymphocyte) na al'ada ne, raguwa ko raguwa a farkon matakin haɓakawa.
Ya kamata a dogara da yanayin da aka tabbatar da shi ta hanyar mai cutar ko kuma wani shaidar jini kamar yadda aka bayyana a cikin binciken bincike: (1) gwajin PCR na ainihi don SARS-CoV-2, (2) jerin kwayoyin cutar da ke nuna bambancin bambancin da aka sani a cikin sabon coronavirus, (3) gwajin jini a cikin SARS-CoV-2 don kwayar cutar IgM da IgG, ko kuma kwayar cutar SARS-CoV-2-IgG mai cutarwa, ko kuma wani abu mai cutarwa, wanda ya zama mai saurin canzawa, ko kuma ya tashi sama da matakin dawowa fiye da matakin tashin hankali ≥4.
An saka gwajin PCR na lokaci-lokaci don ganowa na kwayar nucleic a cikin hanyoyin numfashi ko samfuran jini a cikin bita na biyu (18 ga Janairu, 2020) da na uku (22 ga Janairu, 2020).
Bayan an kara samfurin jini don gano abin da ke haifar da cutar a cikin gyara na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020), an ƙara tabbacin nazarin jini a cikin sabuntawa ta bakwai.
Waɗannan gyare-gyare sun ba da damar ci gaba da aiki tare da masu bincike don gano mafi kyawun ganowar nucleic acid don saurin ganowa, gami da ɗaukar jini, wanda ke haɓaka wadatar samfuran daban-daban, kuma yana ba da kyakkyawan sakamako na ƙwayoyin cuta na musamman bisa ga ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayyadun ƙayensu.
Bugu da kari, akwai ƙarin tabbaci da ke gargadi mu da mu yi taka tsantsan game da marasa lafiya da ke nuna alamun cutar da kuma marasa cutar.
Saboda haka, ya kamata a sabunta jadawalin gudanawar Zhou et al. saboda sun rarraba mutanen da ba su da alamun asibiti a matsayin masu ƙarancin haɗari.
Tsarin ƙididdiga dole ne a tabbatar da shi ta hanyar ayyukan asibiti da karatu.
A ƙarshe, muna son ƙarin bayanan kai tsaye da kuma tsokaci daga masu karatu.
Muna ba da shawarar cewa duk wanda ake zargi da cutar ko wanda aka tabbatar da cutar ya bi sabbin umarnin da aka bayar a kasashensu.
A matsayinmu na ƙungiya, za mu ci gaba da sabunta jagorarmu a cikin lokaci don taimakawa.
An samu karin mutane biyar da suka mutu sakamakon cutar COVID-19 a Bangladesh, wanda ya kai na yau da kullum.
A jiya, Bangladesh ta tabbatar da sabbin mutuwar COVID-19 guda biyar a cikin kwana ɗaya.
Wannan shi ne adadin mutane da suka mutu a rana guda saboda cutar.
A yau, adadin mutanen da suka kamu da cutar da aka ruwaito daga Cibiyar Kula da Cututtuka da Cututtuka ta Bangladesh (IEDCR) sun hada da marasa lafiya 114 da ke jinya da kuma masu lafiya 33 da ke zaune a gida.
An samu mutuwar mutane 17 a cikin wannan hari.
A wani rahoto na kan layi, Daraktan IEDCR, Dr Meerjady Sabrina Flora ta ce akwai maza hudu da mace daya da suka mutu.
A cewar Dr. Meerjady, marasa lafiya biyu sun haura shekaru 60, biyu suna tsakanin shekaru 51 zuwa 60, kuma daya yana tsakanin shekaru 41 zuwa 50.
Ta kuma ce, biyu daga cikin wadanda suka mutu daga Dhaka ne.
Hukumar Lafiya ta Duniya (WHO) ta ayyana COVID-19 a matsayin annoba a ranar 11 ga Maris.
Wani jami'in asibiti ya shaida wa kamfanin dillancin labarai na Anadolu Agency cewa Jalal Saifur Rahman, daraktan hukumar yaki da cin hanci da rashawa ta Bengal, wanda ke jinya a asibitin Kuwait Maitree, yana daya daga cikin wadanda suka mutu sakamakon cutar.
A cikin wata sanarwa ta bidiyo a ranar Asabar, Ministan Sufuri da Gidajen Bangladesh Obaidul Quader ya ce za a dakatar da sufuri na jama'a har zuwa Asabar mai zuwa fiye da yadda aka tsara.
An fara dakatar da zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya za a kawo karshen ranar Asabar, 4 ga Afrilu.
An ci gaba da ba da izinin jigilar kayayyakin masarufi, magunguna, mai da abinci.
Matsalar COVID-19 ta farko da aka samu a Bangladesh ita ce matar mutum biyu da daya daga cikinsu ya dawo daga Italiya a ranar 8 ga Maris.
A ranar 19 ga watan Maris, dukkansu uku sun warke.
SARS-CoV-2 ya wuce miliyan daya na kamuwa da cutar a duniya
A ranar Alhamis, adadin masu kamuwa da cutar SARS-CoV-2 ya zarce miliyan a duniya, in ji bayanan Jami'ar Johns Hopkins.
Akalla mutane 52,000 sun mutu sakamakon cutar COVID-19, cutar da coronavirus ke haifarwa.
A ranar da aka tabbatar da kamuwa da cutar ta coronavirus a Malawi da kuma mutuwar da ta shafi cutar ta coronavirus a Zambia, wannan rana ce ta kafa sabon tarihi.
A ranar Alhamis, Koriya ta Arewa ta ce tana daya daga cikin 'yan kasashen da ba su da cutar coronavirus.
Har zuwa jiya, Hukumar Lafiya ta Duniya ta ba da rahoton 1,051,635 masu kamuwa da cutar, ciki har da 79,332 da aka tabbatar a cikin awanni ashirin da huɗu da suka gabata a ranar 4 ga Afrilu, 10am (00800 UTC).
A Amurka, an samu sama da 244,000 na cutar coronavirus da ke da alaƙa da mutuwar mutane akalla 5,900.
CBS ta ruwaito cewa, bisa ga bayanan Jami'ar Johns Hopkins, sama da mutane 1000 ne suka mutu a Amurka ranar Laraba sakamakon kamuwa da cutar coronavirus.
A duk duniya, kasashe sun sanar da tsauraran matakai don hana yaduwar cutar.
A ranar Alhamis, magajin garin Moscow Sergei Sobyanin ya tsawaita dokar hana fita a birnin har zuwa ranar 1 ga watan Mayu.
A fadin kasar, Shugaba Vladimir Putin ya sanar da cewa 'yan kasar Rasha za su ci gaba da samun albashi ba tare da zuwa aiki ba har zuwa ranar 30 ga watan Afrilu.
Majalisar Portugal ta kada kuri'ar kara wa'adin gaggawa na kwanaki 15 da kuri'u 215 da suka nuna goyon baya, 10 a kan daya, da kuma 1 a kan daya.
Saudiyya ta tsawaita dokar hana fita a birnin mai tsarki na Makka da Madina har zuwa karshen mako, inda dokar hana fita ta fara aiki ne tsakanin karfe 3 na rana da karfe 6 na safe.
Thailand ta shirya aiwatar da dokar hana fita tsakanin karfe 10 na dare zuwa 4 na safe.
Gwamnan Ohio, Mike DeWine, ya sanar da cewa jihar ta tsawaita dokar hana fita daga gida har zuwa ranar 1 ga Mayu.
An rage iyakar sayen takardar bayan gida a shaguna a Australia.
A ranar Asabar da Lahadi da yamma, kantunan Woolworths da Coles na Australiya sun iyakance takardar bayan gida zuwa fakiti biyu da fakiti ɗaya a kowane sayayya a duk shagunan su na ƙasa.
A ranar Litinin, ALDI ta fara gabatar da iyakancewar sayar da fakiti daya kawai ga kowane mutum.
An sanya takunkumin a kan shafin yanar gizo da kuma a shafukan Facebook na hanyoyin samar da kayayyaki.
Masu sayen suna ta yin ajiyar kayayyaki, idan har ya zama dole, saboda tsoron COVID-19.
A ranar Laraba, Woolworths ya kuma iyakance sayen takardar bayan gida zuwa kaya guda daya a kowane oda.
Wannan canjin ya biyo bayan iyakancewar da Woolworths da Coles suka gabatar a ranar 4 da 5 ga Maris, inda aka fara sayar da kaya guda hudu kawai.
Coles ta ruwaito a cikin wani rahoto da ta fitar a ranar 8 ga watan Maris cewa, a yawancin shagunan da ke sayar da abubuwa hudu kawai, ana sayar da kayayyaki cikin sa'a guda, kuma tana amfani da wannan bukatar a matsayin "ba a taɓa ganin irinta ba", amma a cikin wani sakon Facebook, ALDI ta kira wannan bukatar "ba zato ba tsammani".
Wani mai magana da yawun kamfanin Woolworths ya ce, an samu karuwar tallace-tallace a mako na baya.
Wani kantin sayar da kayan kwalliya a Canberra ya iyakance adadin da aka yarda da shi zuwa biyu a makon da ya gabata.
Don rage karancin kayayyaki, Coles ya ba da umarni da yawa daga masu samar da kayayyaki kuma ya ƙara yawan jigilar kayayyaki. Woolworths ya ɗauki ƙarin kayayyaki kuma ya tabbatar da cewa kayayyaki sun isa da wuri don shirin musamman na ranar Laraba, wanda ALDI ya tsara.
Russell Zinnemann, darektan zartarwa na kungiyar 'yan kasuwar sayar da kayayyaki ta Australiya, ya ce 'yan kasuwar na son kara yawan kayayyakin da suke ajiyewa, amma hukumomin yankin sun takaita lokacin da manyan motocin ke iya zuwa.
Ya ce, "Masu samar da kayayyaki suna kokarin biyan bukatar, kuma suna fatan cewa za a samu karancin al'amura na musamman, wanda zai haifar da karin kudin samarwa".
ALDI ta sanar a ranar Talata cewa wasu shagunan ba za su iya gudanar da siyarwar ranar Laraba ba bayan tallace-tallace na farko.
A wani rahoto da News.com.au ta fitar, Dr. Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce, kantunan sayar da kayayyaki suna cike kayayyaki a kowane dare.
Ya yi sharhi cewa, takardar bayan gida abu ne mai ɗaukar wuri, kuma ƙananan adadi ne kawai za a iya adanawa, kuma lokacin da aka sayar da su, akwai manyan wuraren da aka bari a kan fage, saboda haka rashin takardar bayan gida yana sa mutane baƙin ciki.
Russell Zimmer na ABC News ya ce, "Idan akwai wadataccen kayan aiki a kan dandamali a Coles da Woolworths, idan akwai kayayyaki kamar takardar wanka da kayan tsabtace jiki, da kuma yawan adadin, za ku iya rage haɗarin zuwa mafi ƙarancin".
Kamfanin sayar da takarda na bayan gida mai sake amfani da shi, Who Gives a Crap, ya ce a ranar Laraba sun rasa kayan.
Kamar yadda News.com.au ta ruwaito, kamfanonin samar da takardar wanka na Kleenex, Kimball Clock da kuma kamfanin samar da kayan wanka na Sorben sun yi aiki tukuru na tsawon awanni 24 da 7 don ci gaba da samar da kayayyakin.
Shafin yanar gizo na tallace-tallace na gidaje, Domain.com, ya fara ba da takardar bayan gida kyauta a cikin gwanjo a Melbourne, inda masu sayar da gidaje suka ba da kyauta ga masu siye don samun ƙarin lokacin hutu na mako don ranar ma'aikata.
A cikin jaridar NT da ake bugawa a Darwin a ranar Alhamis, an saka takarda guda takwas da aka yi niyyar amfani da su a matsayin takarda ta gida.
A cewar rahoton ABC Australia na ranar 3 ga Maris, da farko an yi jinkirin sanya takunkumi a shagunan, kuma sun ce ba su da shirin sanya takunkumi ga masu siye.
Russell Zimmerman ya kara da cewa, akwai bukatar kayayyaki da dama, ciki har da abin rufe fuska, kayan tsabtace jiki, kayan bushewa, kayan wanke hannu da gari.
Hakazalika, a waje da Ostiraliya, babban kantin sayar da kan layi na Burtaniya, Ocado, ya iyakance sayen takardar bayan gida na Andres zuwa fakiti 12 a ranar Lahadi.
Hukumar Lafiya ta Duniya ta ayyana annobar COVID-19.
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta ayyana cutar COVID-19 da ke faruwa yanzu, wanda ke haifar da kwayar cutar SARS-CoV-2.
"Yadda cutar ta yadu" kawai tana nufin yadda cutar ta yadu, ba ma yadda cutar ta yadu ba, WHO ta yi gargadin gwamnatoci cewa suna bukatar su dauki matakan:
Kowace ƙasa tana da ikon sauya yanayin annobar.
Babban Sakataren WHO Tedros Adnanum Gebrechtspeer ya ce, "Idan a mayar da martani, kasashe za su gano, gwada, bi da, ware, bi da kuma motsa mutane".
"Muna mai da hankali sosai ga matakan gargadi na yaduwar cutar da kuma matakin gaggawa, da kuma matakin gargadi na zaman lafiya".
A cewar tsohon daraktan Cibiyoyin Kula da Cututtuka da Rigakafin Amurka, Dr. Tom Frieden, annobar ta zama "abin da ba a taɓa gani ba".
A cikin wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce babu wani kwayar cutar numfashi da aka gano da ta ci gaba da yaduwa a duniya sai dai cutar sankara.
Gabriela Yassup ya bayyana irin wannan ra'ayin: "Ba mu taɓa ganin annobar cutar coronavirus ba".
Ya kara da cewa, "Ba mu taɓa ganin wata annoba da za a iya sarrafawa ba".
Bayan fitowar sabuwar cutar ta duniya, WHO ta yanke shawarar ayyana gaggawa ta lafiyar jama'a ta duniya a watan Janairu.
Dokta Anthony Fauci, darektan Cibiyar Kula da Allergies da cututtuka masu yaduwa ta Amurka, ya ce yanayin zai iya zama mafi muni idan aka yi la'akari da yanayin cutar.
A ranar Alhamis, kamfanin dillancin labarai na AP ya ce a duniya akwai akalla mutane 126,000 da suka kamu da cutar COVID-19 kuma sama da mutane 4,600 sun mutu.
Cutar cutar coronavirus ta 2019-20 annoba ce ta cutar coronavirus mai saurin kamuwa da cuta ta 2019 (COVID-19), wanda cutar coronavirus mai saurin kamuwa da cuta ta numfashi ta 2 (SARS-CoV-2) ta haifar.
An gano cutar a watan Disamba na 2019 a Wuhan, China, kuma an ayyana dokar ta baci ta duniya ta 30 ga Janairu, 2020, sannan kuma an ayyana cutar a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, kimanin mutane miliyan 1.61 ne suka kamu da cutar COVID-19 a kasashe da yankuna 210 kuma an kiyasta mutuwar mutane 97,000.
Kimanin mutane 364,000 sun warke.
An kiyasta cewa adadin mutanen da suka kamu da cutar a kasar Sin ya kai kashi 4 cikin dari, yayin da a duniya ya kai tsakanin kashi 13.04 cikin dari a Aljeriya da kuma kashi 0.08 cikin dari a New Zealand.
Alamun da suka fi kowa sun hada da zazzabi, tari da kuma numfashi mai wuya.
Cutar ta iya haifar da ciwon huhu da kuma cututtukan numfashi mai tsanani (Acute Respiratory Distress Syndrome).
Lokacin bayyanar cututtuka daga kamuwa da cutar yawanci yana da kwanaki biyar, amma yana iya ɗaukar kwanaki 2 zuwa 14.
Ba a san maganin rigakafi ko kuma maganin da zai iya kashe cutar ba.
Babban hanyar magani shine magani da taimako dangane da bayyanar cututtuka. Hanyoyin rigakafin da aka ba da shawarar sun hada da wanke hannu, rufe baki idan ka tari, nisantar wasu mutane da kuma keɓe kai da kuma kula da kai idan ana zargin cewa ka kamu da cutar.
Hukumomi a duk duniya sun amsa ta hanyar hana tafiye-tafiye, sanya takunkumin sa ido, dokar hana fita da dare, sarrafa haɗarin aiki da rufe wuraren kasuwanci.
Cutar ta lalata tattalin arzikin duniya, ta haifar da jinkirta ko soke abubuwan wasanni, addini, siyasa da al'adu. Kasuwancin taro saboda tsoro ya kara tsananta rashin wadata a wurare da yawa.
A cikin kasashe 193, makarantu da jami'o'i sun rufe a matakin kasa ko na yanki, wanda ya shafi kimanin kashi 99.4 cikin dari na yawan daliban duniya.
Bayan yada labaran karya game da cutar a yanar gizo, an sami fargaba da nuna wariya ga mutanen da ke zaune a yankin da cutar ta fi yawa, mutanen da ke da asalin Gabas da Kudu maso gabashin Asiya da kuma na kasar Sin.
Rage yawan tafiye-tafiye da rufe masana'antu sun rage gurbataccen iska da kuma fitar da carbon.
Hukumomin kiwon lafiya na Wuhan, babban birnin kasar Sin, sun ba da rahoton kamuwa da cutar huhu a ranar 31 ga Disamba, 2019, sakamakon yanayin da ba a san dalilin ba, kuma an fara binciken a farkon Janairu, 2020.
Yawancin masu cutar suna da alaƙa da kasuwar sayar da kayayyaki ta Hunan, saboda haka ana tunanin cewa cutar ta samo asali ne daga tushen dabbobi.
Kwayar cutar da ke haifar da cutar, SARS-CoV-2, sabon nau'in kwayar cutar da aka gano, tana da alaƙa da kwayar cutar bat coronavirus, kwayar cutar ta scurvy, da SARS-CoV. An gano cewa mai haƙuri da aka fara ganowa da alamun cutar ya kamu da cutar a ranar 1 ga Disamba, 2019.
Kashi biyu bisa uku na farkon kamuwa da cutar da aka ruwaito a watan Disamba na 2019 ya shafi kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba a South China Morning Post ya nuna cewa, idan aka gano wani sabon kamuwa da cutar a ranar 17 ga Nuwamba, 2019, mutum mai shekaru 55 a lardin Hubei na iya zama wanda ya kamu da cutar ta farko. Yayin da sabbin cututtuka ke raguwa a China, an sami tashin hankali a Italiya, Iran da Koriya ta Kudu, kuma adadin sabbin cututtuka a wajen kasar Sin ya zarce adadin sabbin cututtuka a kasar Sin a karon farko, in ji WHO a ranar 26 ga Fabrairu, 2020.
Akwai yiwuwar raguwar yawan adadin wadanda suka kamu da cutar da suka nuna alamun rashin lafiya.
A ranar 26 ga watan Fabrairu, an samu karancin cututtuka a tsakanin matasa masu shekaru 19 zuwa kasa, wanda ya kai kasa da kashi 2.4 na adadin cututtuka a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya Patrick Vallance ya kiyasta cewa kashi 60% na yawan mutanen Burtaniya za su sami rigakafin gungun bayan kamuwa da cutar.
An kira mutanen da suka yi gwajin COVID-19 kuma an tabbatar da cewa suna da cutar a ƙarƙashin ƙa'idodin hukuma masu cutar.
Babu wata kasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta a ranar 23 ga watan Maris, kuma kasashe da dama kamar Italiya, Netherlands, Spain da Switzerland suna da manufofin hukuma na hana gwajin wadanda ke da alamun rashin lafiya.
Wani bincike da aka buga a ranar 16 ga Maris ya nuna cewa kimanin kashi 86% na kamuwa da cutar COVID-19 a China har zuwa ranar 23 ga Janairu ba a gano su ba kuma an gano cewa cututtukan da ba a lissafa su ba ne tushen asalin kamuwa da cutar a kashi 79% na waɗanda suka kamu da cutar.
A cikin wani rahoto da aka fitar a ranar 30 ga watan Maris, an kiyasta cewa adadin wadanda suka kamu da cutar a Italiya ya fi wadanda suka kamu da cutar da yawa.
Hasashen farko na lambar asalin (R0) don COVID-19 ya kasance 1.4 zuwa 2.4.
Wani bincike da Cibiyoyin Kula da Cututtuka da Rigakafin Amurka suka buga ya kammala da cewa zai iya zama 5.7.
Yawancin mutane da ke fama da COVID-19 sun warke.
A cikin mutanen da ba su yi hakan ba, lokaci daga bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, kuma yawanci kwanaki 14 ne don bayyanar cututtuka.
A ranar 10 ga Afrilu, 2020, adadin mutanen da suka mutu sakamakon COVID-19 ya kai kusan 97,000.
A China, kashi 80% na waɗanda suka mutu sun haura shekaru 60 a ranar 5 ga Fabrairu, kuma kashi 75% suna da yanayin kiwon lafiya na asali, gami da cututtukan zuciya da ciwon sukari.
Wannan ba ya haɗa da waɗanda suka mutu ba tare da magani ba, kamar gida, gidajen tsofaffi, da sauransu, saboda ainihin mutuwar COVID-19 na iya zama mafi girma.
Wani ɓangare na bayanan da aka samu daga Italiya ya nuna cewa adadin mutuwar COVID a lokacin barkewar cutar ya ninka sau 4 zuwa 5 na ainihin mutuwar.
Wani mai magana da yawun Cibiyar Kula da Cututtuka ta Amurka (CDC) ya yarda cewa mun san cewa adadin mutuwar ba shi da yawa. Ana yin lissafin ƙasa a Amurka, kuma bayanan da ba a bayyana ba sun tabbatar da wannan bayanin. Irin wannan ƙididdigar sau da yawa yakan faru a lokutan annoba, kamar lokacin annobar cutar naman alade ta H1N1 a shekarar 2009.
Mutuwa ta farko a wajen kasar Sin ta faru ne a kasar Philippines a ranar 1 ga watan Fabrairu, yayin da ta farko a wajen Asiya ta faru a Faransa a ranar 14 ga watan Fabrairu.
A waje da babban yankin kasar Sin, Iran, Koriya ta Kudu da Italiya sun yi rikodin fiye da mutane goma sha biyu da suka mutu kafin ranar 28 ga watan Fabrairu.
A ranar 13 ga watan Maris, an samu mutuwar mutane fiye da arba'in a kasashe da yankuna a duk nahiyoyin duniya, sai dai Antarctica. Ana amfani da hanyoyi da dama wajen lissafin adadin mutuwar.
Waɗannan ƙididdigar sun bambanta dangane da yanki da lokaci, kuma sun sami rinjaye daga halaye na alƙaluma kamar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da kamuwa da cuta ta fara, da shekaru, jinsi, da yanayin gaba ɗaya. Adadin mutuwa da cutar ya raba adadin mutuwar da aka tabbatar a cikin takamaiman lokaci.
A cewar kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.0 (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Adadin ya bambanta daga yanki zuwa yanki.
A cikin kasar Sin, kimantawar cutar da mutuwar ta ragu daga kashi 17.3% (ga mutanen da ke nuna alamun cutar a cikin kwanaki 1 zuwa 10 na Janairu 2020) zuwa kashi 0.7% (ga mutanen da ke nuna alamun cutar bayan 1 ga Fabrairu 2020). Sauran kimantawa sun hada da mafi girman adadin mutuwar cutar (CFR) da ke nuna yawan mutanen da suka kamu da cutar (ko an gano cutar ko ba a gano ba) da kuma yawan mutanen da suka kamu da cutar (IFR).
Wannan ba wani lokaci ba ne, amma an samo shi ne daga yin amfani da ƙwayoyin cuta a cikin mutane da suka kamu da cutar ta hanyar hanyoyin da aka gano cewa sun kamu da cutar.
Masu bincike da dama sun yi kokarin kirga wannan adadi a cikin wasu al'ummomi.
A cewar cibiyar nazarin ilmin da ke tushen bayanan a Jami'ar Oxford, yawan mutuwar da ke tattare da cutar a cikin kowacce annoba ya kai tsakanin kashi 0.1 zuwa kashi 0.39 cikin dari.
Babban kimantawa na wannan sikelin ya yi daidai da binciken da aka bincika tare da ƙididdigar tasirin gwaji akan kimantawar mutuwar da gwajin bazuwar COVID-19 na farko a cikin Jamus.
Hukumar lafiya ta duniya WHO ta ce za a iya shawo kan annobar.
Lokacin da cutar ta kai kololuwa da ƙarshen ba a sani ba kuma yana iya bambanta ta wurin.
Maseboni, daga Jami'ar Jihar Aslan, ya ce idan ba a sarrafa shi ba, za a ci gaba da yaduwar cutar a al'ada kuma za a iya fara rage yawan cutar yayin da masu cutar ke raguwa.
Amma a yanzu, kusan ba zai yiwu a yi hasashen lokacin da hakan zai faru ba.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin China Zhong Nanshan ya ce, idan dukkan kasashe suka hada kai don bin shawarar WHO kan matakan dakile yaduwar cutar, za a iya kawo karshen annobar a watan Yuni.
A ranar 17 ga watan Maris, Adam Kucharski na Makarantar Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula da Kula
Wani bincike da kwalejin Imperial College ta gudanar karkashin jagorancin Neil Furguson ya ce ana bukatar nisantar mutane da sauran matakan har sai an samu allurar rigakafi (wataƙila watanni 18 ko sama da haka).
William Schnaffer na Jami'ar Vanderbilt ya ce ba za a iya ganin cutar ta corona ta kare ba saboda yadda cutar ke yaduwa da sauri, kuma yana iya canzawa zuwa cutar yanayi kuma yana iya dawowa kowace shekara.
Rashin sake kamuwa da cutar ya dogara da rigakafin jama'a da kuma yawan canjin kwayoyin.
Alamun COVID-19 ba su da cikakkun bayanai, kuma mutanen da ke kamuwa da cutar ba sa nuna alamun cutar.
Alamun cututtuka guda biyu da suka fi yawa sune zazzabi (88%) da tari mai bushe (68%).
Alamun da ba sa bayyanawa sun hada da gajiya, fitowar kwayar cutar ta mucous membrane a cikin numfashi, rashin jin ƙamshi, rashin numfashi, ciwon wuya, ciwon tsoka, ciwon kai, rawar jiki, tashin zuciya, toshewar jijiyoyin jini, amai da kumfa. A cewar sanarwar WHO, mutum daya cikin shida da suka kamu da cutar ya kamu da rashin lafiya mai tsanani kuma yana fama da matsalar numfashi.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun ba da alamun gaggawa kamar wahalar numfashi, ciwon kirji ko damuwa, tashin hankali kwatsam, wahalar bacci, da kumfa a fuska ko lebe. Idan akwai alamun, ana ba da shawarar neman kulawar likita nan da nan. Ci gaban cutar na iya zama mai tsanani na ciwon huhu, bayyanar cututtukan numfashi kwatsam, kumburi da mutuwa daga guba ta jini.
Wasu mutane da suka kamu da cutar ba su nuna alamun cutar ba amma an tabbatar da su a matsayin masu kamuwa da cutar a lokacin gwajin. Saboda haka, masu bincike sun ba da shawarar cewa a kula da mutanen da suka yi hulɗa da mutanen da suka kamu da cutar sosai don kawar da kamuwa da cutar.
A kasar Sin, an kiyasta cewa yawan marasa cutar na daga kashi 44 zuwa 100.
Lokaci na al'ada na farawa (lokacin tsakanin kamuwa da cutar da bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa 14, kuma yawanci yana nuna alamun cutar a cikin kwanaki biyar. Wani misali wanda ba a bayyana ba shine ƙididdigar ƙarancin ƙanshi da dandano a cikin marasa lafiya da ke kamuwa da COVID-19 wanda ya fara da kashi 30 cikin ɗari, daga baya ya ragu zuwa 15%.
Har yanzu akwai wasu bayanai da za a bincika don sanin yadda cutar ke yaduwa.
An yi imanin cewa cutar ta fi yaduwa ta hanyar ƙananan ƙwayoyin ruwa da ke fitowa daga haɗuwa da coughing, hancin, ko magana. Haɗin kai yana tsakanin mita 1 zuwa 2 (ƙafa 3 zuwa 6).
Bincike ya nuna cewa yin tari ba tare da rufewa ba zai iya haifar da ƙwayoyin ruwa masu tsayi daga mita 4.5 zuwa mita 8.2.
Wasu sun ba da shawarar cewa cutar na iya yaduwa ta hanyar ƙwayoyin cuta da ke fitowa daga magana, wanda ke iya zama a cikin iska na dogon lokaci. Ko da yake ƙwayoyin cuta na numfashi da aka samar yayin numfashi yayin magana na iya fitowa, gabaɗaya, ba a yaduwar cutar ta iska.
Za a iya samun sa a bakin mutane ko hanci ko kuma a numfashin su cikin huhu.
Wasu hanyoyin kiwon lafiya kamar saka bututu da aikin gaggawa na zuciya (CPR) na iya haifar da zubar da ruwa a cikin hanyar numfashi, wanda ke haifar da saurin isar da kwayoyin cikin iska da kuma yaduwar su ta hanyar iska.
Ana iya yada cutar ta hanyar taɓa idanun mutum, hanci, ko baki bayan ta taɓa wani abu da ya taɓa, ciki har da fata.
Akwai damuwa game da yaduwar cutar ta hanyar fitsari, amma ana ganin cewa wannan zai iya zama mai saurin wucewa.
Gwamnatin China ta musanta yiwuwar kamuwa da cutar SARS-CoV-2 daga najin mutum zuwa abincin wani. Ko da yake ana iya kamuwa da cutar kafin bayyanar cututtuka da kuma a cikin matakan cutar, kwayar cutar tana da saurin kamuwa a cikin kwanaki uku na farko bayan bayyanar cututtuka.
Ana iya gano cutar kwanaki uku kafin bayyanar cututtuka, saboda haka ana iya yin la'akari da kamuwa da cutar kafin bayyanar cututtuka.
Akwai rahotanni kaɗan na cututtukan da ba a nuna alamun su ba, amma a wasu ƙasashe an gano su yayin da ake bin diddigin waɗanda ake zargi da kamuwa da cutar.
Cibiyar Kula da Cututtuka da Cututtuka ta Turai (ECDC) ta ce ba a san yadda sauƙin cutar ke yaduwa ba, amma mutum ɗaya yana iya cutar da mutane biyu zuwa uku. Kwayar cutar na iya rayuwa a kan fuska na tsawon sa'o'i zuwa kwanaki.
Musamman, an gano cewa kwayar cutar na iya rayuwa har tsawon kwanaki uku a kan filastik (polypropylene) da karfe 304, rana a kan kwali, da kuma awanni huɗu a kan tagulla.
Ya dogara da yanayin yanayi da zafin jiki. An gano COVID-19 a cikin dabbobin gida da sauran dabbobi.
Babu wata hujja da ta nuna cewa dabbobi na iya daukar kwayar cutar zuwa ga mutane, amma hukumomin Burtaniya sun ba da shawarar wanke hannuwanku bayan kowane irin hulɗa da dabbobi, kamar yadda ya kamata a yi bayan kowane irin hulɗa da wuraren da mai cutar zai iya shiga.
Cutar coronavirus na numfashi mai tsanani 2 (SARS-CoV-2) wani sabon kwayar cuta ne. An fara gano shi a cikin mutane uku da ke da alaƙa da cututtukan numfashi mai tsanani da ke faruwa a Wuhan.
Dukkanin bayyanar cutar SARS-CoV-2 na cikin kwayoyin cutar coronaviruses ne. A wajen jikin mutum, kwayar cutar tana mutuwa a cikin sabulu na gida wanda ke narkar da murfin kariya. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
An yi imanin cewa cutar ta samo asali ne daga dabbobi zuwa ga mutane.
A cewar nazarin kwayoyin halittar, kwayar cutar coronavirus ta kasance cikin rukuni guda na kwayar cutar beta-corona a cikin nau'in kwayar cutar ta sarbi (genus B) tare da nau'ikan kwayoyin halittar da suka samo asali daga bat.
Ya yi daidai da kashi 96% a matakin kwayoyin halitta tare da wasu samfuran kwayar cutar bat coronavirus (BatCov RaTG13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci ne kawai a cikin amino acid a wasu sassan jerin kwayoyin halitta tsakanin nau'in kwayar cutar ta diski da nau'in kwayar cutar mutum guda biyu.
A yanzu, kwatancen dukkanin kwayoyin halitta na rayuwa sun gano cewa akwai daidaito sama da kashi 92 cikin dari tsakanin kwayar cutar coronavirus ta mai ciyar da tururuwa ta Afirka da SARS-CoV-2, kuma wannan binciken kawai bai isa ya tabbatar da cewa mai ciyar da tururuwa ta Afirka shine mai watsa cutar ba.
Ana iya gano cutar a ɗan lokaci bisa ga bayyanar cututtuka, amma za a iya tabbatar da hakan ta hanyar yin kwafin kwayar cutar ta hanyar yin kwafin kwayar cutar ta hanyar yin amfani da hanyar rRT-PCR ko CT scan.
A cikin wani binciken da ya kwatanta PCR da CT a Wuhan, CT tana da ƙwarewar ƙwarewa fiye da PCR amma ba ta da daidaito, kuma yawancin halayen hoto sun yi kama da sauran cututtukan huhu da yanayin cutar.
A watan Maris na 2020, Kwalejin X-ray ta Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwajin COVID-19 ko a matsayin gwajin farko.
Hukumar ta WHO ta fitar da jerin hanyoyin gwajin RNA don SARS-CoV-2, wanda aka fara fitarwa a ranar 17 ga Janairu.
Gwajin yana amfani da ainihin lokacin polymerase chain reverse transcription (rRT-PCR).
Ana iya yin gwajin ne ta hanyar numfashi ko kuma ta hanyar jinin mutum.
Ana samun sakamakon gwajin a cikin 'yan sa'o'i zuwa 'yan kwanaki.
A cikin wannan binciken, an yi amfani da maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin
Har zuwa 6 ga Afrilu, 2020, ba a tabbatar da ingancin su ba har zuwa isa don tabbatar da cewa ana iya amfani da su a ko'ina.
A cikin gwajin jini na Amurka, wanda Cellex ke gudanarwa, dakunan gwaje-gwaje ne kawai aka amince da su don amfani da gaggawa.
Ana yin hoto da kuma CT ga mutanen da ke nuna alamun cutar, ciki har da bayyanar da wasu wurare marasa kyau a cikin manyan huhu da kuma ruwa a cikin huhu, don gano halaye na musamman.
Ƙungiyar masu duba ido ta Italiya tana tattara bayanan hoto na marasa lafiya da aka tabbatar da su kuma tana gina wani bayanan kan layi na duniya.
Saboda kamannin alamun cutar da wasu cututtuka kamar su kwayar cutar numfashi, ba zai yiwu a tantance COVID-19 ba tare da tabbacin PCR ba.
Wani babban bincike da aka gudanar a China wanda ya kwatanta sakamakon CT na kirji da PCR ya nuna cewa daukar hoto na iya yin aiki cikin sauri da sauƙi, kodayake ba shi da cikakkun bayanai game da kamuwa da cuta, kuma ya ba da shawarar cewa ya kamata a yi amfani da shi azaman kayan aikin gwaji a yankunan da ke fama da cutar.
Ana ci gaba da gina cibiyoyin sadarwa masu rikitarwa na AI don gano fasalin bayyanar cutar ta hanyar daukar hoto da CT.
Sauran dabarun hana yaduwar cutar sun hada da kiyaye tsabtar mutum, wanke hannu, taba idanu, hanci ko baki ba tare da wanke hannaye ba, da kuma yin tari da tari a cikin nama, sannan a jefa kayan cikin kwandon shara kai tsaye.
An riga an shawarci mutanen da ke dauke da cutar da su sanya abin rufe fuska na tiyata a cikin jama'a.
An kuma ba da shawarar yin nesa da juna don hana yaduwar cutar. Gwamnatoci da yawa sun hana duk tafiye-tafiye marasa mahimmanci zuwa ko daga ƙasashe da yankuna masu kamuwa da cutar.
Amma cutar ta riga ta kai ga yaduwar al'ummomi a sassa da dama na duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi, inda mutane a cikin waɗannan al'ummomin ba su san inda suka kamu da cutar ba. Ana ba da shawarar ma'aikatan kiwon lafiya da ke kula da wani wanda ke da cutar su yi amfani da rigakafin rigakafi, rigakafin haɗuwa da farko da kuma abin rufe ido. Binciken haɗuwa hanya ce mai mahimmanci ga hukumomin kiwon lafiya don tantance tushen kamuwa da cuta da hana ƙarin kamuwa da cuta.
Amfani da gwamnati ta yi da bayanan wurin da ake samu daga wayoyin salula don wannan dalili ya haifar da damuwa game da tsaron bayanan sirri, kuma Freedom International da wasu kungiyoyi sama da 100 sun fitar da sanarwa da ke neman a sanya takunkumi kan irin wannan sa ido.
An ba da shawarar aikace-aikacen wayar hannu daban-daban don aiwatarwa ko amfani da sa kai, kuma har zuwa 7 ga Afrilu, 2020, sama da gungun masana goma sha biyu suna aiki kan hanyoyin magance bayanan sirri, kamar amfani da Bluetooth na mai amfani don shiga cikin wayar hannu ta kusa.
Idan akwai kusanci da wanda aka gwada yana dauke da cutar COVID-19, za a aika da sanarwar ga masu amfani. Yanayin kamuwa da cuta da ke yaduwa kamar wanke hanci da kuma wanke baki da kayan wanke baki, ra'ayoyi ne marasa inganci.
Ko da yake cibiyoyi da dama suna kan ci gaba da bunkasa cutar, amma har yanzu babu maganin COVID-19.
Ana ba da shawarar yin wanka don hana yaduwar cutar.
CDC ta shawarci mutane su wanke hannayensu da sabulu akai-akai na akalla sakan ashirin, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun kasance da ƙazanta sosai, kafin cin abinci da bayan yin tari, tari, ko hanci.
Wannan saboda cutar ta fito ne daga jikin mutum, kuma cutar tana iya fashewa ta hanyar kumfa da aka rufe da sabulu na gida, wanda ke haifar da mutuwa.
CDC ta kuma ba da shawarar yin amfani da maganin wanke hannu mai dauke da barasa wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na barasa idan ba ku shirya wanke hannu da sabulu da ruwa ba.
Hukumar ta WHO ta shawarci mutane da su guji taɓa idanunsu, hanci da baki ba tare da wanke hannayensu ba.
Surfaces na iya cire yawancin narkewa ciki har da 62%-71% na giya, 50%-100% isoprosanol giya, 0.1% sodium hydrogen chloride, 0.5% hydrogen oxide da 0.2%7.5% na sodium-iodine (ta hanyar fuskantar ruwa mai kashe kwayoyin cuta a cikin minti daya don saman karfe mai tsayayye).
Sauran magungunan kashe ƙwayoyin cuta kamar su benzalkonium chloride da chrohexidine gluconate ba su da ƙarfi sosai.
CDC ta ba da shawarar cewa idan akwai zargin ko tabbatar da cutar COVID a cikin gine-gine, kamar ofis ko cibiyoyin renon yara, to, a kashe duk wuraren da ake amfani da su, kamar ofisoshin, dakunan wanka, wuraren jama'a, kayan lantarki na jama'a kamar su Allunan, fuskokin taɓawa, mabuɗan rubutu, na'urorin sarrafawa, da ATM.
Kungiyoyin kiwon lafiya sun bukaci mutane su rufe bakinsu da hanci da ƙusa, su rufe su da nama, kuma su zubar da nama nan da nan idan suna yin tari ko hancin.
Ana ƙarfafa masu kamuwa da cutar su sanya abin rufe fuska na tiyata, kuma sanya abin rufe fuska yana rage yawan da kuma nisan da za a iya kaiwa ga ƙwayoyin ruwa da ke yaduwa ta hanyar magana, hancin da tari.
Hukumar lafiya ta duniya WHO ta ba da umarni kan lokacin da kuma yadda za a yi amfani da abin rufe fuska.
A cewar Stephen Griffin, masanin ilimin cutar a Jami'ar Leeds, sanya abin rufe fuska na iya rage mutane da ke fama da rashin tsaftace-tsabtace hannu da kuma fuskokinsu, wanda shine babban tushen kamuwa da cuta. An kuma ba da shawarar yin amfani da abin rufe fuska ga waɗanda ke kula da wanda ke da cutar.
Hukumar ta WHO ta ba da shawarar cewa mutane masu lafiya su sanya abin rufe fuska ne kawai idan suna cikin haɗarin haɗari, kamar waɗanda ke kula da mai cutar COVID-19, amma ta ce sanya abin rufe fuska zai iya taimaka wa mutane su guji taɓa fuskokinsu.
A kasashe da dama, an fara kamfen don ƙarfafa masu tafiya a cikin jama'a su sanya abin rufe fuska da hanci.
A Amurka, CDC ta ba da shawarar sanya abin rufe fuska da aka yi da sutura ba na likita ba. A China, masu lafiya sun ba da shawarar musamman don amfani da abin rufe fuska na likita wanda za'a iya zubar dashi idan ana yin hulɗa da mutane fiye da mita 1 (ƙafa uku).
An ba da shawarar yin amfani da abin rufe fuska na tiyata yayin amfani da sufuri na jama'a ko a wuraren taruwa a Hong Kong.
Jami'an kiwon lafiya na Thailand suna ƙarfafa mutane su sanya abin rufe fuska a gida kuma su wanke su kowace rana.
Chernivtsi da Slovenia sun hana zirga-zirgar jama'a ba tare da sanya abin rufe fuska ba ko rufe hanci da baki.
A ranar 16 ga Maris, an bukaci mutane da su sanya abin rufe fuska yayin da suke tafiya a wuraren jama'a a Vietnam don kare kansu da sauran mutane.
Gwamnatin Ostiraliya ta ba da umarnin cewa duk wanda ya shiga manyan kantuna ya sanya abin rufe fuska.
An umarci duk wanda ke zuwa wuraren jama'a a Isra'ila ya sanya abin rufe fuska.
A ranar 1 ga Afrilu, Taiwan, wanda ke samar da abin rufe fuska miliyan 10 a rana tun tsakiyar watan Maris, ta sanar da cewa fasinjojin jiragen kasa da na bas na birni dole ne su sanya abin rufe fuska.
Panama ta ba da shawarar sanya abin rufe fuska a duk lokacin da ta fita waje, kuma ta ba da shawarar samar da abin rufe fuska na gida ga waɗanda ba za su iya sayan abin rufe fuska ba.
An sake amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia da Singapore.
Nisa nesa na zamantakewa ya ƙunshi ayyukan da ke sarrafa kamuwa da cuta da nufin rage yaduwar cutar ta hanyar rage hulɗa tsakanin mutane.
Matakan sun hada da keɓewar keɓewa, ƙuntata tafiye-tafiye, da rufe makarantu, wuraren aiki, filayen wasanni masu iska, gidajen sinima, ko cibiyoyin kasuwanci.
Mutum na iya yin amfani da hanyoyin zamantakewa na rashin tuntuɓar mutum, kamar zama a gida, iyakance tafiya, guje wa wuraren jama'a, amfani da hanyoyin sadarwa marasa tuntuɓar, da kuma guje wa hulɗa ta jiki da wasu.
Gwamnatoci da dama yanzu suna tilasta ko kuma ƙarfafa nisantar jama'a a yankunan da cutar ta shafa.
An rage yawan taron jama'a da aka ba da shawarar da hukumomin gwamnati da kungiyoyin kiwon lafiya na Amurka suka ba da shawarar 250 (idan ba a yaduwar COVID-19 a yankin ba) zuwa 50 kuma daga baya zuwa 10.
A ranar 22 ga Maris, 2020, Jamus ta hana taron mutane sama da biyu. CDC ta ba da shawarar cewa tsofaffi da waɗanda ke da rashin lafiya na asali, kamar su masu ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini da waɗanda ke da haɗarin kamuwa da cututtukan cututtukan cututtukan cututtukan zuciya, da cututtukan cututtukan zuciya, su zauna a gida idan ya yiwu. A ƙarshen Maris, 2020, WHO da sauran kungiyoyin kiwon lafiya suna ci gaba da hulɗa da mutane da yawa daga nesa ko nesa.
Amfani da kalmar "yanke kai daga zamantakewar jama'a" ya haifar da fassarar cewa mutane su kasance cikin keɓewa gaba ɗaya, ba tare da hulɗa da wasu ba ta hanyar da ba ta dace ba. Wasu hukumomi sun ba da jagororin kiwon lafiya na jima'i don amfani a lokacin cutar.
Sun hada da ƙarfafa yin jima'i da wanda ba shi da cutar ko kuma wanda ba ya nuna alamun cutar.
An ba da shawarar keɓe kai a gida ga waɗanda suka gwada COVID-19 da waɗanda ke da shakku cewa sun kamu da cutar.
Ma'aikatun kiwon lafiya sun fitar da cikakkun bayanai don bin ƙa'idodin keɓewa. Gwamnatoci da yawa sun ƙarfafa ko kuma sun kafa dokar hana keɓewa ga duk mazauna yankunan da ke fama da cutar.
An ba da umarnin keɓewa da tsauraran matakan kulawa ga membobin rukunin haɗari mafi girma.
Duk wanda ya taɓa hulɗa da wanda ke da cutar COVID-19, ko ya ziyarci yanki ko ƙasashe da ke da ƙaruwar cutar, ana ƙarfafa su su keɓe kansu na tsawon kwanaki 14 tun lokacin da suka kasance tare da shi.
Dabaru na sarrafa yaduwar cutar sune ƙuntatawa ko kuma hanawa da ragewa.
Ana gudanar da sarrafawa a farkon matakan cutar, tare da gano waɗanda ke da cutar, keɓewa da sauran matakan sarrafa cutar, da kuma hana yaduwar cutar a cikin sauran al'umma.
Idan ba za a iya sarrafa yaduwar cutar ba, dole ne a sauya zuwa matakin rage cutar: a dauki matakai don rage yaduwar cutar da rage tasirin ta a kan tsarin kiwon lafiya da al'umma.
Ana iya haɗa ayyukan hanawa da ragewa a lokaci guda.
Don magance yaduwar cutar a duniya, ana buƙatar ƙarin matakai na ƙuntatawa ta hanyar rage adadin kamuwa da cuta zuwa ƙasa da ɗaya. ƙoƙari ne na rage ƙaruwar kamuwa da cuta a matsayin wani ɓangare na sarrafa yaduwar cutar.
Wannan zai rage hadarin da ke tattare da ayyukan kiwon lafiya da ke fama da matsalar, kuma zai ba da karin lokaci don maganin da hanyoyin da za a bi don ganowa.
Matakan likita da na waje don sarrafa yaduwar cutar sun hada da tsabtace hannu, sanya abin rufe fuska da keɓe kai, hanyoyin rigakafin mutum, da kuma hanyoyin da aka tsara don rage hulɗa ta jiki, kamar rufe makarantu da soke taron jama'a, da kuma ayyukan zamantakewar jama'a don karɓar da kuma ƙarfafa shiga cikin ayyukan da aka ambata a sama, da kuma tsabtace muhalli kamar tsabtace fuska.
A wasu ƙasashe, an yi amfani da matakan daban-daban don shawo kan yaduwar cutar.
Koriya ta Kudu ta fara gwajin taro da keɓewa a wurare, kuma an ba da gargadi game da motsin mutanen da ke da cutar.
Singapore ta ba da tallafin kuɗi ga waɗanda suka kamu da cutar kuma suka sanya kansu a keɓe, kuma suna ba da babbar tarar ga waɗanda suka kasa yin hakan.
Taiwan ta haɓaka samar da abin rufe fuska da hanci, kuma ta ɗauki matakan hana adana kayan kiwon lafiya. Gwaje-gwaje iri ɗaya ga Burtaniya da Amurka sun gano cewa akwai manyan ƙalubale a cikin rage kamuwa da cuta (kawai ragewa, ba dakatar da yaduwar) da ragewa (juyawa ci gaban cutar).
Ka'idojin sauƙaƙewa na iya rage yawan buƙatun kiwon lafiya zuwa kashi biyu bisa uku da rabin mutuwar, duk da dubban dubban mutuwar da kuma matsalolin tsarin kiwon lafiya.
Za a iya ƙara matsa lamba kan hanyoyin ragewa, amma idan aka rage matakan a duk tsawon lokacin da cutar ke yaduwa a cikin al'umma (idan maganin ya fara samuwa), cutar na iya sake yaduwa cikin sauri kuma ana buƙatar kiyayewa.
Rage cutar na bukatar dogon lokaci kuma yana iya haifar da lalacewar zamantakewa da tattalin arziki.
Babu takamaiman maganin rigakafin cutar COVID-19, amma ana ci gaba da aiki kan samar da maganin, gami da gwajin magungunan da ake da su.
Shan magungunan sanyi, shan ruwa da hutawa na iya sauƙaƙa alamun cutar.
Dangane da tsananin kamuwa da cutar, ana iya buƙatar maganin oxygen, maganin ciwon daji da taimakon numfashi.
Yin amfani da steroids na iya ƙara sakamako.
Ana kuma gudanar da gwaje-gwaje kan magungunan da aka amince da su don maganin wasu cututtukan kwayar cutar COVID-19.
WHO ta kuma ce hanyoyin gargajiya da magunguna na gida na iya taimakawa wajen rage alamun cutar SARS-CoV-19.
WHO ta bayyana cewa inganta iya aiki da canza kulawar lafiya bisa ga bukatun marasa lafiyar COVID-19 shine babban matakin amsa cutar.
Ofishin Yankin WHO da ECDC sun fitar da jagororin ga asibitoci da kuma ayyukan kiwon lafiya na asali don sauya albarkatu a matakai da yawa, gami da mayar da hankali kan gwajin gwaji na dakin gwaje-gwaje don gwajin COVID-19, kawar da hanyoyin jefa kuri'a, keɓewa da keɓewar marasa lafiya masu cutar COVID-19, haɓaka ƙwarewar kulawa ta gaggawa ta hanyar horar da ma'aikata da haɓaka adadin masu numfashi da wuraren zama.
Akwai ra'ayoyi da dama game da wanda ya fara da farko (wanda ake kira "marasa lafiya zero").
Ana iya gano yiwuwar barkewar cutar ta coronavirus a ranar 1 ga Disamba, 2019, a Wuhan, lardin Hubei na kasar Sin.
A cikin wata daya, adadin masu kamuwa da cutar coronavirus a Hubei ya tashi a hankali.
Yawancin su suna da alaƙa da kasuwar sayar da abincin teku ta Huangnan, inda ake sayar da dabbobi masu rai, kuma ɗayan ra'ayoyin shine cewa cutar ta fito ne daga irin wannan dabba ko kuma, a wasu kalmomin, cewa cutar ta samo asali ne daga dabba zuwa mutum. An gano cutar ta Ninean da ba a san dalilin ba a ranar 26 ga Disamba, kuma an kula da shi ne daga Dr. Zhang Jixian a asibitin da ke kula da cutar, wanda shi kansa ya sanar da CDC a Wuhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a Asibitin Wuhan ta sanar da abokan aikinsu cewa suna da wani nau'in coronavirus mai kama da SARS.
Likitoci takwas, ciki har da Li Wenliang, sun sami gargadi daga 'yan sanda saboda yada jita-jita, yayin da wani, Ai Fen, ta sami gargadi daga shugabanninta saboda tayar da hankali.
Hukumar Lafiya ta Wuhan daga baya ta fitar da sanarwa ga jama'a a ranar 31 ga Disamba kuma ta sanar da WHO.
Bayan samun isassun rahotanni game da cutar huhu da ba a bayyana sunayensu ba, hukumomin kiwon lafiya na Wuhan sun fara gudanar da bincike a farkon watan Janairu.
Wuhan, cibiyar sufuri da babbar hanyar jirgin kasa, tare da yawan tafiye-tafiye don bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin bikin
A ranar 20 ga watan Janairu, China ta ba da rahoton kusan sabbin kamuwa da cutar 140, ciki har da biyu a Beijing da ɗaya a Shenzhen.
Bayan haka, bayanan hukuma sun nuna cewa mutane 6,174 sun nuna alamun cutar a ranar 20 ga Janairu, 2020. A ranar 26 ga Maris, Amurka ta zarce China da Italiya a matsayin mafi yawan masu kamuwa da cutar a duniya. A ranar 9 ga Afrilu, 2020, an sanar da cewa akwai mutane miliyan 1.61 da suka kamu da cutar a duniya, tare da mutuwar mutane 97,000, kuma sama da mutane 364,000 sun warke.
Aƙalla akwai mutum ɗaya da ya kamu da cutar a kusan 200 na ƙasar da yankuna.
A Turai, saboda annobar, kasashe da dama a yankin Schengen sun takaita zirga-zirgar jama'a da kuma sanya takunkumi a kan iyakoki.
Matakan matakin kasa sun hada da matakan hana zirga-zirga (wanda ake kira da dokar zama a gida, dokar zama a rufin gida, ko kuma kulle-kulle) da kuma dokar hana fita.Kamar mutane miliyan 300, wato kashi 90% na Amurka, sama da miliyan 50 a Philippines, sama da miliyan 59 a Afirka ta Kudu da kuma mutane biliyan 1.3 a Indiya, an kulle su a ranar 2 ga Afrilu.
A ranar 26 ga watan Maris, mutane biliyan 1.7 ne ke fama da wani nau'i na kulle-kulle a duniya, wanda ya karu zuwa biliyan 2.6 (kashi ɗaya bisa uku na yawan mutanen duniya) kwana biyu bayan haka.
An fara gano tabbataccen cutar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019, kuma rahotanni marasa tabbas sun ce farkon cutar ya faru ne a ranar 17 ga Nuwamba.
Dr. Zhang Jixian ta kamu da tarin cututtukan huhu da ba a san dalilin su ba a ranar 26 ga Disamba, kuma a daidai lokacin da aka gano ta, ta sanar da Wuhan Jainghan CDC daga asibitinta a ranar 27 ga Disamba.
A ranar 27 ga Disamba, 2019, gwajin farko na kwayar halittar mutum ya gano cutar coronavirus mai kama da SARS.
Hukumar Lafiya ta Hukumar Kula da Lafiya ta Wuhan ta ba da gargadi ga jama'a a ranar 31 ga Disamba.
A ranar ne aka sanar da WHO.
A yayin da ake ta yin gargadin, 'yan sanda sun gargadi likitoci a Wuhan kan yada jita-jita game da cutar.
Hukumar Lafiya ta kasa ta kasar Sin ta ce ba ta da tabbacin cewa akwai cutar daga mutum zuwa mutum.
A karshen watan Janairu, babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping ya kaddamar da wani babban kamfen na karfafa gwiwa don shawo kan yaduwar cutar, wanda gwamnatin kasar Sin ta kira da sunan yaki na jama'a.
A ranar 23 ga watan Janairu, an dakatar da zirga-zirgar zirga-zirga zuwa Wuhan a cikin abin da aka kwatanta da mafi girman keɓewa a tarihin ɗan adam, wanda ya faɗaɗa zuwa manyan birane 15 a lardin Hubei, wanda ya shafi mutane miliyan 57.
An haramta amfani da motoci masu zaman kansu a cikin birnin.
An soke bikin Sabuwar Shekarar Sin (wanda aka shirya yi a ranar 25 ga Janairu) a wurare da yawa.
Hukumomi sun kuma sanar da cewa suna gina asibitin wucin gadi na Huoshenshan, wanda za a kammala shi cikin kwanaki 10.
An gina wani asibiti, asibitin Leishenshan, don kula da ƙarin marasa lafiya.
Baya ga sabbin asibitoci, an kara gina wasu gine-gine 14 kamar su Cibiyar Taro da Wasanni a Wuhan a matsayin asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki karin matakai, ciki har da bayar da sanarwar kiwon lafiya ga masu yawon bude ido da kuma tsawaita hutun bikin bazara don shawo kan kamuwa da COVID-19.
An rufe jami'o'i da makarantu a fadin kasar.
An kuma kafa wasu shirye-shirye da sauran shirye-shirye a Hong Kong da Macau, musamman a makarantu da jami'o'i.
An fara aiwatar da tsarin aiki na nesa a yankuna da dama na kasar Sin.
An kuma kafa dokar hana zirga-zirga a cikin da kuma wajen lardin Hubei.
An gudanar da gyare-gyare na sufuri na jama'a da rufe gidajen tarihi na ɗan lokaci a duk faɗin China.
An aiwatar da takunkumin tafiye-tafiye na jama'a a birane da yawa, kuma kusan mutane miliyan 760 (fiye da rabin yawan jama'a) suna fuskantar wasu nau'ikan takunkumin fita daga gida. Cutar ta kai matakin kamuwa da cuta a duniya a watan Maris, kuma hukumomin China sun aiwatar da tsauraran matakai don hana ƙwayoyin cuta daga wasu ƙasashe shiga ƙasar.
A ranar 23 ga watan Maris, an samu mutum daya da ya kamu da cutar a babban yankin kasar Sin, wanda ya kamu da cutar ne ta hanyar wani matafiyi da ya dawo daga Istanbul zuwa Guangzhou, kwanaki biyar kafin a kafa dokar killace duk matafiya na kasashen waje da ke shiga birnin.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya bayyana cewa an iya dakatar da yaduwar cutar a cikin kasar Sin kuma an iya sarrafa lamarin.
A ranar ne, bayan watanni biyu da sanya dokar hana fita ta cikin gida, an sassauta takunkumin hana zirga-zirga a birnin Hubei, ban da Wuhan. A cikin sanarwar da ma'aikatar harkokin wajen kasar Sin ta fitar a ranar 26 ga watan Maris, 2020, ta dakatar da masu riƙe da biza ko izinin zama daga ranar 28 ga watan Maris, ba tare da bayyana takamaiman lokacin da wannan manufar za ta ƙare ba.
Masu son zuwa China dole ne su nemi biza a Ofisoshin Jakadancin China da Ofisoshin Jakadancin.
Gwamnatin kasar Sin ta bukaci sake bude kasuwanci da masana'antu a ranar 30 ga watan Maris, tare da bayar da tallafin kudi don karfafa masana'antu. Gwamnatin tarayya ta bukaci likitocin iyali da su yi jana'izar ta yanar gizo kawai, bisa ka'idar hana taruwar cutar COVID-19, amma majalisar dokokin jihar ta sanar da yin hutun minti uku na zaman lafiya a duk fadin kasar a ranar 4 ga Afrilu da karfe 10:00 na yamma, daidai da bikin Kung Fu.
A ranar 20 ga Janairu, 2020, an tabbatar da cewa akwai cutar COVID-19 da ta bazu daga China a Koriya ta Kudu.
Hukumar kiwon lafiya ta kasar ta bayar da rahoton karuwar adadin wadanda suka kamu da cutar a ranar 20 ga watan Fabrairu, wadanda yawancinsu sun kamu da cutar ne daga taron da aka yi a garin Daegu na wani sabon kungiyar addini da aka sani da Sinchongi Church of Jesus Christ.
Masu bautar Shincheonji da suka ziyarci Daegu, Koriya ta Kudu daga Wuhan, sun yi zargin cewa sun kasance asalin cutar.
A ranar 22 ga watan Fabrairu, 1,261 daga cikin mabiya cocin 9,336 ko 13% sun nuna alamun cutar. Koriya ta Kudu ta sanar da matakin gaggawa a ranar 23 ga Fabrairu, 2020.
A Koriya, an tabbatar da fiye da mutane 2,000 da suka kamu da cutar a ranar 28 ga Fabrairu, kuma ya tashi zuwa 3,150 a ranar 29 ga Fabrairu.
An kuma sanya dukkan sansanonin sojin Koriya ta Kudu a keɓe bayan da sojoji uku suka gwada suna dauke da cutar.
Koriya ta Kudu ta gabatar da wani shiri da ake kira mafi girma kuma mafi kyawun taro a duniya don gwada mutane don cutar da ke keɓe masu kamuwa da cutar, tare da bin diddigin waɗanda suka taɓa su da kuma keɓewa.
Tsarin gwajin ya hada da yin tafiya zuwa kasashen waje da dawowa da kuma bayar da rahotanni na gaggawa game da alamun cutar ta hanyar aikace-aikacen wayar hannu, gano cutar a kan tafiya da kuma bayar da rahoto game da sakamakon gwajin a rana mai zuwa, tare da haɓaka damar gwaji zuwa mutane 20,000 kowace rana.
A farkon, an yi tawaye game da yadda Shugaba Moon Jae-in ya amsa cutar a cikin jama'ar Koriya ta Kudu.
A cikin 'yan Koriya da dama, akwai wadanda suka sanya hannu kan bukatar a sauke Moon daga kurkuku da kuma amsa da ya bayar, inda suka ce gwamnati ta kasa magance cutar.
A ranar 23 ga watan Maris, Koriya ta Kudu ta ba da rahoton mafi ƙarancin adadin masu kamuwa da cutar a cikin kwana ɗaya a cikin makonni huɗu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk sabbin masu shigowa daga kasashen waje za a killace su na tsawon makonni biyu.
A ranar 1 ga Afrilu, wata kafar yada labarai ta ruwaito cewa Koriya ta Kudu ta karbi buƙatun gwaji na cutar daga kasashe daban daban 121.
An ba da rahoton farkon tabbataccen cutar SARS-CoV-2 a Iran a ranar 19 ga Fabrairu, kuma mutane biyu sun mutu daga baya a wannan ranar, a cewar Ma'aikatar Lafiya da Ilimi na Likita.
Matakan farko na gwamnati sun hada da soke bukukuwa da sauran al'adu, wasanni, sallar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da dala tiriliyan biyar don yaki da cutar.
Shugaban kasar Hassan Rohini ya ce a ranar 26 ga watan Fabrairun 2020 babu wani shiri na killace yankunan da cutar ta bulla, sai dai a killace mutane.
A watan Maris, an sanar da tsare-tsaren da za su takaita zirga-zirgar tsakanin birane, duk da yawan zirga-zirgar birane kafin bikin sabuwar shekara ta Farisa, Nowruz.
An ci gaba da bude wuraren ibada na Shi'a a Qom, Iran, har zuwa ranar 16 ga Maris, 2020. Iran ta zama cibiyar yaduwar cutar bayan China a watan Fabrairu.
A yayin da ake zargin cewa an boye adadin wadanda suka kamu da cutar a Iran, sama da kasashe goma sun gano cewa cutar ta shafi Iran a cikin gida har zuwa 28 ga watan Fabrairu, wanda ke nuna cewa cutar ta fi wadanda suka kamu da cutar 388 da gwamnatin Iran ta sanar a wannan ranar.
A ranar 3 ga watan Maris, an rufe majalisar dokokin Iran bayan da aka ce 23 daga cikin 'yan majalisa 290 sun kamu da cutar.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci manyan jami'an tsare-tsaren Iran da su saki masu kare hakkin dan adam da ke tsare a kurkuku saboda rashin jituwa ta lumana, tare da sakin dukkan fursunonin da ke tsare a ciki.
An kuma ce, cibiyoyin da ke rufe kofa, wadanda ba su da isasshen kulawar lafiya, kamar sansanonin tsare mutane, na iya zama mafi hadarin kamuwa da kwayar cutar.
Gwamnatin Iran ta ce a ranar 15 ga watan Maris, mutane 100 ne suka mutu a rana daya, wanda shine mafi girma a kasar tun lokacin da cutar ta fara yaduwa.
A ranar 17 ga watan Maris, an kashe akalla jami'an gwamnati da tsoffin 'yan siyasa 12 a cikin wani taron da aka yi a majalisar dokokin Iran.
A ranar 23 ga Maris, Iran ta sami sabbin mutane 50 a kowace awa da kuma sabon mutum daya da ke mutuwa a kowane minti goma saboda cutar coronavirus.
A cewar jami'an WHO, cutar ta fi yawan wadanda aka samu a Iran sau biyar fiye da yadda aka ruwaito.
Tattalin arzikin Amurka a Iran ya haifar da koma bayan tattalin arziki, wanda ya haifar da koma bayan tattalin arziki, da kuma koma bayan tattalin arziki a cikin bankin kasar.
Babban Kwamishinan 'Yancin Dan Adam na Majalisar Dinkin Duniya ya bukaci a sassauta takunkumin hana hana hana hana hana ayyukan kasashen da cutar ta fi shafa, ciki har da Iran.
Yaduwar cutar ta bayyana ne a ranar 31 ga watan Janairu, lokacin da wasu matafiya biyu 'yan kasar Sin suka gwada tabbatacciyar cutar SARS-CoV-2 a Rome, inda aka tabbatar da cewa akwai wasu cututtuka a Italiya.
A sakamakon karuwar adadin wadanda suka kamu da cutar, gwamnatin Italiya ta dakatar da zirga-zirgar jiragen sama da ke tafiya zuwa China kuma ta ayyana dokar ta baci.
An gano cewa barkewar COVID-19 ta fara ne a ranar 21 ga Fabrairu, tare da tabbatar da mutane 16 a Labardi. A ranar 22 ga Fabrairu, majalisar ministocin ta ba da umarnin matakin don shawo kan yaduwar cutar, gami da keɓewa na mutane sama da 50,000 a garuruwa 11 a ƙarƙashin tsarin yanki na arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce ba a ba da izinin shiga ko fita daga wuraren da cutar ta barke ba.
"Gwamnatin Italiya ta ba da umarnin rufe makarantu da jami'o'i a duk faɗin ƙasar, tun da mutuwar mutane 100 sun faru a Italiya a ranar 4 ga Maris".
A ranar 9 ga watan Maris, an dakatar da duk wasannin wasanni na akalla wata guda, duk da cewa an dakatar da duk manyan wasannin wasanni, ciki har da wasannin kwallon kafa na Serie A, har zuwa watan Afrilu.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkan kasuwancin, sai dai manyan kantuna da kantunan magunguna. A ranar 6 ga Maris, Kwalejin Kula da Magunguna, Magunguna da Kula da Gaggawa da Maidowa ta Italiya (SIAARTI) ta buga shawarwarin ɗabi'a na likita game da kulawar mai haƙuri mai mahimmanci, wanda ya kamata a yi amfani da shi.
A ranar 19 ga watan Maris, Italiya ta samu mutuwar mutane 3,405 sakamakon kamuwa da cutar, inda ta zarce China a matsayin kasar da ta fi kowacce mutuwa a duniya sakamakon cutar coronavirus.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta tura jiragen sama 9 na soja dauke da kayayyakin kiwon lafiya zuwa Italiya.
A ranar 5 ga Afrilu, Italiya ta sami mutane 128,948 da suka kamu da cutar, 15,887 sun mutu, kuma 21,815 sun warke, mafi yawan su a yankin Lombardy.
Rahoton CNN ya nuna cewa yawan tsofaffi a Italiya da rashin gwajin cutar a kan lokaci ne ke haifar da hauhawar mutuwar.
A lokacin da cutar ta fara bulla, Burtaniya ta kasance cikin kasashe da ta fi kowa jin dadi a cikin kasashen da cutar ta shafa, kuma har zuwa ranar 18 ga Maris, 2020, gwamnatin Burtaniya ba ta aiwatar da kowane nau'i na nisantar jama'a ko sanya ido kan 'yan kasarta ba.
A sakamakon haka, an soki gwamnatin saboda jinkirin mayar da martani ga halin da al'umma ke ciki. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da shawarar dakatar da tafiye-tafiye marasa mahimmanci da duk fannonin zamantakewa, da yin aiki daga gida idan ya yiwu, da kuma guje wa shaguna, gidajen cin abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnati ta sanar da cewa za ta rufe duk kantunan da ke buɗe don nishaɗi kamar mashaya da filin wasa da wuri-wuri kuma za ta biya ma'aikata har zuwa £ 2,500 a wata da kashi 80% na albashi don hana rashin aikin yi a lokacin annobar. A ranar 23 ga Maris, Firayim Minista ya ba da sanarwar cewa ya ga ya zama dole a bi tsauraran matakan nisantar da kai, ƙuntata taron mutane sama da biyu, da kuma ƙuntatawa kan tafiya da fita waje.
A wani bangare kuma, 'yan sanda sun yi amfani da wannan dokar ta hanyar tara kuɗi da kuma raba mutane daga taron jama'a.
An kuma umarci a rufe yawancin kasuwancin da ake ganin suna bukatar ci gaba da budewa, ciki har da manyan kantuna, kantin sayar da magunguna, bankuna, kantin sayar da kayayyaki, kantin sayar da man fetur da kuma wuraren gyaran motoci.
A ranar 20 ga watan Janairu, an tabbatar da kamuwa da cutar COVID-19 ta farko a yankin Pacific Northwest na jihar Washington, namiji ne wanda ya dawo daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu, an kafa Kwamitin Kula da Cutar Korona na Fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta ayyana dokar ta baci ta kiwon lafiya ta jama'a kuma ta sanya takunkumi kan shigowar masu yawon bude ido daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka ta Gwamnatin Amurka ta sanar da cewa sun kirkiro na'urar gwajin kansu.
Duk da haka, yana da wahala a san yanayin cutar a lokacin saboda jinkirin da Amurka ta yi wajen gudanar da gwajin.
Gwajin bai yi tasiri ba saboda rashin ingantattun kayan aikin da gwamnatin tarayya ta bayar a watan Fabrairu. Gwamnatin tarayya ba ta ba da izinin kayan aikin gwaji daga kungiyoyi masu zaman kansu (masana kimiyya, makarantu, jami'o'i) ba har zuwa ƙarshen Fabrairu, wanda ke buƙatar mutane su cika ka'idoji don yin gwaji har zuwa farkon Maris (kuma ya buƙaci amincewar likita).
Washington Post ta ruwaito cewa a ranar 27 ga watan Fabrairu, kasa da gwaje-gwaje 4,000 ne kawai aka gudanar a Amurka.
A ranar 13 ga watan Maris, jaridar The Atlantic ta ruwaito cewa an kammala gwajin gwajin kasa da 14,000.
A ranar 22 ga watan Maris, AP News ta ce, mutane da yawa da ke da alamun cutar sun jira sa'o'i ko kwanaki don yin gwaji. Bayan mutuwar farko a Amurka, a ranar 29 ga watan Fabrairu, Washington ta ba da rahoton cewa Gwamna Jay Inslee ya ayyana dokar ta baci.
Makarantu a yankin Seattle sun soke azuzuwan su a ranar 3 ga Maris, kuma an rufe makarantu a duk faɗin ƙasar a tsakiyar watan Maris. Wani rukunin masu ilimin cututtukan cuta a Kwalejin Imperial ta London sun ba da shawarar hasashen tasirin sabon coronavirus a kan ƙasar a Amurka a ranar 6 ga Maris, 2020.
A wannan ranar, Shugaba Trump ya sanya hannu kan Dokar Saurin Shirye-shiryen Coronavirus da Amsa, wanda ke ba da dala biliyan 8.3 a cikin kudaden gaggawa ga hukumomin tarayya don magance barkewar cutar.
Manyan kamfanoni suna sanya takunkumin tafiye-tafiye ga ma'aikata, soke tarurruka, da kuma karfafa ma'aikata su yi aiki daga gida.
A ranar 11 ga watan Maris, Trump ya sanar da dakatar da tafiye-tafiye zuwa mafi yawan Turai, ban da Burtaniya, na tsawon kwanaki 30 daga ranar 13 ga watan Maris.
A rana mai zuwa, ya tsawaita takunkumin zuwa Burtaniya da Ireland.
A ranar 13 ga watan Maris, ya ayyana dokar ta baci a fadin kasar, wanda hakan zai sa a fara amfani da kudaden tarayya wajen magance bala'i.
Tun daga ranar 15 ga watan Maris, an rufe ko rage lokutan aiki a kamfanoni da dama a fadin Amurka don rage yaduwar cutar.
A ranar 17 ga watan Maris, an tabbatar da bullar cutar a duk jihohi 50 da gundumar Columbia. A ranar 23 ga watan Maris, an bayar da rahoton cewa New York City tana da mutane 10,700 da ke dauke da cutar coronavirus, wanda ya fi adadin wadanda suka kamu da cutar a Koriya ta Kudu.
Gwamnan ya ce a ranar 25 ga Maris, ana ganin cewa nisantar jama'a na aiki, saboda an ga cewa adadin masu kamuwa da cutar ya ninka sau biyu daga kwanaki 2.0 zuwa 4.7.
A ranar 28 ga watan Maris, New York City ta samu mutane 32,308 da suka kamu da cutar, kuma 672 sun mutu sakamakon cutar. Amurka ta ba da rahoton a ranar 26 ga watan Maris cewa ta fi kowace kasa a duniya, ciki har da China da Italiya, yawan wadanda suka kamu da cutar coronavirus.
A cewar wani rahoto na kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump ya yanke shawarar tsawaita dokar nisantar jama'a har zuwa 30 ga Afrilu.
A wannan ranar ne aka ajiye jirgin asibiti na Amurka mai dauke da gadaje 1,000 a New York.
A ranar 3 ga Afrilu, an sami rikodin mutuwar mutane 884 a cikin awanni 24 a Amurka.
A jihar New York, adadin wadanda suka kamu da cutar ya kai sama da 100,000 a ranar 3 ga Afrilu. Fadar White House ta fuskanci hukunci saboda rashin kula da hadarin, da sanarwar jama'a ga jami'an kiwon lafiya da masana kimiyya game da cutar, da kuma umarnin yin hulɗa da haɗin gwiwa tare da ofishin mataimakin shugaban kasa Mike Pence a cikin watsa labarai.
An raba jam'iyyun biyu game da goyon bayan da Trump ya samu game da yadda ya magance matsalar.
Wasu jami'an Amurka da wasu kafofin yada labarai sun soki dogaro da shigo da kayayyakin gaggawa daga China, ciki har da kayayyakin kiwon lafiya da ake bukata.
An yi amfani da tsarin tafiye-tafiye na iska don tsara taswirar wuraren da cutar ta yadu da kuma kimanta yanayin kamuwa da cuta, kuma an buga wannan bincike a cikin mujallar Travel Medicine a tsakiyar watan Janairu na 2020.
Bayanai na 2018 na Kungiyar Kula da Sufurin Jiragen Sama ta Duniya sun nuna cewa Bangkok, Hong Kong, Tokyo da Taipei sune manyan wuraren da fasinjoji suka fi yawa daga Wuhan.
An kuma bayar da rahoton cewa Dubai, Sydney, da Melbourne sune wuraren da mutane ke zuwa daga Wuhan.
An sanar da tsibirin Bali cewa ya kamata ya kasance a cikin manyan wurare 20 da ke da matukar bukatar kiyayewa yayin da biranen Australiya ke buƙatar kiyayewa. Australia ta ba da sanarwar shirin gaggawa na sabon coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ba a samu ƙarin bayani game da COVID-19 ba, kuma Australia ta ce za ta ƙarfafa kula da kan iyakoki da sadarwa a matsayin martani ga annobar.
A ranar 21 ga watan Maris, an ayyana dokar ta baci ta lafiyar dan adam a Australia.
Da yake akwai ingantaccen sa ido kan sufuri na jama'a a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan kasarsu da ma'aikatan diflomasiyya daga yankin, da farko ta hanyar jiragen haya zuwa kasashen su na asali, tare da samun izinin hukumomin kasar Sin.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand sun fara shirin kwashe 'yan kasarsu zuwa inda suka fi aminci.
Pakistan ta ce ba za ta dauki mataki ba don dawo da 'yan kasarta da ke cikin kasar Sin.
A ranar 7 ga watan Fabrairu, gwamnatin Brazil ta sami damar kwashe 'yan kasar Poland hudu, da wani dan kasar Sin, da kuma wani dan Indiya, da kuma wasu 'yan kasar Brazil 34 ko kuma danginsu.
A lokacin da jirgin ya tsaya a wani wuri kafin ya koma Brazil, 'yan kasar Poland, China da Indiya sun sauka daga jirgin.
An killace 'yan Brazil da suka ziyarci Wuhan a wani sansanin soji kusa da Brasilia.
A cikin kwana daya, 'yan Kanada 215 (176 daga jirgin farko da gwamnatin Amurka ta yi haya, da 39 daga na biyu) an sanya su a cikin sa ido na makonni biyu daga Wuhan zuwa CFB Trenton.
A ranar 11 ga watan Fabrairu, wani jirgin sama daga Wuhan dauke da 'yan Kanada 185 ya sauka a filin jirgin sama na CFB Trenton.
A ranar 3 da 4 ga watan Fabrairu, hukumomin Australiya sun kai 'yan kasar 277 zuwa wani wurin da ake tsare da su a tsibirin Kirsimeti, wanda aka sake fasalin shi a matsayin wurin da ake tsare da cutar, inda suka zauna tsawon kwanaki 14.
Jirgin ceto na New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma fasinjojin (ciki har da wasu 'yan asalin Australiya da wasu daga kasashen Pacific) an killace su a sansanin Sojan Ruwa na Whampawera a arewacin Auckland.
A ranar 15 ga watan Fabrairu, Amurka ta sanar da cewa za ta kwashe Amurkawa daga jirgin ruwan Diamond Princess zuwa inda ba su da lafiya.
A ranar 21 ga watan Fabrairu, wani jirgin da ke dauke da fasinjoji 129 na 'yan Kanada da ke cikin jirgin Diamond Pricess ya sauka a garin Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasarta daga Iran zuwa inda suke lafiya. A ranar 14 ga watan Maris, jirgin kamfanin jiragen sama na Afirka ta Kudu da gwamnatin Afirka ta Kudu ta yi haya ya dawo da 'yan Afirka ta Kudu 112.
An gudanar da gwajin lafiya kafin tashi, kuma an bar 'yan Afirka ta Kudu huɗu da ke nuna alamun cutar coronavirus don rage haɗarin.
An mayar da 'yan Afirka ta Kudu ne kawai da suka yi gwajin lafiya kuma suka sami lafiya.
A matsayin mataki na farko, an gwada dukkan 'yan Afirka ta Kudu marasa cutar, ciki har da dukkan ma'aikatan jirgin, matukan jirgi, ma'aikatan otal,' yan sanda da sojoji, waɗanda suka shiga cikin aikin sadaukarwa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye wasu daga cikin dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, ma'aikatar harkokin wajen kasar Sin ta ce kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun ba da tallafi ga kasar Sin.
Wasu daliban kasar Sin da ke halartar jami'o'in Amurka sun ce sun hada kai a fadin yankin Chicago don kai agaji zuwa yankunan da cutar ta addabi inda suka samu nasarar isar da kayan rufe fuska N95 guda 50,000 zuwa asibitocin lardin Hubei a ranar 30 ga watan Janairu. A hadin gwiwa da kungiyar agaji ta FedEx, kungiyar agaji ta bayar da 200,000 na kayan rufe fuska tare da wasu kayan kariya na mutum, ciki har da safofin hannu da riguna, zuwa asibitin lardin Wuhan a ranar 30 ga Janairu.
"A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun sanar da cewa sun ba da gudummawar dala miliyan 100 ga WHO don samar da rigakafi da kuma hanyoyin magance cutar da za ta iya hana "masu fama da cutar a Afirka da Kudancin Asiya".
A ranar 6 ga watan Fabrairu, Sanata Richard Gordon ya ba da gudummawar abin rufe fuska 200,000 ga Philippines bayan da ya aika da abin rufe fuska miliyan 3.16 zuwa Wuhan, a cewar rahoton Ineraksyon.
A ranar 19 ga watan Fabrairu, kungiyar 'yan ci-rani ta Singapore ta sanar da cewa za ta aika da kayayyakin agaji da suka kai dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da gudummawar abin rufe fuska miliyan daya ga Wuhan, Turkiyya ta ba da kayan aikin likita, Rasha ta aika da kayan aikin likita sama da tan 13 zuwa Wuhan, Malaysia ta sanar da bayar da gudummawar safar hannu na likita miliyan 18 ga China, Jamus ta ba da kayan aikin likita iri-iri, ciki har da rigunan Hersem 10,000, Amurka ta ba da gudummawar kayan aikin likita tan 17.8 ga China, kuma ta yi alkawarin ba da ƙarin dala miliyan 100 na taimakon kuɗi ga ƙasashen da abin ya shafa. Lokacin da al'amuran suka daidaita a China, China ta ba da taimako ga ƙasashe da yawa da cutar ta shafa.
A watan Maris, China, Cuba da Rasha sun aika da kayan aikin likita da masana zuwa Italiya don magance yaduwar cutar coronavirus.
Jammar, wani dan kasuwa, ya aika da kayan gwaji miliyan 1.1, da abin rufe fuska miliyan 6 da rigunan kariya 60,000 zuwa Addis Ababa, Habasha, don rarraba daga Tarayyar Afirka.
Daga baya ya aika da kayan gwaji 5,000, abin rufe fuska 100,000 da na'urorin numfashi biyar zuwa Panama.
Ma ya kuma ba da gudummawar kayan aikin likita ga Kanada. Kasashen Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwarsu game da abin rufe fuska da kayan gwajin da aka yi a China.
Misali, a Spain, an dawo da na'urorin gwajin cutar coronavirus 58,000 na kasar Sin tare da daidaito na kashi 30 cikin dari, yayin da a Netherlands, an dawo da abin rufe fuska 600,000 na kasar Sin tare da lahani.
A Belgium, an dawo da abin rufe fuska 100,000 da ba su dace da amfani ba, abin da ake tsammanin daga China ne, amma a zahiri daga Colombia ne.
A wani bangare kuma, kasashen Latin Amurka da Afirka na karbar kayan agaji daga China. A ranar 2 ga watan Afrilu, Bankin Duniya ya fara shirin samar da agaji na gaggawa ga kasashe masu tasowa.
Hukumar ta WHO ta ba da shawarar cewa hukumomin kasar Sin su gudanar da kokarin da suke yi na shawo kan annobar.
"WHO ta lura da wani muhimmin bambanci tsakanin hukumomin China, wadanda ake zargi da yin ɓoye-ɓoye da suka jinkirta ayyukan rigakafi da sarrafawa a lokacin barkewar cutar SARS ta 2002-2004, da kuma gwamnatin tsakiya, wacce ke sakin bayanai na yau da kullun kafin hutun Sabuwar Shekarar Sin don "guje wa firgita" a lokacin rikicin na yanzu".
A ranar 23 ga watan Janairu, yayin da yake mayar da martani kan shawarar da hukumomin tsakiya suka yanke na aiwatar da dokar hana zirga-zirga a Wuhan, wakilin WHO Gordon Gallia ya yi sharhi cewa, "Tabbas ba shawarar WHO bane". Ya kuma ce, "Wannan muhimmin alama ne na ƙudurin sarrafa annobar a wuraren da aka fi taruwa", inda ya kira ta "marasa misali a tarihin ɗan adam". Bayan tabbatar da kamuwa da cutar a cikin mutane a waje da China a ranar 30 ga Janairu, da kuma lokacin da cutar ta bazu a cikin wasu ƙasashe, WHO ta bayyana cutar a matsayin babbar matsalar lafiyar jama'a, kuma ta kasance farkon lokacin PIC a cikin 2009.
"Darakta Janar na WHO Tedros Edhanwan ya ce sanarwar PHEIC "ta zama mai wahala saboda yiwuwar barkewar cutar a duniya, musamman a ƙasashe masu ƙarancin kuɗi da matsakaitan kuɗi waɗanda ba su da ingantaccen tsarin kiwon lafiya".
Tedros ya amsa da cewa, "babu wani dalili da zai sa a dauki matakan da za su iya tsoma baki ba dole ba a tafiye-tafiye da cinikayya ta kasa da kasa", kuma ya ce, "WHO ba ta bayar da shawarar hana kasuwanci da tafiye-tafiye ba".
A ranar 5 ga watan Fabrairu, WHO ta nemi al'umma ta duniya da ta ba da dala miliyan 675 don tallafawa shirye-shiryen dabarun a ƙasashe masu ƙarancin kuɗi.
Tedros ya fitar da sanarwa inda ya ce "za mu iya zama masu karfi a cikin mafi rauninmu" kuma ya bukaci al'umma ta duniya da su "sanya hannun jari a yau, in ba haka ba za a biya mai girma a wani lokaci". A wani taron manema labarai a ranar 11 ga Fabrairu, WHO ta ba da sunan cutar COVID-19.
A wannan rana, Sakatare Janar na Majalisar Dinkin Duniya António Guterres ya amince da bayar da "ikon da dukkan tsarin Majalisar Dinkin Duniya ke da shi" don taimakawa wajen mayar da martani, in ji Tedros.
An kafa kungiyar kula da hadarin ta Majalisar Dinkin Duniya, wanda ya ba da damar hadin gwiwar amsawar Majalisar Dinkin Duniya baki daya. Kasashe membobin WHO sun ba su damar mai da hankali kan mayar da hankali kan martani na kiwon lafiya yayin da sauran hukumomi ke kawo ƙwarewarsu don magance tasirin zamantakewa, tattalin arziki da ci gaba da ya haifar da barkewar cutar.
A ranar 14 ga watan Fabrairu, an kafa wata kungiya ta hadin gwiwa da kasar Sin karkashin jagorancin WHO, tare da masana na kasa da kasa da na WHO a kan lamarin, don taimakawa kasar Sin wajen gudanar da aikin gida, da kuma gudanar da bita da bita kan yadda ake fuskantar tsananin cutar da kuma yaduwar cutar a manyan cibiyoyin kasa da bita da tarurruka, da kuma gudanar da nazarin filin kan tasirin ayyukan da ake yi a matakin gunduma da birni, ciki har da na birni da na karkara. A ranar 25 ga watan Fabrairu, WHO ta fara sanar da cewa duniya ta fi son yin shiri don cutar ta coronavirus, kuma ta ce, idan cutar ta zama annoba, ta yi iya ƙoƙarin da ta dace, ta ce, "ya kamata kasar ta yi a matakin shiri".
A sakamakon karuwar yaduwar cutar a Iran, WHO ta tura tawagar hadin gwiwa zuwa Iran don kimanta halin da ake ciki. A matakin duniya, jami'an WHO sun ce matakin barazanar na iya tashi daga kashi 10 zuwa 10 cikin 100 a matakin annobar, kuma ya kasance mafi girma a matakin gargadi da kimanta hadari.
Myrin, darektan gudanarwa na shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin wani ra'ayi na yanzu: "Akwai abu daya da kowane gwamnati a duniya ke bukatar ta sarrafa: Tashi".
"Kwayar cutar tana kan hanyarta, kuma kuna buƙatar kasancewa a shirye", ya yi kira ga duniya da ta dauki matakan da suka dace don kauce wa "mafi munin yanayi".
Ryan ya kara da cewa, "bayanan da muke da su yanzu ba su da inganci sosai don jami'an kiwon lafiyar jama'a su ayyana cutar a matsayin annoba ta duniya, kuma yin hakan zai nuna cewa mun yarda da cewa duk mutane a duniya za su kamu da cutar".
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya ta ayyana cutar coronavirus a matsayin annoba.
Darakta Janar ya ce WHO na da matukar damuwa game da yadda cutar ta kai matakin da ya kamata a kula da shi, da kuma yadda ake samun karancin adadin wadanda suka kamu da cutar. An yi ta sukar WHO kan rashin isasshen matakan da ta dauka wajen shawo kan annobar, ciki har da jinkirin ayyana dokar ta baci ta kiwon lafiya da kuma jinkirin ayyana cutar a matsayin annoba.
A ranar 6 ga watan Afrilu, mutane 733,000 suka sanya hannu a kan bukatar da ake yi na yin murabus daga mukamin daraktan WHO Tedros Adhanom.
A ranar 26 ga Maris, 2020, masana 'yancin dan adam na Majalisar Dinkin Duniya sun jaddada muhimmancin girmama hakkin dan Adam na kowane mutum a lokacin annobar COVID-19.
Kungiyar ta ce kowa na da hakkin samun taimakon da zai ceci ransa, kuma gwamnati ce ke da alhakin hakan.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama dalilin nuna bambanci ga wasu mutane ba.
Masana sun jaddada cewa kowane mutum yana da hakkin samun lafiya, ciki har da masu nakasa da kuma wadanda ke cikin kananan kungiyoyi, tsofaffi, 'yan gudun hijira marasa gida, marasa gida, wadanda ke cikin matsanancin talauci, wadanda ke tsare, amma kuma 'yan gudun hijira da sauran kungiyoyi marasa tsari da ke bukatar tallafin gwamnati.
Hukumomin duniya suna magance tasirin tattalin arziki da zamantakewar rikicin COVID-19.
Kungiyar hadin gwiwar tattalin arziki da ci gaba ta kirkiro wani dandamali don samar da cikakken bayani da kuma ra'ayoyi kan manufofin mayar da martani a cikin kasashe daban-daban a duniya.
Daga tsara manufofi don ƙarfafa tsarin kiwon lafiya da tattalin arziƙin duniya zuwa magance tasirin kulle-kulle da ƙuntatawa kan tafiye-tafiye, cibiyar dijital ta ƙunshi tsarin sa ido kan manufofin ƙasa, wanda ke nufin taimakawa ƙasashe suyi nazari da juna da kuma sauƙaƙe haɗin kai na duniya game da ƙalubalen coronavirus.
Eduardo Bolsonaro, dan shugaban Brazil, Gabriel Sanaro, Ministan Harkokin Wajen Birtaniya, Michael Golff, da Amurka sun zargi gwamnatin China kan yadda ta magance annobar cutar a lardin Hubei na kasar Sin.
An kori gwamnoni da yawa na matakin gunduma na jam'iyyar kwaminis ta kasar Sin (CPC) saboda yadda suka bi da sa ido na musamman a tsakiyar kasar Sin, alama ce ta rashin gamsuwa da yadda tsarin siyasa ke amsa yaduwar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa an yi wannan yunkurin ne don kare babban sakataren jam'iyyar kwaminis ta kasar Sin Xi Jinping daga fushin jama'a kan yaduwar cutar coronavirus.
Wasu jami'an kasar Sin (kamar Zhao Lijian) sun yi watsi da cewa COVID-19 ya samo asali ne a Amurka ko Italiya, kuma sun ƙi amincewa da gaskiyar cewa cutar coronavirus ta samo asali ne daga Wuhan.
Gwamnatin Donald Trump ta Amurka ta yi amfani da sunan coronavirus a matsayin cutar China ko Wuhan, kuma ta ce, "yanke bayanan da China ta yi ya sa cutar ta zama annoba ta duniya". Wasu masu sukar sun yi tir da wannan furucin a matsayin karkatar da hankali game da wariyar launin fata da kuma kasawar gwamnatin da ke jagorantar cutar.
An samu labarin duk abin da ya shafi China ne daga abin da aka ambata a matsayin dabarun sadarwa na gwamnatin Amurka da ke da kebul wanda ya bayyana dabarun sadarwa da aka fara a Majalisar Tsaro ta Kasa a birnin Daleb.
"An umurce mu da mu yada wannan sakon ta kowace hanya, ciki har da taron manema labarai da shirye-shiryen talabijin. " "A cewar majiyoyi kamar Politico, Foreign Policy da Bloomberg, kokarin da China ke yi na kai agaji ga kasashen da cutar ta shafa na daga cikin yunkurin yada labarai ne na rinjayar duniya".
"Majalisar harkokin wajen Tarayyar Turai, José Boyer, ta yi gargadin cewa akwai "talakawa" a cikin kokarin samun rinjaye a fagen siyasa da kuma manufofin siyasa".
Borel ya kara da cewa, China tana kokarin samar da yanayi daban da Amurka, don zama mai alhakin da kuma amintaccen abokin tarayya.
A yayin da kasar Sin ke kai taimakon agaji ga Venezuela da Iran, a lokaci guda kuma ta bukaci a dage takunkumin Amurka kan Syria da Venezuela da Iran.
An dakatar da kyautar abin rufe fuska 100,000 da Jack Ma ya bayar ga Cuba a ranar 3 ga Afrilu saboda takunkumin Amurka.
An zargi jami'an Amurka da yin amfani da kayan agaji da aka ba wa wasu kasashe don amfanin kasashensu.
An yi muhawara game da abin rufe fuska tsakanin Jamhuriyar Czech, Italiya da sauran ƙasashe kamar Jamus, Austria da Switzerland.
Bugu da kari, Turkiyya ta kama daruruwan na'urorin numfashi da aka yi niyyar turawa zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta yi zargin cewa kasashen Turai sun kasa nuna hadin kai yayin da cutar coronavirus ke addabar Italiya.
Jakadan Italiya a Tarayyar Turai Maurizio Massari ya ce China ce kawai ta mayar da martani a bangarorin biyu.
"Ba lallai ba ne alama ce mai kyau ga haɗin kan Turai".
Bayan tattaunawa ta waya da Firayim Ministan Italiya Giuseppe Conte a ranar 22 ga Maris, Shugaba Vladimir Putin ya shirya cewa sojojin Rasha za su kai ma'aikatan lafiya na soja, da na'urorin kwantar da hankali na musamman da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta nakalto wani babban jami'in yada labarai na siyasa da ba a bayyana sunansa ba, yana mai cewa, kashi 80 cikin 100 na taimakon da Rasha ta bayar ba shi da amfani, kuma kadan ne kawai ke amfani Italiya.
Majiyar ta zargi Rasha da yin ayyukan siyasa da na siyasa da kuma na ta'addanci.
Gwamnan Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Maio sun yi watsi da rahoton kafofin watsa labarai kuma sun ce suna godiya.
Rasha ta tura jirgin jigilar kayayyaki zuwa Amurka don kawo taimakon likita.
Mai magana da yawun Kremlin Dmitry Peskov ya ce Putin ya yi imanin cewa lokacin da ya ba da tallafi ga abokan aikinsa na Amurka, masana'antun magunguna na Amurka za su iya dawo da taimako a lokacin da ake buƙata yayin da ake haɓaka samar da kayan aikin likita da kayan aiki.
"Nazarin Sojojin NATO na Defender 2020 wanda aka shirya gudanarwa a Jamus, Poland da kasashen Baltics, wanda shine mafi girman atisayen Sojoji na Tsakiya tun karshen Yakin Cacar Baki, zai zama wani tsari na rage girman".
"A halin yanzu, ba wai kawai sojojin Amurka da na kasashen Turai ba ne ke fuskantar barazana a lokacin rikicin lafiyar jama'a, har ma da rayukan mutanen kasashen da suke aiki", in ji babban sakataren kungiyar kare makaman nukiliya Kate Hudson, "Gwamnatin Iran ta sha wahala sosai daga cutar, inda kimanin 'yan majalisa goma sha biyu da kuma shugabannin siyasa 15 na yanzu ko na baya suka kamu da cutar".
Shugaban Iran Hassan Rohini ya aika da wasika ga shugabannin duniya a ranar 14 ga Maris, 2020, yana neman taimako. A cikin wasikar, ya bayyana cewa kasarsa na fama da yaduwar cutar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin da Amurka ta kafa a kan Iran.
Masu binciken siyasa sun yi hasashen cewa hakan zai iya shafar damar da Donald Trump ke da ita na neman shugabancin kasar a shekarar 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta yi muni yayin barkewar cutar.
Koriya ta Kudu ta soki Japan kan kokarin da take yi na rashin nuna gaskiya da kuma rashin nuna himma, lokacin da Japan ta sanar da cewa duk wani baƙo daga Koriya ta Kudu zai yi keɓewa na makonni biyu a wuraren da gwamnati ta tsara.
A farkon, jama'ar Koriya ta Kudu sun yi ta murabus game da yadda Shugaba Moon Jae-In ya amsa rikicin.
'Yan kasar Koriya sun sanya hannu kan wata sanarwa da ke zargin Moon da rashin kula da cutar da gwamnatin ta yi, ko kuma yabonsa kan yadda ya kula da cutar. Kasashe suna da ikon kafa dokar ta baci a lokacin da suke amsa cutar.
Wasu masu sukar sun yi zargin cewa wannan ya sa gwamnatoci su kara karfafa ikon su.
A Hungary, majalisar dokokin kasar ta amince da bai wa Firayim Minista Vitaly Orbán iko ba tare da iyakancewa ba, dakatar da zabe da majalisar dokoki, da kuma hukunta wadanda suka yada labaran karya game da cutar da yadda gwamnati ta magance annobar.
Haɓaka kayan aiki a duniya don magance cutar coronavirus ya haifar da wasu cututtukan samar da kayayyaki, kamar su yankewa ba tare da buƙata ba, sayayya mai yawa saboda tsoro, da kuma dakatar da masana'antu da ayyukan sufuri.
Hukumar Abinci da Magunguna ta Amurka ta ba da gargadin karancin magunguna da kayan kiwon lafiya saboda karuwar bukatar masu amfani da kuma rashin daidaito a samar da kayayyaki.
Tashin hankali da yawan sayayya ya haifar da sayen kayayyaki da yawa a shagunan kayan masarufi, da abinci, takardar wanka da kwalaben ruwa, da sauransu, inda aka ga rashin kayayyaki a yankuna da dama.
An riga an ba da gargadi game da jinkirin jigilar kayan lantarki, musamman a masana'antar fasaha.
A cewar Darakta Janar na WHO Tedros Adnanwang, bukatar kayan kariya ta mutum ya ninka sau 100.
Wannan bukatar ta haifar da hauhawar farashin sau ashirin fiye da yadda aka saba kuma ya jinkirta isar da kayayyakin kiwon lafiya na tsawon watanni hudu zuwa shida.
WHO ta kuma yi gargadin cewa, wannan ya haifar da karancin kayan kariya na mutum a duniya, wanda zai iya sanya ma'aikatan kiwon lafiya cikin hadari.
A Ostiraliya, annobar ta ba da sabuwar dama ga masu sayen kayayyakin Australiya da ke sayar da kayayyaki zuwa China ta hanyar digo (mutum daga wajen China yana sayen kayayyaki ga wani a cikin China).
Wannan yunkuri ya haifar da karancin madara a wasu manyan kantuna, wanda daga bisani gwamnatin Ostiraliya ta dakatar. Kasashe biyu sun sami karancin abinci musamman a arewacin Italiya da yankin Wuhan, sakamakon karuwar cutar COVID-19 da kuma karuwar bukatar kayayyakin abinci.
A cikin shirin da ke nuna yiwuwar rashin abinci mai yawa a Turai da Arewacin Amurka, China da Italiya sun hana ajiyar kayayyaki masu mahimmanci da kuma cinikin haramtacciyar hanya don kauce wa hakan.
A cewar wakilan masana'antu, ba a sami raguwa mai yawa a cikin muhimmin bangare na samar da kayan gona a arewacin Italiya ba, amma farashin zai iya tashi.
A Wuhan, babban birnin kasar, jami'an gwamnatin kasar Sin sun fitar da naman alade don tabbatar da cewa jama'a suna da isasshen abinci.
A Italiya, akwai irin wannan dokar da ta tanadi bukatun ajiya ga masu samar da abinci a irin wannan yanayin gaggawa.
Rashin tattalin arzikin duniya ya shafi China. A ranar 16 ga Maris, wata majiya ta ruwaito cewa, matakan da gwamnati ta dauka na rage yaduwar cutar sun yi sanadin mummunan tasirin tattalin arzikin China a farkon watanni biyu na shekarar 2020, inda tallace-tallace na sayar da kayayyaki suka ragu da kashi 20.5%.
Kasar Sin ita ce cibiyar tattalin arziki da masana'antu, kuma lokacin da cutar ta bulla, an ga cewa ita ce babbar barazana ga tattalin arzikin duniya.
Agatha Damaris na sashen bincike na tattalin arziki ya yi hasashen cewa kasuwannin za su ci gaba da zama marasa karko har sai an sami cikakken bayani game da sakamakon da ake tsammani.
A watan Janairun 2020, wasu manazarta sun yi hasashen cewa tasirin koma bayan tattalin arziki kan ci gaban duniya a lokacin annobar zai iya zama mafi muni fiye da lokacin barkewar cutar SARS ta 2002-2004.
Wani gwani a Jami'ar Washington da ke St. Louis ya kiyasta cewa tasirin da aka samu a kan sarkar samar da kayayyaki ta duniya ya kai dala biliyan 300, kuma zai iya wucewa har tsawon shekaru biyu.
Kungiyar Kasashen Da Ke Fitar Da Man Fetur (OPEC) ta ruwaito cewa farashin mai na cikin wani yanayi na rashin tabbas bayan da ya fadi sakamakon karancin bukatar da kasar Sin ke samu.
Kasuwancin duniya sun fadi a ranar 24 ga Fabrairu saboda karuwar adadin masu kamuwa da cutar COVID-19 a wajen China.
A ranar 27 ga Fabrairu, alamun hannun jari na Amurka, ciki har da NASDAQ-100, S&amp;P 500 da Dow Jones Industrial Average, sun faɗi saboda ƙaruwar damuwar cutar coronavirus, wanda ya kasance mafi ƙarancin faɗuwa tun daga 2008.
Dukkanin alamomin uku sun ragu zuwa sama da kashi 10 cikin 100 a karshen mako.
A ranar 28 ga watan Fabrairu, Scope Ratings GmbH ta amince da darajar darajar China, amma ta ci gaba da nuna rashin amincewa.
Kasuwancin hannayen jari sun sake yin raguwa a ranar 16 ga Maris, mafi girma a cikin shekaru da suka gabata, dangane da fargabar cutar coronavirus.
Mutane da yawa suna tunanin yiwuwar koma bayan tattalin arziki.
Masanin tattalin arziki Mohamed El-Erian ya yaba wa manyan bankuna da kasashen da suka dauki matakin gaggawa.
Bankunan tsakiya sun amsa da sauri fiye da lokacin rikicin na 2008.
Kasuwancin yawon bude ido na daga cikin manyan masana'antun da suka fi fama da matsalar saboda takunkumin tafiye-tafiye, rufe wuraren jama'a, ciki har da wuraren da yawon bude ido ke jan hankali, da kuma shawarwarin da gwamnatoci ke bayarwa game da duk wata tafiya a duniya.
Sakamakon haka, kamfanonin jiragen sama da dama, ciki har da British Airways, China Eastern Airlines da Kwantar Airlines sun soke zirga-zirgar su saboda karancin fasinjoji, kuma kamfanin jirgin sama na cikin gida na Burtaniya Flybe ya fadi.
Tasirin da ke kan masana'antar jirgin ruwa ya kai wani matakin da ba a taɓa gani ba.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Cutar ta faru ne a daidai lokacin da babban lokacin yawon bude ido na Chunyun, wanda ke da alaƙa da hutun Sabuwar Shekarar Sin.
Kamfanoni masu zaman kansu sun rufe shagunan su da wuraren jan hankali na yawon bude ido kamar su Disneyland na Hong Kong da Shanghai, yayin da gwamnatoci na kasa da na kananan hukumomi suka soke taron jama'a da suka hada da bikin bikin Sabuwar Shekara na shekara-shekara.
An rufe bukukuwan Sabuwar Shekara da wuraren shakatawa da yawa, ciki har da birnin haramtacciyar birni da kuma wuraren ibada na gargajiya a Beijing, don hana taron jama'a.
A larduna 24 cikin 31 na kasar Sin, da birane da yankuna da ke karkashin tsarin karamar hukuma, hukumomi sun tsawaita hutun sabuwar shekara zuwa 10 ga Fabrairu, kuma sun ba da umarnin kada a sake buɗe wuraren kasuwanci kafin wannan ranar.
Yankunan suna wakiltar kashi 80 cikin dari na GDP na kasar da kuma kashi 90 cikin dari na fitar da kayayyakin kasar.
An bayyana matakin amsa cutar a Hong Kong a matsayin mafi girma, an ayyana dokar ta baci, tare da rufe makarantu har zuwa Maris da soke bukukuwan Sabuwar Shekara. Rage lokutan buɗe shaguna da rufewa na ɗan lokaci sun shafi rawar 'yan kasuwa a duniya.
A Turai da Latin Amurka, ziyarar kantin sayar da kayayyaki ta ragu da kashi 40%.
Masu sayar da kayayyaki a Arewacin Amurka da Gabas ta Tsakiya sun ga raguwar kashi 50 zuwa 60 cikin dari.
Haka kuma, yawan mutanen da ke tafiya zuwa cibiyoyin cin kasuwa ya ragu daga kashi 33 zuwa 43% a watan Maris idan aka kwatanta da watan Fabrairu.
Masu buɗe cibiyoyin siyayya a duk duniya suna amfani da ƙarin hanyoyin da aka ƙayyade, kamar ƙara tsabtace gidaje, shigar da masu auna zafin jiki da kuma bincika zafin jiki na masu siye, soke abubuwan da suka faru. Hukumar Tattalin Arzikin Majalisar Dinkin Duniya don Latin Amurka ta kiyasta cewa yawan mutanen da ke cikin matsanancin talauci a Latin Amurka na iya tashi daga miliyan 14 zuwa miliyan 22 a lokacin barkewar cutar fiye da yadda ya faru kafin barkewar cutar.
A watan Janairu da Fabrairu na 2020, lokacin da cutar ta yi yawa a birnin Wuhan, mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Kusan mutane miliyan 300 na bakin haure a yankunan karkara na kasar Sin sun makale a gidajensu a yankunan cinikayya ko kuma a lardin Hubei. Sama da Amurkawa 10 sun rasa ayyukansu a watan Maris na 2020 kuma sun nemi taimakon gwamnati.
The Federal Reserve Bank of Saint Louis ya kiyasta cewa cutar ta coronavirus za ta iya haifar da asarar ayyuka miliyan 47 a Amurka, kuma rashin aikin yi zai iya kaiwa kashi 32 cikin dari. A Indiya, rufewar ta sa ma'aikata baƙi na Indiya sama da miliyan goma (ma'aikata na yau da kullun) marasa aiki. Wani bincike da aka yi ta Jami'ar Angus Reid ya gano cewa kashi 44% na mutanen Kanada na da irin wannan rashin aikin yi.
A rabin watan Maris, an cire wa ma'aikatan Faransa miliyan hudu daga biyan kudin rashin aikin yi na wucin gadi, kuma an samu ma'aikata miliyan daya a Burtaniya a cikin shirin bashi na rufewa. Kimanin kamfanoni miliyan biyu a Jamus sun tura ma'aikatansu zuwa shirye-shiryen aiki na ɗan lokaci da gwamnati ke bayarwa, wanda aka fi sani da Kurzarbeit.
Faransa da Burtaniya sun bi tsarin na Jamus na biyan diyya na gajeren lokaci.
Cutar ta yi mummunan tasiri ga bangarorin fasaha da al'adun gargajiya, da kuma ayyukan ƙungiyoyi, da ma'aikata da masu zaman kansu a duk duniya.
Ƙungiyoyin fasaha da al'adu sun yi ƙoƙari su ci gaba da aikin su na samar da damar yin amfani da al'adu ga jama'a, da kiyaye lafiyar ma'aikatansu da jama'a, da kuma samar da tallafi ga masu fasaha (wanda galibi gwamnati ke bayarwa).
A watan Maris na 2020, jami'o'i, gidajen tarihi, dakunan karatu, wuraren shakatawa da sauran gine-ginen al'adu a duk duniya an rufe su har abada, tare da soke ko dakatar da nune-nunen su, bukukuwa da nishaɗi.
A sakamakon haka, an yi ƙoƙari sosai don samar da wasu ayyuka ta hanyar dandamali na dijital. Wani kwanan nan kuma mai saurin haɓaka saboda cutar shine soke ayyukan addini, manyan wasannin motsa jiki, da sauran abubuwan zamantakewa kamar kide kide da wake-wake, taron fasaha da nunin tufafi.
An kuma yi wa masana'antar fim rauni. Vatican ta sanar da cewa an soke halartar makon tashin Almasihu daga matattu, wanda ake gudanarwa a Roma a makon karshe na azumi, don tunawa da wahalar Kristi.
A wasu wurare, an shawarci tsofaffi Kiristoci su zauna a gida maimakon halartar taron Lahadi. Wasu suna tuka motoci suna gudanar da ibadar, wasu majami'u kuma suna ba da damar yin addu'o'in ta hanyar rediyo, watsa shirye-shiryen kan layi, ko talabijin.
An rufe cocin Roman Katolika da wuraren ibada da wuraren ibada na Kirista, an soke sauran ayyukan addini, an hana tarurruka a cikin majami'u, masallatai, majami'u, majami'u da kuma gidajen ibada.
Ma'aikatar Lafiya ta Iran ta dakatar da ayyukan ibada a ranar Juma'a a yankunan da cutar ta shafa, sannan ta rufe masallatai. Saudiyya ta hana masu hawan haikalin kasashen waje shiga, tare da hana 'yan kasarsu zuwa wuraren ibada a Makka da Madina.
Cutar ta haifar da wasu daga cikin gagarumin dakatarwar kalandar wasanni ta duniya tun bayan yakin duniya na biyu.
An soke ko dakatar da yawancin manyan wasannin wasanni, gami da gasar cin kofin zakarun Turai ta 2019-20, 2019-20 Premier League, UEFA Euro 2020, kakar NBA ta 2019-20 da kuma kakar NHL ta 2019-20.
Shirye-shiryen wasannin Olympics na bazara na 2020, wanda aka shirya fara a ƙarshen Yuli, an dakatar da shi saboda cutar. Kwamitin wasannin Olympic na kasa da kasa ya sanar a ranar 24 ga Maris cewa za a iya canzawa zuwa kwanan wata bayan shekarar 2020, ba daga baya ba fiye da lokacin bazara na 2021. Gidajen caca da sauran wuraren wasan caca a duniya sun rufe, kuma an soke watsa shirye-shiryen wasan caca kai tsaye.
Wannan ya sa yawancin 'yan caca suka juya zuwa caca ta kan layi, kuma bisa ga shafukan caca na kan layi, sun sami karuwar sabbin biyan kuɗi. Har ila yau, ya shafi masana'antar nishaɗi, kuma yawancin ƙungiyoyin kiɗa sun dakatar ko soke waƙoƙin.
An dakatar da duk wani wasan kwaikwayo a manyan gidajen sinima, kamar su gidajen rawa a Broadway.
Wasu masu fasaha sun nemi hanyoyin da za su ci gaba da yin aikinsu da kuma raba su a Intanet maimakon salon wasan kwaikwayon na gargajiya. Misali, suna ƙirƙirar raye-raye na raye-raye ko kuma abubuwan da suka shafi yanar gizo, inda masu zane-zane ke yin, rarraba, da kuma gabatar da aikinsu ga masu sauraro.
A cikin wannan yanayi na rashin daidaito, mutane da yawa sun fi son abin dariya da kuma shagala, saboda haka an sami memes da yawa na yanar gizo da suka shafi cutar coronavirus.
Tun bayan barkewar cutar COVID-19, an ga rashin daidaito ga mutanen asalin Gabashin Asiya da kuma sauran yankuna masu kamuwa da cutar, da karuwar tsoratar da baƙi da kuma wariyar launin fata a Turai, Amurka da sauran ƙasashe.
Tsoro, shakka da kuma nuna adawa suna faruwa a kasashe da dama, musamman a Turai, Gabashin Asiya da Arewacin Amurka da yankin Asiya da Pacific.
Tun daga watan Fabrairu, rahotanni sun nuna cewa akwai ra'ayoyin wariyar launin fata da kungiyoyi daban-daban a duniya suka bayyana cewa Sinawa sun cancanci cutar ko kuma ana hukunta su da adalci.
A wasu kasashen Afirka ma, muna ganin tashin hankalin adawa da China.
Mutane da yawa da suka zauna a Wuhan da Hubei sun ba da rahoton cewa an yi musu wariya bisa asalinsu.
An samu tallafi daga yanar gizo da kuma waje ga 'yan kasar Sin a yankunan da cutar ta addabi.
Tun da yake Italiya ita ce kasa ta farko da ta fara fuskantar mummunan barkewar cutar COVID-19 a Turai, bayan da cutar ta yadu zuwa wasu kasashen da ba a taba kamuwa da ita ba, mutane a kasashen da suka hada da Malaysia, New Zealand, Singapore da Koriya ta Kudu sun sanya hannu kan takardun neman hana shigar da 'yan kasar Sin zuwa kasashensu a kokarin dakile yaduwar cutar.
A cikin wata sanarwa da aka wallafa a shafin Twitter, an yi amfani da hashtag #ChineseDontComeToJapan, wanda ya zama ruwan dare a Japan.
Wasu mutanen Asiya, ciki har da Sinawa a Burtaniya da Amurka, sun ba da rahoton cewa suna fama da wariyar launin fata da kuma cin zarafin da ake yi musu.
Masu sukar sun yi tsokaci kan yadda shugaban Amurka Donald Trump ya kira cutar coronavirus da sunan China virus, wanda ya zama wata kalma mai nuna kyamar Sin da wariyar launin fata.
A Ukraine, masu zanga-zanga sun kai hari kan motocin bas da ke dauke da 'yan kasar Ukraine da kuma' yan kasashen waje da suka yi hijira daga Wuhan zuwa Novosibirsk.
Dalibai daga arewa maso gabashin Indiya, wanda ke kan iyakar China, da ke karatunsu a manyan biranen Indiya sun ce cutar ta coronavirus ta kawo cikas.
Dilis Ghosh, shugaban jihar Bharatiya Janata Party a West Bengal, ya ce Allah yana ramawa Sinawa saboda lalata dabi'a.
Bayan haka, ofishin jakadancin China a Guangzhou ya yi tir da maganganun da ake kira "maras gaskiya". Cutar ta haifar da fargaba da kuma wariyar launin fata a kan mutanen da ba Sinawa ba da ke zaune a China, kuma an bayyana baƙi a matsayin ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓarnar ɓararararararararararararararararararararararararar ɗararararar ɗar ɓar ɗar ɗar ɗar ɗar ɗar ɗar ɗar ɗar ɗar ɓar ɗar ɓar ɓar ɗar ɗar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɗar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar ɓar
Yawancin jaridu da ke biyan kuɗi na wata-wata sun cire fasalin da ke ba da damar karantawa daga biyan kuɗi don duk ko wasu labaran cutar coronavirus.
Masu wallafa wallafe-wallafen kimiyya da dama sun wallafa takardu na kimiyya game da yaduwar cutar don kowa ya samu ya karanta.
Wasu masana kimiyya sun zaɓi su raba sakamakon su a kan sabobin preprint kamar bioRxiv.
Cutar cutar mai yaduwa - cuta ce mai yaduwa ta kwayar cutar mai tasowa. Sau da yawa, yawanta yana da ban mamaki a cikin yaduwar cutar ko hanyar watsawa.
A cikin shekara ta 2000, an yi wa mutane fiye da miliyan biyu a duniya, fiye da miliyan ɗari huɗu a duniya, ana samun cutar a kowace shekara.
A cikin shekara ta 2000, mutane fiye da miliyan uku sun kamu da cutar.
An yi amfani da wannan hanyar don a yi amfani da shi a matsayin hanyar da za a iya samun 'yanci daga cin hanci da rashawa, da kuma cin hanci da rashawa.
Gwajin gwaje-gwaje na SARS-CoV-2 game da cutar coronavirus na numfashi na 2019 (COVID-19) sun haɗa da hanyoyin gano kasancewar kwayar cutar da kuma gano ƙwayoyin cuta da aka samar don amsa cutar.
RT-PCR, wanda ke gano RNA na ƙwayoyin cuta na coronaviruses, ya tabbatar da kasancewar ƙwayoyin cuta a cikin marasa lafiya.
An tsara wannan gwajin ne musamman don gano RNA na SARS-CoV-2.
An tabbatar da cutar kwanan nan ko mai aiki.
Ana iya amfani da gano kwayar cutar (plasma) don ganewar asali da kuma bincike a cikin al'umma.
Gwajin kwayar cutar na nuna ko akwai mutanen da suka kamu da cutar, ciki har da wadanda ba su da alamun cutar ko kuma wadanda ba su da alamun cutar.
Sakamakon gwajin zai iya tantance ainihin yawan mutuwar cutar da matakan garkuwar garkuwar jama'a.
Babu wata ƙasa da ta iya bayyana tabbataccen bayani game da yaduwar cutar a cikin jama'arta har zuwa Maris 2020 saboda ƙuntatawa na gwaji.
Har zuwa ranar 23 ga watan Maris, babu wata kasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma adadin gwajin da aka yi ya bambanta sosai a ƙasashe da yawa.
Wannan bambancin yana da tasiri sosai a kan yawan mutuwar waɗanda aka gano, wanda ya fi yawa a wasu ƙasashe.
Ta amfani da ainihin lokacin polymerase chain reverse transcription (rRT-PCR), ana iya yin gwajin a kan samfuran hanyoyin numfashi da aka yi amfani da su ta hanyoyi daban-daban, gami da samfurin hanci, hanci, ko kuma fitsari.
A cikin kwanaki da yawa, ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki 2.
Gwajin RT-PCR na hanci da na hanci da na hanci yana da tabbaci ne kawai a cikin makon farko na cutar.
Daga baya, kwayar cutar ta ci gaba da yaduwa a cikin huhu, kuma ta ɓace a cikin makogwaro.
A mako na biyu, waɗanda ke da cutar za su iya yin gwajin ko dai ta hanyar yin amfani da bututun da ke tsotse kayan samfurin daga cikin hanyoyin numfashi mai zurfi ko kuma ta hanyar yin fitsari.
A watan Janairun 2020, an gudanar da gwajin PCR na farko ta amfani da fasahar polymerase chain reverse transcription (rRT-PCR) a cikin lokaci na ainihi a Charité a Berlin, wanda ya samar da kayan gwaji 250,000 a matsayin tushen rarraba ta Hukumar Lafiya ta Duniya (WHO).
United Kingdom ta gano gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya gano kayan bincike na SARS-CoV-2 na PCR na matakin likita a ranar 28 ga Janairu, 2020.
A China, BGI Group ita ce ta farko da ta sami amincewa daga Hukumar Kula da Kayayyakin Magunguna ta China don amfani da gaggawa don kayan gwajin PCR-based SARS-CoV-2. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafi (CDC) sun rarraba kayan aikin gano RT-PCR na 2019-Novel coronavirus (2019-nCoV) na ainihi zuwa dakunan gwaje-gwaje na kiwon lafiyar jama'a ta hanyar rarraba kayan aiki na kasa da kasa.
Sakamakon gwajin kwayoyin halitta guda uku a cikin tsofaffin kayan gwajin, wanda ya hada da kwafin kwayar cuta da gwajin kwalba a CDC a Atlanta, ba su da cikakkun bayanai. Ya kasance a cikin watan Fabrairu na 2020 a matsakaita, ƙasa da 100 a cikin samfurin kwayoyin da za a iya yin nasara a kowace rana.
An ba da izinin gwajin a cikin jihohi da kuma gidajen gwaje-gwaje don fara gwajin, saboda ba a iya yanke shawarar karɓar gwajin tare da kayan biyu ba har zuwa 28 ga Fabrairu, 2020.
Hukumar Abinci da Magunguna ta amince da gwajin a karkashin izinin amfani da gaggawa. Dakunan gwaje-gwaje na kasuwanci na Amurka sun fara gwajin a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa gwajin COVID-19 na RT-PCR yana samuwa a duk ƙasar.
Quest Diagnostics ya yi irin wannan aiki don samun damar gwajin COVID-19 a duk faɗin ƙasar a ranar 9 ga Maris, 2020.
Ba a sanar da wani iyakance na adadi ba. Za a gudanar da tattara kwayoyin halitta da kuma gudanar da ayyukan ne bisa ga bukatun da CDC ta tsara.
Cibiyar Bincike ta Jihar ta Virology da Biotechnology (VECTOR) ce ta haɓaka gwajin COVID-19 a Rasha.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, Mayo Clinic ta ba da rahoton cewa ta gano gwajin don gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami izinin FDA don gwajin da za a yi a cikin awowi 3.5, wanda zai iya yin kusan gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin amfani da gaggawa ga Abbott Labs don gwada tsarin Abbott na m2000. A baya, FDA ta ba da irin wannan izinin ga Hologic, LabCorp, da Thermo Fisher Scientific.
Hakazalika, Cepheid ta sami izinin amfani da gaggawa (EUA) daga FDA don gwajin minti 45 a ranar 21 ga Maris, 2020.
FDA ta amince da gwajin da ke amfani da fasahar isomeric nucleic acid amplification maimakon PCR.
Ba a buƙatar daidaitawar da ake buƙata na sake zagayowar zafin jiki, amma wannan hanyar tana ba da sakamako mai kyau a cikin minti biyar da sakamakon rashin cutar a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka, kuma Abbott na fatan kara samarwa don yin gwaje-gwaje 50,000 a kowace rana. Taiwan tana haɓaka gwajin da ke amfani da kwayar cutar ta nucleocapsid (N-protein) ta kwayar cutar ta coronavirus, wanda ake tsammanin zai samar da sakamako a cikin mintuna 15 zuwa 20 kamar yadda gwajin zazzabin saurin sauri yake.
Wani bita na harshen Maris na 2020 ya nuna cewa zane-zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi a kan zanen da aka yi.
Halaye na yau da kullun akan CT sun haɗa da gano abubuwa da yawa na gilashi a bangarorin biyu, ba tare da daidaito a gefen ba, tare da rarraba baya.
A yayin da cutar ke ci gaba, ana samun rinjaye da wuri da kuma haɗin kai.
Ko da yake binciken da aka yi a Wuhan, asalin cutar ta duniya, ya kwatanta PCR da CT, ba shi da daidaito, amma bayyanarsa tana da yawa a cikin wasu cututtukan huhu da ci gaban cutar, kuma CT tana da ikon ƙira sosai fiye da PCR.
A watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar cewa kada a yi amfani da CT a matsayin gwajin farko don gwada COVID-19 ko don ganewar asali. A watan Maris na 2020, CDC ta ba da shawarar PCR a matsayin gwajin farko.
Wani bangare na amsawar garkuwar jiki ga kamuwa da cuta shine samar da kwayoyin cuta, ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da cuta, kimanta rigakafi, da kuma sanya ido a kan mutane a cikin kwanaki 7 da suka gabata bayan bayyanar cututtuka. Ana iya gudanar da bincike a cikin manyan dakunan gwaje-gwaje (CLT) ko a wuraren gwajin kulawa (PoCT).
Tsarin sarrafa kansa mai saurin tunani a yawancin dakunan gwaje-gwaje na likita zai iya yin waɗannan gwaje-gwajen, amma ingancin su zai dogara ne akan saurin samar da sakamako na kowane tsarin.
Ana iya amfani da samfuran tsokoki na layi don nazarin amsawar rigakafi, amma ana amfani da su a cikin samfurin jini mai yawa don CLT.
Ana samun samfurin jini guda ɗaya don PoCT, yawanci ta hanyar huda fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar matakin cirewa kafin a gwada. A ranar 26 ga Maris, 2020, FDA ta gano ƙungiyoyi 29 waɗanda suka sanar da hukumar kuma yanzu suna iya rarraba gwajin antibody ɗin su.
A karshen watan Maris na shekarar 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don kayan aikin su, wanda zai iya gano IgG da IgA antibodies masu tasiri akan kwayar cutar a cikin jinin mutum.
Yana iya gwada daruruwan samfura a cikin awanni kaɗan, kuma yana da sauri fiye da gwajin PCR na RNA na gargajiya.
Yawancin lokaci ana iya gano kwayoyin cutar cikin kwanaki 14 bayan fara kamuwa da cutar. Birtaniya ta gano cewa na'urorin gwajin kwayoyin cutar da ta saya a farkon watan Afrilu ba su yi aiki yadda ya kamata ba.
Hong Kong ta kafa tsarin da zai sa marasa lafiya masu zargi su zauna a gida.  Ma'aikatar gaggawa za ta ba marasa lafiya gilashin samfurin nama  Sun sanya haushi a ciki, kuma sun dawo da sakamakon ba da daɗewa ba. NHS ta Burtaniya ta sanar da cewa wannan gwaji ne na farko a cikin tsarin gwajin marasa lafiya masu zargi a gida, wanda zai kawar da yiwuwar cewa mai haƙuri zai iya cutar da wasu idan ya zo asibiti kuma ya yi amfani da motar asibiti.  A cikin hanyar gwajin motar mota don marasa lafiya da ake zargi da COVID-19, masana na iya amfani da samfuran rigakafi masu dacewa.
Cibiyoyin gwajin tuki suna taimaka wa Koriya ta Kudu ta sami saurin, mafi yawan gwaji fiye da kowace ƙasa. A Jamus, ƙungiyar likitocin inshorar lafiya ta kasa ta ce a ranar 2 ga Maris, suna iya yin gwaje-gwaje 12,000 a rana a cikin keɓewar su, daga 10,700 da aka yi a makon da ya gabata.
Idan likita ya ba da umarnin yin gwajin, kamfanin inshora zai biya kuɗin.
A cewar shugaban Cibiyar Robert Koch, Jamus tana da damar yin gwajin 160,000 a mako.
A ranar 19 ga watan Maris, an fara gudanar da gwajin zirga-zirga a birane da dama.
Ba a san adadin gwajin da aka yi a Jamus ba har zuwa 26 ga Maris, 2020, saboda an fitar da sakamakon cutar ne kawai.
An fitar da gwajin gwaji na farko na dakin gwaje-gwaje tare da gwajin SARS-CoV-2 33,491 (6.9%) da kuma jimlar kwayoyin halitta 483,295 a cikin kalandar 12/2020, gami da makon 12/2020. Masu bincike a asibitocin Technion da Rambam a Isra'ila sun gano hanyar da za su iya gwada samfuran lokaci guda daga marasa lafiya 64. Ana ci gaba da ƙarin gwaje-gwaje idan an tattara samfuran kuma an gano cutar a cikin samfurin.
Tsarin, wanda ya dauki kwanaki biyar da kafa Wang Jian, wanda ya jagoranci BGI, ya nuna cewa idan ba a yi amfani da wannan damar ba, za a iya samun kamuwa da cutar da kashi 47 cikin dari a Hubei, kuma farashin kula da keɓewar tafiye-tafiye zai ninka.
Nan take, asibitocin Wuhan da asibitocin Huai'an a Guangzhou, Tianjin, Beijing, da Shanghai sun biyo baya a cikin birane 12 a duk faɗin China.
A ranar 4 ga Maris, 2020, gwajin wucewa na yau da kullun yana da gwaje-gwaje 50,000 a kowace rana. Tushen buɗe tushen ne, kuma an tsara shi sosai, injin da aka samar ta Origami Assays yana iya gwada COVID-19 akan samfuran ƙwayoyin cuta na marasa lafiya 1122 a cikin kwana ɗaya ta amfani da ƙwayoyin cuta 93 kawai. Ana iya amfani da waɗannan ƙirar masu rarrabuwa a cikin ƙananan dakunan gwaje-gwaje ba tare da buƙatar robots masu sarrafa ruwa ba.
A watan Maris, abin da ya rage ga gwajin taro a EU, Burtaniya da Amurka shine karancin kayan aikin gwajin.
Wannan ya sa wasu marubuta suka gano hanyoyin shirya samfurin da suka hada da dumama samfurin na mintuna 5 a zafin jiki 98 °C (208 °F) don fitar da kwayoyin halittar RNA don ƙarin gwaji. A ranar 31 ga Maris, Hadaddiyar Daular Larabawa (UAE) ta sanar da cewa yanzu tana da gwajin cutar coronavirus a cikin kowace al'umma fiye da kowace ƙasa, kuma tana kan hanyar isa ga mafi yawan yawan jama'arta.
Wannan haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin haɗin
An gina dakin gwaje-gwaje na tsawon kwanaki 14 kuma yana gudanar da gwaje-gwaje na RT-PCR dubu goma a rana, kuma shine na farko a duniya wanda ke aiki a wannan sikelin a wajen China.
An gano hanyoyin gwaji daban-daban don gano abubuwa daban-daban na bayanan kwayar cutar coronavirus a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar Lafiya ta Duniya ta bayar da sinadarin Jamus don kayan aikinta ga ƙasashe masu ƙarancin kuɗi ba tare da buƙatar albarkatu don samar da kansu ba.
Cibiyoyin Kula da Cututtuka da Kula da Cututtuka na Amurka sun jinkirta samun samfuran a Amurka, kuma ba su samu ba har zuwa 28 ga Janairu. A farkon barkewar cutar, China da Amurka suna da matsaloli game da amincin kayan gwajin, kuma waɗannan ƙasashe da Ostiraliya ba su da isasshen kayan samar da kayan gwaji da gwajin da masana kiwon lafiya suka ba da shawarar har sai an cika buƙatun.
A wani bangare kuma, masana sun ce samun damar yin gwajin a Koriya ta Kudu na iya taimakawa wajen rage yaduwar cutar coronavirus.
Gwamnatin Koriya ta Kudu ta gina ikon yin gwaji a cikin shekaru, musamman a cikin dakunan gwaje-gwaje masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta bukaci a hanzarta shirye-shiryen gwaji a matsayin hanya mafi kyau don rage yaduwar cutar ta COVID-19. Babban bukatar gwaji saboda yaduwar cutar ya sa dubban daruruwan gwaje-gwaje a dakunan gwaje-gwaje masu zaman kansu na Amurka, suna ta yanke kayan aiki da kayan aikin sunadarai.
A watan Maris na shekarar 2020, kasar Sin ta bayar da rahoton matsalar daidaito a cikin kayan gwajin su.
A Amurka, CDC ta samar da kayan gwaji da suka kunshi kurakurai guda 10. Gwamnati ta cire shingen da ke hana gwajin masu zaman kansu. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology na kasar Sin, Ltd, amma an gano cewa sakamakon ba daidai bane.
Kamfanin ya bayyana cewa sakamakon da ba daidai ba na iya zama sakamakon gazawar tattara samfura ko amfani da kayan aikin gwaji daidai.
Ma'aikatar Spain ta ce za ta dawo da na'urorin bincike da ke samar da sakamako mara kyau kuma a maimakon haka za a maye gurbin na'urorin bincike da kamfanin Shenzhen Bioeasy ya samar. Kashi 80 cikin 100 na na'urorin bincike na kasar Sin da Jamhuriyar Czech ta saya sun samar da sakamako mara kyau. Slovakia ta sayi na'urori masu bincike miliyan 1.2 daga kasar Sin, kuma an gano cewa ba su samar da sakamako daidai ba.
Firayim Minista Matovic ya ba da shawarar a zubar da su a cikin Danube. Ates Kara na Ma'aikatar Lafiya ta Turkiyya ya ce kayan gwajin da Turkiyya ta sayo daga China suna da babban kuskuren kuskure kuma ba a yi amfani da kayan aikin ba. Kasar Burtaniya ta sayi kayan gwajin miliyan 3.5 daga China, amma a farkon Afrilu 2020 ta sanar da cewa ba za su iya amfani da su ba.
Gwajin da kuma keɓewar mutanen da ke dauke da cutar da kuma bin diddigin mutanen da suka yi hulɗa da mutanen da ke dauke da cutar SARS-CoV-2 sun ba da sakamako mai kyau.
Masu bincike a garin Vo na Italiya, inda aka fara samun mutuwar COVID-19 a cikin kwanaki goma, sun yi gwajin sau biyu ga kusan mutane 3,400 na garin.
Kusan rabin mutanen da aka gwada basu da alamun cutar, kuma duk wanda ya kamu da cutar an sanya shi cikin keɓewa.
Ta hanyar takunkumin tafiye-tafiye, zai iya kawar da sabbin kamuwa da cuta.
Ta hanyar tsauraran matakan bin diddigin, gwaji da keɓewa, annobar cutar coronavirus ta 2020 a Singapore ta sami saurin yaduwa fiye da sauran ƙasashe masu tasowa, ba tare da buƙatar ƙuntatawa a cikin gidajen abinci da wuraren sayar da kayayyaki ba.
An soke abubuwa da yawa kuma an bukaci mazauna Singapore su zauna a gida a ranar 28 ga Maris, amma an sake buɗe makarantu a kan lokaci a ranar 23 ga Maris, bayan ƙarshen hutun makaranta.
Yawancin sauran ƙasashe sun yi amfani da ƙa'idodin bin diddigin lamba, ƙuntatawa kan balaguron shiga cikin gida, da kuma keɓewa a cikin gudanar da cutar, amma ba su da ƙarfi a cikin ƙuntatawa, misali, Iceland da Koriya ta Kudu.
Wani bincike na kididdiga ya gano cewa kasashe da suka fi yin gwaji suna da ƙananan mutuwar mutuwa, mai yiwuwa saboda ƙasashen sun fi iya gano alamun rashin ƙarfi ko babu.
WHO ta ba da shawarar cewa ƙasashe waɗanda ba su da damar gwaji da kuma dakunan gwaje-gwaje na ƙasa waɗanda ke da ƙarancin ƙwarewa a kan COVID-19 su aika da samfuran farko masu inganci guda biyar da samfuran COVID-19 marasa inganci guda goma zuwa ɗayan dakunan gwaje-gwaje 16 da WHO ta tsara don tabbatarwa.
Daga cikin dakunan gwaje-gwaje guda 16, bakwai suna Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amurka da ɗaya a Ostiraliya.
A cikin jadawalin da ke ƙasa, an nuna cewa kashi 50% na masu kamuwa da cutar a cikin gwaje-gwajen da aka yi sun shafi manufofin gwajin ƙasar.
Kasar da ke yin gwajin cutar ga mutanen da ke asibiti kawai, ko da kuwa suna da alamun cutar ko a'a, za ta kasance mai girma, duk da haka, idan aka kwatanta da ƙasashe waɗanda ke yin gwajin cutar a duk faɗin ƙasar, duk da haka, kashi na gwajin da aka gano ya fi girma.
Wanke hannu, wanda kuma aka sani da tsabtace hannu, shine aikin wanke hannayen mutum da nufin cire datti, mai, ƙwayoyin cuta, ko wasu abubuwa marasa so.
Wanke hannuwanka da sabulu a wasu lokuta masu mahimmanci a rana yana hana kamuwa da cututtuka da yawa, kamar zawo da cututtukan sauro.
Idan mutane ba su wanke hannayensu ba kafin su taɓa idanunsu, hanci da baki (yankin fitsari), za su iya kamuwa da cututtukan numfashi, kamar su sanyi ko mura.
Lokacin da ya fi muhimmanci a wanke hannu da sabulu da ruwa a rana sun hada da kafin zuwa gidan wanka da kuma bayan canza tufafin jariri ko bayan canza kayan wanka, kafin ciyar da jariri, kafin shirya abinci ko kuma kafin ma'amala da nama mai kyau, kifi ko kaza.
Idan sabulu da ruwa ba su samuwa, za ka iya wanke hannunka da toka.
Kafin, a lokacin da ake dafa abinci, da kuma bayan an gama.
Kafin da kuma bayan kula da marasa lafiya.
Bayan an canza dips ko bayan an tsabtace jariri a gidan wanka.
Bayan ka yi hancinka, ka yi tari, ko ka yi hancinka, kana iya yin wasu abubuwa da yawa.
Idan ka taɓa dabba, abincin dabba, ko sharar dabba.
Tsabtace hannu na likita yana nufin ayyukan tsabtace muhalli da ke da alaƙa da ayyukan likita.
Wanke hannu kafin shan magani ko kulawar likita na iya hana ko rage kamuwa da cutar.
Babban manufar wanke hannu a cikin likitanci shine tsabtace hannayenmu daga ƙwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta masu cutarwa) da kuma sunadarai masu haɗari ko masu cutarwa.
Yana da mahimmanci ga waɗanda ke sarrafa abinci a maimakon abinci ko waɗanda ke aiki a cikin yanayin likita, amma kuma yana da mahimmanci ga jama'a gaba ɗaya.
Wanke hannu na iya haifar da fa'idodi da yawa na kiwon lafiya, gami da rage yaduwar mura, kwayar cutar coronavirus da sauran cututtukan da ke yaduwa, hana kamuwa da cututtukan hanji, da rage kamuwa da cututtukan numfashi.
A wannan yanayin, yawan mutuwar jarirai a cikin gida ya yi ƙasa.
Wani bincike na 2013 ya nuna cewa inganta al'adar wanke hannu na iya haifar da ɗan ci gaba a cikin ci gaban dogon lokaci a cikin yara 'yan ƙasa da shekaru biyar.
A kasashe masu tasowa, yawan mutuwar yara ya danganci cututtukan numfashi da na ciki, kuma ana iya rage su ta hanyar sauya halayyarsu kamar sabulu da wanke hannu.
Wannan mataki mai sauki zai iya rage mutuwar wadannan cututtuka da kusan kashi 50%.
Shigar da hankula da ke inganta wanke hannu na iya rage yawan hawan jini da kashi uku, wanda ya yi daidai da samar da tsaftataccen ruwa a yankunan da ke da karancin kudin shiga.
Kashi 48% na raguwar lokacin fitsari na iya danganta ga sabulu da wanke hannu. Sabulu da wanke hannu sune mafi inganci da tsada don hana fitsari da cututtukan numfashi masu tsanani (ARI), kamar yadda ake aiwatar da su kai tsaye a gidaje, makarantu, da al'ummomi a duk duniya.
Cutar huhu, babbar cutar ARI, ita ce babbar hanyar mutuwar yara 'yan kasa da shekaru biyar, tana kashe kusan yara miliyan 1.8 a kowace shekara.
Kusan yara miliyan 3.5 ne ke mutuwa a kowace shekara saboda cutar amai da kuma cutar huhu.
UNICEF ta ce yin amfani da sabulu da wanke hannu kafin cin abinci da bayan wanka zai iya ceton rayuka fiye da rigakafi ko magani, rage mutuwar cututtukan ciki da kashi ɗaya, da kuma rage mutuwar cututtukan numfashi da kashi ɗaya cikin huɗu.
Ana amfani da wanke hannu tare da sauran hanyoyin wanke ruwa a matsayin wani ɓangare na shirye-shiryen ruwa, magudanar ruwa da tsabtace muhalli (WASH).
A cikin wannan labarin, an bayyana cewa, "Masu zanga-zanga sun yi watsi da wannan shirin na nuna cewa, ba za a iya samun damar yin amfani da wannan shirin ba".
Wani karamin sakamako na wanke hannu shine cewa yawan wanke hannu yana haifar da lalacewar fata ta hanyar bushewar fata.
Wani binciken Danish na 2012 ya gano cewa yawan wanke hannu na iya haifar da narkewar fata, wanda aka fi sani da itching, dusar ƙanƙara ko ciwon hannu, wanda ya zama ruwan dare a cikin ma'aikatan kiwon lafiya.
Ana ganin wanke hannu sau da yawa a matsayin wata alama ta cutar OCD.
Akwai lokuta biyar a rana da ya kamata a wanke hannu da sabulu don rage yaduwar cutar daga fitsari zuwa baki: bayan wanka (tashin jiki, yin fitsari), bayan wanke hancin jariri (canza kayan wanka), kafin ciyar da jariri, kafin cin abinci, da kuma kafin shirya abinci ko sarrafa nama, kifi ko kaza.
Sauran lokutan da ya kamata a yi amfani da hanyar wanke hannu daidai don hana kamuwa da cuta sun hada da kafin da bayan maganin ɓarna ko rauni, bayan hanci, tari, ko hancin hanci, bayan hulɗa da ƙazamar dabbobi ko dabbobi, da bayan kula da shara.
Yawancin ƙasashe ba su da sabulu da kuma tsabtace hannu.
A shekarar 2015, binciken wanke hannu a kasashe 54 ya nuna cewa kusan kashi 38.7% na iyalai suna amfani da sabulu da wanke hannu. Wani bincike na shekarar 2014 ya nuna cewa Saudi Arabia ce ke da kashi 97 cikin dari, Amurka tana da matsakaici da kashi 77 cikin dari, kuma China tana da kashi 23 cikin dari. An gabatar da hanyoyi da yawa na canza halayyar don inganta sabulu da wanke hannu a lokacin da ya fi dacewa.
A cikin wannan labarin, an bayyana cewa, "Kasuwancin Lafiya na Duniya" wanda Ma'aikatar Ilimi ta aiwatar a Philippines misali ne na babban aiki na inganta lafiyar yara da ilimi.
A cikin wannan shirin na kasa, ana yin wanka sau biyu a shekara, ana wanke hannaye da sabulu a kowace rana, ana kuma wanke haƙora a kowace rana da maganin shafawa.
An yi nasarar aiwatar da shi a Indonesia.
Ana kawar da kwayoyin cuta daga fata ta hanyar sabulu ko sabulu mai tsabta.
Babban aikin tukunyar sabulu da sabulu shine rage shingen narkewa da haɓaka narkewa.
Man fetur da furotin, waɗanda sune abubuwan ƙasa na halitta, ba sa narkewa cikin ruwa da sauƙi, don haka wankewa da ruwa kawai ba zai iya tsabtace fata yadda ya kamata ba.
Amma tsaftacewa ta hanyar isar da ruwa mai kyau yana taimakawa.
Saboda yanayin sake amfani da sabulu, sabulu yana iya riƙe kwayoyin cuta daga amfani da su a baya.
Wasu 'yan nazarin da suka yi nazari kan kamuwa da kwayoyin cuta daga sabulun sabulu da ke dauke da kwayar cutar sun kammala da cewa ba zai yiwu a kamu da kwayoyin cuta ba idan aka cire su da sabulu.
CDC ta ba da shawarar yin amfani da sabulu mai tsabta don wanke hannu.
An tallata sabulu mai kashe kwayoyin cuta musamman ga mutanen da suka san lafiyarsu.
Har zuwa yau, babu wata hujja da ta nuna cewa ana amfani da maganin rigakafi na musamman ko kuma maganin rigakafi na zaɓaɓɓu don ƙwayoyin cuta masu cutar da kwayoyin halitta.
Amma sabulun da ke kashe kwayoyin sun hada da kayan aikin kashe kwayoyin da aka saba amfani dasu kamar Trichlorin, wanda ke da matakai da yawa na juriya ga kwayoyin.
Saboda haka, sabulu mai kashe kwayoyin ba zai iya zama mai inganci kamar yadda aka tsara ba, idan ba a zaɓi mai tsayayyar maganin rigakafi ba.
Baya ga kayan shafawa da kayan kare fata, yawancin kayan kwalliyar zamani suna amfani da acid (acetic acid, ascorbic acid, acetic acid) a matsayin mai daidaita pH, da sinadarin benzoic acid da sauran kayan shafawa na fata (wanda zai iya ƙunsar laxatives, bitamin, foda, man fetur). Binciken da aka yi daga Jami'ar Kiwon Lafiyar Jama'a ta Oregon ya nuna cewa, yin amfani da kayan shafawa na maganin rigakafi kamar su triphosphate yana da kyau ga masu cutar da ke hana kamuwa da cuta da kuma kawar da ƙwayoyin cuta a hannu.
Ba za a iya yin amfani da ruwan da ya dace da wanke hannu ba don ya kashe kwayoyin cuta.
Kwayoyin cuta suna girma da sauri a zafin jiki (37°C).
Amma ruwan dumi da sabulu ya fi ruwan sanyi tasiri wajen kawar da ƙazanta da kuma kitse na halitta da ke riƙe da ƙwayoyin cuta.
Amma akasin abin da aka yarda da shi, binciken kimiyya ya nuna cewa amfani da ruwan zafi ba shi da wani tasiri wajen rage yawan kwayoyin cuta a hannu.
Mai tsabtace hannu ko mai kashe hannu shine mai tsabtace hannu mai tushen ruwa.
A ƙarshen shekarun 1990 da farkon karni na 21, kayan aikin wanke hannu na ruwa (wanda aka fi sani da wanke hannu na barasa, wanke hannu, ko wanke hannu) sun zama sananne.
Yawancin lokaci ana amfani da isopropyl alcohol ko ethanol a matsayin gel, ta amfani da carbolamine (acrylic acid polymer) a matsayin wakili mai narkewa, ko kuma a matsayin ruwa ta amfani da humidifier kamar glycerin, ko kuma a matsayin foda don sauƙaƙe amfani da rage tasirin bushewar giya.
Ƙara mai rauni na hydrogen peroxide yana ƙara haɓaka aikin yaƙi da ƙwayoyin cuta. Sanitizers na hannu tare da akalla 60 zuwa 95% na barasa suna da tasiri wajen kashe ƙwayoyin cuta.
Maganin tsabtace ruwan sha yana kashe kwayoyin cuta, kwayoyin cuta masu yawa (MRSA da VRE), TB, da wasu ƙwayoyin cuta (ciki har da HIV, Rhesus, RSV, rhinovirus, hepatitis, zazzabin cizon sauro, da hepatitis).
Tsabtace hanci mai dauke da barasa 70% yana kashe kwayoyin cuta a hannu da kashi 99.97% (rage 3.5 na loz ko rage 35 na decibels) bayan dakika 30 na tsotsa, kuma bayan minti 1 na tsotsa yana kashe kwayoyin cuta a hannu da kashi 99.99% zuwa 99.999% (rage 4 zuwa 5). Masu tsabtace hannu suna da tasiri sosai ga ƙwayoyin cuta kuma ba su da tasiri ga wasu ƙwayoyin cuta.
Don cututtukan Norovirus ko Norovirus, wanda ke haifar da cututtukan gastrointestinal da ke haifar da cututtukan hanji, masu tsabtace hannu masu amfani da barasa ba su da illa. Yi amfani da tsabtace hannu ko kuma mai tsabtace hannu don tabbatar da cewa hannayenka sun isa ko tsaftace su.
Ana goge duka gabashin da yammacin hannayen hannu da tsakanin da saman dukkan yatsun hannu, kusan na dakika 30 har sai sun bushe kamar ruwa, kumfa ko jelly.
Cibiyar Kula da Cututtuka da Rigakafin Amurka ta ba da shawarar wanke hannu maimakon wanke hannu da kayan wanke hannu idan hannayen sun kasance masu ƙazanta sosai.
Shahararren wannan maganin ya dogara ne akan sauƙin amfani da saurin kashe ƙwayoyin cuta, amma idan akwai, kada a maye gurbin wankewa da sabulu da ruwa daidai.
Idan ba a sanya masu laushi a cikin ruwan shafawa ba kuma / ko masu hana fata, yin amfani da kayan wanke hannu na tushen giya na iya haifar da bushewar fata.
Ƙara man shafawa da / ko wasu kayan shafawa na fata a cikin ƙirar zai iya rage ko kawar da tasirin bushewar fata na giya.
A cikin gwaji na asibiti, kayan wanke hannu na tushen giya waɗanda ke ƙunshe da masu laushi na fata sun haifar da ƙarancin ƙaiƙayi da bushewar fata fiye da sabulu ko kayan shafawa masu hana ƙwayoyin cuta.
Rashin jin daɗi na taɓawa, cutar taɓawa ta taɓawa, ko kuma rashin jin daɗi ga barasa ko kuma ƙwarewa ga kayan wanki na giya ba safai suke faruwa.
Abin sha'awa shine, ƙananan cututtukan cututtukan fata da ke haifar da rashin jin daɗi idan aka kwatanta da wanke hannu da sabulu da ruwa.
Ko da yake suna da tasiri, magungunan tsabtace ruwa ba su kawar da hannayen daga kwayoyin halitta ba, amma suna kashe hannayen hannu.
Wannan ya faru ne saboda masu tsabtace hannu ba su da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuktukan cututtuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuktuk
Ingancin maganin wanke hannu mara giya yana da matukar kusa da abubuwan da ke ciki da kuma tsarin hadawa, kuma a tarihi ya kasance ƙasa da tasirin barasa da maganin shafawa.
Abubuwan da aka yi amfani da su kwanan nan na amfani da benzalkonium chloride sun nuna daidaito da haɗin kai na aikin rigakafi lokacin amfani, ba kamar barasa ba, wanda ƙimar tasirinsa ya ragu, wanda zai iya faruwa bayan ƙarin amfani da ƙarin ƙwayoyin cuta na fata.
Mutane da yawa a cikin ƙananan al'ummomi ba su iya sayen sabulu kuma suna amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙasa na iya zama mai tasiri fiye da ruwa kawai, amma ba kamar sabulu ba.
Wani abin damuwa shi ne, idan aka gurɓata ƙasa ko toka da ƙananan ƙwayoyin cuta, zai iya ƙara yaduwar cutar maimakon rage cutar.
Kamar sabulu, toka ma mai kashe ƙwayoyin cuta ne, saboda idan ta haɗu da ruwa, tana haifar da ruwa mai narkewa.
WHO ta ba da shawarar amfani da toka da yashi maimakon sabulu idan babu sabulu.
Cibiyoyin Kula da Cututtuka na Amurka sun ba da shawarar cewa tsaftace hannu ya ƙunshi waɗannan matakan:
Ka sa hannunka su yi sanyi ko zafi.
Tun da tasoshin wanke hannu na tsaye na iya zama datti, ana ba da shawarar yin amfani da ruwa mai gudana ne kawai idan babu bambancin zafin jiki.
Ka shafa hannayenka da sauran sabulu, ciki har da saman wuyan hannu, tsakanin yatsunsu da kuma ƙarƙashin ƙusa, don fitar da kumfa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna son wanke hannayensu sosai idan suka wanke hannayensu da sabulu maimakon ruwa kawai.
Yi ta gogewa da wankewa na akalla dakika 20.
Yin shafa yana haifar da tausa kuma yana kawar da ƙwayoyin cuta a cikin fata, yayin da yin shafa na dogon lokaci zai iya kawar da ƙwayoyin cuta.
Yi wanka sosai da ruwa mai gudana.
Wanke hannu a cikin kwandon wanka na iya sake gurɓata hannayenka.
Ka yi amfani da tawul mai tsabta don ka bushe ko kuma ka bar shi ya bushe.
Hannun da ke da ruwa da kuma mai laushi suna da saukin kamuwa da kwayar cuta. Yawancin lokaci, wuraren da aka fi ƙazanta su ne yatsunsu, wuyan hannu, tsakanin yatsunsu da ƙusa.
Rashin ƙusa da ƙusa na iya adana ƙwayoyin cuta.
Ana ba da shawarar sau da yawa don kiyaye hannayenka daga bushewa. Gashin fata na iya haifar da lalacewar fata, wanda ke ƙara haɗarin sake kamuwa da cuta.
"Akwai zaɓuɓɓuka masu tsada daban-daban don yin wanka hannu a wuraren da babu ruwan sha da sabulu, misali - ta hanyar zuba ruwa daga akwatin ruwa mai murabba'i ko tukunyar busassun da ke da ramuka masu girman da ya dace, da / ko amfani da toka idan ya cancanta a cikin ƙasashe masu tasowa. A cikin yanayi inda wadatar ruwa ta iyakance (kamar makarantu a ƙasashe masu tasowa ko yankunan karkara) akwai hanyoyin ceton ruwa kamar 'pipes ɗaya' da sauran zaɓuɓɓuka masu arha".
Tashin ruwa shine fasaha mai sauki wanda aka zana ruwa mai kyau a kan igiya kuma a cikin ƙafafun kafa yana zuba ruwa mai yawa a kan sabulu da hannu.
Ko da yake bushewar hannu mai inganci wani bangare ne na tsarin tsabtace hannu, har yanzu ana muhawara kan mafi ingancin bushewa a gidajen wanka na jama'a.
Yawancin bincike sun nuna cewa takardar wanki ta fi na'urar busar hannu mai amfani da lantarki da ake samu a gidajen wanka da yawa.
A shekarar 2008, wani bincike da aka gudanar da shi a Jami'ar Westminster, London, wanda ya samu tallafin kungiyar Tissue Symposium, wani masana'antar kera takarda, ya kwatanta matakan tsaftacewa da kuma rigakafin kamuwa da cuta na takarda, na bushewar hannu na iska, da na bushewar hannu na iska.
A matsakaici, adadin kwayoyin cuta a yatsunsu ya karu da kashi 194 cikin dari bayan wanke hannu da bushewa da na'urar bushewa ta iska, kuma ya karu da kashi 254 cikin dari a kan yatsun hannu.
A matsakaici, bushewar iska yana haifar da karuwar kwayoyin cuta da kashi 42% a yatsun hannu da 15% a hannun hannu.
Bayan wanke hannu da kuma goge hannu da tawul din takarda, jimillar adadin kwayoyin sun ragu da kashi 76 cikin dari a kan yatsun hannu da kashi 77 cikin dari a kan dabino. Masana kimiyya sun gudanar da gwaje-gwaje don tabbatar da ko kowane irin bushewa yana iya yadawa ga sauran masu amfani da gidan wanka da kuma yanayin gidan wanka.
Mai bushe hannu, wanda ke yin famfo daga ma'adinai a cikin saurin 180 m/s (650 km/h, 400 mph), yana iya busa hannaye da kwayoyin cuta daga ma'adinai zuwa cikin sauran masu amfani da gidan wanka da kuma kewayen gidan wanka har zuwa nisan mita 2.
Amfani da na'urar busar hannu mai iska yana yaduwa da kwayoyin cuta daga na'urar busar har zuwa mita 0.25.
A cikin binciken da TÜV Produkt und Umwelt ya gudanar a shekarar 2005, an kimanta hanyoyi daban-daban na bushe hannu.
Bayan bushe hannayen, mun lura da wadannan canje-canje a cikin adadin kwayoyin:
Akwai masana'antun bushe-bushe hannu daban-daban, kuma an kwatanta bushe-bushe hannu da bushe-bushe hannu tare da takarda mai tsabta.
Yin wanka da kayan wanke hannu hanya ce mai amfani yayin tafiya inda sabulu da ruwa ba su da amfani.
Ana buƙatar maganin wanke hannu mai tushen barasa ya ƙunshi aƙalla kashi 60% na barasa.
Tuni dai bayan da likitan Hungary Ignaz Semmelweis ya gano tasirin wanke hannu a rigakafin cutar a cikin asibiti, wanke hannu ya zama al'ada a fannin kiwon lafiya.
Akwai na'urorin lantarki da ke ba da amsa don faɗakar da ma'aikatan asibiti idan sun manta da wanke hannu.
Wani bincike ya gano cewa amfani da su ya rage yawan kamuwa da cutar.
Wanke hannu na likita shine tausa kowane ɓangare na hannu tare da sabulu da ruwa mai laushi ko gel akan fata na aƙalla sakan 15.
Ya kamata ku wanke hannayenku tare da yatsunsu.
Idan akwai lalacewa a ƙarƙashin kusoshi, ana iya amfani da goga na Bristol don cire su.
Kwayoyin cuta na iya zama a cikin ruwa a hannayenku, saboda haka yana da mahimmanci a cire ruwan da tsabta kuma a bushe shi da tawul mai tsabta.
Bayan bushewa, ya kamata a yi amfani da takarda mai wanki don rufe ruwa (da kuma buɗe kofa, idan ya cancanta).
Wannan yana hana sake kamuwa da cutar daga waɗannan fuska zuwa hannun.
"Manufar wanke hannu a cikin dakin aikin kiwon lafiya ita ce kawar da kwayoyin cuta masu cutarwa ("" ƙwayoyin cuta "") da kuma hana su kamuwa da cuta".
Jaridar New England Medical Journal ta rubuta cewa ko da yake rashin wanke hannu ya kasance matakin da ba a yarda da shi a yawancin yanayin kiwon lafiya, yawancin likitoci da ma'aikatan jinya sun manta da wanke hannayensu kafin su sadu da marasa lafiya, wanda ke haifar da kamuwa da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu matakai masu sauki na iya rage yawan kamuwa da cututtukan jini da ke hade da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ana iya samun shawarwari na kungiyar kan tsaftace hannu a shafin yanar gizon kungiyar domin jama'a suyi tsokaci.
Wani bincike da ya dace da wannan shi ne na Whitby et al.
Idan ana bukatar bin ka'idoji, ana iya auna da tabbatar da tsabtace hannu ta hanyar injunan kasuwanci.
"Kungiyar Lafiya ta Duniya ta kafa 'yan dakiku biyar' na wanke hannu"
Bayan ka sha jini ko kuma ruwan ciki
Kafin aikin, babu ƙwayoyin cuta; da kuma
Bayan kulawar mai haƙuri, ban da sabulu, ana ƙara wasu sinadarai masu kashe ƙwayoyin cuta (sabunan da ke dauke da maganin sauro ko kuma sabulu masu hana ƙwayoyin cuta) don ƙara aikin kashe ƙwayoyin cuta a kan kayan aikin tsabtace hannu.
Irin wannan aikin kashewa ya zama dole a cikin yanayin da ke da yawa na ƙwayoyin cuta masu ƙwayoyin cuta ko kafin a yi aiki. Ba a buƙatar bututun mai rufewa ta atomatik, chlorhexidine ko iodine don yin aikin tiyata, wankewa da bushewa da wankewa da kuma tsabtace hannu tare da goga mai tsabta don shafawa da kuma sauran kayan aikin tsabtace hannu don tsabtace hannayenka.
Ya kamata a cire dukkan kayan aikin hannu.
Wannan aikin yana buƙatar wanke hannaye da yatsun hannu har zuwa yatsun hannu, yawanci na mintuna 2-6.
Ba na bukatar dogon lokaci na yin magana.
Idan ka wanke hannunka, kada ka bar ruwan da ke kan yatsunka ya koma hannunka.
Bayan ka gama wanke hannu, ka bushe hannayenka da kayan kashe cutar, sannan ka saka kayan tiyata.
Don rage yaduwar kwayar cutar, wanke hannu ko amfani da maganin wanke hannu kafin da kuma bayan kulawar.
An gano cewa mafi kyawun fa'idar wanke hannu don sarrafa cututtukan cututtukan staphylococcus a asibitoci ya kasance daga kashi 20 cikin ɗari na farkon wankewar, kuma an sami fa'idodi kaɗan na ƙarin lokacin da aka ƙara yawan wanke hannu sama da kashi 35 cikin ɗari.
Sabulu da wanka na yau da kullun sun ninka sau uku na kamuwa da cuta ta hanyar abinci idan aka kwatanta da sabulu da wanka na antibacterial. Rubbing hannu da ruwa mai tushen barasa da matsakaicin lokacin wanka na dakika 30 da sabulu mai hana ƙwayoyin cuta idan aka kwatanta da sabulu da wanka na antibacterial, yin tausa da ruwan giya yana rage ƙwayoyin cuta da kashi 26%.
Wanke hannu da sabulu da ruwa ya fi maganin wanke hannu na tushen giya tasiri wajen rage yawan kwayar cutar H1N1 influenza A da kuma cutar Clostridium difficile a hannaye. Ayyukan inganta tsaftace hannu a wuraren kiwon lafiya na iya haɗawa da wayar da kan ma'aikata game da wanke hannu da kuma shan giya, haɓaka wadatar kayan aikin tsabtace hannu, da kuma sanar da ma'aikata ta hanyar rubutu da magana.
Ana bukatar ƙarin bincike kan abin da ya fi dacewa a cikin waɗannan matakan a cikin wuraren kula da lafiya daban-daban.
A kasashe masu tasowa, ana ganin sabulu da wanke hannu a matsayin hanya mai tsada da mahimmanci don inganta lafiyar jiki da abinci mai gina jiki.
Amma rashin isasshen ruwa, sabulu ko kayan wanke hannu a gidaje, makarantu da wuraren aiki na iya zama matsala ga al'adun wanke hannu a duniya.
Misali, a yawancin yankunan karkara na Afirka, akwai zaɓuɓɓuka masu araha don gina wanka, amma akwai ƙarancin wanka kusa da gidajen wanka na sirri ko na jama'a.
Amma rashin wanke hannu ya fi nasaba da al'ada fiye da rashin sabulu ko ruwa.
Tallafawa da tallafawa sabulu da wanke hannu na iya tasiri kan yanke shawara, kara wayar da kan jama'a game da fa'idodin wanke hannu, da kuma haifar da sauye-sauyen halaye na dogon lokaci ga mutane da yawa.
Ana buƙatar saka idanu da kimantawa don aiki yadda ya kamata.
Wani nazari na tsari na binciken 70 ya gano cewa hanyoyin da al'umma ke bi wajen yaduwar al'adar wanke hannu a cikin LMICs (kasashe masu karancin kudi da matsakaitan kudi) sun yi tasiri yayin da kamfen din tallatawa na kafofin sada zumunta bai yi tasiri ba. Wani misali na inganta al'adar wanke hannu a makarantu shine tsarin UNICEF na duniya wanda ke karfafa wa dalibai gwiwa su yi amfani da hanyoyin da suka fi sauki da kuma tsada a makarantu don wanke hannayensu da sabulu.
Lokacin da suka cika mafi ƙarancin ƙa'idodi, makarantu na iya canzawa daga tauraro ɗaya zuwa mafi yawan taurari uku.
Gina wuraren wanke hannu na iya zama wani ɓangare na aikin inganta wanke hannu wanda ke nufin rage cututtuka da mutuwar yara.
Ranar Tsabtace Hannun Duniya misali ne na kamfen na wayar da kan jama'a wanda ke neman cimma nasarar sauya halayya. UNICEF ta ba da shawarar yin amfani da emoji na wanke hannu sakamakon annobar cutar coronavirus ta 2019-20.
Wasu nazarin sun yi la'akari da cikakken tsadar tsararren wanke hannu a ƙasashe masu tasowa ta hanyar guje wa DALYs.
Amma, wani ra'ayi shine inganta sabulu da wanke hannu yana da tsada sosai fiye da sauran hanyoyin ruwa da tsabtace jiki.
Maganin wanke hannu yana da mahimmanci ga lafiyar ɗan adam, musamman ga mutanen da ke cikin yanayi mai saukin kamuwa, kamar su uwaye da suka haihu ko sojoji da suka ji rauni a asibiti, an fara ganewa ne a tsakiyar karni na 19 da likitan Hungary Ignaz Semmelweis da Ingilishi Florence Nightingale, wanda ya kafa aikin jinya na zamani, wanda su ne farkon masu kirkirar tsabtace hannu a Vienna, Austria.
A lokacin, yawancin mutane suna da tabbacin cewa cututtukan sun samo asali ne daga ƙanshin ƙanshi, wanda ake kira miasmas.
Yaduwar cututtukan da ke yaduwa ta hanyar abinci da cututtukan da ke da alaƙa da kiwon lafiya a cikin shekarun 1980s sun sa Cibiyoyin Kula da Cututtuka da Rigakafi na Amurka su ƙara ƙarfafa tsabtace hannu a matsayin muhimmin hanyar hana yaduwar cututtuka.
Barkewar cutar sankarar naman alade a shekarar 2009 da kuma barkewar cutar COVID-19 a shekarar 2020 sun kara wayar da kan mutane a kasashe da dama game da muhimmancin wanke hannu da sabulu wajen kare kai daga irin wadannan cututtuka masu yaduwa.
Alal misali, a Jamus, an rataye allunan da ke nuna yadda za a wanke hannu daidai a kusa da wuraren wanka na gine-ginen gwamnati da na ofisoshin gwamnati da kuma a filayen jiragen sama.
Maganar "wanke hannuwanku" tana nufin cewa wani ya bayyana rashin son ɗaukar alhakin wani abu ko kuma raba wani abu.
Wannan kalmar ta samo asali ne daga nassi a cikin littafin Matta inda Pontius Bilatus ya wanke hannunsa saboda yanke shawarar gicciye Yesu, amma ya zama kalmar da aka fi amfani da ita a wasu al'ummomin Ingilishi.
A cikin Shakespeare's Macbeth, Lady Macbeth ta fara wanke hannayenta da tsananin ƙoƙari don tsabtace hoton da aka nuna ta hanyar nuna jin ta laifin laifin da ta aikata da kuma laifin da ta sa mijinta ya aikata.
Mutane suna wanke hannayensu sau da yawa fiye da sauran mutane, kuma suna daraja kayan wanke hannu fiye da sauran, bayan sun tuna ko kuma suna tunanin halaye na lalata.
Bugu da ƙari, waɗanda ke da irin wannan tunani kuma suna da damar wanke hannayensu daga baya ba sa shiga cikin wasu ayyukan tsabtace tsabta kamar aikin sa kai.
Addinai suna ba da shawarar wanke hannu don tsabta da dalilai na al'ada. Wanke hannu ba tare da sabulu ba, tare da wanke hannu kawai, wani nau'in wanke hannu ne na al'ada wanda aka yi amfani da shi a addinai da yawa, ciki har da Baha'i, Hindu, Tabitha da Nathil Yadiyyan na Yahudanci, Labrador a cikin Kiristanci, da Wad a cikin Musulunci. Wasu addinai kuma suna ba da shawarar wanke hannu bisa ga lafiyar jiki, musamman bayan yin wasu ayyuka.
Addinin Hindu, addinin Yahudanci da addinin Islama sun koyar da wanke hannu bayan amfani da bayan gida.
Bugu da ƙari, addinin Hindu, Buddha, Sikh, addinin Yahudanci da Musulunci suna yin al'ada don wanke hannu kafin da bayan cin abinci.
Gudanar da haɗarin aiki don COVID-19.
Gudanar da haɗarin aiki don COVID-19 shine amfani da hanyoyin lafiya da lafiya na aiki don kula da haɗarin aiki don hana cutar coronavirus 2019 (COVID-19).
Daidaitaccen sarrafawa a wurin aiki ya dogara da yanayin aiki da manufofin aiki, da kuma yanayin haɗarin da ke tattare da haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗ
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), ayyuka da ke da haɗarin kamuwa da cuta da ƙarancin haɗari ga mutane da kuma wasu abokan aiki, sun ba da shawarar matakan rigakafin kamuwa da cuta na asali, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan ba su da lafiya, kiyaye ƙa'idodin hanci da tari, da yin tsabtace muhalli na yau da kullun a wurin aiki.
Ayyukan da ke buƙatar yin hulɗa na yau da kullun ko kusa da waɗanda ba su san ko ake zargin suna da COVID-19 ba, da kuma ayyukan da ke iya kamuwa da cutar ta hanyar yaduwar jama'a ko balaguron ƙasa da ƙasa, suna cikin haɗarin kamuwa da cuta.
Wannan ya hada da ma'aikata da ke hulɗa da jama'a, kamar makarantu, wuraren aiki masu cunkoson jama'a, da kuma wasu wuraren da ake sayar da kayayyaki da yawa.
Baya ga ayyukan rigakafin kamuwa da cuta na asali, kula da haɗari ga wannan rukunin sun haɗa da amfani da iska mai iska mai ƙarfi, kariya daga hanci, da kuma samun kayan kariya na mutum idan ya zama dole don hulɗa da mutumin da ke da COVID-19.
OSHA ta bayyana cewa ma'aikatan kiwon lafiya ko na asibiti na zuciya da ke hulɗa da mutanen da aka sani ko ake zargin suna da COVID-19 suna da babban haɗarin haɗari idan sun kasance ma'aikata da ke tattara ko sarrafa samfuran ƙwayoyin cuta daga mutanen da aka sani ko ake zargin suna da COVID-19 ko kuma suna yin ƙwayoyin iska.
Kula da haɗarin da ya dace da waɗannan ma'aikata sun haɗa da sarrafa injiniya kamar ɗakunan iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska da kuma kayan kariya na mutum wanda ya dace da manufa ta aiki.
Cutar COVID-19 tana da tasiri da yawa a wuraren aiki.
Ma'aikata na iya rasa aiki saboda rashin lafiya, bukatar kula da wasu, ko kuma damuwa game da yiwuwar haɗuwa.
Yanayin kasuwanci na iya canzawa a cikin buƙatun kayayyaki da kuma yadda ake samun waɗannan kayayyaki (mafi mahimmanci: cin kasuwa ba tare da lokutan cunkoso ba, ko kuma hanyar isar da kaya ko sabis na sayayya ta mota).
A ƙarshe, jigilar kayayyaki daga yankunan da COVID-19 ya yadu na iya jinkiri. Shirye-shiryen cututtukan cututtuka da shirin amsawa na iya amfani da su azaman jagora ga ayyukan kariya.
Shirye-shiryen suna magance tushen haɗari, gami da haɗarin da ke tattare da wurare daban-daban da manufofin kasuwanci, haɗarin da ke tasowa daga tsarin gida da na al'umma, da kuma matakan haɗarin ma'aikata na mutum, kamar tsufa ko yanayin kiwon lafiya na dogon lokaci.
Sun kuma bayyana matakan da ake buƙata don magance waɗannan haɗarin kuma suna iya samar da matakan tallafi don yanayin da zai iya tasowa sakamakon barkewar cutar.
Shirye-shiryen kamuwa da cuta da shirye-shiryen amsawa ana aiwatar dasu ne bisa shawarwari na kasa ko na yanki.
Manufofin da ake da su na magance annobar sun hada da rage kamuwa da cutar a tsakanin ma'aikata, kare mutanen da ke cikin hadarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗarin haɗ
Matsayin cutar a cikin al'ummomin da ake aiki da su yana shafar yadda ake amsawa.
Matsakaicin matakan sarrafa haɗari tsari ne da aka yi amfani da shi sosai a cikin lafiyar aiki da kiwon lafiya don rarraba hanyoyin sarrafa haɗari bisa ga inganci.
Lokacin da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingantattun matakan sarrafawa sune na injiniya, sannan na gudanarwa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da injiniya ya ƙunshi keɓance ma'aikata daga haɗarin da ke tattare da aiki ba tare da dogaro da aikin ma'aikaci ba kuma yana iya zama mafita mafi tsada don aiwatarwa.
Gudanar da gudanarwa yana nufin canji a cikin manufofin aiki ko hanyoyin da ma'aikaci ko mai aiki ke buƙatar yin aiki.
Kayan kariya na mutum (PPE) ba su da inganci kamar yadda injiniyoyi da sarrafawa suke, amma suna taimakawa wajen kare wasu haɗuwa.
Ya kamata a zaɓi kowane irin PPE bisa ga haɗarin da ma'aikaci ke fuskanta a wurin aiki, a saka su daidai (misali, ramuka masu numfashi), a saka su daidai, a bincika su a kai a kai, a kula da su yadda ya kamata, a maye gurbin su yadda ya kamata, a cire su yadda ya kamata, a tsabtace su, sannan a adana su ko a jefar da su ba tare da an yi musu rauni ba.
A cewar Hukumar Kula da Lafiya da Lafiya a Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari suna da ƙarancin haɗuwa da jama'a da sauran abokan aiki.
Ayyukan rigakafin kamuwa da cuta na yau da kullun da aka ba da shawarar ga duk wuraren aiki sun haɗa da wanke hannu sau da yawa da kyau, ƙarfafa ma'aikata su kasance a gida idan rana ba ta da kyau, rufe tari da hancin, halayen numfashi, gami da bayar da nama da ajiye shara, shirya don sadarwa ta nesa ko ware wuraren aiki idan ya cancanta, hana ma'aikata amfani da wasu shirye-shirye da kayan aiki, da ci gaba da kiyaye tsabtace yau da kullun a wurin aiki da mahalli.
Gano mutane da sauri da kuma keɓewa daga mutane masu cutar yana da mahimmanci wajen kare ma'aikata, abokan ciniki, baƙi da sauran mutane a wurin aiki.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun ƙarfafa ma'aikata da ke da alamun cututtukan numfashi na kwatsam su zauna a gida har sai an sami zazzabi, zazzabi, da sauran alamun cutar aƙalla awanni 24 ba tare da shan maganin zazzabi ko kuma magungunan da ke canza alamun ba, da kuma sauƙaƙe manufofin haƙuri na rashin lafiya, da kuma cewa ma'aikata su iya zama a gida don kula da dangin da ke da rashin lafiya, da kuma sanar da ma'aikata game da manufofin.
A cewar OSHA, ma'aikatan da ke yawan ko kuma kusanci da marasa lafiya da ake zargi da kamuwa da COVID-19 ko kuma waɗanda ba a san su ba a cikin nisan kafa shida (1.8 m) suna cikin ayyukan da ke da matsakaicin haɗarin kamuwa da cutar. Koyaya, mutum na iya kamuwa da SARS-CoV-2 saboda ya yi tafiya a cikin ƙasar kwanan nan zuwa wani yanki inda cutar ta COVID-19 ta yadu, wanda ke haifar da yaduwar cutar a cikin kasuwancin da mai haƙuri ke aiki.
Waɗannan sun haɗa da ma'aikata waɗanda suka taɓa haɗuwa da jama'a, kamar makarantu, yanayin aiki mai ɗumbin yawa, da wasu wuraren sayar da kaya na kantin sayar da kaya. Hakanan sun haɗa da shigar da masu tace iska masu inganci a cikin kulawar injiniya don ƙungiyoyin haɗari mafi girma, ƙara yawan shigar iska, shigar da shinge na zahiri kamar su takunkumin numfashi na roba, da kuma shigar da windows masu wucewa don sabis na gaggawa. Waɗannan sun haɗa da samar da hanyoyin magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ma'aikata a cikin wannan rukunin masu haɗari ba sa buƙatar amfani da na'urorin numfashi.
Kulawa da ya dace don kare ma'aikata da sauran fasinjoji idan wani ya kamu da cutar a cikin jirgin sun hada da ware mutumin da ke da cutar daga sauran mutane na nisan kafa 6, sanya ma'aikacin jirgin sama don kula da mara lafiya, da kuma ba wa mara lafiya abin rufe hanci lokacin da yake tari ko yin hancin, ko kuma sanya mara lafiya ya rufe hanci da bakinsa da takarda.
Ya kamata ma'aikatan jirgin su sanya safofin hannu na likita mai yuwuwa lokacin da suke hulɗa da fuskoki masu cutar ko ruwan jiki ko kuma lokacin da suke kula da matafiyi mara lafiya. Idan ya yiwu, ma'aikatan jirgin ya kamata su sanya ƙarin kayan kariya na mutum idan sun lura da alamar zazzabi ko ci gaba da tari ko wahalar numfashi a cikin matafiyin mara lafiya.
A cikin jakunkuna masu kariya na haɗarin halittu, ana zubar da safofin hannu da sauran kayan da za a iya amfani da su sau ɗaya kuma a wanke su kuma a shafa su. Don jiragen ruwa na kasuwanci, gami da jiragen ruwa na alatu da sauran jiragen ruwa na fasinja, ana aiwatar da matakan sarrafa haɗari, gami da jinkirta tafiya da keɓewa yayin rashin lafiya, da sanar da cibiyar kiwon lafiya a cikin jirgin nan da nan idan zazzabi da sauran alamun cutar suka bayyana yayin tafiya.
CDC ta ba da shawarar rufe makarantu da gidajen renon yara na ɗan lokaci don tsabtace ko kashe ƙwayoyin cuta idan wani wanda ke da cutar ya taɓa shiga cikin ginin makaranta, ko ya yadu a cikin al'umma ko a'a.
Ana iya aiwatar da dabarun nisantar jama'a kamar tafiye-tafiye na filin, tarurruka, da sauran manyan tarurrukan jama'a kamar su motsa jiki ko karatun waƙa, ko cin abinci a kantin kofi, haɓaka sararin tebur, tsara jadawalin ba tare da rikici tsakanin lokutan isowa da tashi ba, iyakance baƙi masu mahimmanci, da amfani da wuraren asibiti na musamman don yara masu alamun cutar.
A lokacin da ake samun kamuwa da cuta a cikin al'ummomin gida, ana iya yin la'akari da dabarun nisantar da jama'a, da kuma tsawaita rufe makarantun. CDC ta ƙaddara haɗarin lafiya na kusa ga jami'an tilasta yin doka waɗanda ke gudanar da ayyukan yau da kullun.
Jami'an tilasta bin doka da ke hulɗa da waɗanda aka tabbatar ko ake zargin suna da cutar COVID-19 an ba da shawarar su bi umarnin da likitocin gaggawa ke bi, gami da amfani da kayan kariya na mutum.
Idan aka samu kusanci a lokacin tashin hankali, ma'aikata za su tsabtace da kuma kashe kayan aikin su da kayan aikin su ta hanyar amfani da kayan aikin tsabtace gida ko kuma kayan wanki kafin a sake amfani da su, sannan a bi ka'idodin shigar da zubar da kayan aikin PPE da aka yi amfani da su da kuma shigar da su da kuma zubar da su.
OSHA ta rarraba wasu ma'aikatan kiwon lafiya da na sashin aikin kirji a matsayin masu haɗarin haɗari ko haɗari sosai.
Ayyukan da ke da haɗari sun haɗa da bayar da kiwon lafiya, samarwa, dakin gwaje-gwaje da ma'aikatan sufuri na likita waɗanda ke hulɗa da waɗanda suka san ko ake zargin suna da COVID-19.
Idan ma'aikata suka tattara ko kuma suka sarrafa COVID-19 daga mutanen da suka san ko ake zargi da cutar, kuma suka watsa su cikin iska, wannan yana haifar da haɗari mai yawa.
Tsarin da ke fitar da kwayoyin zuwa cikin iska ya hada da tube, hanyoyin rage tari, duba bututun numfashi, wasu hanyoyin da gwajin hakori, ko kuma samun samfurin nama na ciki.
Ayyukan cututtukan zuciya masu haɗari sun haɗa da ma'aikatan da ke cikin shirya gawawwakin marasa lafiya waɗanda aka sani ko ake zargin suna da COVID-19 a lokacin mutuwarsu. Idan sun yi gwajin zuciya, suna da haɗari sosai. Har ila yau, ana gudanar da ƙarin aikin injiniya don waɗannan rukunin haɗarin, gami da hanyoyin samar da ƙwayoyin cuta masu tashi a cikin iska, gami da ɗakunan keɓewa don marasa lafiya da aka sani ko ake zargin suna da COVID-19.
Tsarin iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska mai iska.
Za a sarrafa samfuran kwayoyin ta hanyar matakan tsaro na matakin 3 na farko.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar cewa a sanya marasa lafiya da ke zuwa a wuraren keɓewa dangane da zargin ko rashin cutar COVID-19. OSHA ta ba da shawarar cewa duk wanda ke da cutar SARS-CoV-2 ko kuma wanda aka sani da cutar, wanda ke aiki a cikin nisan ƙafa 6 daga marasa lafiya, da kuma waɗanda ke aiwatar da hanyoyin kamar su numfashi ta hanyar shigar da bututun numfashi, ya sa kayan numfashi.
A cikin yanayin cikakken shirin kariya na numfashi wanda ya ƙunshi gwajin motsa jiki, horo da gwaji na asibiti a Amurka, ana amfani da abin rufe fuska mai tace N95 da aka amince da NIOSH ko mafi kyau.
Sauran masks na numfashi na iya samar da ƙarin kariya da kwanciyar hankali ga ma'aikaci. COVID-19 cuta ce ta hanyar numfashi maimakon yaduwa ta ruwa na jiki, don haka WHO ba ta ba da shawarar rufewa gaba ɗaya ba.
Hukumar ta WHO ta ba da shawarar cewa ma'aikatan gwaji su yi amfani da abin rufe fuska na tiyata kawai a wurin shiga.
WHO ta ba da shawarar yin amfani da abin rufe fuska, tabarau na iyo ko abin rufe fuska, riguna da safar hannu ga waɗanda ke karɓar samfuran ƙwayar numfashi daga marasa lafiya na COVID-19 ba tare da samar da ƙwayoyin cuta ba.
Idan aka yi amfani da hanyar samar da kwayoyin halittar iska, ana maye gurbin abin rufe fuska na tiyata da abin rufe fuska na numfashi na N95 ko FFP2.
Dangane da karancin wadatar kayan aikin PPE a duniya, WHO ta ba da shawarar rage yawan bukatun PPE kamar yadda zai yiwu ta hanyar amfani da fasahar sadarwa ta zamani don samar da kiwon lafiya (telemedicine), amfani da shinge na zahiri kamar windows masu haske, ba da izinin sanya kayan aikin kawai ga waɗanda za su shiga cikin ɗakin da ake riƙe da mai cutar COVID-19, amfani da PPE don ayyukan da ake buƙata kawai, amfani da na'urar numfashi ɗaya ba tare da cirewa ba yayin kula da marasa lafiya da yawa da ke da cutar iri ɗaya, kula da hanyoyin samar da PPE da daidaitawa, da ƙarfafa amfani da suturar kai ga waɗanda ba su nuna alamun cutar ba.
Daga: Katherine Maher, Shugaba na Gidauniyar Wikimedia
Don: Dukan ma'aikatan Wikimedia Foundation
Rubutun: [COVID-19] Rage Matsaloli da Shirya Gabatarwa
Ranar da aka aika: 14 ga Maris, 2020 00:24 UTC
An ba da lasisi: CC0. Babu haƙƙin mallaka.
A cikin wannan watan, mutane suna neman abubuwan da suka fi dacewa da kansu.
Yaduwar COVID-19 ta nuna alaƙarmu da ɗabi'armu a duniya.
Ko da yake ba mu da al'ada ga waɗannan ƙalubalen, mun san cewa amsarmu mafi kyau ta dogara ne akan tausayi, haɗin kai, da kuma gina al'umma a zuciyar wannan ƙungiyar.
A cikin wannan sakon, ya ce: "Abin da ya faru a cikin 'yan sanda da kuma yadda suka yi aiki tare da su, ya nuna cewa sun kasance masu daraja da kuma masu daraja, kuma sun kasance masu daraja da kuma daraja, kuma sun kasance masu daraja da kuma daraja, kuma sun kasance masu daraja da kuma daraja, kuma sun kasance masu daraja da kuma daraja.
Ba zan iya zama mai alfahari da ku ba.
A makon da ya gabata, wani ya ce an yaba masa saboda aikin da ya yi.
Suna tunatar da duniya yadda Wikipedia ke da muhimmanci a yanzu don canzawa da kuma yadda alama ce mai ƙarfi ga wannan muhimmin albarkatun don ci gaba da kasancewa kan layi da kuma samun dama ga kowa.
Ko dai abokan aikinka ne suka ba da gudummawar don inganta wurin aiki ko kuma al'ummarka ta guji haɗari, aikinka ne ya sa hakan ya yiwu.
A duniya, ana bukatar bayanan da Wikipedia ke bayarwa yanzu fiye da kowane lokaci.
Wannan lokaci ne da abin da muke yi, da kuma yadda muke yi, zai yi tasiri mai ma'ana a duniya.
Saboda muhimmancin wannan aiki da kuma yadda abokan aikinku suke da hannu a ciki, za mu yi wasu gyare-gyare masu mahimmanci daga makonni masu zuwa kan yadda za mu yi aiki tare.
"Na yi farin ciki sosai da na ga cewa na yi amfani da lokacin da na samu na yin wa'azi a ƙasashen waje.
Kamar yadda Robyn ta fada a baya, ƙungiyar C ta tattauna game da haɗin gwiwarsu da kuma jadawalin su na kwanaki da watanni masu zuwa a daren jiya.
A cikin wannan tattaunawar, mun yi la'akari da tunaninmu game da yadda za mu iya amsawa da kyau ga abin da muke fuskanta kuma mafi kyawun hanyar da za mu iya kiyaye ci gaban ƙungiyar a wannan lokacin.
A cikin duka, suna son su kawar da damuwa kuma su tallafa wa burin kasuwancin su na dogon lokaci.
Idan kana bukatar ka sake kira, to babu matsala.
Ga dukkan ma'aikata, 'yan kwangila da ma'aikata da ma'aikata:
A cikin wannan labarin, an bayyana cewa, "A cikin wannan labarin, an gano cewa, a cikin wani yanki na kasar Sin, an yi wa 'yan bindiga fyade a birnin New York, inda suka yi zargin cewa sun yi wa 'yan bindiga fyade.
Ba ma sanar da cewa an rufe mana ofis. - Idan za ka iya yin aiki fiye da sa'o'i na yau da kullum, mai wa'azi zai iya amfani da kai.
Duniya ba ta da tabbas, amma fifikonmu shi ne mu biya duk bukatunku, ko kuna bukatar kula da ƙaunatattunku, ko kuna bukatar sayan kayayyaki, ko kuma kuna bukatar ganin likita.
Ba wai kuna bin lokacinku ba.
Kada ku yi aiki idan kuna rashin lafiya.
A cikin wannan labarin, an bayyana cewa, "Mutanen da suka yi wa'azi a yankin sun yi imani da cewa, ba za a iya yin wannan ba.
Ba a bukatar ranar rashin lafiya ko PTO: Ka yi magana da manajanka kuma ka taimaki ƙungiyarka ta sake tsara kalandarku da jadawalinku don su rufe manyan wuraren aiki.
(Idan ka gwada tabbatacce ga COVID-19, don Allah sanar da Bryan a cikin T&C Ops don T&C zai iya taimaka maka samun kulawa mai kyau daga tallafi da gudanarwa.)
Za a biya ma'aikatan da suke biyan sa'a cikakken albashi.
Kamar yadda muka fada, mun sake ƙaddara don girmama aikinmu na ƙwazo ga masu kwangila da abokan aikinmu na ɗan lokaci.
A cikin yanayi na al'ada, ana biyan kowa albashi bisa ga yawan lokutan da ya yi aiki.
A cikin takardar, an ce kana rashin lafiya kuma bai kamata ka yi aiki ba.
Idan kana son aiki, muna goyon bayan ka.
Mutane da yawa suna amfani da aiki don sauya yanayin damuwa a cikin muhallin su.
A cikin wannan labarin, mun tattauna da wasu 'yan jarida da suka yi amfani da wannan hanyar ta yanar gizo.
A wani lokaci kuma, wannan wani abu ne da ya kamata ku kula da kanku.
Muna rokon ka da ka tuntubi manajanka, ko kuma za mu iya sanin abin da za mu yi kuma mu yi shawarwari da shi.
A wasu lokatai, muna iya yin wasu ayyuka da ba su da muhimmanci.
Akwai wasu abubuwa da za mu ci gaba da yi.
SRE, HR Ops, Trust, da kuma tsaro da kuma kungiyoyin neman kudi (a tsakanin sauran sassan) suna yin muhimmiyar aiki wajen samar da karin tallafi da ake bukata.
Za mu canza mayar da hankali ga aiki tare da dukkan sassan don gano manufofin yanzu da kuma abin da ke da mahimmanci ga manufofin kasuwancinmu.
Akwai abubuwa da yawa da za a yi a gabanmu, kuma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan ka yi jinkiri yanzu, ba zai cutar da kai ba a nan gaba.
Ba mu shirya tafiya sau biyu don samun saurin ba bayan mun wuce annoba.
Ba za ku bukaci karin lokaci ba don ku cika wa'adin da ba zai yiwu ba a yanzu.
Za mu yi aiki don kafa sababbin manufofi da kuma jadawalin da suka dace, da kuma amincewa da cewa yanayin ya canza.
(Shirin Shekara-shekara) Me game da APP?
Sun fi son daidaita lokacin da za su fitar da shirin su na 2020-2021 don daidaita sabon rayuwarsu da kuma tsammanin lokutan aiki na yau da kullun.
Manufarmu ita ce ta ba da shawarar tsawaita shirinmu na 2019-2020 wanda zai ba da damar ƙarin lokaci don tsara kasafin kuɗi don ba da damar ma'aikata su ba da fifiko ga mahimman ayyuka, kula da kansu da ƙaunatattun su, don ba da damar waɗanda suke son yin ko kuma suke son yin jadawalin da aka rage a cikin 'yan makonni masu zuwa.
Wannan tsawaita jadawalin zai sauƙaƙa nauyin aiki da ake shirin yi da kuma matsin lamba a kan ƙungiyar gaba ɗaya.
A mako mai zuwa za su gabatar da takardarsu ga kwamitin, kuma da zarar sun sami amincewarsu, za su sanar da wakilai da ƙungiyar game da yanayin ƙarshe na mataki na gaba.
Na gode wa ƙungiyar APP don jagoranci a nan.
"Aikin da muke yi a ofishinmu yana da kyau sosai, kuma yana da kyau sosai".
A makon da ya gabata, an gano cewa ɗaya daga cikin abokan aikinmu a San Francisco yana da cutar COVID-19.
Amma, tare da wasu matakan tsaro, mun yi hayar ƙungiyar masu tsabtace ƙwayoyin cuta don kashe duk wani shafi a teburinmu da kujeru da sauransu a ofishinmu na San Francisco.
Sun yi amfani da maganin rigakafin cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cutar cuta.
Ginin ya kafa tsarin kula da kansu na amfani da kayayyaki da ke tallafawa amincin masu haya.
A lokacin da suka yanke shawarar dawowa, ofishin ya shirya su sosai don su ji daɗi.
Ofishin su na DC yana cikin WeWork, inda suka raba hanyoyin COVID-19 tare da dukkan ma'aikatan DC.
A cikin makon da ya gabata, mun canza ofishin mu na DC zuwa cikakken tsarin aiki na nesa, daidai da jagororin da aka raba daga San Francisco.
Kamar yadda wasu abokan aikinmu na NYC suka sani, muna kuma tattaunawa kan yin hayar wani wuri a Brooklyn.
Ana ci gaba da tattaunawar, amma akwai yiwuwar jinkiri.
Wasu daga cikin abokan aikinsu suna aiki ne daga nesa a karon farko.
A cikin wannan labarin, za ku ji labarin yadda abokan aiki na dogon lokaci suka yi amfani da wannan hanya don su ba ku shawara.
Ka rage tsawon tarurruka zuwa awa daya ko biyu.
Idan kana bukatar ayyuka masu tsawo, ka yi tunanin yadda za ka rarraba su a cikin kwanaki da yawa.
Ka bayyana taron a fili, ka shirya, kuma ka aika da abin da za a karanta a gaba.
Sauke bidiyo a cikin asalin don sauƙaƙe haɗin kai da sadarwa tare da shirye-shirye kamar Google Docs da Zoom.
Ka sa kowane taro ya kasance da sauƙi a tuna: Ka gaya wa wani ya lura da tattaunawar, ya rubuta jerin waɗanda za su tattauna, kuma ya taimaka wa wani ya rubuta ko kuma ya rubuta bayanin tare, don a yi tambayoyi.
Idan kana bukatar belun kunne mai dadi, ka aika imel zuwa ga goyon bayan fasaha.
Ku kashe kuɗin da kuke samu daga motsa jiki a kan goge haƙoranku.
Shiga cikin layin #remoties akan Slack don tattaunawa da abokan aikinka game da ayyukan raba aiki.
Ƙungiyar HR tana nazarin jagorar tsarin samar da kayan aiki na yanar gizo don tallafawa ci gaban ayyukan da aka rarraba a fadin gidauniyar.
A makon da ya gabata, mun nemi dukkan kungiyoyin al'umma da ke samun tallafi su dakatar da taron jama'a, kamar taron editocin da Wikimedia ke tallafawa, har sai WHO ta ayyana ƙarshen cutar.
Za mu sanar da su cewa mun fahimci cewa bukatarsu ta sokewa da sauran takunkumi ba zai hana su kammala ayyukan da suka riga suka amince da su ba kuma ba za mu hukunta kowa ba saboda jinkirta ko canza manufofin.
A mako mai zuwa, za mu ci gaba da samar da ƙarin jagorori kan Wikimedia da sauran taron al'umma na yanki da na kan layi.
Ko da yake sun yi baƙin ciki da rashin haɗin kai, suna jin dadi idan sun kasance a fili kuma suna mai da hankali ga al'ummomin su, Wikimedia da sauransu.
A nan gaba, CRT tana aiki don gina shafin Meta-Wiki don jama'a su iya lura da tasirin da kuma bin diddigin hanyoyin sadarwa.
Ka yi nazari na kai tsaye kan batutuwan da suka shafi COVID-19.
Muna tura muku gayyata zuwa kalandarku don taron ma'aikatan na musamman na ranar Alhamis mai zuwa 14:00 UTC/07:00 PT.
Za mu yi amfani da wannan lokacin don raba ƙarin gyare-gyare, amsa tambayoyinku, da kuma tattauna da juna.
Za mu fuskanci wannan tare kuma a shirye muke mu taimaka ta kowace hanya.
A halin yanzu, zaku iya ci gaba da bincika bayanai a cikin wannan imel ɗin kuma ku sami duk sauran bayanan da ba a sani ba game da COVID-19 a cikin Office Wiki.
CRT za ta ci gaba da samar da sabbin bayanai a kan wadannan shafuka, kuma za ta tabbatar da cewa duk bayanan suna cikin wuri guda.
Muna kuma aiki don ci gaba da hulɗa tare da ma'aikatanmu da ke zaune a ƙasashe waɗanda ke da ciwon cutar a halin yanzu.
Idan kana da tambayoyi game da tafiye-tafiye, abubuwan da suka faru, babban aiki ko ƙalubalen inshora ko wani abu da kake buƙatar taimako, kada ka yi jinkirin sanar da CRT kuma ka yi aiki tare.
Muna shirye mu ba da taimako da sadarwa idan ya cancanta.
Idan kuna da wani abu na sirri ko na sirri, don Allah aika imel zuwa Bryan Juan: Daraktan Human Resources na Ayyukan Kasuwanci na Duniya.
Ba za mu iya ganin ko ɗaya daga cikin waɗannan canje-canje a matsayin aikinmu ko kuma aikinmu ba.
Maimakon haka, a yanzu suna bukatar a gane su, kuma su yarda da aikinsu da kuma hakkokinsu a hanyar da ba su taɓa yi ba.
Waɗannan su ne abubuwan da muka yi imani da su, kuma dole ne su tallafa wa juna idan ba haka ba za mu iya ci gaba da aiki, mu ba su taimakon da suke buƙata ta hanyar ayyukanmu, kuma mu ci gaba da ba da sabis ɗin da suke dogara da shi a duniya.
A lokacinsa, ayyukansa suna jiransa.
Yanzu lokaci ya yi da za mu tallafa wa juna da kuma samar da sarari don muhimman ayyuka da za su faru a cikin makonni da watanni masu zuwa.
Don mu cimma wannan, muna bukatar ku duka ku kula da kanku da iyalanku, ko kuma ku kasance mafi kyau a gare ku idan bukatunku suka taso.
Yanzu fa, ina roƙonka, ka wanke hannuwanka, kada ka taɓa fuskarka.
Catherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, da Tony S) da sauran ƙungiyar jagoranci (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
b'Angiotensin-converting enzyme2 (ACE2) wani enzyme ne wanda ke mannewa da farfajiyar kwayoyin da ke cikin huhu, jijiyoyin jini, zuciya, koda da hanji.
ACE2 yana da matukar amfani wajen magance cututtukan zuciya da jijiyoyin jini saboda yana hana aikin enzyme mai canza Angiotensin (ACE) ta hanyar rage matakin Angiotensin-II da kuma kara yawan Ang (1-7). ACE2 kuma yana aiki a matsayin hanyoyin shiga cikin kwayar halitta ga wasu coronaviruses.
An fi kiran wannan enzyme a cikin mutum hACE2.
Angiotensin-converting enzyme 2 wani nau'in zinc ne wanda ke dauke da metallloenzyme wanda ke zaune a cikin endothelial da sauran kwayoyin halitta.
Kwayar ACE2 tana dauke da yankin N-terminal peptidase M2 da kuma yankin C-terminal collectrin na jigilar amino acid na koda.
ACE2 shine furotin mai wucewa guda ɗaya na nau'in I wanda yake aiki akan farfajiyar ƙwayoyin cikin huhu da sauran ƙwayoyin cuta tare da yankin da enzyme ya kunna.
An cire yankin waje na ACE2 daga yankin a cikin membrane ta wani enzyme da ake kira sheddase, kuma furotin mai narkewa da aka samar yana gudana cikin jini kuma daga ƙarshe ya fita cikin fitsari.
ACE2 yana cikin yawancin sassan jiki - ACE2 yana da alaƙa da ƙwayoyin cuta na ƙwayoyin cuta na nau'in II, ƙwayoyin enterocyte na hanji, ƙwayoyin jijiyoyin jini da ƙwayoyin jijiyoyin jini, da ƙwayoyin jijiyoyin jini a yawancin sassan jiki.
Ana kuma iya gano bayyanar ACE2 mRNA a cikin kwakwalwar kwakwalwa, ɓangaren kwakwalwa, ɓangaren ƙwaƙwalwar ƙwaƙwalwa, ɓangaren ƙwaƙwalwar ƙwaƙwalwa da kuma ƙwaƙwalwar ƙwaƙwalwa, wanda ke kula da hormones da ake buƙata don jiki, da tsarin juyayi da kuma hormones.
Babban aikin ACE2 shine yin aiki azaman mai hana ACE.
ACE yana tura kwayar cutar angiotensin I zuwa angiotensin II, wanda ke sa jini ya zama mai taushi.
Bayan haka, ACE2 yana cire carboxyl-terminal amino acid phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) wanda aka rarraba shi da ruwa a cikin angiotensin (1-7), mai yaduwar jijiyoyin jini (H-Asp-Arg-Val-Tyr-Ile-His-Pro-OH).
ACE2 na iya yin yaƙi da wasu ƙwayoyin cuta da yawa, ciki har da [des-Arg9]-bradkinin, aspirin, neurotensin, dinophene A, da ghrelin.
ACE2 kuma yana daidaita tafiyar da mai ɗaukar amino acid mai tsaka tsaki SLC6A19 ta hanyar membrane kuma yana da alaƙa da cutar Hartnup.
ACE2, furotin na membrane, shine mai karɓar wuri a matsayin babbar hanyar shiga cikin ƙwayoyin cuta don wasu ƙwayoyin cuta na coronaviruses, gami da HCoV-NL63, SARS-CoV (kwayar cutar da ke haifar da SARS) da SARS-CoV-2 (kwayar cutar da ke haifar da COVID-19).
Musamman, haɗuwa da SARS-CoV da SARS-CoV2 ƙwayoyin cuta S1 a cikin yankin enzymatic na ACE2 a farfajiyar ƙwayoyin cuta na iya haifar da shigar da ƙwayar cuta da enzyme zuwa cikin ɗakunan endocytes da ke cikin ƙwayoyin.
Wannan shigarwar kuma tana buƙatar daidaita furotin S ta hanyar mai karɓar mai karɓar TMPRSS2, wanda a halin yanzu ana nazarin shi azaman maganin furotin. Saboda haka, wasu masu bincike sun ba da shawarar cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaƙar kamuwa da cuta.
Koyaya, ƙungiyoyi masu yawa na ilimi da ƙungiyoyin gudanarwa sun ba da shawarar ci gaba da amfani da daidaitattun masu hana ACE da maganin ARB.
Wani bincike da ya hada da bita na tsari da kuma bayanan kididdiga da aka fitar a ranar 11 ga Yuli, 2012 ya gano cewa ACE inhibitors suna da alaƙa da raguwar cutar huhu da kashi 34% idan aka kwatanta da nazarin kwatankwacin.
"Bugu da kari, ""an ga cewa cutar cututtukan huhu ta ragu lokacin da aka yi musu magani da masu hana ACE, musamman a cikin marasa lafiya da ke fama da bugun jini da cututtukan zuciya, tare da karuwar haɗarin cutar huhu. ""
Sakamakon ya kasance mai ƙarfi ga dukkan masu cutar cutar huhu, amma shan magungunan hana ACE na iya rage mutuwar da ke da alaƙa da cutar huhu.
An gano cewa ACE2 na mutum (rhACE2) wanda aka tsara shi da kwayoyin halitta shine sabon magani don mummunan lalacewar huhu, wanda ke haifar da tsarin rigakafi na lipopolytic wanda ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Bayan tsawon lokacin da maganin yake aiki na awa 24 a mako, rabin lokacin da rhACE2 ke aiki a jikin mutum ya kai awa 10 kuma yana da mintuna 30 kafin fara aikin.
Yawancin binciken sun nuna cewa rhACE2 na iya zama magani mai yuwuwa ga mutanen da basu da juriya ga masu saurin hana tsarin renin-angiotensin (anti-RAS) ko kuma cututtukan da ke da hauhawar angiotensin II. An gwada rhACE2 a cikin gwaji na asibiti don maganin cututtukan cututtukan numfashi mai tsanani.
"B'COVID-19 apps aikace-aikacen software ne na wayar hannu da aka tsara don aiwatar da bin diddigin haɗuwa, watau gano mutanen da ke da cutar ("haɗuwa") a cikin martani ga annobar cutar coronavirus ta 2019-20".
A wasu yankuna da yankuna masu iko, an kirkiro ko kuma an gabatar da aikace-aikace da yawa tare da tallafin gwamnati.
An kirkiro wasu tsarin don samar da aikace-aikacen bin diddigin taɓawa.
An sami damuwa game da tsaron bayanan sirri, musamman game da tsarin da ke bin diddigin wurin da masu amfani da aikace-aikacen suke.
Sauran hanyoyin da za a iya amfani da su don rage tsangwama sun hada da amfani da raƙuman Bluetooth don adana bayanan nesa tsakanin mai amfani da sauran wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa aikace-aikacen da ke amfani da Bluetooth kai tsaye a cikin tsarin aikin su na Android da iOS.
A China, gwamnatin kasar Sin ta kirkiro wani manhajar da ta hada da Alipay don bawa 'yan kasar damar duba ko sun taba hulɗa da mutanen da ke dauke da cutar COVID-19.
An riga an yi amfani da shi a cikin birane sama da 200 a China. A Singapore ana amfani da aikace-aikacen da ake kira TraceTogether.
An kirkiro wannan manhajar ne ta hanyar kungiyar kwararru na IT na yankin kuma an samar da ita kyauta kuma za a mika ta ga gwamnati. An fara amfani da StopKorona!, wani manhajar da ke kan Bluetooth a Arewacin Macedonia don bin diddigin mutanen da suka kamu da cutar da kuma taimakawa hukumomin kiwon lafiya su amsa cikin sauri.
An kirkiro manhajar ne daga Ma'aikatar Sadarwa da Fasaha da Ma'aikatar Lafiya.
Tun daga ranar 14 ga Afrilu, 2020, ana jiran amincewar aikace-aikacen daga Google Play Store da Apple App Store.
"Gwamnati ta sanar a ranar 12 ga Afrilu cewa an kammala aikin kirkirar manhajar bin diddigin taɓawa kuma za a fara amfani da ita cikin 'yan makonni. Ana shirin yin irin wannan aikace-aikacen a Ireland da Faransa ("Covid"). "
Dukansu Ostiraliya da New Zealand suna la'akari da haɓaka aikace-aikace bisa tushen aikace-aikacen TraceTogether na Singapore da yarjejeniyar BlueTrace. Rasha tana da niyyar ƙaddamar da aikace-aikacen geofencing don marasa lafiya da ke zaune a Moscow waɗanda ke da cutar COVID-19 don tabbatar da cewa ba sa fita daga gida.
Ross Andersen, Farfesa a fannin Injiniyan Tsaro a Jami'ar Cambridge, ya lissafa wasu matsaloli na yau da kullun da ke faruwa a tsarin aikace-aikacen, gami da rashin inganci da kuskuren tabbatarwa idan ƙananan mutane ke amfani da aikace-aikacen.
"Don magance damuwar yaduwar aikace-aikacen "ƙwarewar cutar coronavirus" ko "matsattara", Apple ya iyakance waɗanne nau'ikan ƙungiyoyi ne za su iya ƙara aikace-aikacen da suka shafi cutar coronavirus a cikin App Store, kuma kawai ƙungiyoyi masu doka ko kuma masu daraja ne za su iya sanya su".
Google da Amazon sun aiwatar da irin wannan takunkumi.
Masu fafutukar kare bayanan sirri sun bayyana damuwarsu game da tasirin sa ido kan mutane ta hanyar amfani da aikace-aikacen cutar coronavirus, musamman idan aka cire kayan aikin sa ido da aka kirkira don sa ido kan annobar coronavirus bayan cutar ta ƙare.
Kungiyar kare hakkin dan adam ta kasa da kasa da kuma wasu kungiyoyi sama da 100 sun fitar da wata sanarwa da ke neman a sanya takunkumi kan irin wannan sa ido.
Kungiyoyi sun bayyana sharudda takwas don ayyukan gwamnati.
Dole ne a yi bincike na tsaftacewa bisa doka, dole ne a yi shi bisa buƙata, kuma dole ne a daidaita shi.
Ana iya samun ƙarin lokacin tsauraran matakan da ke ƙunshe da ƙa'idodin doka waɗanda ke ƙayyade ƙarshen lokaci na atomatik.
Za a iyakance amfani da bayanai don dalilai na COVID-19.
Ya kamata a bayyana cewa ana buƙatar kare bayanan sirri da rashin bayyana sunayen, kuma ana buƙatar kare bayanan bisa hujjoji.
Ana buƙatar yin aiki don hana sanya sa ido ta hanyar dijital ya zama mafi girman nuna bambanci da keɓewa.
Dokar ta tanadi yadda za a raba bayanai da mutane da kungiyoyi na waje.
Ya ce, "Ya kamata a yi doka da za ta kare 'yan kasa daga zalunci da kuma hakkin 'yan kasa su mayar da martani ga zalunci.
"Za a bukaci "cikakken shiga" na dukkan "masu ruwa da tsaki"" ciki har da kwararrun kiwon lafiyar jama'a da kungiyoyin da ba a kula da su ba. The German Chaos Computer Club (CCC) da kuma Reporter ohne Grenzen (RSF) sun kuma fitar da jerin abubuwan da za a yi".
Shirin Google/Apple da aka gabatar yana nufin magance matsalar sa ido ta ci gaba ta hanyar kawar da tsarin sa ido daga tsarin aiki na na'urorin su.
Wasu ƙasashe sun yi amfani da hanyar bin hanyar yanar gizo maimakon aikace-aikace don kawar da buƙatar saukar da aikace-aikace da kuma damar guje wa sa ido.
An amince da bin diddigin hanyar sadarwa a Isra'ila.
A cikin wasu hanyoyin sadarwa na yanar gizo, wanda ke ba da damar samun bayanan wuri, akwai wasu manyan matsalolin tsaro na sirri.
Duk da haka, ba duk tsarin da ke kunshe da sabobin cibiyar sadarwa ba ne ake buƙatar samun damar bayanan wuri na mutum. An ƙirƙiri tsarin adana bayanan sirri da yawa waɗanda ke amfani da sabobin cibiyar sadarwa don sadarwa kawai (duba sashe na ƙasa).
A Koriya ta Kudu, an yi amfani da wata hanyar da ba ta da amfani da app don bin diddigin mutum da ke da cutar.
Maimakon amfani da wata manhaja, tsarin yana tattara bayanai da suka hada da bayanan da aka gano ta hanyoyi daban-daban, ciki har da na'urar hannu da bayanan biyan kuɗi ta katin, kuma yana haɗa su don aika faɗakarwa ta hanyar saƙonni ga waɗanda ke da yiwuwar kamuwa da cutar.
Baya ga amfani da wannan bayanin don faɗakar da mutanen da ke da yiwuwar hulɗa da cutar, gwamnati ta ba da damar samun bayanai na wuri, wanda ya ba da izinin yin hakan, saboda canje-canje da yawa a cikin dokar kare bayanai tun bayan barkewar cutar MERS.
A cikin wannan labarin, an bayyana cewa, "Masu amfani da yanar gizo da kuma masu amfani da yanar gizo suna amfani da wannan bayanin a cikin aikace-aikacen da kuma shafukan yanar gizo.
Ba a bayyana cikakken bayani ba har zuwa ranar 6 ga Afrilu, 2020.
Binciken taɓawa don kare tsaron bayanan sirri ra'ayi ne wanda ya sami tabbaci sosai ta hanyar takaddun bincike na yau da kullun wanda aka tsara aƙalla tun 2013. A ranar 7 ga Afrilu, 2020, ƙungiyoyin masana da yawa suna aiki akan hanyoyin da suka dace don tsaron bayanan sirri, kamar amfani da fasahar Bluetooth Low Energy (BLE) don yin rikodin hulɗar mai amfani da sauran wayoyin salula.
Duk da haka, PEPP-PT ƙoƙari ne na daidaitawa wanda ya ƙunshi duka hanyoyin rarrabuwa da kuma rage rarrabuwa, kuma ba hanya ɗaya ba ce. Tsarin rarrabuwa da rage rarrabuwa ya haɗa da Tsaro na Tsaro na Tsaro na Tsaro na Tsaro (DP-PPT/DP-3T), Lambobin Saduwa na wucin gadi (TCN, FKA Contact Event Numbers, CEN), Tsarukan Tsaro na Tsaro da Tsaro (PACTs) don Kula da Sadarwar Wayar Hannu, da sauransu.
A cikin waɗannan hanyoyin, za a yi binciken bazuwar bayanan sirri a cikin na'urar kawai kuma ba za a taɓa samun damar fita daga na'urar ba.
Ƙungiyoyi a MIT Media Lab suna aiwatar da SafePaths, wani dandamali wanda ke ba da damar amfani da takamaiman hanyoyin da za a iya amfani da su yayin tattara bayanai na wuri ko hanyar shiga don bin diddigin yaduwar COVID-19.
Ya dogara ne akan bayanan da aka buga a watan Maris na 2020 mai taken "Kula da Tsaron Bayanan Sirri a Lokacin annobar "Apps Gone Rogue". Wani irin wannan yunƙuri shine dandamali na SafeTrace daga Enigma MPC, wani kamfani da ke haɓaka fasahar tsaro na sirri wanda aka fara shi a MIT Media Lab.
SafeTrace yana amfani da ingantaccen fasahar kayan aiki don bawa masu amfani damar raba mahimman bayanai game da wuri da bayanan lafiya tare da sauran masu amfani da hukumomi ba tare da yin watsi da sirrin bayanan su ba.
Kungiyar TCN ta duniya ta kafa a ranar 5 ga Afrilu, 2020, ta hanyar kungiyoyin da suka haɗu da kusan irin wannan tsarin da kuma hanyoyin aiki tare, tare da manufar rage bambancin da kuma samar da aikace-aikacen sa ido da faɗakarwa da za a iya amfani da su tare a duniya, wanda shine babban mahimmin abu don karɓar yarjejeniya.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta ba da damar yin amfani da yarjejeniyar BlueTrace kyauta a cikin aikace-aikacen hukuma na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, waɗanda ke sarrafa dandamali na wayar hannu na Android da iOS, sun ba da sanarwar hanyar bin diddigin taɓawa, suna da'awar cewa wannan hanyar ta dogara ne akan haɗin fasahar Bluetooth mai ƙarancin ƙarfi da kuma ɓoye / karanta bayanan sirri, don kare tsaron bayanan sirri.
Sun kuma bayyana cikakkun bayanai game da manyan fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, ana shirin fitar da tsarin a matakai uku:
Gwamnatoci sun gabatar da kayan aiki don ƙirƙirar aikace-aikacen bin diddigin cutar coronavirus na doka don kare bayanan sirri
Don haɗa aikin kai tsaye a cikin iOS da Android, Google da Apple suna shirin magance matsalolin sa ido na yau da kullun ta hanyar fitar da tsarin farko ta hanyar sabunta tsarin aiki sannan kuma cire tsarin a cikin hanyar da ta dace yayin da barazanar ta ƙare.
b' Sake tsara magani (wanda kuma aka sani da sake tsara magani, sake fasalin, sake fasalin ko gyaran jiyya) shine sake tsara maganin da aka amince dashi don magance wata cuta ko yanayin likita daban da wanda aka fara amfani dashi.
Wannan wani bangare ne na binciken kimiyya wanda ake gudanarwa a halin yanzu don samar da ingantaccen magani na COVID-19.
Sauran hanyoyin bincike sun hada da samar da allurar rigakafin COVID-19 da kuma shigar da jini a cikin jini na mutanen da suka kamu da cutar kuma suka warke. SARS-CoV-2 ya ƙunshi sunadarai 66 masu magani, kowannensu yana da wurare da yawa na hada kwayoyin.
Binciken waɗannan rukunin yanar gizon yana ba da gudummawa ga aikin da ke da ma'ana wanda ke haɓaka maganin rigakafi mai tasiri don yaƙar sunadarai na COVID-19.
Muhimman sunadarai da SARS-CoV-2 ke niyya sune sunadarai kamar su papaya, RNA polymer mai dogaro da RNA, helix, S protein da ADP ribosphate.
Hussein AA, et al sun yi nazarin magungunan da yawa da ke nazarin su don gano mafi kyawun hanyar daidaitawa tare da magungunan da aka amince da su don inganta haɓakar maganin SARS-CoV-2 a cikin binciken farko na asibiti don ba da shawara game da ƙirar binciken asibiti.
Chloroquine magani ne na cutar zazzabin cizon sauro wanda ake amfani da shi wajen magance wasu cututtukan da ke hana amfanin jiki.
A ranar 18 ga watan Maris, WHO ta sanar da cewa Chloroquine da Hydroxychloroquine sun kasance cikin magungunan guda hudu da aka bincika a matsayin wani ɓangare na gwajin gwaji.
Gwamnan jihar New York Andrew Cuomo ya sanar da cewa gwajin chlorine da hydroxychloroquine na jihar New York zai fara ne a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta amince da amfani da hydroxychloroquine sulfate da hydroxychloroquine phosphate a ƙarƙashin izinin gaggawa (EUA).
Ba a amince da maganin ba ta hanyar tsarin gwajin gwaji na FDA. EUA ta amince da shi ne kawai a matsayin gwajin gaggawa ga marasa lafiya da ke asibiti kuma ba su da damar yin gwajin gwaji.
Cibiyar Kula da Cututtuka (CDC) ta ce ba a tabbatar da yadda za a yi amfani da Hydroxychloroquine ba, ko sashi ko tsawon lokacin da za a yi amfani da shi don hana ko magance cutar SARS-CoV-2.
Likitoci sun ce ana amfani da magunguna ne kawai idan ba su da wani zaɓi.
Wata ƙungiyar bincike ta Turkiyya a Istanbul tana gudanar da karamin bincike kan amfani da chlorine tare da sinadarin soda, bitamin A, bitamin C da bitamin E.
An gudanar da bincike mai zurfi a jami'ar Duke da kuma jami'ar Oxford.
Makarantar Likita ta NYU London tana gudanar da gwaji kan yadda za a hana amfani da sinadarin hydroxychloroquine cikin aminci.
An bukaci gwajin asibiti na kasar Sin a Wuhan da Shenzhen don nuna cewa Favipira yana da tasiri sosai.
35 daga cikin marasa lafiyar da ke shanyewa sun sami sakamako mara kyau a cikin kwanaki 4 na tsaka-tsakin, amma daga cikin marasa lafiya 45 da ba su samu ba, tsawon lokacin rashin lafiya ya kai kwanaki 11.
A wani bincike da aka gudanar a Wuhan, an yi wa marasa lafiya 240 da ke fama da cutar huhu, an ba rabin su maganin favipiravir, sauran kuma umifenovir.
Hukumar Kula da Magunguna ta Italiya ta gargadi jama'a cewa akwai ƙarancin shaida a cikin kayan magani kuma ana ci gaba da gwajin.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magunguna daga Japan don adanawa da kuma amfani da sojojin don isar da magunguna zuwa asibitocin jami'a waɗanda ke kula da marasa lafiya na COVID-19.
Shinzo Abe ya gabatar da shirin da Trump ya yi na sayen magunguna, a yayin da cutar ke yaduwa, kuma magunguna na iya zama marasa tasiri a cikin manyan cututtuka.
Ba a tabbatar da amfanin ba ga mata masu juna biyu da kuma wadanda ke kokarin samun ciki.
Wani bincike na hade maganin rigakafin kwayar cutar retroviral (lopinavir) da maganin rigakafin cutar HIV/AIDS (ritonavir) (Keltra) ya kammala da cewa babu wani amfani.
An kirkiro magunguna da ke hana yaduwar cutar HIV ta hanyar ɗaure shi da sunadarai.
Wata ƙungiyar bincike a Jami'ar Colorado na ƙoƙarin inganta magunguna don gano mahaɗan da ke haɗuwa da enzymes na SARS-CoV-2. Akwai wasu maganganu a cikin ƙungiyar kimiyya game da tushen da ke jagorantar sake tsara magungunan da aka tsara musamman don cutar HIV/AIDS.
Hukumar ta WHO ta hada da maganin rigakafin cutar retrovirus (lopinavir) / rigakafin cutar HIV/AIDS (ritonavir) a cikin gwajin hadin gwiwar kasa da kasa.
Gilead Sciences ce ta kirkiro Remdesivir don maganin cutar Ebola da kuma cutar Marburg. Daga baya Gilead Sciences ta gano cewa za a iya amfani da Remdesivir a cikin hanyoyin rage cutar filo-, pneumo-, paramyxo- da coronavirus.
Wani batun da ke tattare da maganin kashe kwayar cuta shine inganta garkuwar jiki ta hanyar sauye-sauye wanda zai iya haifar da ƙarin rashin lafiya da yaduwar cuta.
Wasu daga cikin gwajin farko da aka ba da shawarar maganin RADSV sun nuna cewa yana da wata babbar hanyar hana rigakafi. Akwai gwaji da yawa na asibiti da ke gudana, ciki har da biyu daga asibitocin Jami'ar Kelsey da ke gudanar da aikin a cikin matsakaiciyar cutar da kuma a cikin mafi munin cutar.
Ana gudanar da gwaji uku na asibiti tare da maganin cutar kumburi na bitamin C ga mutanen da ke fama da cutar COVID-19 da ke kwance a asibiti, tare da placebo biyu (China da Kanada) tare da sarrafawa, da kuma placebo ɗaya ba tare da sarrafawa ba (Italiya).
Jihar New York ta fara gwajin maganin rigakafin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya ta Duniya da Magunguna ta Japan (NCGM) ta shirya yin gwajin asibiti na Teijin don alveolar (cysliconide), maganin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Za a yi gwajin mataki na biyu na wani nau'in Angiotensin-Converting Enzyme 2 a kan marasa lafiya 200 da ke kwance a asibitoci a Denmark, Jamus da Austria don tantance tasirin maganin.
Masu bincike a Jami'ar Zuciya ta Montreal a Kanada suna nazarin rawar da Colchicine ke takawa wajen rage yawan kumburi da cututtukan huhu a cikin marasa lafiya da ke fama da cutar COVID-19.
Binciken mai suna COLCORONA ya tattara mutane 6000 masu shekaru 40 zuwa sama da suka kamu da cutar COVID-19 kuma suna fama da wasu alamun rashin lafiya da ba sa bukatar a kwantar da su a asibiti.
Ba a ba da shawarar a zabi mata masu juna biyu ko mata masu shayarwa ko kuma wadanda ba su yi amfani da maganin hana haihuwa mai inganci ba.
A Italiya, ana gwada wasu magungunan jini.
Ana amfani da ƙananan nauyin kwayar halittar Hyperine a cikin maganin marasa lafiya kuma ana tura hukumomin magunguna na Italiya don buga jagororin amfani da shi.
An sanar da binciken Maltese Center kan amfani da inozaprin a cikin rigakafin cututtuka da magungunan magani a cikin marasa lafiya 300 a Italiya a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 kwayar cuta ce, an mai da hankali kan sake tsara maganin rigakafin cutar da aka amince da shi don bullar cutar da ta gabata, kamar MERS, SARS, da West Nile Virus.
Ribevirin: A cikin na bakwai, an ba da shawarar Ribevirin don maganin COVID-19 bisa ga jagororin da aka gyara na kasar Sin.
Umifenovir: A cikin jagororin kasar Sin na 7 da aka sake fasalin, an bada shawarar yin amfani da Umifenovir don maganin COVID-19.
Wasu daga cikin magungunan rigakafin da aka sanya sun sake zama maganin COVID-19 na ɗan lokaci:
Toshilizumeb (mai karɓar Anti-IL-6): An amince da shi daga China.
Har ila yau, duba gwaji a Italiya da China, da Tocilizumab #COVID-19.
B'A COVID-19 shine allurar rigakafin cutar coronavirus ta 2019 (COVID-19).
Babu wani rigakafin da ya yi nasara a gwajin asibiti, amma ana kokarin yin rigakafi.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin cutar SARS-CoV-2 a cikin watanni 18 ba.
A watan Afrilu, akwai magunguna guda biyar da aka gabatar a matsayin allurar rigakafi a cikin gwajin lafiya na matakin I.
An fara gano cutar COVID-19 a watan Disamba na 2019.
Babban barkewar cutar ya bazu a duniya a shekarar 2020, wanda ya haifar da saka hannun jari da bincike mai yawa don samar da allurar rigakafi.
Kungiyoyi da dama suna amfani da kayan da aka fitar don samar da yiwuwar maganin rigakafin cutar SARS-CoV-2.
A watan Afrilu, an tabbatar da cewa an aiwatar da muhimmin matakin CEPI na samar da allurar rigakafi tare da saurin aiki, samarwa, sikelin amfani da kuma amfani a duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa akwai dandamali daban-daban na fasaha guda 10 bisa ga bincike da aiwatarwa da aka gudanar a farkon 2020 don ƙirƙirar rigakafin da ke da tasiri don yaƙar COVID-19.
Babban alkawuran dandalin da suka kai ga binciken tsaro na Phase I sun hada da:
Nucleic acid (DNA da RNA) (mai ɗaukar mataki na I da kuma maganin da aka tsara: Moderna, mRNA-1273)
Maganin da ya shafi kwayar cutar (mai aiwatar da matakin I da maganin da aka tsara: CanSino Biologics, adenovirus nau'in 5 maganganun da aka bayyana)
A cikin watan Afrilu, rahoton masana kimiyya na CEPI ya nuna cewa akwai sabbin magunguna guda 115 a farkon matakan samarwa, tare da ayyukan tabbatarwa 78 da ke gudana (da 79 bisa ga Jami'ar Milken) da kuma ayyukan 37 da aka sanar da su amma ba a bayyana bayanai sosai ba (wanda ake iya ɗauka a cikin tsarin tsarawa ko ƙirar ƙira).
A cikin ƙayyade magunguna masu tasiri, gwajin Mataki na I-II yana ɗaukar gwajin aminci da gwaji na farko, wanda ke ɗaukar nau'ikan magungunan magunguna marasa tasiri da ke sarrafawa.
A cikin binciken tasirin cutar a mafi kyawun allurai, gwajin matakin III ya ƙunshi ƙarin mahalarta, gami da ƙungiyar sarrafawa, da gwajin tasirin rigakafin cutar.
Daga cikin alluran rigakafi 79 da ake samarwa (wanda aka amince da shi a farkon watan Afrilu na 2020), 74 ba a gwada su a kan mutane ba tukuna (har yanzu ana gudanar da gwajin farko).
A ranar 24 ga watan Janairu, 2020, Jami'ar Queensland a Ostiraliya ta sanar da cewa tana binciken yiwuwar yin allurar rigakafin kwayar halitta da za ta iya gyara kwayoyin cutar ta hanyar kwayar halitta don tayar da martani na rigakafi.
A Kanada, a ranar 24 ga Janairu, 2020, Cibiyar Alurar riga kafi ta kasa da kasa (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da cewa ta fara samar da allurar rigakafin da nufin fara gwajin mutum a 2021.
An sanar da ayyukan samar da allurar rigakafin ne a Cibiyar Kula da Cututtuka da Rigakafin Cutar ta China a ranar 26 ga Janairu, 2020, da kuma Jami'ar Hong Kong a ranar 28 ga Janairu, 2020.
A ranar 29 ga Janairu, 2020, kamfanonin hada magunguna na Janssen karkashin Hanneke Schuitemaker sun sanar da cewa sun fara aikin samar da allurar rigakafi.
Janssen tana aiki tare da Vaxart, abokin aikinta na fasahar kere kere, don samar da maganin rigakafi.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da cewa ta haɗu tare da Vaxart a matsayin abokin haɗin gwiwa don samar da allurar rigakafi.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya fitar da takarda game da yadda ake samar da allurar rigakafi ta hanyar fasahar kama da wacce ake amfani da ita don maganin rigakafin cutar kansa.
A ranar 25 ga watan Maris, shugaban kungiyar masu binciken ya sanar da cewa sun kammala hada allurar rigakafin kuma sun fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani reshen kamfanin Generex, NuGenerex Immuno-Oncology, ya sanar da cewa suna kan wani aikin rigakafi don samar da maganin rigakafin da zai iya yaki da COVID-19.
Suna son samar da maganin da za su iya gwadawa a kan mutane cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington da ke St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Cibiyar Kula da Bincike da Kayan Likita ta Sojojin Amurka a Fort Detrick, yammacin Maryland, da Cibiyar Nazarin Sojoji ta Walter Reed a Silver Spring, sun sanar da cewa suna aiki don samar da allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ya sanar da haɗin gwiwa tare da Novavax Inc.
A cikin aikin samar da allurar rigakafi.
Ƙungiyoyin bincike na haɗin gwiwa sun ci gaba da sanar da tsare-tsaren su don gwajin gwaji da gwajin gwaji na matakin I da za a gudanar a watan Yuli na 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna aiki tare da ƙungiyoyi daban-daban guda 11 kuma za su ɗauki shekara daya da rabi zuwa biyu kafin a samar da allurar rigakafi, koda kuwa za a iya yin hakan da wuri-wuri.
A ranar 12 ga Maris, 2020, kamfanin Medicago, wani kamfanin kere kere na kimiyyar halittu da ke Quebec City, Quebec, ya sanar da cewa ya samar da kwayar cutar coronavirus, tare da wani bangare na kudade daga jami'o'in bincike na kiwon lafiya na Kanada.
Ana gudanar da gwajin gwaji na allurar rigakafin tare da shirin gwajin mutum a watan Yuli ko Agusta 2020.
"To, a farkon makon, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba da "babban kyauta" ga CureVac don samun damar yin amfani da allurar rigakafin COVID-19, wanda gwamnatin Jamus ta ƙi".
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da cewa ya haɗu da kamfanin BioNTech na Jamus don haɓaka allurar rigakafin mRNA.
Ana sa ran fara allurar rigakafin da ke kan mRNA, BNT162, wanda a halin yanzu yana cikin gwajin asibiti na gwaji, a watan Afrilu na 2020.
A Italiya, kamfanin Takis Biotech na Italiya ya sanar a ranar 17 ga Maris 2020 cewa za su sami sakamakon gwajin farko a watan Afrilu na 2020 kuma za su iya fara gwajin gwajin su na ƙarshe a kan mutane a cikin kaka.
A Faransa, a ranar 19 ga Maris, 2020, Coalition for Preventive Infectious Preparedness Innovations (CEPI) ta sanar da saka hannun jari na dala miliyan 4.9 a cikin wani rukunin bincike na allurar rigakafin COVID-19 wanda ya hada da Institut Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh.
Sauran masu saka hannun jari a cikin aikin COVID-19 na CEPI sune Moderna, Curevac, Inovio, Novavax, Jami'ar Hong Kong, Jami'ar Oxford da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin sabbin alluran rigakafi guda shida akan dabbobi.
A ranar 20 ga Maris, 2020, masu bincike a Kwalejin Imperial ta London sun sanar da cewa suna kan samar da rigakafin RNA na COVID-19.
An samar da maganin a cikin kwanaki 14 bayan an samu kwayar cutar daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da cewa za ta kashe dala miliyan 275 na Kanada don gudanar da ayyukan bincike 96 kan hanyoyin kiwon lafiya don yaƙar COVID-19, gami da haɓaka sabbin alluran rigakafi a kamfanoni da jami'o'in Kanada kamar Medicago da Jami'ar Saskatchewan.
A halin yanzu, gwamnatin Kanada ta sanar da cewa za ta kashe dala miliyan 192 na Kanada musamman don samar da allurar rigakafin COVID-19, tare da shirin gina bankin allurar rigakafin ƙasa wanda ke da sabbin alluran rigakafi da za a iya amfani da su idan har wani sabon barkewar cutar coronavirus.
A ranar 2 ga Afrilu, 2020, masu bincike a Makarantar Likita ta Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc na yiwuwar allurar rigakafin COVID-19 a kan beraye, kuma MNA ta gabatar da allurar rigakafin SARS-CoV-2 S1 na musamman wanda zai iya samar da rigakafin cutar mai yiwuwa wanda ya fara a makonni biyu bayan allurar.
A Kanada, a ranar 16 ga Afrilu, 2020, Jami'ar Kwalejin Kiwon Lafiya ta Waterloo ta sanar da cewa an samar da sabon allurar rigakafin DNA wanda za a iya samun ta ta hanyar hanci.
An tsara DNA don yin kwafi a cikin kwayoyin halittar mutum ta amfani da bacteriophages, wanda ke haifar da kwayar cutar da ba ta da cutarwa, wanda ke motsa tsarin garkuwar jiki don samar da kwayoyin cutar da ke yaki da cutar SARS-CoV-2.
A watan Maris na 2020, gwamnati uku na Amurka, masana'antu, da jami'o'i sun haɗu da albarkatun lissafi na lissafi daga Hewlett Packard Enterprises, Amazon, Microsoft, da Google don samun damar yin amfani da manyan kwamfutoci daga IBM.
Wasu alluran rigakafi suna da tasirin heterologous, wanda ake kira da tasirin da ba na musamman ba.
Wannan yana nufin cewa suna iya samun fa'ida fiye da cutar da suke hanawa.
Wani gwaji na bazuwar a Australia yana ƙoƙarin yin rajistar ma'aikatan kiwon lafiya 4,170.
A wasu lokuta, ana iya samun cewa alluran rigakafin ba su da lafiya ko kuma ba su da tasiri.
Binciken farko na kimanta tasirin maganin COVID-19 ta amfani da samfuran dabbobi na musamman kamar beraye da aka maye gurbin ACE2, sauran dabbobin dakin gwaje-gwaje, da kuma na dabbobi marasa ɗan adam sun nuna cewa ana buƙatar haɗin gwiwar ƙasa da ƙasa don magance ƙwayoyin cuta masu rai: matakan tsaro na 3 da matakan tsaro na yau da kullun.
An gwada alluran rigakafin SARS da MERS a kan samfuran dabbobi.
A shekarar 2020, babu magani ko rigakafin cutar SARS da ya tabbatar da cewa yana da lafiya da tasiri a cikin mutane.
A cewar takardun bincike da aka buga a shekarar 2005 da 2006, ganowa da kuma samar da sabbin alluran rigakafi da magunguna don maganin cutar SARS ya kasance babban fifiko ga gwamnatoci da hukumomin kiwon lafiyar jama'a a duk duniya.
A lokacin barkewar cutar MERS, ana tsammanin binciken SARS na yanzu zai zama da amfani wajen gano alluran rigakafi da hanyoyin magance cutar MERS-CoV.
A watan Maris na shekarar 2020, wani allurar rigakafin MERS (wanda ya dogara da DNA) ya kammala gwajin gwaji na farko a kan mutane, kuma wasu uku suna kan gwaji, kuma dukkansu alluran rigakafin ƙwayar cuta ne, su ne maganin adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) da MVA-vectored (MVA-MERS-S).
A cikin wani rahoto da aka wallafa a shafukan sada zumunta, an bayyana wata ka'ida ta makirci da ke nuna cewa an riga an san cutar da ke bayan COVID-19 kuma an riga an sami maganin rigakafin.
Takardun mallakar da aka tabbatar da su ta hanyar sakonnin kafofin watsa labarun daban-daban sun yi nuni da takardun mallakar da ke akwai na tasirin kwayoyin halitta ga wasu nau'ikan kwayar cutar coronavirus kamar SARS da kuma alluran rigakafi.
Cutar kwayar cutar korona ta 2019 (COVID-19) annoba ce mai saurin yaduwa da cutar coronavirus 2 (SARS-CoV-2).
Alamun cutar sun hada da zazzabi, tari, da kuma numfashi.
Sauran alamun na iya zama gajiya, ciwon tsoka, amai, ciwon wuya, rashin jin ƙamshi, da ciwon ciki.
Lokacin bayyanar cututtuka yawanci yana kusa da kwanaki biyar, amma yana iya zama tsakanin kwana biyu zuwa goma sha huɗu.
Yawancin marasa lafiya suna da ƙananan alamun cutar, amma wasu suna iya samun cutar huhu da lalacewar gabobin jiki da yawa.
Ya zuwa ranar 17 ga Afrilu, 2020, an samu kamuwa da cutar miliyan 2.24 da mutuwar sama da 153,000 a kasashe da iyakoki 210.
Fiye da mutane 568,000 sun warke. Kwayar cutar tana yaduwa tsakanin mutane, galibi ta hanyar ɗigon da ke fitowa daga tari, hancin ko magana, sau da yawa a lokacin hulɗa ta kusa.
Saurin numfashi yana fitar da wannan kwayar, kuma yawanci ba ta iya kaiwa nesa sosai, kuma tana sauka a ƙasa ko kuma a saman ƙasa.
Mutane da yawa suna iya kamuwa da cutar ta hanyar taɓa idanunsu, hanci, ko baki bayan sun taɓa wani abu da ke dauke da cutar.
Kwayar cutar na iya rayuwa har tsawon sa'o'i 72 a kan farfajiyar.
Ko da yake akwai yiwuwar kamuwa da cuta kafin bayyanar cututtuka da kuma a cikin matakan ƙarshe na cutar, lokacin da ya fi tsanani shine a cikin kwanaki uku na farko bayan bayyanar cututtuka. Hanyar ganewar asali shine ainihin lokacin da aka sake yin amfani da polymerase chain reaction (rRT-PCR) a cikin hanci da hanci.
Ana ba da shawarar yin amfani da abin rufe fuska ga mutanen da ke da cutar da waɗanda ke kula da su.
Wasu hukumomi sun ba da shawarar hana amfani da abin rufe fuska, wasu sun ba da shawarar yin amfani da abin rufe fuska, wasu kuma sun ba da shawarar yin amfani da shi, wasu kuma sun ba da shawarar yin amfani da abin rufe fuska ga jama'a.
A halin yanzu, babu allurar rigakafin COVID-19 ko magani ga wani kwayar cutar.
An samu kamuwa da cutar a yankin a mafi yawan kasashen da ke cikin dukkanin yankuna shida na WHO.
Mutanen da suka kamu da kwayar cutar na iya zama marasa alamun cutar ko kuma suna iya nuna alamun cutar kamar mura kamar zazzabi, tari, gajiya da wahalar numfashi.
Alamun gaggawa sun hada da wahalar numfashi, ciwon kirji ko matsi, tashin hankali, wahalar farkawa, da kuma fuska ko lebe. Ana ba da shawarar neman magani nan da nan idan waɗannan alamun sun bayyana.
Ana iya samun alamun cututtukan sama na numfashi kamar yin tari, hancin hanci, ko ciwon makogwaro.
An gano kashi daban-daban na alamun cututtukan narkewar abinci, kamar su amai, amai da kuma amai.
Wasu daga cikin marasa lafiya a China sun fara nuna kawai ciwon kirji da bugun zuciya.
A wasu, cutar na iya haifar da ciwon huhu, lalacewar gabobin jiki, da mutuwa.
Ana kiransa lokacin haihuwar.
Lokacin farawa don COVID-19 yawanci yana cikin kwanaki biyar zuwa shida, amma yana iya kasancewa tsakanin kwanaki biyu zuwa 14.
Kashi 97.5 na mutanen da ke nuna alamun cutar za su yi hakan ne cikin kwanaki 11.5 bayan kamuwa da cutar. Rahotanni sun nuna cewa ba duka mutanen da ke da cutar ba ne ke nuna alamun cutar.
Ba a san cikakken matsayin mutanen da ba su da alamun cutar a cikin kamuwa da cutar, amma shaidar farko ta nuna cewa suna iya haifar da yaduwar cutar.
Ba a san yawan mutanen da ke dauke da cutar ba tare da nuna alamun cutar ba, kuma cibiyar kula da cututtuka ta Koriya (KCDC) ta ba da rahoton cewa kashi 20 cikin 100 na duk waɗanda aka tabbatar da cutar ba su da alamun cutar a lokacin da suke asibiti.
Hukumar Lafiya ta kasa ta kasar Sin ta fara sanya marasa cutar a cikin jerin marasa lafiya na yau da kullun a ranar 1 ga Afrilu, 130 (78%) daga cikin mutane 166 da suka kamu da cutar a wannan ranar ba su da alamun cutar a lokacin gwajin.
Tashin hanci da kuma hawaye na iya ɗaukar ƙwayoyin cuta masu yawa.
Magana da ƙarfi tana fitar da ruwa fiye da magana ta al'ada.
Wani bincike da aka yi a Singapore ya nuna cewa tari ba tare da kariya ba na iya kaiwa ga saukad da ruwa har tsawon mita 4.5 (15 feet).
Ko da yake cutar ba ta zama kwayar iska ba, Cibiyar Kimiyya ta Kasa ta gano RNA na cutar a cikin samfurori na rana daga masu karɓar iska da aka sanya a cikin kwance a waje da ɗakunan jama'a.
Hanyoyin kiwon lafiya kamar su sakawa ta hanyar numfashi da kuma sake farfado da zuciya da huhu (CPR) suna haifar da narkewar narkewar numfashi a cikin ƙananan ƙwayoyin da ke yawo a cikin iska, wanda ke haifar da kamuwa da cuta ta hanyar iska.
Wannan yana da ƙananan haɗari yayin da ake tsoron cewa za a iya samun kamuwa ta hanyar fitsari. Kwayar cutar tana da mafi girman kamuwa yayin da ake nuna alamun.
Ko da yake ba a san yadda sauƙin cutar ke yaduwa ba, cibiyar rigakafin cututtuka ta Turai (ECDC) ta ce mutum ɗaya na iya yaduwa daga mutum biyu zuwa uku. Kwayar cutar na iya rayuwa daga awanni zuwa kwanaki a kan fuskoki.
Musamman, an gano cewa kwayar cutar na iya rayuwa har kwana daya a kan takarda, har kwana uku a kan filastik (fasahar roba (polypropylene) da karfe (AISI 304) da kuma har tsawon awa hudu a kan 99% na tagulla.
Koyaya, ya bambanta dangane da zafi da zafin jiki.
Sabulu da kayan wankewa ma suna da tasiri idan aka yi amfani da su yadda ya kamata, ba wai kawai suna lalata kayan mai na kwayar cutar ba, suna sanya ta rashin aiki, amma kuma suna hana su zuwa fata da sauran wurare.
Sauran ruwa kamar benzalkonium chloride da chloroxide gluconate (mai kashe kwayoyin cuta na asibiti) ba su da tasiri sosai. A cikin binciken Hong Kong, an sami samfurin hanci a matsayin matsakaici kwana biyu bayan shigar asibiti.
A cikin marasa lafiya shida zuwa biyar, samfurin farko ya nuna mafi girman kwayar cutar, kuma a cikin mara lafiya ta shida, gwajin rana ta biyu ya nuna mafi girman kwayar cutar.
Kwayar cutar coronavirus mai saurin kamuwa da cuta ta numfashi ta 2 (SARS-CoV-2) ita ce sabuwar kwayar cutar coronavirus mai saurin kamuwa da cuta ta numfashi da aka fara warewa daga mutane uku da ke da cutar huhu da ke da alaƙa da al'ummar da ke fama da cutar numfashi mai saurin kamuwa da cuta a Wuhan.
Dukkanin halayen cutar SARS-CoV-2 na faruwa a cikin wasu nau'ikan coronaviruses na halitta.
A wajen jikin mutum, cutar tana kashe mutane ta hanyar fashewar kumfa da sabulu na gida ke karewa. SARS-CoV-2 yana da alaƙa da asali SARS-CoV.
A cikin huhu, cutar ta shiga cikin ƙwayoyin gida ta hanyar enzyme na canzawa na angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin AV2 na nau'in 2 a cikin huhu, saboda huhu sune ɓangarorin da COVID-19 ya fi shafar.
Kwayar cutar tana ɗaure da ACE2 kuma tana amfani da wani ƙwayoyin halitta na musamman da ake kira papilloma don shiga cikin ƙwayoyin mai karɓa.
A Wuhan, China, kashi 12 cikin 100 na masu dauke da cutar suna fama da ciwon zuciya, wanda ya fi faruwa a cikin cututtuka masu tsanani.
Amsar kumburi da kuma rashin ƙarfi na tsarin garkuwar jiki a yayin ci gaban cutar yana haifar da ƙaruwar cututtukan zuciya, amma kuma mummunan lalacewar ƙwayar zuciya na iya kasancewa tare da mai karɓar ACE2 a cikin zuciya.
Ana samun masu karɓar ACE2 a cikin zuciya kuma suna da hannu cikin ayyukan zuciya.
An samu karuwar yawan jini a cikin jijiyoyin jini (31%) da kuma toshewar jini a cikin jijiyoyin jini (25%) a cikin marasa lafiya da ke kula da su a cikin dakin kulawa mai tsanani tare da kamuwa da cutar COVID-19, kuma ana iya danganta hakan da rashin ci gaba.
SARS-COV-2 yana da wani nau'in canji na al'ada ga ƙwayoyin cuta na numfashi waɗanda ke nuna ACE2, amma marasa lafiya da ke fama da COVID-19 mai tsanani suna da alamun bayyanar fata da fata a duk jikin su.
An nuna cewa ana danganta tarin IL-6 da ke fitar da kwayoyin cutar, musamman kwayoyin cutar ta GM-CSF-secreting T cells, da kuma cututtukan huhu masu tsanani a cikin marasa lafiya na COVID-19.
An kuma bayar da rahoton kamuwa da kwayar cutar lymphocyte a gwajin kirji.
Hukumar ta WHO ta sanar da wasu hanyoyin gwajin cutar.
Hanyar da aka saba amfani da ita wajen yin gwajin ita ce amsa ta polymerase-transfer-reverse-reaction (rRT-PCR) a ainihin lokacin.
Ana yin wannan gwajin ne ta hanyar daukar samfurori na numfashi da aka samu ta hanyar daukar samfurori na nasolabi'a tsakanin hanci da makogwaro, amma ana iya amfani da samfurori na hanci ko kuma samfurin mucous membrane.
A cikin kwanaki da yawa, ana samun sakamako a cikin 'yan sa'o'i zuwa kwana biyu.
Ana iya amfani da gwajin jini, amma suna buƙatar samfuran jini da aka ɗauka a kowace shekara, kuma sakamakon yana da ƙarancin ƙima nan take.
Masana kimiyya na kasar Sin sun ware kwayar cutar coronavirus kuma sun fitar da tsarin kwayoyin halitta wanda ya ba da damar dakunan gwaje-gwaje a duniya su samar da gwajin polymerase chain reaction (PCR) don gano cutar.
An gano gwajin antibody (wanda zai iya gwada cutar a halin yanzu da waɗanda suka kamu da cutar a baya) a ranar 4 ga Afrilu 2020, amma har yanzu ba a yi amfani da shi ba.
Kwarewar Sinawa game da gwajin ya nuna cewa daidaito ya kai kashi 60 zuwa 70 cikin dari.
Hukumar FDA ta Amurka ta amince da gwajin farko na kulawar wuri don amfani a ƙarshen wannan watan a ranar 21 ga Maris, 2020. Jagororin bincike da asibitin Zhongnan na Jami'ar Wuhan ya ba da shawarar hanyoyin bincike bisa alamun asibiti da haɗarin cututtukan cututtuka.
An gano fashewar ƙwayoyin cuta a farkon kamuwa da cuta tare da rarrabawar gefen baya mara daidaituwa, da ƙananan gilashi a cikin huhu biyu.
Yayin da cutar ke ƙaruwa, za a iya samun kaurin murfin huhu, taurin fuska (kaurin labule tare da cikawar haƙoran da ba a daidaita ba) da kuma ƙarancin ƙwayoyin cuta.
Akwai bayanai kaɗan game da raunuka da aka gani ta hanyar microscopy da kuma abubuwan da ke tattare da ilimin lissafi na COVID-19.
Wasu daga cikin manyan cututtukan cututtukan zuciya da aka gano a cikin binciken zuciya sune:
A cikin shekara ta 2000, an yi wa mutane da yawa a duniya, da kuma a wasu ƙasashe, gwaji da kuma gwaji da aka yi a kan ƙwayoyin cuta da kuma ƙwayoyin cuta da ke sa mutane su yi baƙin ciki.
Ana iya gano nau'ikan nau'ikan cutar huhu guda huɗu na cutar cutar huhu kamar haka:
Cutar cutar huhu mai saurin ragewa: shigar huhu, yawan ƙwayar cuta, ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa da ƙaruwa.
Cutar huhu mai tsanani: Rashin ruwa mai guba da kuma lalacewar kumburi (DAD).
DAD na iya zama sanadin cututtukan numfashi mai tsanani (ARDS) da kuma rashin isashshen iskar oxygen.
An warkar da ciwon huhu. Ruwa daga hanyoyin aviola da kuma samar da fibroids na huhu
Ƙarfin jini: Yaduwar jini a cikin jijiyoyin jini (DIC), amsawar ƙwayar cuta ta mutum
Hanyoyin rigakafi don rage yiwuwar kamuwa da cutar sun hada da zama a gida, guje wa wuraren taruwa, wanke hannu sau da yawa tare da sabulu da ruwa na akalla sakan 20, yin tsaftace numfashi mai kyau, da kuma gujewa taɓa idanu, hanci ko baki da hannaye marasa wanke.
CDC ta ba da shawarar rufe baki da hanci da nama lokacin da kake yin tari ko hancin, kuma idan ba a sami nama ba, amfani da ƙwanƙwasawa.
Ana ƙarfafa tsabtace hannu sosai bayan tari ko hancin.
CDC ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a a matsayin wani ɓangare na iyakance kamuwa da cuta daga mutanen da ba su da alamun cutar. Dabarun nesa da jama'a suna nufin rage haɗuwa da mutane masu kamuwa da cutar tare da rufe makarantu da wuraren aiki, ƙuntata tafiye-tafiye, da kuma soke manyan tarurrukan jama'a.
Ka'idojin nisantar mutane sun hada da nisantar mutane da nisan akalla kafa 6 (mita 1.8).
Babu magani da aka sani da ke da tasiri don hana COVID-19, kuma saboda ba a sa ran samun allurar rigakafi har zuwa farkon 2021 ba, babban ɓangare na gudanar da COVID-19 shine ƙoƙarin rage yawan cutar, wanda ake kira "sanya layin".
CDC ta kuma shawarci mutane su wanke hannayensu da sabulu da ruwa na akalla dakika 20 bayan cin abinci, hanci, tari, ko yin hanci, musamman bayan sun je gidan wanka ko kuma idan hannayensu sun yi datti.
Ya kuma ba da shawarar yin amfani da wanke hannu da ke dauke da barasa aƙalla kashi 60 cikin ɗari, amma idan sabulu da ruwa suna da sauƙi. Don yankunan da ba su da damar samun ruwan wanke hannu na kasuwanci, WHO ta ba da dabarun samar da gida guda biyu.
A cikin waɗannan ƙirar, aikin rigakafin ƙwayoyin cuta ya fito ne daga ethanol ko isopropanol.
Ana amfani da hydrogen peroxide a matsayin mai taimakawa wajen kawar da ƙwayoyin cuta. Ba shine mai amfani da sinadarin don maganin kashe wuka ba.
An haɗa glycerin a matsayin mai riƙe danshi.
Ana gudanar da mutane ta hanyar samar da kulawa da sauran abubuwan da ke da tasiri, ciki har da maganin ruwa, isar da iskar oxygen.
CDC ta ba da shawarar cewa duk wanda ake zargin yana da kwayar cutar ya sa abin rufe fuska na yau da kullun.
Ana amfani da maganin oxygenation na membrane na waje (ECMO) don magance matsalar numfashi, amma ana kuma yin la'akari da fa'idodi.
Don inganta garkuwar jiki, ya kamata mu bi tsafta, rayuwa mai kyau da cin abinci.
Magungunan tallafi na iya zama da amfani ga waɗanda ke da alamun rashin lafiya a farkon matakin kamuwa da cutar. WHO da Hukumar Kula da Lafiya ta China sun fitar da shawarwari don kula da waɗanda ke asibiti tare da COVID-19.
Likitocin kulawa da kuma likitocin ciwon huhu a Amurka sun tattara shawarwarin magani daga bangarori daban-daban na kiwon lafiya a cikin IBCC, tushen bayanai kyauta.
Ya zuwa watan Afrilu na 2020, babu wani magani na COVID-19.
Don bayyanar cututtuka, wasu masana likitanci suna ba da shawarar paracetamol (acetaminophen) fiye da ibuprofen don amfani na farko.
Ya kamata a yi matakan rigakafi don rage haɗarin yaduwar kwayar cutar, musamman a wuraren kula da lafiya, lokacin da ake aiwatar da hanyoyin da ke taimakawa a numfasa ta hanyar sutura ko kuma na'urorin numfashi na hannu.
Ga masu kula da lafiya da ke kula da mutanen da ke da cutar COVID-19, CDC ta ba da shawarar bin ƙa'idodin rigakafi, rigakafin haɗuwa, da rigakafin ƙwayoyin cuta na iska, da kuma kula da marasa lafiya a cikin ɗakin keɓewar ƙwayoyin cuta ta iska (AIIR).
Abubuwan da aka ba da shawarar su ne: rigunan PPE, na'urar numfashi ko abin rufe hanci, abin rufe ido, da safofin hannu na likita. Idan akwai, ka fi amfani da na'urar numfashi (maimakon abin rufe fuska).
An amince da masu numfashi na N95 don amfani da masana'antu, amma FDA ta ba da izinin amfani da abin rufe fuska ta hanyar izinin gaggawa (EUA).
An tsara su ne don kare su daga ƙwayoyin cuta kamar ƙura a cikin iska, amma babu tabbacin inganci akan takamaiman wakili na ilimin halittu don amfani ba tare da alamar ba.
CDC ta ba da shawarar yin amfani da abin rufe fuska, da kuma sabbin kayan rufe fuska idan ba a samun abin rufe fuska.
Yawancin mutane da ke kamuwa da COVID-19 ba su da cuta sosai har da za su buƙaci na'urar numfashi ko makamancin haka, amma wasu sun buƙaci na'urar numfashi.
Akwai binciken da ake yi a halin yanzu game da nau'in kayan aikin numfashi na marasa lafiya da ke fama da cutar COVID-19 a cikin asibiti, kuma wasu shaidu sun nuna cewa ana iya guje wa shigar da bututun numfashi ta hanyar matsi mai ƙarfi na hanci ko kuma ta hanyar iska mai ƙarfi.
Ba a san ko ɗayan biyun na haifar da irin wannan fa'ida ga waɗanda ke da ciwo mai tsanani ba.
Wasu likitoci sun fi son zama tare da na'urar numfashi mai ƙarfi, idan ya yiwu, idan aka kwatanta da na'urar numfashi mai ƙarfi tare da babban iska. Wannan hanya tana iyakance yaduwar ƙananan ƙwayoyin da ke cikin iska.
A yawancin ƙasashe masu tasowa, ƙarfin tsarin kiwon lafiya na iya magance ƙaruwar bala'in COVID-19 mai tsanani har zuwa asibiti, kuma babu isasshen gadaje na asibiti ga kowane mutum.
Wani bincike a kasar Sin ya nuna cewa kashi 5 cikin 100 na yara sun shiga sashen kulawa na musamman, kashi 2.3 cikin 100 sun bukaci taimakon numfashi, kuma kashi 1.4 cikin 100 sun mutu.
Kashi 30% na mutanen da ke da COVID-19 a asibiti a China suna ci gaba da shiga ICU.
COVID-19 na iya haifar da bayyanar cututtukan numfashi na kwatsam, wanda ke haifar da wahalar numfashi ta hanyar inji, saboda yana da wahala samun iskar oxygen.
Ana buƙatar masu numfashi da PEEP masu tsayi waɗanda ke da ikon yin matsin lamba da ake buƙata don haɓaka isar da iskar oxygen yayin rage haɗarin lalacewar huhu da lalacewa tsakanin huhu da kirji.
Tsoffin na'urorin numfashi ba sa samun babban PEEP.
Binciken yiwuwar maganin ya fara ne a watan Janairun 2020, kuma ana gwada magungunan kashe ƙwayoyin cuta da yawa a gwajin asibiti.
Ramdisiba ne ya fi kowa samun nasara.
Ko da yake zai iya ɗaukar har zuwa 2021 don fitowar sabon magani, an riga an amince da yawancin magungunan da aka gwada don sauran amfani kuma ana ci gaba da gwajin gwaji.
Ana iya gwada maganin kashe kwayar cutar a cikin marasa lafiya masu tsanani.
Hukumar Lafiya ta Duniya ta shawarci masu sa kai su shiga gwajin inganci da amincin hanyoyin magani. FDA ta ba da izinin ɗan lokaci don amfani da ruwan jini na mai warkewa a matsayin magani na gwaji lokacin da rayuwar mutum ke cikin haɗari ko haɗari.
Ba a kammala gwajin asibiti da ake buƙata don nuna cewa yana da lafiya da tasiri ga cutar ba.
A watan Fabrairun 2020, kasar Sin ta kaddamar da manhajar wayar salula don magance barkewar cutar.
Masu amfani suna buƙatar shigar da sunansu da lambar ID.
Wannan app din yana amfani da bayanan sa ido don gano haɗarin kamuwa da cutar.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Idan aka gano wata barazana, app din ba wai kawai yana ba da shawarar keɓe kai ba ne, har ma yana sanar da jami'an kiwon lafiya na gida. A Koriya ta Kudu, Taiwan da Singapore, ana bin diddigin mutane ta amfani da babban tsarin nazarin bayanai a wayoyin salula, fasahar gane fuska, bin diddigin wayar salula da fasahar ƙwaƙwalwar wucin gadi don gano waɗanda ke da cutar da waɗanda suka yi hulɗa da su.
A watan Maris na shekarar 2020, hukumomin tsaro na gwamnatin Isra'ila sun sami damar sa ido kan bayanan wayar hannu na mutanen da ake tsammanin suna da cutar coronavirus.
Ana daukar matakan tsaurara tsauraran matakan kiyayewa da kuma kare wadanda suka yi mu'amala da mutanen da suka kamu da cutar.
Tun a watan Maris na shekarar 2020, Deutsche Telekom ta raba bayanan wurin da aka tattara tare da Robert Koch Institute, wata hukumar gwamnatin tarayya ta Jamus, don gudanar da bincike da kuma hana yaduwar cutar.
Rasha ta yi amfani da fasahar gane fuska don gano masu keta dokar hana fita.
Kwamishinan kiwon lafiya na yankin Italiya Giulio Gallera ya ce kamfanonin wayar salula sun sanar da shi cewa kusan kashi 40 cikin 100 na mutanen Italiya suna tafiya a wata hanya.
Gwamnatin Jamus ta gudanar da gasar shiga ba tare da izini ba na tsawon sa'o'i 48 a karshen mako tare da mahalarta sama da dubu 42.
A wani bangare kuma, Shugaban Estonia Kersti Kaljulaid ya bukaci duniya da ta kirkiro hanyoyin magance yaduwar cutar coronavirus.
Mutane da yawa suna jin tsoron ƙuntatawa, ƙuntatawa na tafiya, tasirin magani, ko kuma kamuwa da cuta.
BBC ta nakalto Rory O'Connor cewa: "Rashin zaman lafiya, kadaici, damuwar lafiya, damuwa da koma bayan tattalin arziki, duk wani hadari ne da ke barazana ga lafiyar mutane da kuma rayuwarsu".
Cutar na iya zama mai sauƙin kamuwa da cutar, kamar yadda sauran cututtukan sama na numfashi, kamar sanyi, ke nunawa, tare da rashin alamun cutar ko kuma babu alamun cutar.
Masu rauni yawanci suna samun sauki cikin makonni biyu, yayin da masu tsanani ko masu tsanani ke daukar makonni uku zuwa shida don samun sauki.
Bayanai daga wasu ƙwayoyin cuta masu kama da SARS da MERS sun nuna cewa mata masu juna biyu na iya samun cutar COVID-19. Amma ba a sami cikakken bayani game da cutar COVID-19 ba. A wasu mutane, COVID-19 na iya cutar da huhu kuma ya haifar da ciwon huhu.
A cikin mutanen da cutar ta fi shafa, COVID-19 na iya saurin ci gaba zuwa mummunar cutar numfashi (ARDS) wanda ke haifar da rashin numfashi, guba ta jini, ko kuma rashin aiki da gabobin jiki.
Sabbin cututtukan da suka shafi COVID-19 sun hada da cutar jini, rashin daidaiton jini, da kuma cutar zuciya, koda da hanta.
Rashin daidaiton jini, musamman ma karuwar lokacin tsaron jini (clogging time) an gano shi a kashi 6 cikin dari na waɗanda aka kwantar da su a asibiti tare da COVID-19, kuma an gano aikin koda mara kyau a kashi 4 cikin dari na wannan rukunin.
An kiyasta cewa kashi 20-30% na mutanen da ke da COVID-19 suna da ƙaruwar enzymes na hanta (transminases).
A cewar rahoton, matsakaicin lokacin da cutar ta fara nuna alamun cutar zuwa lokacin mutuwa kwanaki 10 ne, kuma a cikin kwanaki biyar, mutum yana asibiti.
Koyaya, matsakaicin lokaci tsakanin asibiti da mutuwa kwana bakwai ne ga marasa lafiya da aka tura zuwa ICU.
A cikin nazarin farko, matsakaicin lokaci daga bayyanar cututtuka zuwa mutuwa ya kasance kwanaki 14 tare da tsawon kwanaki 6 zuwa 41.
Wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin (NHC) ta gudanar ya nuna cewa mace mace na da kashi 1.7 cikin 100 na mace da namiji 2.8 cikin 100.
Gwajin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cut cut cut cut cut cut cut cut
An gano canje-canje a cikin ƙwayoyin cutar a cikin ƙwayoyin huhu.
Hoton huhu yana kama da bayyanar cututtukan numfashi na hanzari (ARDS).
Hukumar Lafiya ta kasa ta kasar Sin ta ruwaito cewa kashi 11.8% na wadanda suka mutu sun nuna lalacewar zuciya ta hanyar yawan troponin ko kuma dakatar da zuciya.
A Amurka, kashi 89% na wadanda aka kwantar a asibiti suna da cutar, a cewar bayanan Maris. Samun damar samun albarkatun kiwon lafiya da tattalin arzikin al'umma na yanki na iya shafar yawan mutuwar.
Kimanin yawan mutuwar daga yanayi ya bambanta saboda bambance-bambance na yanki, amma kuma saboda matsalolin fasaha.
Rashin kula da yanayin rashin lafiya na iya haifar da mutuwar da ta wuce kimantawa.
Amma, gaskiyar cewa sakamakon cutar ya kasance mutuwa ga waɗanda suka kamu da ita a baya, ana iya cewa an rage yawan mutuwar yanzu.
Masu shan sigari sun fi masu shan sigari sau 1.4 na fuskantar mummunan bayyanar COVID-19 da sau 2.4 na fuskantar kulawa mai mahimmanci da mutuwa.
Hukumomin asibiti na Hong Kong sun ce masu warkewa suna da raguwar aikin huhu daga kashi 20 zuwa 30%, kuma binciken da aka yi na huhu yana nuna lalacewar jiki.
Hakanan yana iya haifar da bayyanar cututtuka bayan warkewa, kuma ana kula da shi a cikin sashen kulawa mai mahimmanci.
Har zuwa Maris na 2020, ba a san ko cutar ta riga ta sami tasiri mai tsawo a cikin waɗanda suka warke daga cutar ba.
Ko da yake akwai yiwuwar kamuwa da cutar bisa ga halayyar wasu ƙwayoyin cuta, an ba da rahoton cewa a cikin waɗanda suka warke daga barkewar COVID-19, suna sake dawowa a cikin gwajin coronavirus daga baya.
A cikin waɗannan mutanen, ragowar kamuwa da cuta na iya zama mafi muni fiye da sake kamuwa da cuta.
Wataƙila kwayar cutar ta samo asali ne ta hanyar halitta kuma ta samo asali ne ta hanyar asalin dabbobi.
Ko da yake ba a san ainihin asalin cutar ba, a watan Disamba na 2019, cutar ta kusan kai mutum zuwa mutum.
Nazarin farko na 41 da aka tabbatar da cutar COVID-19 da aka buga a cikin Janairu 2020 a cikin The Lancet ya nuna ranar farkon bayyanar cututtuka a ranar 1 ga Disamba, 2019.
A cikin takardun da WHO ta fitar, an ba da rahoton farkon bayyanar cutar a ranar 8 ga Disamba, 2019.
Ana amfani da ma'auni daban-daban don ƙididdigar yawan mutuwar.
Wadannan lambobin sun bambanta ta yanki da tsawon lokaci, kuma sun dogara ne da yawan gwajin, ingancin kiwon lafiya, hanyoyin magani, lokacin fara barkewar cutar, da kuma halaye na mutane kamar shekaru, jinsi da kuma lafiyar gaba daya.
Bayan 2019, WHO ta sanya lambobin gaggawa don cutar ICD-10 a matsayin U07.1 don mutuwar cutar SARS-CoV-2 da aka tabbatar da dakin gwaje-gwaje, kuma U07.2 don mutuwar cutar COVID-19 da aka gano ta hanyar gwajin asibiti na SARS-CoV-2 ko gwajin cutar.
Bisa ga kididdigar Jami'ar Johns Hopkins, yawan mutuwar mutane a duniya ya kai kashi 6.9 bisa dari (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Ƙididdigar sun bambanta ta yanki. Sauran ma'auni sun haɗa da yawan mutuwar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan
Wannan ƙididdigar ba ta da iyakance lokaci, amma ta dogara ne akan takamaiman adadin mutanen da suka kamu da cutar ta hanyar ƙarfin aikin.
Ko da yake ba a iya gano kwayoyin cutar a cikin dukkan mutanen da suka kamu da cutar ba, amma samun kwayoyin cutar na iya ba da bayanin yawan mutanen da suka kamu da cutar.
A cikin ƙauyen Castiglione d'Adda, wanda shine cibiyar kamuwa da cutar a Italiya, 80 (1.7%) na yawan jama'a 4,600 sun mutu.
An yi amfani da cutar a Gangelt a lokacin bikin Carnival, inda ta yaɗu tsakanin matasa, saboda haka akwai ƙananan mutuwar, kuma ba a iya samun irin wannan ƙididdigar a kan duk mutuwar COVID-19.
Bugu da ƙari, tsarin kiwon lafiya na Jamus ba shi da matsala.
A Netherlands, kimanin kashi 3 cikin 100 na masu ba da jini suna da rigakafin cutar.
A cikin wannan shekarar, an samu mutuwar mutane 69 daga COVID-19 (kashi 0.004 cikin dari na yawan jama'a).
Tasirin cutar da kuma yawan mutuwar da ta haifar sun bambanta tsakanin maza da mata.
A cikin binciken da aka yi a China da Italiya, an gano cewa maza suna da yawan mutuwar da ya fi na mata.
Bambancin lokaci tsakanin maza da mata ya kai kashi 90 ne kawai, kuma maza suna da mafi girman haɗari a cikin shekarunsu na 50.
A kasar Sin, yawan mace-macen maza ya kai kashi 2.8 cikin dari, yayin da mace ta kai kashi 1.7 cikin dari.
Ba a san ainihin dalilin bambance-bambance shida ba, amma kwayoyin halitta da al'ada na iya zama wani abu.
Bambancin tsarin garkuwar jiki bisa jinsi, yawan shan sigari da kuma kamuwa da cututtukan zuciya kamar hawan jini a cikin maza fiye da mata, sun hada da yawan mace-mace.
A Turai, kashi 57% na waɗanda suka kamu da cutar maza ne, kuma kashi 72% na waɗanda suka mutu daga COVID-19.
Ya zuwa watan Afrilu na 2020, gwamnatin Amurka ba ta yi bin diddigin bayanan da suka shafi jima'i na kamuwa da COVID-19 ba.
Bincike ya nuna cewa cututtukan da ke haifar da kwayar cuta kamar Ebola, HIV, zazzabin cizon sauro da SARS suna shafar maza da mata daban.
Mata sun fi yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, kuma suna da babban hadarin kamuwa da cutar.
Hukumar Lafiya ta Duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar zai zama COVID-19.
Shugaban WHO Tedros Adhanom Ghebreyesus ya bayyana cewa yana magana ne game da ranar 31 ga Disamba, 2019, lokacin da aka fara gano cutar CO a cikin coronavirus, VI a cikin Virus, D a cikin cutar da 19 a cikin cutar.
Don hana zargi, an sanya sunaye bisa ga shawarwarin duniya ba tare da yin nuni da wuraren da aka danganta ba (misali, China), nau'in dabbobi, ko rukunin mutane. An sanya sunan cutar da ke haifar da COVID-19 mai tsanani mai saurin numfashi coronavirus 2 (SARS-CoV-2).
WHO ta kara amfani da kalmar "COVID-19 virus" da kuma "virus da ke haifar da COVID-19" a cikin hulɗar jama'a.
An kira cutar da kwayar cutar a matsayin cutar coronavirus.
A lokacin barkewar cutar a Wuhan, China, an kira wannan kwayar cutar da cutar a matsayin coronavirus da Wuhan coronavirus.
A watan Janairun 2020, WHO ta ba da shawarar cewa a matsayin sunayen tsaka-tsaki na cutar da cutar, 2019-nCov da 2019-nCoV suna da cutar numfashi mai tsanani, daidai da jagororin 2015 da suka saba da amfani da wuraren cutar da sunayen ƙwayoyin cuta.
An sanar da sunayen hukuma COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda iyakancewar iya aiki a hanyoyin rarraba kayayyaki na yau da kullun, wasu masana'antun dijital suna buga kayan kiwon lafiya kamar masu karanta hanci da masu numfashi.
A wani misali, lokacin da asibiti na Italiya ke bukatar bawul din numfashi, amma mai yinsa bai iya kawo shi a lokacin da ake bukata ba, sai karamin kamfanin da ke yankin ya mayar da martani, kuma yanzu ya samar da bawul din 100 da ake bukata cikin dare.
Tun bayan barkewar COVID-19, an samu tarin ka'idojin dabaru, labaran karya da kuma labaran karya game da asalin cutar, yaduwarta, rigakafinta, magani da sauran fannoni, kuma ya yadu cikin sauri a yanar gizo.
Mutane na iya yada cutar zuwa wasu dabbobi.
Binciken bai sami tabbacin yaduwar kwayar cutar a aladu, naman alade da kaji ba.
Babu wani magani ko rigakafi da aka amince da shi don magance cutar.
A cikin COVID-19, bincike na duniya kan alluran rigakafi da magunguna ana gudanar da shi ta hanyar hukumomin gwamnati, kungiyoyin masana da masu bincike na masana'antu.
A watan Maris, Hukumar Lafiya ta Duniya ta ƙaddamar da gwajin haɗin gwiwa don kimanta tasirin maganin ƙwayoyin cuta huɗu da ke da tasiri, waɗanda ake ganin sune mafi inganci.
Ko da yake ba a samu allurar rigakafi ba, hukumomi daban-daban suna gudanar da kamfen na rigakafi.
Dukansu SARS-CoV da SARS-CoV-2 suna amfani da mai karɓar ACE2 don shiga cikin ƙwayoyin ɗan adam, wanda ya yi amfani da ayyukan da aka riga aka yi don SARS-CoV.
Ana gudanar da gwajin dabarun rigakafi guda uku.
A farko dai, masu bincike suna kokarin samar da maganin rigakafin cutar.
Amfani da kwayar cutar da ba ta da aiki ko kuma ta mutu yana nufin saurin haifar da amsawar garkuwar jikin mutum ga sabon kamuwa da cutar COVID-19.
Manufar rigakafin da aka yi da kwayar cutar ta biyu, wato kwayar cutar, ita ce samar da rigakafin da zai karfafa garkuwar jikin mutum don ya yi yaki da wasu kwayar cutar.
A cikin masu kamuwa da cutar SARS-CoV-2, binciken ya mayar da hankali kan furotin S-spike wanda ke taimakawa cutar ta shiga cikin mai karɓar mai karɓar enzyme na ACE2.
Dabara ta uku ita ce maganin rigakafin nucleic acid (DNA ko RNA, sabuwar hanya ce ta gano rigakafi).
A ranar 16 ga watan Maris, 2020, an fara gwajin farko na rigakafin tare da masu ba da gudummawa guda hudu a Seattle.
A cikin allurar rigakafin akwai lambar kwayar halitta mai lafiya da aka karɓa daga kwayar cutar da ke haifar da cutar. An ba da shawarar haɓaka dogaro da ƙwayoyin cuta masu rigakafi a matsayin wata ƙalubale a cikin samar da allurar rigakafin SARS-COV-2, amma wannan yana da rikici.
A watan Afrilu na 2020, an samu fiye da gwaji 300 na asibiti.
Yawancin gwaje-gwajen sun bincika ingantattun hanyoyin magance zazzabin cizon sauro, gami da bincike huɗu kan hydroxychloroquine da chloroquine.
Rahoton da aka fitar a karshen watan Afrilu ya nuna cewa, kasashe da dama na cikin tara na gwajin mataki na uku kan ramdesivir, maganin da ke da niyyar sake amfani da kwayar cutar, wanda ya shafi yawancin binciken kasar Sin.
An fara ci gaba da nazarin ci gaban asibiti don allurar rigakafin COVID-19 da magani a watan Afrilu na 2020. Ana nazarin magungunan riga-kafi da yawa na yanzu don maganin COVID-19. Sun haɗa da ramdesivir, chloroquine, da hydroquine, lapinavar/ritonavar, da lapinavar/ritonavar, da kuma interferon beta.
Ana sa ran samun tabbaci kan tasirin Ramdeeva a watan Maris na 2020.
An samu ci gaba a cikin maganin a cikin marasa lafiya da aka yi wa maganin da ba a tabbatar da amfani da shi ba.
Ana gudanar da gwajin mataki na uku a Amurka, Italiya da China. An fara nazarin chloramphenic acid a China a watan Fabrairun 2020 wanda aka yi amfani da shi a baya don magance cutar zazzabin cizon sauro.
Amma akwai kira ga masu bincike su yi nazari kan batun.
Hukumomin kiwon lafiya na Koriya da China sun goyi bayan amfani da chloramphenicol.
Koyaya, shawarar yau da kullun shine gram ɗaya, amma Wuhan Virology Science ya lura cewa ninki biyu na wannan yana da haɗari sosai kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin amfani da maganin gaggawa na Hydroxychloroquine da chloroquine tare da amincewar likitoci da ke kula da mutanen da ke da COVID-19. A cikin jagororin na bakwai na kasar Sin, an kuma haɗa da maganin COVID-19 tare da Interferon, Ribberine ko Unifenoz.
Bayanai na farko sun nuna cewa ana buƙatar allurai masu yawa na maganin cutar don hana cutar SARS-CoV-2 a cikin gwajin.
An ba da shawarar nitrazoneid don ƙarin nazarin cikin jiki bayan nuna ƙarancin ƙarancin SARS-CoV-2. Cikakken ƙwayar ƙwayar cuta ta 2 (TMPRSS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar amsawa ga mai karɓar ACE2.
Nazarin da aka yi kan chlorine da hydroxychloroquine, ko sun ƙunshi azeramine ko a'a, suna da manyan ƙuntatawa waɗanda suka hana ci gaba da nazarin jama'ar likita. Ba a san ko wace rawa ce Okseltimber ke takawa a cikin maganin COVID-19 ba tare da hana SARS-CoV-2 daga waje ba.
A cikin matakan COVID-19 na ƙarshe, ana iya samun abin da ake kira martani na jiki wanda ake kira cytokine stoma.
Akwai tabbacin cewa hydrochloroquine na iya samun kaddarorin anti-cytokine. Bayan wani karamin bincike, Hukumar Lafiya ta Kasa ta China ta kara tossilizumab a cikin jagororin magani.
An gudanar da gwajin matakin 2 na cutar a Italiya bayan da aka gano cewa mutane da ke da cutar sun kamu da cutar.
An hada shi da gwajin jini na plasma pheratin don gano rashin karfin cytokine (lambar cutar da ke haifar da halayen halayen) kuma ana nufin magance ci gaban da ake tsammani shine dalilin mutuwa ga wasu mutanen da ke fama da cutar.
A cikin 2017, FDA ta amince da maganin anti-interleukin-6 mai karɓar magani bisa la'akari da nazarin yanayin da aka sake dubawa don maganin cututtukan da ke haifar da cututtukan cytokine da ba a daidaita ba, wanda ke haifar da dalilai daban-daban, da kuma maganin kwayoyin CAR T.
Ya zuwa yanzu, babu wata hujja da aka sarrafa ta hanyar bazuwar cewa tosilezumeb magani ne mai tasiri ga CRS.
Ana binciken yadda za a iya samar da kwayoyin cuta masu tsabta da aka tsabtace da tsarin rigakafin mutanen da suka warke daga COVID-19 kuma a tura su ga mutanen da suke buƙatar su a matsayin hanyar samar da rigakafi ta atomatik ba tare da allurar rigakafi ba.
An gwada wannan dabarar ne a SARS, kuma sakamakon ba shi da tabbas.
Rage tasirin kwayar cutar wani abu ne da ake tsammanin zai faru, saboda maganin rigakafin cutar na iya zama hanyar sadarwa a cikin yaƙi da SARS-CoV-2.
Koyaya, wasu hanyoyi na iya zama, ƙwayoyin cuta masu dogara da rigakafi da / ko phagocytes.
Sauran hanyoyin maganin rigakafin kai tsaye, kamar su amfani da ƙwayoyin cuta na monoclonal da aka ƙera, ana ci gaba da gwadawa.
Samfurin jini na nanotram wanda ke dauke da takamaiman kwayoyin cutar, wanda shine wani bangare na jini na marasa lafiya masu murmurewa, zai karu don saurin amfani da shi.
Cutar kwayar cuta, wani rukunin cututtuka da ke da alaƙa da juna
Li Wenliang, likita a asibitin Wuhan wanda ya kamu da cutar COVID-19 kuma ya mutu bayan ya kara wayar da kan jama'a game da cutar.
